<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML>
<HEAD>
<!-- Created by: EDGAR Online, Inc. EDGAR Filing HTML Converter, Version: 4.63, http://www.edgar-online.com -->
<TITLE> Sensus Healthcare, Inc. (Form: S-1/A, Received: 05/19/2016 16:57:20) </TITLE>
<META NAME="TABLES" CONTENT="FIS_FORM **FIS_REGISTRATION_FEE **FIS_TABLE_OF_CONTENTS **FIS_PROSPECTUS_SUMMARY **FIS_RISK_FACTORS **FIS_THE_OFFERING **FIS_RISK_FACTORS_2 **FIS_FORWARD_LOOK **FIS_PROCEED_USE **FIS_DIVIDEND_POLICY **FIS_CAPITALIZATION **FIS_DILUTION **FIS_BENEFICIAL_OWNERS **FIS_MANAGEMENTS_DISCUSSION **FIS_BUSINESS **FIS_COMPETITION **FIS_EMPLOYEES **FIS_MANAGEMENT **FIS_NAME_AND_TITLE **FIS_EXECUTIVE_COMPENSATION **FIS_COMPENSATION_TABLE **FIS_STOCKHOLDERS **FIS_BENEFICIAL_OWNERS_2 **FIS_CERTAIN_TRANSACTIONS **FIS_SECURITIES_DESCRIPTION **FIS_FUTURE_SALE **FIS_TAXATION **FIS_UNDERWRITING **FIS_LEGAL_MATTERS **FIS_EXPERTS **FIS_MORE_INFORMATION **FIS_AUDITORS_OPINION **FIS_BALANCE_SHEET **FIS_INCOME_STATEMENT **FIS_STOCKHOLDERS_EQUITY **FIS_CASH_FLOW **FIS_NOTES_TO_FINANCIAL_STATEMENT **FIS_OFFERING_EXPENSE **FIS_INDEMNIFICATION **FIS_SALE_OF_UNREGISTERED_SECURITIES **FIS_EXHIBITS **FIS_UNDERTAKINGS **FIS_SIGNATURES **FIS_EXHIBIT_INDEX FIS_EXHIBIT_1 **FIS_BUSINESS_2 FIS_EXHIBIT_4 FIS_EXHIBIT_4_2 FIS_EXHIBIT_5 FIS_EXHIBIT_23 **FIS_EXPERTS_CONSENT ">
<META NAME="DETECTED PAGES" CONTENT="206">
<STYLE TYPE="text/css">
<!--
	body          { background-color: white; color: black }
	.eolNewPage   { page-break-after: always; line-height: 0; height: 0; margin: 0; padding: 0 }
	.eolLeftAlign { text-align: left; margin-left: auto; margin-right: auto }
	.eolCenter    { text-align: center }
	a:link        { color: blue }
	a:active      { color: red }
	a:visited     { color: purple }
	
	@media print
	{
		@page           { margin: 0.25in }
		body            { font-size: 10pt }
		a               { text-decoration: none }
		thead           { display: table-header-group }
		tfoot           { display: table-footer-group }
		hr.eolPageBreak { display: none }
		.eolPrint50pt   { font-size: 5pt }
		.eolPrint55pt   { font-size: 5.5pt }
		.eolPrint60pt   { font-size: 6pt }
		.eolPrint65pt   { font-size: 6.5pt }
		.eolPrint70pt   { font-size: 7pt }
		.eolPrint75pt   { font-size: 7.5pt }
		.eolPrint80pt   { font-size: 8pt }
		.eolPrint85pt   { font-size: 8.5pt }
		.eolPrint90pt   { font-size: 9pt }
		.eolPrint95pt   { font-size: 9.5pt }
	}
-->
</STYLE>
</HEAD>
<BODY>
<A NAME="eolPage1"></A>
<A NAME="FIS_TOP_OF_DOCUMENT"></A>

<A NAME="V440371_S1A_HTM"></A>
<EFX_FORM>
<A NAME="FIS_FORM"></A>
<DIV STYLE="TEXT-ALIGN: CENTER; MIN-WIDTH: 708">
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
	As filed with the Securities and Exchange Commission on May 19, 2016.
</B>
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: RIGHT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Registration No. 333-209451
</H2>
<DIV STYLE="WIDTH: 100%; DISPLAY: INLINE-BLOCK; *DISPLAY:INLINE; VERTICAL-ALIGN: MIDDLE; BORDER-TOP: 4PT BLACK DOUBLE">
	&nbsp;
</DIV>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	UNITED STATES
<BR>
	SECURITIES AND EXCHANGE COMMISSION
<BR>
	Washington, D.C. 20549
</FONT>
</H1>
<DIV ALIGN="CENTER">
<BR>
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_LINE.GIF" ALIGN="MIDDLE" STYLE="WIDTH: 180PX; HEIGHT: 1PT; TEXT-ALIGN: CENTER">
<BR>
	&nbsp;
</DIV>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	AMENDMENT NO. 4 TO
<BR>
	FORM S-1
<BR>
	REGISTRATION STATEMENT
<BR>
<B>
<I>
	UNDER
<BR>
	THE SECURITIES ACT OF 1933
</I>
</B>
</FONT>
</H1>
<DIV ALIGN="CENTER">
<BR>
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_LINE.GIF" ALIGN="MIDDLE" STYLE="WIDTH: 180PX; HEIGHT: 1PT; TEXT-ALIGN: CENTER">
<BR>
	&nbsp;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 18PT; LINE-HEIGHT: 20PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Sensus Healthcare, Inc.
</H1>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; LINE-HEIGHT: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	(Exact name of Registrant as specified in its charter)
</P>
<DIV ALIGN="CENTER">
<BR>
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_LINE.GIF" ALIGN="MIDDLE" STYLE="WIDTH: 180PX; HEIGHT: 1PT; TEXT-ALIGN: CENTER">
<BR>
	&nbsp;
</DIV>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="708" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="237">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="229">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="237">
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: CENTER">
<TD STYLE="LINE-HEIGHT: 12PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 10PT; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	Delaware
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: 12PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 10PT; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	3841
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: 12PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 10PT; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	27-1647271
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: CENTER">
<TD STYLE="PADDING-LEFT: 0PT; TEXT-INDENT: 0PT; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	(State or other jurisdiction of
<BR>
	incorporation or organization)
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: CENTER">
<B>
	(Primary Standard Industrial
<BR>
	Classification Code Number)
</B>
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: CENTER">
<B>
	(I.R.S. Employer
<BR>
	Identification Number)
</B>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	851 Broken Sound Pkwy. NW #215
<BR>
	Boca Raton, Florida 33487
<BR>
	(561) 922-5808
</FONT>
</H1>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; LINE-HEIGHT: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
	(Address, including zip code, and telephone number, including area code, of Registrant&#146;s principal executive offices)
</B>
</P>
<DIV ALIGN="CENTER">
<BR>
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_LINE.GIF" ALIGN="MIDDLE" STYLE="WIDTH: 180PX; HEIGHT: 1PT; TEXT-ALIGN: CENTER">
<BR>
	&nbsp;
</DIV>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Joseph C. Sardano
<BR>
	President and Chief Executive Officer
<BR>
	Sensus Healthcare, Inc.
<BR>
	851 Broken Sound Pkwy. NW #215
<BR>
	Boca Raton, Florida 33487
<BR>
	(561) 922-5808
</FONT>
</H1>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; LINE-HEIGHT: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
	(Name, address, including zip code, and telephone number, including area code, of agent for service)
</B>
</P>
<DIV ALIGN="CENTER">
<BR>
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_LINE.GIF" ALIGN="MIDDLE" STYLE="WIDTH: 180PX; HEIGHT: 1PT; TEXT-ALIGN: CENTER">
<BR>
	&nbsp;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_2"></A>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	with copies to:
</I>
</B>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="708" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="237">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="229">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="237">
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	David C. Scileppi, Esq.
<BR>
	Robert B. Lamm, Esq.
<BR>
	Gustav L. Schmidt, Esq.
<BR>
	Gunster, Yoakley &amp; Stewart, P.A.
<BR>
	450 E. Las Olas Blvd., Suite 1400
<BR>
	Fort Lauderdale, Florida 33301
<BR>
	(954) 462-2000
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: CENTER">
<B>
	Arthur Levine
<BR>
	Chief Financial Officer
<BR>
	Sensus Healthcare, Inc.
<BR>
	851 Broken Sound Pkwy. NW #215
<BR>
	Boca Raton, Florida 33487
<BR>
	(561) 922-5808
</B>
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: CENTER">
<B>
	Ivan Blumenthal, Esq.
<BR>
	Merav Gershtenman, Esq.
<BR>
	Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
<BR>
	666 Third Avenue
<BR>
	New York, New York 10017
<BR>
	(212) 935-3000
</B>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV ALIGN="CENTER">
<BR>
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_LINE.GIF" ALIGN="MIDDLE" STYLE="WIDTH: 180PX; HEIGHT: 1PT; TEXT-ALIGN: CENTER">
<BR>
	&nbsp;
</DIV>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
	Approximate date of commencement of proposed sale to the public:
</B>
	As soon as practicable after this Registration Statement becomes effective.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box:
<FONT STYLE="FONT-FAMILY: WINGDINGS">
	o
</FONT>
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.
<FONT STYLE="FONT-FAMILY: WINGDINGS">
	o
</FONT>
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.
<FONT STYLE="FONT-FAMILY: WINGDINGS">
	o
</FONT>
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.
<FONT STYLE="FONT-FAMILY: WINGDINGS">
	o
</FONT>
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of &#147;large accelerated filer&#148;, &#147;accelerated filer&#148; and &#147;smaller reporting company&#148; in Rule 12b-2 of the Exchange Act.:
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_3"></A>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="682" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="408">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="258">
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT" ROWSPAN=1 COLSPAN=1>
	Large accelerated filer
<FONT STYLE="FONT-FAMILY: WINGDINGS">
	o
</FONT>
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Accelerated filer
<FONT STYLE="FONT-FAMILY: WINGDINGS">
	o
</FONT>
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT" ROWSPAN=1 COLSPAN=1>
	Non-accelerated filer
<FONT STYLE="FONT-FAMILY: WINGDINGS">
	o
</FONT>
	(do not check if a smaller reporting company)
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Smaller reporting company
<FONT STYLE="FONT-FAMILY: WINGDINGS">
	x
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="WIDTH: 100%; DISPLAY: INLINE-BLOCK; *DISPLAY:INLINE; VERTICAL-ALIGN: MIDDLE; BORDER-TOP: 4PT BLACK DOUBLE">
	&nbsp;
</DIV>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	&nbsp;
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
</EFX_UNIDENTIFIED_TABLE>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage2"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<EFX_REGISTRATION_FEE>
<A NAME="FIS_REGISTRATION_FEE"></A>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_4"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	CALCULATION OF REGISTRATION FEE
</FONT>
</H1>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="424">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="72">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="80">
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	Title of Each Class of
<BR>
	Securities to be Registered
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Proposed
<BR>
	Maximum
<BR>
	Aggregate
<BR>
	Offering
<BR>
	Price
<SUP>
	&#040;1&#041;
</SUP>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Amount of
<BR>
	Registration
<BR>
	Fee
<SUP>
	&#040;2&#041;
</SUP>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Units, each consisting of one share of common stock, $0.01 par value per share, and a warrant to purchase one of a share of common stock
<SUP>
	&#040;3&#041;
</SUP>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	12,578,125
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,267
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Common stock included in the units
<SUP>
	&#040;4&#041;
</SUP>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Warrants to purchase common stock included in the units
<SUP>
	&#040;4&#041;
</SUP>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Common stock underlying the warrants included in the units
<SUP>
	&#040;3&#041;
</SUP>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	15,697,500
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,581
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Representatives&#146; warrant to purchase units
<SUP>
	&#040;4&#041;
</SUP>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	941,850
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	95
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Common stock included in the Representatives&#146; warrants to purchase units
<SUP>
	&#040;4&#041;
</SUP>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Warrants to purchase common stock included in the Representatives&#146; warrants
<SUP>
	&#040;4&#041;
</SUP>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Common stock underlying the warrants to purchase common stock included in the Representatives&#146; warrants
<SUP>
	&#040;5&#041;
</SUP>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	941,850
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	95
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Total
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	30,159,325
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	3,038
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<SUP>
	&#040;6&#041;
</SUP>
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 1PX">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_LINE.GIF" STYLE="WIDTH: 72PX; HEIGHT: 1PT">
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 1PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	(1)
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended. Includes offering price of units that the underwriters have the option to purchase to cover over-allotments, if any.
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 1PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	(2)
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Calculated pursuant to Rule 457(o) under the Securities Act based on an estimate of the proposed maximum aggregate offering price.
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 1PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	(3)
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(i) under the Securities Act. The warrants are exercisable at a per share exercise price equal to $7.80 per share.
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 1PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	(4)
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	No registration fee is required pursuant to Rule 457(g) under the Securities Act.
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 1PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	(5)
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(i) under the Securities Act. The Representatives&#146; warrants are exercisable at a per unit exercise price equal to $7.80 per unit.
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 1PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	(6)
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Previously paid.
</TD>
</TR>
</TABLE>
<DIV ALIGN="CENTER">
<BR>
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_LINE.GIF" ALIGN="MIDDLE" STYLE="WIDTH: 180PX; HEIGHT: 1PT; TEXT-ALIGN: CENTER">
<BR>
	&nbsp;
</DIV>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
	The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the Registration Statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.
</B>
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage3"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT COLOR="RED">
	The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any state or jurisdiction where the offer or sale is not permitted.
</FONT>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_5"></A>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="657" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 11PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="211">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="203">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="211">
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
<FONT COLOR="RED">
	PRELIMINARY PROSPECTUS
</FONT>
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: CENTER">
<B>
<FONT COLOR="RED">
	SUBJECT TO COMPLETION
</FONT>
</B>
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: RIGHT">
<B>
<FONT COLOR="RED">
	DATED MAY 19, 2016
</B>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_LINE.GIF" STYLE="WIDTH: 100%; HEIGHT: 1PT">
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="657" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 16PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="392">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="249">
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="PADDING-LEFT: 0PT; TEXT-INDENT: -0PT" ROWSPAN=1 COLSPAN=1>
<B>
	1,750,000 Units
</FONT>
</B>
<BR>
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=3>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=3 COLSPAN=1 STYLE="TEXT-ALIGN: CENTER">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_LOGO_SENSUS.JPG" WIDTH="236" ALIGN="MIDDLE" ALT="[GRAPHIC MISSING]">
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT" ROWSPAN=1 COLSPAN=1>
<B>
	&nbsp;&nbsp;
</B>
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT" ROWSPAN=1 COLSPAN=1>
<B>
	Sensus Healthcare, Inc.
</B>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_LINE.GIF" STYLE="WIDTH: 100%; HEIGHT: 1PT">
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	This is a firm commitment initial public offering of units consisting of one share of common stock of Sensus Healthcare, Inc. and a three-year warrant to purchase one share of common stock at an initial exercise price of $7.80 per share. No public market currently exists for our securities. We anticipate that the initial public offering price of our units will be $6.25 per unit.
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We have been approved to list our shares of common stock for trading on the Nasdaq Capital Market under the symbol &#147;SRTS.&#148; We have applied to list our units and warrants on the Nasdaq Capital Market under the symbols &#147;SRTSU&#148; and &#147;SRTSW,&#148; respectively. We are an &#147;emerging growth company&#148; as defined in the Jumpstart Our Business Startups Act of 2012 and, as such, we have elected to comply with certain reduced public company reporting requirements for this prospectus and future filings.
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The shares of our common stock and the warrants to purchase shares of common stock will trade together as units only during the first 52 days following the date of this prospectus, and thereafter, the units will automatically separate and the common stock and warrants will trade separately, unless Northland Securities, Inc. and Neidiger, Tucker, Bruner, Inc., as representatives of the underwriters, determine that an earlier separation date is acceptable.
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
	Investing in our securities involves a high degree of risk. See &#147;Risk Factors&#148; beginning on page
<A HREF="#V440371_S1A_HTM_T1RF">
	14
</A>
	of this prospectus for a discussion of information that should be considered in connection with an investment in our securities.
</B>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
	Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
</B>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_6"></A>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="657" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="481">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="72">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="72">
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
<FONT STYLE="FONT-SIZE: 9PT">
	Per Unit
</FONT>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
<FONT STYLE="FONT-SIZE: 9PT">
	Total
</FONT>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Public offering price
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Underwriting discounts and commissions
<SUP>
	&#040;1&#041;
</SUP>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Proceeds to Sensus Healthcare, Inc., before expenses
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 1PX">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_LINE.GIF" STYLE="WIDTH: 72PX; HEIGHT: 1PT">
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 1PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	(1)
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	See &#147;Underwriting&#148; on page 103 for a description of additional compensation payable to the underwriters.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We have granted a 45-day option to the underwriters to purchase up to 262,500 additional units solely to cover over-allotments, if any, at a price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per unit, less the underwriting discount, provided that in no event may exercise of this option occur after separation of the units occurs.
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_7"></A>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The underwriters expect to deliver our units to purchasers in the offering on or about &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016.
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<I>
	Joint Book-Running Managers
</I>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="657" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 16PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="320">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="320">
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Northland Capital Markets
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: CENTER">
<B>
	Neidiger, Tucker, Bruner, Inc.
</B>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The date of this prospectus is &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;, 2016
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage4"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	&nbsp;&nbsp;
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_LOGO_SENSUS.JPG" WIDTH="236" ALIGN="MIDDLE" ALT="[GRAPHIC MISSING]">
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_V427757_IMG1.JPG" WIDTH="602" ALIGN="MIDDLE" ALT="[GRAPHIC MISSING]">
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<DIV STYLE="MARGIN-TOP: 1PX; MARGIN-BOTTOM: 1PX; WIDTH: 48%; DISPLAY: INLINE-BLOCK; *DISPLAY:INLINE; VERTICAL-ALIGN: TOP">
	The
<B>
	SRT-100
</B>
<SUP>
	TM
</SUP>
	and
<B>
	SRT-100 Vision
</B>
<SUP>
	TM
</SUP>
	products are photon x-ray low energy superficial radiotherapy systems that provide patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell carcinoma.
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We have received 510(k) marketing clearance from the FDA, European CE marking certification, CFDA (the Chinese FDA equivalent) and Health Canada approval, and recently received regulatory clearance for Russia. Our SRT-100 system is currently installed in over 220 locations across 12 different countries.
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_V427757_IMG2.JPG" WIDTH="288" ALIGN="MIDDLE" ALT="[GRAPHIC MISSING]">
</P>
</DIV>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage5"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
</EFX_REGISTRATION_FEE>
<EFX_TABLE_OF_CONTENTS>
<A NAME="FIS_TABLE_OF_CONTENTS"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<A NAME="V440371_S1A_HTM_TOC">
</A>
	TABLE OF CONTENTS
</FONT>
</H1>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_8"></A>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="552">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="40">
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_TPS">
	PROSPECTUS SUMMARY
</A>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_TPS">
	1
</A>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T1RF">
	RISK FACTORS
</A>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T1RF">
	14
</A>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T2LI">
	CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION
</A>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T2LI">
	38
</A>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T3UOP">
	USE OF PROCEEDS
</A>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T3UOP">
	40
</A>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T4DP">
	DIVIDEND POLICY
</A>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T4DP">
	41
</A>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T5CC">
	CORPORATE CONVERSION
</A>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T5CC">
	42
</A>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T6CA">
	CAPITALIZATION
</A>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T6CA">
	44
</A>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T7DI">
	DILUTION
</A>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T7DI">
	45
</A>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T8MDA">
	MANAGEMENT&#146;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
</A>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T8MDA">
	47
</A>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T9BU">
	BUSINESS
</A>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T9BU">
	56
</A>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T10M">
	MANAGEMENT
</A>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T10M">
	76
</A>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T11EAM">
	EXECUTIVE AND DIRECTOR COMPENSATION
</A>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T11EAM">
	81
</A>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T12PS">
	PRINCIPAL STOCKHOLDERS
</A>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T12PS">
	90
</A>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T13CRA">
	CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
</A>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T13CRA">
	92
</A>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T14DOC">
	DESCRIPTION OF SECURITIES
</A>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T14DOC">
	95
</A>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T15SEF">
	SHARES ELIGIBLE FOR FUTURE SALE
</A>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T15SEF">
	99
</A>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T16SF">
	MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS
</A>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T16SF">
	100
</A>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T17U">
	UNDERWRITING
</A>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T17U">
	104
</A>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T18LM">
	LEGAL MATTERS
</A>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T18LM">
	113
</A>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T19EX">
	EXPERTS
</A>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T19EX">
	113
</A>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T20WYC">
	WHERE YOU CAN FIND MORE INFORMATION
</A>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T20WYC">
	113
</A>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T21FSO">
	FINANCIAL STATEMENTS OF SENSUS HEALTHCARE, INC.
</A>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_T21FSO">
	F-1
</A>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Neither we nor the underwriters have authorized anyone to provide you with any information other than that contained in this prospectus, any amendment or supplement to this prospectus or in any free writing prospectus we may authorize to be delivered or made available to you. The underwriters and we take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. We are offering to sell securities and seeking offers to buy securities only in jurisdictions where offers and sales are permitted. The information in this prospectus is complete and accurate only as of
	the date on the front cover of this prospectus, regardless of the time of delivery of this prospectus or any sale of securities.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
	For investors outside the United States:
</B>
	&nbsp;&nbsp;We have not, and the underwriters have not, done anything that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the U.S. Persons outside the U.S. who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of the securities and the distribution of this prospectus outside the U.S.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	i
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage6"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	MARKET DATA AND FORECASTS
</FONT>
</H1>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Unless otherwise indicated, information in this prospectus concerning economic conditions, our industry, our markets and our competitive position is based on a variety of sources, including information from independent industry analysts and publications, as well as our own estimates and research. Our estimates are derived from industry and general publications, studies and surveys conducted by third-parties, as well as data from our own internal research. Industry publications, studies and surveys generally state that they have been obtained from sources believed to be reliable.
</P>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	FINANCIAL STATEMENT PRESENTATION
</FONT>
</H1>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The financial statements as of December 31, 2014 and 2015, and for the years ended December 31, 2013, 2014 and 2015, and for the three months ended March 31, 2015, are those of Sensus Healthcare, LLC. Financial information related to the fiscal years ended December 31, 2011 and 2012 presented in this prospectus has been derived from the unaudited and audited financial statements, respectively, of Sensus Healthcare, LLC for such periods not included in this prospectus. On January 1, 2016, we completed a corporate conversion pursuant to which Sensus Healthcare, Inc. succeeded to the business of Sensus Healthcare, LLC, and the
	unit holders of Sensus Healthcare, LLC became stockholders of Sensus Healthcare, Inc., as described under the heading &#147;Corporate Conversion.&#148; In this prospectus, we refer to this transaction as the &#147;corporate conversion.&#148; The corporate conversion has been reflected retroactively for all periods presented. Effective January 1, 2016, we are subject to corporate income taxes.
</P>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	TRADEMARKS AND TRADENAMES
</FONT>
</H1>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	This prospectus includes our trademarks such as SRT-100
<SUP>
	TM
</SUP>
	, SRT-100 Vision
<SUP>
	TM
</SUP>
	, SRT-100 Lynx
<SUP>
	TM
</SUP>
	, SRT University
<SUP>
	TM
</SUP>
	, and Sentinel
<SUP>
	TM
</SUP>
	which are each protected under applicable intellectual property laws and are the property of Sensus Healthcare, Inc. Solely for convenience, trademarks, service marks and tradenames referred to in this prospectus may appear without the &reg;,
<SUP>
	TM
</SUP>
	or
<SUP>
	SM
</SUP>
	symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or the right of the
	applicable licensor to these trademarks, service marks and tradenames. This prospectus may also contain trademarks, service marks, tradenames and copyrights of other companies, which are the property of their respective owners.
</P>
</EFX_TABLE_OF_CONTENTS>
<EFX_PROSPECTUS_SUMMARY>
<A NAME="FIS_PROSPECTUS_SUMMARY"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	ABOUT THIS PROSPECTUS
</FONT>
</H1>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Except where the context otherwise requires or where otherwise indicated, the terms &#147;Sensus,&#148; &#147;Sensus Healthcare,&#148; &#147;we,&#148; &#147;us,&#148; &#147;our,&#148; &#147;our company&#148; and &#147;our business&#148; refer to Sensus Healthcare, Inc.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	ii
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage7"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT BLACK SOLID; BORDER-BOTTOM: 1PT BLACK SOLID; BORDER-RIGHT: 1PT BLACK SOLID; BORDER-LEFT: 1PT BLACK SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<A NAME="V440371_S1A_HTM_TPS">
</A>
	PROSPECTUS SUMMARY
</FONT>
</H1>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<I>
	This summary highlights certain information about us and this offering contained elsewhere in this prospectus. Because it is only a summary, it does not contain all the information that you should consider before investing in our securities and it is qualified in its entirety by, and should be read in conjunction with, the more detailed information appearing elsewhere in this prospectus. Before you decide to invest in our securities, you should read the entire prospectus carefully, including &#147;Risk Factors&#148; beginning on page
<A HREF="#V440371_S1A_HTM_T1RF">
	14
</A>
	and our financial statements and the accompanying notes included in
	this prospectus.
</I>
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Company Overview
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We are a medical device company, headquartered in Boca Raton, Florida, specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy. Superficial radiation therapy is based on a technology with decades of successful clinical use treating various benign and malignant skin conditions. Prior to the introduction of Mohs surgery and linear accelerators in the late 1960s and early 1970s, the predecessor of superficial radiation therapy, orthovoltage, was the standard of care in treating several skin conditions, including skin cancer. When Mohs surgery was
	developed and linear accelerators, or LINACS, were introduced to treat cancer, the manufacturers of the orthovoltage devices abandoned manufacturing these products believing that Mohs surgery and linear accelerators would ultimately become the standard of care in treating skin cancer. We believe that orthovoltage device manufacturers may have perceived these newer procedures and technology as being superior to orthovoltage for a number of reasons, including (i) the fact that Mohs surgery did not require significant capital investment, other than specialized medical training, (ii) that higher-powered LINACS offered the ability to treat a wider variety of conditions because of its deeper x-ray penetration, and (iii) the perceived impracticalities of orthovoltage machines due to their large size. As a result, the orthovoltage technology became largely dormant.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Recently, healthcare providers are recognizing the benefits of superficial radiation therapy and there is a resurgence of this technology. Based on a retrospective analysis published in
<I>
	the Journal of the American Academy of Dermatology
</I>
	in 2012, recurrence rates for all tumors at two and five years were 1.9% and 5.0%, respectively, for cases of cutaneous basal cell carcinoma and squamous cell carcinoma treated with superficial radiation therapy, matching the recurrence rates for Mohs surgery. We believe this study illustrates the effectiveness of superficial radiation therapy in the treatment of non-melanoma skin
	cancer. Superficial radiation therapy is also an effective treatment modality for keloids, which are firm, rubbery lesions or shiny, fibrous nodules, that can vary from pink to the color of the patient&#146;s flesh or red to dark brown in color, in conjunction with surgical removal. One recent study has indicated that surgical excision combined with platelet rich plasma and post-operative in-office superficial radiation therapy can achieve a non-recurrence rate of 100% at the fourth to eleventh month follow-up. No other treatment modality known to us leads to a greater non-recurrence rate.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We believe that modern superficial radiation therapy technology has improved over its orthovoltage predecessor. With modern technology, such as that found in the SRT-100, an equipment system manufactured by us, there is very low radiation scatter, which is significantly below the threshold defined by the American Association of Physicists in Medicine and the Conference of Radiation Control Program Directors, Inc. Our technologies preserve healthy tissue while attacking only the cancer cells because, unlike LINACS, the SRT-100 uses low energy photon x-rays, which are only capable of penetrating skin up to approximately five
	millimeters. Further, while orthovoltage devices were very large (requiring a dedicated room), the SRT-100 is a mobile unit with a 30" x 30" footprint. Additionally, with a shift in the demographics of skin cancer patients due to an aging population, we believe superficial radiation therapy offers certain benefits that may not have been relevant decades ago when skin cancer patients were generally younger. For example, patients with certain health conditions or who have been prescribed certain medications may not be good candidates for surgical procedures, such as Mohs surgery, due to the additional health risks these procedures present.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Although Mohs surgery, a procedure involving the progressive removal of microscopic layers of cancer-containing skin until all cancer cells are removed, is one of the leading methods to treat non-melanoma skin cancer, there are significant downsides to this procedure. For example, patients often experience pain following the procedure. In addition to the inconvenience and pain involved with undergoing Mohs surgery, there are several other potential unpleasant aspects that may affect the surgical area, such as temporary or
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	1
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage8"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT BLACK SOLID; BORDER-BOTTOM: 1PT BLACK SOLID; BORDER-RIGHT: 1PT BLACK SOLID; BORDER-LEFT: 1PT BLACK SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	permanent numbness, temporary or permanent weakness, itching, enlarged scarring, and other post-surgical complications. Superficial radiation therapy treatments typically take less than one minute per treatment, and therapy requires multiple visits. Often, patients undergoing superficial radiation therapy treatment will need three to four treatments per week for up to four consecutive weeks to achieve the desired results. Additionally, superficial radiation therapy is typically limited to the treatment of surface-based skin cancers because of the limited penetrating ability of the radiation used. Therefore, while safe and
	effective for many skin cancers, superficial radiation therapy typically is ineffective in treating skin cancer in advanced stages.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We believe that our products provide patients with a safe and virtually pain-free alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell carcinoma, and other skin conditions, including keloids. Our products also allow dermatologists to retain non-melanoma skin cancer patients, rather than referring them to other specialists, while offering radiation oncologists an alternative to costly linear accelerator-based treatments with a process that is less invasive, more time-efficient, and which improves practice economics.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We offer the SRT-100 product family, which we anticipate will be complemented by additional models and options in the future. With over 220 installations in 12 countries, we believe our SRT-100 product family to be a global leader in the superficial radiation therapy space.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We own two patents in the U.S. (U.S. Patent Nos. 7372940 and 7263170) related to the SRT-100 system and a third patent application pending in the U.S., China and Russia. We have also submitted two provisional patent applications and are in the process of preparing several other provisional patent applications. We have received 510(k) marketing clearance from the U.S. Food and Drug Administration, or FDA, European CE marking certification, CFDA (the Chinese equivalent of the FDA), and Health Canada approval. We also received regulatory clearance for Russia in the fourth quarter of 2015. These governmental clearances and
	approvals are required to market and sell medical devices to customers located in the countries or areas covered by these agencies. We are currently marketing our SRT-100 in both the U.S. and abroad to private dermatology practices and private and hospital-based radiation oncology practices. We have been active in bringing this system to the global marketplace since the fourth quarter of 2010 and have a growing distribution network to sell the SRT-100 to healthcare providers in the U.S. and internationally.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Market Opportunity
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	According to the Skin Cancer Foundation, over the past three decades, more people have had skin cancer than all other forms of cancer combined. In fact, according to the U.S. Surgeon General, over the last three decades, the number of people experiencing skin cancer has grown at a higher rate than that of all other cancers combined, with approximately five million new skin cancer cases are diagnosed annually in the U.S., with an estimated annual treatment cost of over $8 billion. Skin cancer categories include melanoma, basal or squamous cell carcinomas (i.e., non-melanoma skin cancer), mycosis fungoides, Kaposi&#146;s
	sarcoma, Paget&#146;s disease and apocrine carcinoma. According to the U.S. Cancer Statistics Working Group, the annual death rate from skin cancer in the U.S. exceeds 9,000. According to the Skin Cancer Foundation, one out of five Americans is at risk for developing some form of skin cancer during their lifetime. Increased exposure to the sun without skin protection, a decreasing natural ozone layer, and the increase in the aging population demographic are often cited as the chief causes of this increase. Furthermore, MD Anderson Cancer Institute estimates that approximately half of all Americans will have skin cancer at least once by the time they are 65. The primary treatment options, each of which provides high non-recurrence rates and low recurrence, include surgery and less invasive superficial radiation therapy.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	As a result of the anticipated growth in both skin cancer incidence and treatment costs, we believe that we are well positioned to provide treatment options that are mutually beneficial to healthcare providers and patients. Because the SRT-100 is uniquely capable of effectively treating skin cancers located in the sensitive head and neck regions, where over 80% of skin cancers occur, we anticipate a growing demand in the healthcare market for our product line.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In addition to the skin cancer market, we believe there is a significant market for our products in the treatment of other skin conditions, such as keloids. We estimate that the incidence rates of keloids to be three to four times greater than non-melanoma skin cancer, and expect this market will continue to grow as the
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	2
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage9"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT BLACK SOLID; BORDER-BOTTOM: 1PT BLACK SOLID; BORDER-RIGHT: 1PT BLACK SOLID; BORDER-LEFT: 1PT BLACK SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	population increases. In addition to keloids, we are exploring the use of superficial radiation therapy for other indications, including psoriasis, eczema, and systemic scleroderma.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Our Products and Services
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The SRT-100 is a mobile superficial radiation therapy system designed primarily for the non-invasive treatment of non-melanoma skin cancer. We believe the SRT-100 provides a cost-effective alternative to surgery and high dose radiation therapy. It is also an effective treatment modality for keloids, in conjunction with surgical removal. The SRT-100 provides photon x-ray low energy radiation therapy to treat patients through a safe, virtually painless, and substantially non-scarring treatment that is particularly useful for the treatment of non-melanoma skin cancer and keloids occurring on the head and neck regions, which are
	generally more delicate areas that can be difficult to treat otherwise. We believe that the SRT-100 enhances practice economics by allowing dermatologists to retain non-melanoma skin cancer patients, rather than refer them to other specialists for treatment. Moreover, the SRT-100 can provide radiation oncologists with an efficient, less costly and minimally invasive alternative to linear accelerator&#150;based treatments, thereby improving the patient experience and practice economics.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The innovative SRT-100 system is designed for effectiveness and ease of use. The current features include specific x-ray and automatic filtering technique factors for accurate skin cancer treatment, visual verification of the treated area, a compact design for device mobility, connectivity to digital systems, reduced space requirements, and integrated safety controls for both the patient and the clinician. In addition to the SRT-100, we also offer the SRT-100 Vision and SRT-100 Lynx models. The SRT-100 Vision provides users with a unique superficial radiation therapy-tailored treatment planning application that integrates an
	embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning and comprehensive dosimetry parameters that allows for more accurate and precise treatment and which enhances patient outcomes and workflow efficiency. The SRT-100 Lynx incorporates hardware and software enhancements that allow for integration of the SRT-100 system with electronic medical records and similar systems.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We plan to continue conducting research and development for product line expansions to address a broader and more diversified market and to provide additional solutions to the existing and future customer base. We anticipate that the next generation of the SRT-100 will be a more modular platform that will include some of the technologies developed for the SRT-100 Vision, and at the same time, can be competitively configured to compete in other global value markets.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We anticipate that we will continue developing our technology with the goal of optimizing workflow for users and positively impacting patients&#146; quality of life and outcomes. We believe our focus will allow us to provide advanced and seamless data portability in enterprise and cloud environments to make data readily available and interchangeable for practitioners, payors, and patients, while delivering products with very high levels of reliability and efficacy. As a result, we expect our products and services will achieve commercial and clinical success worldwide and thus bolster our financial viability. As new features
	and capabilities are added to our product portfolio, we believe our users will gain access to a broader patient population, expanded reimbursement potential, and that our offerings will directly address the requirements and needs of accountable care organizations and the trend toward bundling of payments. We believe that this will allow us to increase list prices as our product line is enhanced and improved, which should positively impact our future results of operations and margins.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In addition to our products, we offer the Sentinel service program, which provides our customers comprehensive protection for their SRT-100 and SRT-100 Vision systems.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Our Strengths
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Cost effective products for a global market.
</I>
</B>
	&nbsp;&nbsp;Our products offer a solution for today&#146;s cost conscious healthcare market. Our products rely on superficial radiation therapy, which we believe is an effective and less expensive procedure for the treatment of non-melanoma skin cancer and other skin conditions than existing treatment options. The productivity and reliability associated with our products, along with our related service offerings, allow our customers to quickly and easily install and deploy our products in their respective practices while reducing downtime. Our products offer reduced
	treatment times, yet provide similar, or better,
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	3
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage10"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT BLACK SOLID; BORDER-BOTTOM: 1PT BLACK SOLID; BORDER-RIGHT: 1PT BLACK SOLID; BORDER-LEFT: 1PT BLACK SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	outcomes when compared with other treatment modalities for non-melanoma skin cancer and keloids. We believe that we are ideally positioned to meet the demands of the reforming healthcare systems by providing higher quality care at a lower cost with a better patient experience.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Exclusive focus on a large, growing market.
</I>
</B>
	&nbsp;&nbsp;The U.S. Surgeon General estimates that the skin cancer market represents an over $8 billion opportunity in the U.S. alone, which we expect will continue to grow. This growth is being driven by increased incidence of skin cancer and other skin conditions among the general population. We also estimate that the potential market for the treatment of keloids is even larger than the skin cancer market. Because our products offer an effective alternative treatment option, we believe that we are positioned as one of a limited number of companies exclusively focused
	on the use of superficial radiation therapy for the treatment of non-melanoma skin cancer and other skin conditions, such as keloids.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Highly experienced management and medical advisory team.
</I>
</B>
	&nbsp;&nbsp;We have assembled a senior management team and medical advisory board with significant experience in the healthcare industry. Our leadership team has a long track record in introducing numerous disruptive technologies and products to the healthcare market in the field of radiology, oncology and interventional medicine. Members of our management team also have experience in product development, launching new products into the healthcare market and selling medical devices and technology to hospitals and private healthcare practices through direct
	sales organizations, distributors and manufacturers. We also collaborate with a network of leading medical advisors in the design and use of our products.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Extensive product support network.
</I>
</B>
	&nbsp;&nbsp;In addition to the SRT-100 product line, we offer a unique and dedicated superficial radiation therapy support network for clinicians and therapists, which includes site planning and preparation, system deployment and installation, a national and global network of medical physicists for system commissioning and calibration, a dedicated service network, a dedicated clinical applications and education network and service, SRT University, and online and live customer support. We believe that by offering these dedicated and tailored services we have enhanced our brand and
	gained market presence.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Relationships with the medical community.
</I>
</B>
	&nbsp;&nbsp;We are actively involved in scientific, medical, and commercial organizations and communities. We are a member of the American Cutaneous Oncology Society (ACOS), which is a dedicated superficial radiation therapy scientific and medical society that promotes the betterment and further education on all superficial radiation therapy-related subject matter and topics, across multi-disciplinary fields, such as radiation oncology, dermatology, medical physics, plastic surgery, physician assistants, and radiation therapy technologists. We anticipate that we will be
	able to leverage our involvement in these organizations to increase awareness of the benefits of radiation therapy and increase sales of our products.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Our Strategy
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our goal is to be a leading medical device company providing innovative, noninvasive solutions for the treatment of non-melanoma skin cancer and other skin conditions. The key elements of our strategy include:
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Increase acceptance of superficial radiation therapy as the standard of care for non-melanoma skin cancer, keloids and other skin conditions.&nbsp;&nbsp;
</I>
</B>
	We believe a great opportunity exists in creating an awareness of our treatment options for consumers. We believe dermatologists are now recognizing that surgery is not the only solution, or necessarily the best solution, for treating skin cancer or other skin conditions, such as keloids, and superficial radiation therapy can now be recognized as a valuable modality in their toolbox. The 95% non-melanoma skin cancer non-recurrence rate at the five-year follow-up
	(according to one study with 95% confidence intervals) achieved with superficial radiation therapy, combined with the benefit of a better cosmetic outcome and what we believe to be a more certain reimbursement environment compared to the reimbursement environment when we began selling our products, creates a significant opportunity for us to expand our market share. Focused consumer and practitioner educational awareness of the benefits of superficial radiation therapy is a key for our success. We are seeking to leverage our relationships with medical and other organizations to increase public awareness of superficial radiation therapy treatment options.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Drive adoption and awareness of SRT-100 among specialists, physicians, administrators and patients
</I>
</B>
<B>
	.&nbsp;&nbsp;
</B>
	We intend to educate specialists, physicians, administrators and patients on the compelling case for
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	4
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage11"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT BLACK SOLID; BORDER-BOTTOM: 1PT BLACK SOLID; BORDER-RIGHT: 1PT BLACK SOLID; BORDER-LEFT: 1PT BLACK SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	the treatment of non-melanoma skin cancer with the SRT-100. We believe that increased awareness of the benefits of superficial radiation therapy will favorably impact sales of the SRT-100. Additionally, we believe that our products will allow dermatologists to treat patients without having to refer them to specialists for treatment and will free-up larger, higher power equipment, such as linear accelerators, for oncologists to treat other patients whose treatment requires the use of these other devices.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Develop new technology products and services.
</I>
</B>
	&nbsp;&nbsp;Since acquiring the SRT-100 technology, we have developed optional add-on technology products and service options which have enhanced the operational capabilities of our SRT-100, including the SRT-100 Vision and SRT-100 Lynx. We believe continued research and development of both new and existing technology will be critical to our success.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Pursue opportunities to enhance our product offerings.
</I>
</B>
	&nbsp;&nbsp;We intend to continue to expand applications of our superficial radiation therapy technology and vigorously protect those innovations through patent applications. We may also opportunistically pursue the licensing or acquisition of complementary products and technologies to strengthen our market position or improve product margins.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Expand our sales organization to support growth.
</I>
</B>
	&nbsp;&nbsp;We intend to expand our highly-trained direct sales organization and broaden our relationships with distributor partners to increase sales and drive revenues.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Lessen our dependency on third party manufacturers.
</I>
</B>
	&nbsp;&nbsp;We are exploring the possibility of reducing our reliance on third party manufacturers by bringing certain manufacturing, service and research and development functions in-house, which could include the acquisition of equipment and other fixed assets or the acquisition or lease of a manufacturing facility.
</P>
</EFX_PROSPECTUS_SUMMARY>
<EFX_RISK_FACTORS>
<A NAME="FIS_RISK_FACTORS"></A>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Risk Factors
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Investing in our securities involves substantial risk, and our ability to successfully operate our business is subject to numerous risks, including those that are generally associated with our industry. Any of the risks set forth in this prospectus under the heading &#147;Risk Factors&#148; may limit our ability to successfully execute our business strategy. You should carefully consider all the information set forth in this prospectus and, in particular, should evaluate the specific risks set forth in this prospectus under the heading &#147;Risk Factors&#148; in deciding whether to invest in our securities. The following is a
	summary of some of the principal risks we face:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	market acceptance of the SRT-100;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	our ability to successfully commercialize our products, including SRT-100;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	our ability to compete effectively in selling our products and services;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	our ability to expand, manage and maintain our direct sales and marketing organizations;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	the fact that we have a history of net losses and may not achieve the scale of operation we expect or consistently achieve profitability in the future;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	our actual financial results may vary significantly from forecasts and from period to period;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	our ability to successfully develop new products, improve or enhance our existing products or acquire complementary products, technologies, services or businesses;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	our ability to obtain and maintain intellectual property of sufficient scope to adequately protect our products, including SRT-100, and our ability to avoid infringing or otherwise violating the intellectual property rights of third parties;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	market risks regarding consolidation in the healthcare industry;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	the willingness of healthcare providers to purchase our products generally, and in particular if coverage by, and reimbursement from, third party payors for procedures using our products significantly declines;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	the level and availability of government and third party payor reimbursement for clinical procedures using our products;
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	5
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage12"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT BLACK SOLID; BORDER-BOTTOM: 1PT BLACK SOLID; BORDER-RIGHT: 1PT BLACK SOLID; BORDER-LEFT: 1PT BLACK SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	our ability to effectively manage our anticipated growth;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	changing regulatory requirements applicable to us and our competitors, and our ability to comply;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	our reliance on third party manufacturers and sole- or single-source suppliers;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	our ability to reduce the per unit manufacturing cost of the SRT-100;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	our ability to efficiently manage our manufacturing processes, including our ability to manufacture our products to meet demand;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	regional and global economic recessions;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	our need to obtain additional funds in the future, as well as our ability to comply with covenants resulting from financing transactions;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	the regulatory and legal risks, and certain operating risks, that our international operations subject us to;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	the fact that product quality issues or product defects may harm our business; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	our failure to effectively manage any of the foregoing.
</TD>
</TR>
</TABLE>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Corporate Conversion
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	On January 1, 2016, Sensus Healthcare, LLC converted into a Delaware corporation pursuant to a statutory conversion and changed its name to Sensus Healthcare, Inc. As a result of the corporate conversion, the holders of the different classes of units of Sensus Healthcare, LLC became holders of common stock of Sensus Healthcare, Inc. Holders of warrants and options, respectively, to purchase units of Sensus Healthcare, LLC became holders of warrants and options to purchase common stock of Sensus Healthcare, Inc., respectively. Each unit converted to one share of common stock. Prior to the commencement of this offering, we
	expect to effect a forward stock split of 241.95-for-one. Following the forward stock split, we expect that our existing stockholders will hold approximately 11.0 million shares of our common stock, on a fully diluted basis.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The purpose of the corporate conversion was to reorganize our corporate structure so that the operating company is a corporation rather than a limited liability company and so that our existing investors own shares of our common stock rather than equity interests in a limited liability company. For further information regarding the corporate conversion, see &#147;Corporate Conversion.&#148; References in this prospectus to our capitalization and other matters pertaining to our equity and shares prior to the corporate conversion relate to the capitalization and equity and shares of Sensus Healthcare, LLC, and after the
	corporate conversion, to Sensus Healthcare, Inc.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Except as disclosed in this prospectus, the financial statements and selected historical financial data and other information included in this prospectus give retroactive effect to the corporate conversion. We expect that our conversion from a Delaware limited liability company to a Delaware corporation will not have a material effect on our financial statements, except for the effects of income taxes.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Emerging Growth Company Status
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We are an &#147;emerging growth company&#148; as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, which permits us to elect not to be subject to certain disclosure and other requirements that otherwise would have been applicable to us had we not been an &#147;emerging growth company.&#148; These provisions include:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	reduced disclosure about our executive compensation arrangements;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	no non-binding advisory votes on executive compensation or golden parachute arrangements; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	exemption from the auditor attestation requirement in the assessment of our internal control over financial reporting.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We may take advantage of these exemptions for up to five years or such earlier time as we are no longer an &#147;emerging growth company.&#148; We will qualify as an &#147;emerging growth company&#148; until the earliest of (1) the last day of our fiscal year following the fifth anniversary of the date of completion of this offering,
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	6
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage13"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT BLACK SOLID; BORDER-BOTTOM: 1PT BLACK SOLID; BORDER-RIGHT: 1PT BLACK SOLID; BORDER-LEFT: 1PT BLACK SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	(2) the last day of our fiscal year in which we have annual gross revenue of $1.0 billion or more, (3) the date on which we have, during the previous three-year period, issued more than $1.0 billion in non-convertible debt and (4) the last day of the fiscal year in which we become a &#147;large accelerated filer&#148; as defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended, or the Exchange Act. Under this definition, we will be an &#147;emerging growth company&#148; upon completion of this offering and could remain an &#147;emerging growth company&#148; until as late as December 31, 2021.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In addition, the JOBS Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards. This allows an emerging growth company to delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have irrevocably elected not to avail ourselves of this exemption from new or revised accounting standards and, therefore, we will be subject to the same new or revised accounting standards as other public companies that are not emerging growth companies.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Corporate Information
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Sensus Healthcare, LLC, a Delaware limited liability company, was formed on May 7, 2010, to design, manufacture and market proprietary medical devices specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy. In June 2010, Sensus Healthcare, LLC, a Florida limited liability company (&#147;Sensus (FL)&#148;), acquired all the assets associated with our primary product, the SRT-100, from Topex, Inc. for $1.3 million. Following this acquisition, we relaunched the SRT-100 under the Sensus Healthcare brand. In December 2011, we merged with Sensus (FL),
	with the Delaware limited liability company surviving the merger for the purpose of changing our domicile from Florida to Delaware. On January 1, 2016, we completed a corporate conversion pursuant to which Sensus Healthcare, Inc. succeeded to the business of Sensus Healthcare, LLC, and the equity holders of Sensus Healthcare, LLC became stockholders of Sensus Healthcare, Inc. See &#147;Corporate Conversion.&#148; Our principal executive offices are located at 851 Broken Sound Pkwy. NW #215, Boca Raton, Florida and our telephone number at that address is (561) 922-5808. Our website is located at
<I>
	www.sensushealthcare.com
</I>
	. Our website, and the information on our website, is neither part of this prospectus nor incorporated by reference herein.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	7
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage14"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT BLACK SOLID; BORDER-BOTTOM: 1PT BLACK SOLID; BORDER-RIGHT: 1PT BLACK SOLID; BORDER-LEFT: 1PT BLACK SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
</EFX_RISK_FACTORS>
<EFX_THE_OFFERING>
<A NAME="FIS_THE_OFFERING"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The Offering
</FONT>
</H1>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 35%; PADDING-LEFT: 10PT; TEXT-INDENT: -10PT">
<B>
	Units offered by us
</B>
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	&nbsp;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 0PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH:35%">
<!--SUM1-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	1,750,000 units, each consisting of one share of our common stock and a warrant to purchase one share of common stock.
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 35%; PADDING-LEFT: 10PT; TEXT-INDENT: -10PT">
<B>
	Offering price:
</B>
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	&nbsp;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 0PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH:35%">
<!--SUM1-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	$6.25 per unit ($6.00 attributable to the common stock and $0.25 attributable to the warrant).
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 35%; PADDING-LEFT: 10PT; TEXT-INDENT: -10PT">
<B>
	Units:
</B>
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	&nbsp;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 0PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH:35%">
<!--SUM1-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	&nbsp;&nbsp;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 35%; PADDING-LEFT: 10PT; TEXT-INDENT: -10PT">
	Number outstanding before this offering:
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	&nbsp;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 0PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH:35%">
<!--SUM1-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	0
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 35%; PADDING-LEFT: 10PT; TEXT-INDENT: -10PT">
	Number outstanding after this offering:
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	&nbsp;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 0PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH:35%">
<!--SUM1-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	1,750,000
<SUP>
	&#040;1&#041;
</SUP>
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 35%; PADDING-LEFT: 10PT; TEXT-INDENT: -10PT">
<B>
	Common Stock:
</B>
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%">
<!--SUM2-->
	&nbsp;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 35%; PADDING-LEFT: 10PT; TEXT-INDENT: -10PT">
	Number outstanding before this offering:
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	&nbsp;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 0PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH:35%">
<!--SUM1-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	10,368,041
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 35%; PADDING-LEFT: 10PT; TEXT-INDENT: -10PT">
	Number outstanding after this offering:
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	&nbsp;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 0PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH:35%">
<!--SUM1-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	12,438,041
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 35%; PADDING-LEFT: 10PT; TEXT-INDENT: -10PT">
<B>
	Warrants:
</B>
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	&nbsp;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 0PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH:35%">
<!--SUM1-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	&nbsp;&nbsp;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 35%; PADDING-LEFT: 10PT; TEXT-INDENT: -10PT">
	Number of shares issuable upon exercise of the warrants to be issued in this offering:
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	&nbsp;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 0PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH:35%">
<!--SUM1-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	1,750,000
<SUP>
	&#040;1&#041;
</SUP>
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 35%; PADDING-LEFT: 10PT; TEXT-INDENT: -10PT">
	Exercisability and exercise price:
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	&nbsp;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 0PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH:35%">
<!--SUM1-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	Each warrant issued as part of a unit is exercisable for one share of common stock commencing upon separation and expiring at 5:00 p.m., New York City time, on the third anniversary of the date of issuance. The exercise price will be equal to $7.80 per share.
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 35%; PADDING-LEFT: 10PT; TEXT-INDENT: -10PT">
	Redemption of Warrants:
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	&nbsp;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 0PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH:35%">
<!--SUM1-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	Following the first anniversary of the date of issuance, if certain conditions are met, we may redeem any or all of the outstanding warrants issued as part of a unit at a price equal to $0.01 per warrant.
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 35%; PADDING-LEFT: 10PT; TEXT-INDENT: -10PT">
<B>
	Underwriters&#146; option to purchase additional units from us
</B>
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	&nbsp;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 0PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH:35%">
<!--SUM1-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	We have granted a 45-day option to the underwriters to purchase up to 262,500 additional units solely to cover over-allotments, if any, at a price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per unit, less the underwriting discount, provided that in no event may exercise of this option occur after separation of the units occurs.
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 35%; PADDING-LEFT: 10PT; TEXT-INDENT: -10PT">
<B>
	Separation of shares and warrants included in the units offered hereby
</B>
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	&nbsp;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 0PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH:35%">
<!--SUM1-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	The units will begin trading on, or promptly after, the date of this prospectus. The units will separate at the earlier of (i) 52 days following the date of this prospectus, or (ii) such earlier date as may be determined by the representatives of the underwriters. We will issue a press release and file a Current Report on Form 8-K with the Securities and Exchange Commission announcing such separation date of the units.
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 35%; PADDING-LEFT: 10PT; TEXT-INDENT: -10PT">
<B>
	Use of proceeds
</B>
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	&nbsp;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 0PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH:35%">
<!--SUM1-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	We estimate, based upon the assumed initial public offering price of $6.25 per unit, and without taking into account proceeds we may receive from the exercise of warrants, we will receive net proceeds from the offering of approximately $9.3 million (or
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	8
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage15"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT BLACK SOLID; BORDER-BOTTOM: 1PT BLACK SOLID; BORDER-RIGHT: 1PT BLACK SOLID; BORDER-LEFT: 1PT BLACK SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 35%">
<!--SUM1-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	$10.8 million if the underwriters&#146; option to purchase additional units is exercised in full), after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. We intend to use the proceeds from this offering for:
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 35%; PADDING-LEFT: 10PT; TEXT-INDENT: -10PT">
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	&nbsp;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 0PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH:35%">
<!--SUM1-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
<P STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -20PT; MARGIN-BOTTOM: -12PT">
	&nbsp;&nbsp;&#149;
</P>
<P STYLE="MARGIN-TOP: 0PT; PADDING-LEFT: 20PT">
	the expansion of our sales and marketing activities, including hiring new sales representatives;
</P>
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 35%; PADDING-LEFT: 10PT; TEXT-INDENT: -10PT">
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	&nbsp;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 0PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH:35%">
<!--SUM1-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
<P STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -20PT; MARGIN-BOTTOM: -12PT">
	&nbsp;&nbsp;&#149;
</P>
<P STYLE="MARGIN-TOP: 0PT; PADDING-LEFT: 20PT">
	research and development for new products and improvements to existing products;
</P>
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 35%; PADDING-LEFT: 10PT; TEXT-INDENT: -10PT">
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	&nbsp;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 0PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH:35%">
<!--SUM1-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
<P STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -20PT; MARGIN-BOTTOM: -12PT">
	&nbsp;&nbsp;&#149;
</P>
<P STYLE="MARGIN-TOP: 0PT; PADDING-LEFT: 20PT">
	to pay a dividend owed to former holders of units with a preferred return prior to our corporate conversion, in each case who have not elected to convert such dividend into shares of our common stock at the initial public offering price attributable to the common stock within 30 days following the closing of this offering; and
</P>
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 35%; PADDING-LEFT: 10PT; TEXT-INDENT: -10PT">
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	&nbsp;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 0PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH:35%">
<!--SUM1-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
<P STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -20PT; MARGIN-BOTTOM: -12PT">
	&nbsp;&nbsp;&#149;
</P>
<P STYLE="MARGIN-TOP: 0PT; PADDING-LEFT: 20PT">
	the remainder for working capital and other general corporate purposes. See &#147;Use of Proceeds.&#148;
</P>
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 35%; PADDING-LEFT: 10PT; TEXT-INDENT: -10PT">
<B>
	Dividend policy
</B>
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	&nbsp;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 0PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH:35%">
<!--SUM1-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	We currently expect to retain all future earnings, if any, for use in the operation and expansion of our business and repayment of debt; therefore, we do not anticipate paying cash dividends on our common stock in the foreseeable future. See &#147;Dividend Policy.&#148;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 35%; PADDING-LEFT: 10PT; TEXT-INDENT: -10PT">
<B>
	Risk factors
</B>
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	&nbsp;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 0PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH:35%">
<!--SUM1-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	You should carefully read and consider the information set forth under the heading &#147;Risk Factors&#148; beginning on page
<A HREF="#V440371_S1A_HTM_T1RF">
	14
</A>
	of this prospectus and all other information set forth in this prospectus before investing in our securities.
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 35%; PADDING-LEFT: 10PT; TEXT-INDENT: -10PT">
<B>
	Nasdaq symbols
</B>
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	&nbsp;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 0PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH:35%">
<!--SUM1-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 5%">
<!--SUMMARY GUTTER-->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 60%; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT">
	&#147;SRTS&#148;&nbsp;&#151;&nbsp;common stock; &#147;SRTSU&#148;&nbsp;&#151;&nbsp;units; &#147;SRTSW&#148;&nbsp;&#151;&nbsp;warrants.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 1PX">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_LINE.GIF" STYLE="WIDTH: 72PX; HEIGHT: 1PT">
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 1PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	(1)
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Excludes the Representatives&#146; Warrants and units issuable upon exercise of the over-allotment option.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The common stock to be outstanding after this offering is based on 10,368,041 shares outstanding as of April 30, 2016, after giving effect to our proposed 241.95-for-one forward stock split, and excludes the following as of such date:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	as of April 30, 2016, 14,517 shares issuable upon the exercise of outstanding stock options at a weighted-average exercise price of $4.13 per share;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	as of April 30, 2016, 630,763 shares issuable upon the exercise of warrants at a weighted-average exercise price of $2.42 per share;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	397,473 shares reserved for future issuance under our 2016 Equity Incentive Plan including $1.92 million of restricted stock awards, or 320,000 shares (based on $6.00 per share), expected to be granted to certain of our officers and employees following the pricing of this offering;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	shares issuable upon the election of former holders of units with a preferred return, within 30 days of the closing of this offering to convert all or a portion of the cumulative preferred dividend into shares of common stock at the initial public offering price;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	120,750 units issuable upon exercise of warrants to be issued to the representatives of the underwriters in connection with this offering, at an exercise price per unit equal to $7.80 per unit, as described in the &#147;Underwriting&nbsp;&#151;&nbsp;Representatives&#146; Warrants&#148; section of this prospectus; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	2,133,250 shares of our common stock issuable upon the exercise of warrants issued and sold in this offering.
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	9
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage16"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT BLACK SOLID; BORDER-BOTTOM: 1PT BLACK SOLID; BORDER-RIGHT: 1PT BLACK SOLID; BORDER-LEFT: 1PT BLACK SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Unless otherwise indicated, this prospectus assumes:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	an initial public offering price of $6.25 per unit ($6.00 attributable to the common stock and $0.25 attributable to the warrant);
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	no exercise of the Representatives&#146; Warrants to purchase 120,750 units at an exercise price of $7.80 per unit to be issued to certain of the underwriters described above;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	no exercise of the underwriters&#146; option to purchase additional securities;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	none of the former holders of our limited liability company units with a preferred return elect to convert any portion of their cumulative preferred dividend into shares of common stock at the initial public offering price attributable to the common stock;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	no exercise of the warrants included in the units issued and sold in this offering; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	except in our historical financial statements, the effect of our proposed 241.95-for-one forward stock split to be consummated after the effective time of this registration statement of which this prospectus is a part and prior to the consummation of this offering.
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	10
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage17"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT BLACK SOLID; BORDER-BOTTOM: 1PT BLACK SOLID; BORDER-RIGHT: 1PT BLACK SOLID; BORDER-LEFT: 1PT BLACK SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Summary historical financial data
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The tables below summarize our financial information for the periods indicated. We derived the financial information for the years ended December 31, 2013, 2014 and 2015 from our audited financial statements included elsewhere in this prospectus and for the three months ended March 31, 2015 and 2016 from our unaudited financial statements included elsewhere in the prospectus. We derived the financial information for the years ended December 31, 2011 and 2012 from our unaudited and audited financial statements, respectively, not included in this prospectus. You should read the following information together with the more
	detailed information contained in &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; and our financial statements and the accompanying notes. Our historical results are not necessarily indicative of the results to be expected in any future period.
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_9"></A>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="152">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="48">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="48">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="48">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="48">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="48">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="48">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="56">
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=19>
	For the Years Ended December 31,
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=7>
	For the Three Months Ended March 31,
<BR>
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2011
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2012
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2013
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2014
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2015
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2015
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2016
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	(unaudited)
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=7>
	(unaudited)
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Revenues
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	4,044,867
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	7,020,481
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	10,478,920
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	5,810,205
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	10,273,094
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,929,649
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	3,035,204
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Cost of Sales
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,583,325
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	2,295,196
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	3,600,348
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	2,054,798
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	3,698,687
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	724,179
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,102,370
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Gross Profit
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	2,461,542
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	4,725,285
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	6,878,572
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	3,755,407
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	6,574,407
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,205,470
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,932,834
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Operating Expenses
<BR>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Selling and marketing
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	2,248,559
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	2,875,850
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	3,965,276
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	4,208,241
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	3,742,535
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	916,350
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	944,122
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	General and administrative
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,193,770
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,068,013
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,453,344
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,650,651
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,586,401
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	329,745
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	685,720
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Research and development
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	694,618
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	933,176
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,333,111
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,576,775
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,466,728
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	439,804
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	293,404
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Total Operating Expenses
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	4,136,947
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	4,877,039
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	6,751,731
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	7,435,667
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	6,795,664
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,685,899
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,923,246
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Income (Loss) From Operations
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(1,675,405
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(151,754
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	126,841
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(3,680,260
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(221,257
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(480,429
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	9,588
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Other Income (Expense)
<BR>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Interest expense
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(10,664
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(25,276
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(20,467
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(20,030
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(17,786
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(5,119
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(9,626
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Interest income
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,539
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,253
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	820
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,776
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	288
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	2,755
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Total Other Income (Expense)
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(9,125
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(25,276
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(19,214
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(19,210
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(16,010
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(4,831
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(6,871
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Income (Loss) Before Income Taxes
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(1,684,530
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(177,030
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	107,627
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(3,699,470
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(237,267
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(485,260
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	2,717
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Provision for income taxes
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	636
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Net Income (Loss)
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(1,684,530
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(177,030
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	107,627
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(3,699,470
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(237,267
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(485,260
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	2,081
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Preferential distribution
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(491,095
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(513,332
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(513,332
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(537,693
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(513,332
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(128,333
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Net Income (Loss) Attributable to Common Stockholders
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(2,175,625
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(690,362
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(405,705
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(4,237,163
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(750,599
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(613,593
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	2,081
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Net Income (Loss) Attributable to Common Stockholders
<BR>
	per share&nbsp;&#150;&nbsp;basic
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(70.81
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(19.46
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(10.02
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(103.76
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(18.37
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(15.03
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	0.05
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
<B>
	-&nbsp;diluted
</B>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(70.81
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(19.46
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(10.02
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(103.76
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(18.37
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(15.03
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	0.05
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Pro Forma Net Income (Loss) Attributable to Common Stockholders per share
<SUP>
	&#040;1&#041;
</SUP>
	&nbsp;&#150;&nbsp;basic (unaudited)
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(0.29
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(0.08
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(0.04
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(0.43
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(0.08
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(0.06
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	0.00
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
<B>
	-&nbsp;diluted (unaudited)
</B>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(0.29
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(0.08
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(0.04
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(0.43
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(0.08
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(0.06
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	0.00
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Weighted average number of shares used in computing net loss per share&nbsp;&#150;&nbsp;basic
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	30,723
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	35,471
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	40,482
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	40,835
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	40,857
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	40,835
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	42,852
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
<B>
	-&nbsp;diluted
</B>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	30,723
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	35,471
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	40,482
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	40,835
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	40,857
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	40,835
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	44,070
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Pro Forma Weighted average number of shares used in computing net loss per share
<SUP>
	&#040;1&#041;
</SUP>
	&nbsp;&#150;&nbsp;basic (unaudited)
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	7,433,430
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	8,582,208
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	9,794,620
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	9,880,028
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	9,885,351
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	9,880,028
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	10,368,041
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
<B>
	-&nbsp;diluted (unaudited)
</B>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	7,433,430
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	8,582,208
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	9,794,620
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	9,880,028
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	9,885,351
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	9,880,028
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	10,662,736
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Adjusted EBITDA, non-GAAP
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(1,510,875
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	36,789
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	442,502
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(3,397,462
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	169,914
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(404,871
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	212,710
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 1PX">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_LINE.GIF" STYLE="WIDTH: 72PX; HEIGHT: 1PT">
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 1PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	(1)
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Pro forma per share data gives effect to the 241.95-for-one stock split to be consummated after the effective date of the registration statement of which this prospectus is a part and prior to the consummation of this offering. Pro forma net loss attributable to common stockholders per share consists
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	11
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage18"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT BLACK SOLID; BORDER-BOTTOM: 1PT BLACK SOLID; BORDER-RIGHT: 1PT BLACK SOLID; BORDER-LEFT: 1PT BLACK SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 1PX; TEXT-ALIGN: LEFT">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	of net income divided by the pro forma basic and diluted weighted average number of shares used in computing net loss per share&nbsp;&#151;&nbsp;basic and diluted.
</TD>
</TR>
</TABLE>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Non-GAAP Financial Measures
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Adjusted EBITDA, is a non-GAAP financial measure which we use in our financial performance analyses. This measure should not be considered a substitute for GAAP-basis measures nor should it be viewed as a substitute for operating results determined in accordance with GAAP. We believe that the presentation of Adjusted EBITDA, a non-GAAP financial measure that excludes the impact of net interest expense, certain taxes, depreciation, amortization, litigation settlement expense, and stock compensation expense provides useful supplemental information that is essential to a proper understanding of our financial results. Non-GAAP
	measures are not formally defined by GAAP, and other entities may use calculation methods that differ from ours for the purposes of calculating Adjusted EBITDA. As a complement to GAAP financial measures, we believe that Adjusted EBITDA assists investors who follow the practice of some investment analysts who adjust GAAP financial measures to exclude items that may obscure underlying performance and distort comparability.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The following is a reconciliation of net income to the non-GAAP financial measure referred to in this prospectus as Adjusted EBITDA for the five years ended December 31, 2011, 2012, 2013, 2014 and 2015 and for the three months ended March 31, 2015 and 2016.
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_10"></A>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="136">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="48">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="48">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="48">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="64">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="48">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="48">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="56">
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=19>
	For the Years Ended December 31,
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=7>
	For the Three Months Ended March 31,
<BR>
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2011
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2012
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2013
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2014
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2015
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2015
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2016
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Net Income (Loss), as reported
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(1,684,530
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(177,030
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	107,627
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(3,699,470
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(237,267
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(485,260
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	2,081
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Add:
<BR>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Depreciation and amortization
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	162,693
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	177,321
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	265,557
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	272,649
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	315,599
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	72,798
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	84,795
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Taxes
<SUP>
	&#040;1&#041;
</SUP>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,837
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	11,222
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	49,024
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	3,672
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	69,095
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,141
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	4,844
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Litigation settlement
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	112,500
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Interest, net
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	9,125
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	25,276
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	19,214
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	19,210
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	16,010
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	4,831
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	6,871
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Stock compensation expense
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,080
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	6,477
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	6,477
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,619
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,619
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Adjusted EBITDA, non-GAAP
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(1,510,875
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	36,789
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	442,502
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(3,397,462
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	169,914
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(404,871
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	212,710
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 1PX">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_LINE.GIF" STYLE="WIDTH: 72PX; HEIGHT: 1PT">
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 1PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	(1)
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Taxes include all taxes paid by the Company, other than payroll taxes, including on income, ad valorem, and excise taxes.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_11"></A>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="554" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="258">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="80">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="80">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="88">
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=11>
	As of March 31, 2016
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Actual
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Pro forma
<SUP>
	&#040;1&#041;
</SUP>
<SUP>
	&#040;2&#041;
</SUP>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Pro forma as adjusted
<SUP>
	&#040;2&#041;
</SUP>
<SUP>
	&#040;3&#041;
</SUP>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Balance sheet data:
<BR>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Cash and cash equivalents
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	4,746,539
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	4,746,539
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	14,918,414
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Working capital
<SUP>
	&#040;4&#041;
</SUP>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	4,689,473
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	2,015,276
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	11,294,943
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Total assets
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	9,989,357
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	9,989,357
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	19,269,024
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Total liabilities
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	4,068,428
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	6,742,625
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	6,742,625
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Total stockholders&#146; equity
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	5,920,929
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	3,246,732
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	12,526,399
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Total liabilities and stockholders&#146; equity
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	9,989,357
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	9,989,357
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	19,269,024
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 1PX">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_LINE.GIF" STYLE="WIDTH: 72PX; HEIGHT: 1PT">
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 1PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	(1)
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Pro forma to reflect the accrual of the dividend payable to the former holders of units with a preferred return that was declared upon our conversion from a Delaware limited liability company to a Delaware corporation, effective January 1, 2016.
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 1PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	(2)
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Pro forma and pro forma as adjusted information discussed above are unaudited and illustrative only.
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 1PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	(3)
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Pro forma as adjusted gives effect to (1) the accrual of the dividend payable to the former holders of units with a preferred return that was declared upon our conversion from a Delaware limited liability company to a Delaware corporation and (2) the sale of units in this offering at an assumed initial public offering price of $6.25 per unit, after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us and the application of the proceeds therefrom.
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	12
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage19"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT BLACK SOLID; BORDER-BOTTOM: 1PT BLACK SOLID; BORDER-RIGHT: 1PT BLACK SOLID; BORDER-LEFT: 1PT BLACK SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 1PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	(4)
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Represents current assets less current liabilities.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Each $1.00 increase (decrease) in the assumed initial public offering price of $6.25 per unit would increase (decrease) each of cash and cash equivalents, working capital, total assets and total stockholders&#146; (deficit) equity by approximately $1.6 million, assuming that the number of units offered by us, as set forth on the cover of this prospectus, remains the same, and after deducting underwriting discounts and commissions and estimated offering expenses payable by us. We may also increase or decrease the number of units we are offering. Each increase (decrease) of 1.0 million units in the number of units offered by us
	would increase (decrease) each of cash and cash equivalents, working capital, total assets and total stockholders&#146; (deficit) equity by approximately $5.8 million, assuming that the assumed initial public offering price remains the same, and after deducting underwriting discounts and commissions and estimated offering expenses payable by us. The pro forma as adjusted information discussed above is illustrative only and will adjust based on the actual initial public offering price and other terms of this offering determined at pricing.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	13
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage20"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
</EFX_THE_OFFERING>
<EFX_RISK_FACTORS>
<A NAME="FIS_RISK_FACTORS_2"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<A NAME="V440371_S1A_HTM_T1RF">
</A>
	RISK FACTORS
</FONT>
</H1>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<I>
	Investing in our securities involves risks. In addition to the other information contained in this prospectus, you should carefully consider the following risks before deciding to purchase securities in this offering. The occurrence of any of the following risks might cause you to lose all or a part of your investment. Some statements in this prospectus, including statements in the following risk factors, constitute forward-looking statements. Please refer to &#147;Cautionary Note Regarding Forward-Looking Statements&#148; for more information regarding forward-looking statements.
</I>
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Risks Related to our Financial Position and Operations
</FONT>
</H2>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We have a history of net losses. If we do not consistently achieve profitability, our financial condition and the value of our common stock could suffer.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We have a history of net losses. Our historical losses from inception through March 31, 2016 totaled approximately $7.4 million. If our revenue grows more slowly than currently anticipated, or if operating expenses are higher than expected, we may be unable to consistently achieve profitability, our financial condition will suffer and the value of our common stock could decline. Even if we are successful increasing our sales, we may incur losses in the foreseeable future as we continue to research and develop and seek regulatory approvals for our products.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	If sales revenue from any of our currently cleared products or any additional products that receive marketing clearance from the FDA or approval from other regulatory authorities in the future is insufficient, or if our product development is delayed, we may be unable to achieve profitability. Furthermore, even if we are able to achieve profitability, we may be unable to sustain or increase such profitability on a quarterly or annual basis, which would significantly reduce the value of our common stock.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	If third-party payors do not provide coverage and adequate reimbursement for the use of our products, it is unlikely that our products will be widely used and our revenue will be negatively impacted.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In the U.S., the commercial success of our existing products and any future products will depend, in part, on the extent to which governmental payors at the federal and state levels, including Medicare and Medicaid, private health insurers and other third-party payors provide coverage for and establish adequate reimbursement levels for procedures using our products. The existence of coverage and adequate reimbursement for our products and related procedures by government and private payors is critical to market acceptance of our existing and future products. Neither hospitals nor physicians are likely to use our products if
	they do not receive adequate reimbursement payments for the procedures using our products.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Some private payors in the U.S. may base their reimbursement policies on the coverage decisions determined by the Centers for Medicare and Medicaid Services, which administers the Medicare program. Others may adopt different coverage or reimbursement policies for procedures performed using our products, while some governmental programs, such as Medicaid, have reimbursement policies that vary from state to state, some of which may not pay for our products in an amount that supports our selling price, if at all. A Medicare national or local coverage decision denying coverage for any of the procedures performed with our products
	could result in private and other third-party payors also denying coverage. Medicare (part B) and a number of private insurers in the U.S. currently cover and pay for both non-melanoma skin cancer and keloid treatments using the SRT-100. A withdrawal, or even contemplation of a withdrawal, by Centers for Medicare and Medicaid Services, or CMS, Medicaid or private payors of reimbursements, or any other unfavorable coverage or reimbursement decisions by government programs or private payors, could have a material adverse effect on our business.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Reimbursement systems in international markets vary significantly by country and by region within some countries, and reimbursement approvals must be obtained on a country-by-country basis. In many international markets, a product must be approved for reimbursement before it can be cleared for sale in that country. Further, many international markets have government-managed healthcare systems that control reimbursement for new devices and procedures. In most markets there are private insurance systems as well as government-managed systems. Our products may not be considered cost-effective by international third-party payors or
	governments managing healthcare systems. Furthermore, reimbursement may not be available or, if available, third-party payors&#146; reimbursement policies may adversely affect our ability to sell our products
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	14
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage21"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	profitably. If sufficient coverage and reimbursement are not available for our current or future products, in either the U.S. or internationally, the demand for our products and, consequently, our revenues will be adversely affected.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Substantially all of our revenue is generated from the sale of our SRT-100 and related products, and any decline in the sales of these products or failure to gain market acceptance of these products will negatively impact our business, financial condition and results of operations.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We have focused heavily on the development and commercialization of a limited number of products for the treatment of non-melanoma skin cancer and other skin conditions with superficial radiotherapy. From our inception in 2010 through the date of this prospectus, substantially all of our revenue has been derived from sales of our SRT-100 product line and related services and ancillary products. We expect substantially all of our revenue to be derived from or related to sales of our SRT-100 product line for the foreseeable future. Besides differentiated or enhanced versions of the SRT-100 and ancillary products, we are not
	currently developing or otherwise investing in any other product. If we are unable to achieve and maintain significantly greater market acceptance of superficial radiotherapy for treatment of non-melanoma skin cancer and other skin conditions, or if we do not achieve sustained positive cash flow, then we will be severely constrained in our ability to fund our operations. In addition, if we are unable to market our SRT-100 product line and ancillary products as a result of a quality problem, shortage of components required to for assembly, failure to maintain or obtain regulatory approvals, unexpected or serious complications or other unforeseen negative effects related to the SRT-100 product line and ancillary products, we would lose our only source of revenue, and our business, financial condition and results of operations will be adversely affected.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We may be unable to manufacture our products in quantities sufficient to meet existing demand levels, which would hinder our ability to effectively commercialize our products and increase revenues.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The manufacture of medical devices requires significant expertise and capital investment, including the development of advanced manufacturing techniques and process controls, from us and our key suppliers, to scale up the production process to manufacture sufficient quantities at high volume and with satisfactory production yields. Manufacturers of medical devices often encounter difficulties in production, particularly when scaling up initial production. These problems include difficulties with production costs and yields, quality control and assurance, and shortages of qualified personnel, as well as compliance with strictly
	enforced federal, state and foreign regulations.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In July 2010, we entered into a manufacturing agreement with an unrelated third party for manufacturing and production of the SRT-100 in accordance with our specifications. We continue to do business with the manufacturer pursuant to this agreement, although we or the manufacturer may terminate the agreement with 90 days&#146; written notice or upon at least 60 days&#146; notice prior to the end of each additional one-year renewal period. As discussed elsewhere in this prospectus, we are exploring the possibility of using a portion of the proceeds of this offering to begin reducing our reliance on third party manufacturers by
	bringing certain manufacturing capabilities in-house. However, if eventually implemented, our plan to bring the manufacturing function in-house may not be successful and we may be unable to maintain a relationship with our current manufacturer or establish a relationship with another manufacturer on favorable terms, if at all.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Consequently, we may not, with our third party suppliers, be able to continue to efficiently manufacture our products in sufficient quantities to meet projected demand or to establish sufficient worldwide inventory to fully support our distribution network. Any of these results could cause us to be unable to effectively commercialize our products or increase revenue, adversely affecting our business, financial condition, results of operations and the value of our common stock.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We have a single preferred supplier for the x-ray tubes used in our products and the loss of this preferred supplier could adversely affect us.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We have a single preferred supplier for the x-ray tubes used in our products, although other suppliers exist in the market. The loss of this preferred supplier, or their inability to supply us or our third party manufacturer with adequate components, could hinder our ability to effectively produce our products to meet existing demand levels, especially if we were unable to timely procure x-ray tubes from another supplier in the market, which could adversely affect our ability to commercialize our products and increase our revenues.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	15
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage22"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We may be unable to retain and develop our U.S. sales force and non-U.S. distributors, which would adversely affect our ability to meet our revenue targets and other goals.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	As we launch products, increase current sales efforts and expand into new geographies, we will need to retain, grow and develop our direct sales personnel, distributors and agents. There is significant competition for sales personnel experienced in relevant medical device sales. In addition, the training process is lengthy because it requires significant education for new sales representatives to achieve an acceptable level of clinical competency with our products. Upon completion of training, sales representatives typically require lead time in the field to develop or expand their network of accounts and achieve the
	productivity levels we expect them to reach in any individual territory. If we are unable to attract, motivate, develop, and retain a sufficient number of qualified sales personnel, or if the sales representatives do not achieve the productivity levels expected, our revenue will not grow as expected, and our financial performance will suffer.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In addition, we may not succeed in entering into and maintaining productive arrangements with an adequate number of distributors outside of the U.S. that are sufficiently committed to selling our products in international markets. The establishment and maintenance of a distribution network is expensive and time consuming. Even if we engage and maintain suitable relationships with an adequate number of distributors, they may not generate revenue as quickly as we expect them to, commit the necessary resources to effectively market and sell our products, or ultimately succeed in selling our products. Moreover, if our sales force
	and distributors are unable to attract and retain new customers, we may be unable to achieve our expected growth, and our business could suffer.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Furthermore, some of our distributors may market or sell the products of our competitors. In these cases, the competitors may have the ability to influence the products that our distributors choose to market and sell, for example, by offering higher commission payments, or by convincing the distributors to terminate their relationships with us, carry fewer of our products or reduce their sales and marketing efforts for our products. Any of the foregoing would hinder our ability to meet our revenue targets and other goals.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The future worldwide demand for our current products and our future products is uncertain. Our current products and our future products may not be accepted by hospitals, physicians or patients, and may not become commercially successful.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Physicians and hospitals may not perceive the benefits of our products and may be reluctant or unwilling to adopt our products as a treatment option, particularly in light of existing treatment options, such as Mohs surgery or high dose rate brachytherapy. Additionally, physicians and hospitals may not be aware of the significant advances in technology associated with superficial radiation therapy compared to older technology that was previously used with orthovoltage. While we believe that our products are an efficient and less invasive alternative to other treatments of non-melanoma skin cancer and other skin conditions,
	physicians who are accustomed to using other modalities to treat patients with either non-melanoma skin cancer, keloids or other skin conditions may be reluctant to adopt broad use of our superficial radiotherapy products.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We must grow markets for our products through physician education and awareness programs. Publication in peer-reviewed medical journals of results from studies using our products will be an important consideration in their adoption by physicians and in reimbursement decisions of third-party payors. The process of publication in leading medical journals is subject to a peer-review process. Peer reviewers may not consider the results of studies of our products and any future products sufficiently novel or worthy of publication. Failure to have studies of our products published in peer reviewed journals may adversely affect
	adoption of our products.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Educating physicians and hospitals on the benefits of our products and advancements in superficial radiation technology requires a significant commitment by our marketing team and sales organization. Our products may not become widely accepted by physicians and hospitals. If we are unable to educate physicians and hospitals about the advantages of our products, do not achieve significantly greater market acceptance of our products, do not gain momentum in our sales activities, or fail to significantly grow our market share, we will be unable to grow our revenue, and our business and financial condition will be adversely
	affected.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	16
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage23"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We are in a highly competitive market segment, which is subject to rapid technological change. If our competitors are able to develop and market products that are more effective, less costly, easier to use or otherwise more attractive than any of our products, our business will be adversely impacted.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The medical device industry is highly competitive and subject to technological change. In the arena for technology and products for use in the treatment of non-melanoma skin cancer and other skin conditions, we have three primary competitors, one of which operates in the superficial radiotherapy space largely in the European market, and the other two of which operate in the brachytherapy space in both the U.S. and internationally. While we believe our SRT-100 and related products currently have certain competitive advantages over the products offered by these competitors, our success depends, in part, upon our ability to
	maintain this competitive position. If these competitors improve their existing products, develop new products, or expand their operations, we may be unable to maintain our competitive advantages over these competitors.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Furthermore, new competitors, including companies larger than us, may enter the market in the future and may offer products with similar or alternative functionalities. These companies may enjoy several advantages relative to us, including:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	greater financial and human resources for product development, sales and marketing;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	greater name recognition;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	long-established relationships with physicians and hospitals;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	the ability to offer rebates or bundle multiple product offerings to offer greater discounts or incentives;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	more established distribution channels and sales and marketing capabilities; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	greater experience in and resources for conducting research and development, clinical studies, manufacturing, preparing regulatory submissions, obtaining regulatory clearance or approval for products and marketing cleared products.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Hospitals, physicians and investors may not view our products as competitive with other products that are marketed and sold by new competitors, including much larger and more established companies. Our competitors may develop and patent processes or products earlier than we do, obtain regulatory clearance or approvals for competing products more rapidly than us or develop more effective, more convenient or less expensive products or technologies that render our technology or products obsolete or less competitive. If our existing or new competitors are more successful than us in any of these matters, our business may be harmed.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Our customers are concentrated in the U.S. and China, and economic difficulties or changes in the purchasing policies or patterns of our customers in these countries could have a significant impact on our business and operating results.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Substantially all of our 2014 and 2015 sales were made to customers located in the U.S. and China. For the year ended December 31, 2015 and for the three months ended March 31, 2016, approximately 14% and 20%, respectively, of our product sales were to Chinese customers, with substantially the remainder of our sales to customers in the U.S. Because of our geographic concentrations, our revenue could fluctuate significantly due to changes in economic conditions, the use of competitive products, or the loss of, reduction of business with, or less favorable terms within, these countries. A reduction or delay in orders for our
	products from these countries could materially harm our business and results of operations.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Our future success depends on our ability to develop, receive regulatory approval for, and introduce new products or product enhancements that will be accepted by the market in a timely manner, and if we do not do so, our results of operations will suffer.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	It is important to our business that we continue to build a pipeline of product offerings for the treatment of non-melanoma skin cancer and other skin conditions to remain competitive. Consequently, our success will depend in part on our ability to develop and introduce new products. However, we may be unable to successfully maintain our regulatory clearance for existing products, or develop, obtain and maintain
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	17
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage24"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	regulatory clearance or approval for product enhancements, or new products, or these products may not be accepted by physicians or the payors who financially support many of the procedures performed with our products.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The success of any new product offering or enhancement to an existing product will depend on several factors, including our ability to:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	identify and anticipate physician and patient needs properly;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	develop and introduce new products or product enhancements in a timely manner;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	avoid infringing the intellectual property rights of third parties;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	demonstrate the safety and efficacy of new products with data;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	obtain the necessary regulatory approvals for new products or product enhancements;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	comply fully with U.S. Food and Drug Administration and applicable foreign government agencies&#146; regulations on marketing of new devices or modified products;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	provide adequate training to potential users of our products; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	receive coverage and adequate reimbursement for procedures performed with our products.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	If we do not develop new products or product enhancements in time to meet market demand, if there is insufficient demand for these products or enhancements, or if competitors introduce new products with enhanced functionalities that are superior to those of ours, then our results of operations will suffer.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Our products may become obsolete prior to the end of their anticipated useful lives, and we may be required to dispose of existing inventory or write off the value or accelerate the depreciation of the these assets, each which would materially and adversely impact our results of operations.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We focus on continual product innovation and product improvement. While we believe this provides a competitive edge, it also results in the risk that our products will become obsolete prior to the end of their anticipated useful lives. If we introduce new products or next-generation products prior to the end of the useful life of a prior generation, we may be required to dispose of existing inventory, or write off the value of the these assets, each which would materially and adversely impact our results of operations.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Our success is dependent in large part on our being an early re-entrant into the market for our proprietary superficial radiotherapy systems, and if one or more competitors join us in the market, our marketing efforts and ability to compete would be materially and adversely affected.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our success is dependent in large part on our being an early re-entrant into the market for our proprietary superficial radiotherapy systems. If one or more competitors join us in the market, the increased competition would require us to devote substantial additional resources to our marketing efforts, and our ability to compete may be severely impaired.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Our international operations subject us to certain operating risks, which could adversely impact our results of operations and financial condition.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The sale and shipment of our products across international borders, as well as the purchase of components from international sources, subjects us to U.S. and foreign governmental trade, import and export, and customs regulations and laws. Compliance with these regulations and laws is costly and exposes us to penalties for non-compliance. Other laws and regulations that can significantly impact us include various anti-bribery laws, including the U.S. Foreign Corrupt Practices Act and anti-boycott laws, as well as export control laws. Any failure to comply with applicable legal and regulatory obligations could impact us in a
	variety of ways that include, but are not limited to, significant criminal, civil and administrative penalties, including imprisonment of individuals, fines and penalties, denial of export privileges, seizure of shipments, restrictions on certain business activities and exclusion or debarment from government contracting. Also, the failure to comply with applicable legal and regulatory obligations could result in the disruption of our shipping and sales activities. Any of the foregoing would adversely impact our results of operations and financial condition.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	18
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage25"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our international operations and our international distributors expose us to risks inherent in operating in foreign jurisdictions. These risks include, without limitation:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	difficulties in enforcing or defending intellectual property rights;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	pricing pressure that we may experience internationally;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	a shortage of high-quality sales people and distributors;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	third-party reimbursement policies that may require some of the patients who are treated with our products to directly absorb medical costs or that may necessitate the reduction of the selling prices of our products;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	disadvantage to competition with established business and customer relationships;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	the imposition of additional U.S. and foreign governmental controls or regulations;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	economic instability;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	changes in duties and tariffs, license obligations and other non-tariff barriers to trade;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	the imposition of restrictions on the activities of foreign agents, representatives and distributors;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	potentially adverse tax consequences;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	laws and business practices favoring local companies;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	difficulties in maintaining consistency with our internal guidelines;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	the imposition of costly and lengthy new export licensing requirements;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	the imposition of U.S. or international sanctions against a country, company, person or entity with whom we do business that would restrict or prohibit continued business with the sanctioned country, company, person or entity; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	the imposition of new trade restrictions.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	If any of these events or circumstances were to occur, our sales in foreign countries would be harmed and our results of operations would suffer.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Our operating results may vary significantly from quarter to quarter, which may negatively impact the value of our securities.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our quarterly revenues and results of operations may fluctuate due to the following reasons, among others:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	physician and hospital acceptance of our products;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	the timing, expense and results of research and development activities, and obtaining future regulatory approvals;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	fluctuations in expenses associated with expanding operations;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	the introduction of new products and technologies by competitors;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	sales representatives&#146; productivity;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	supplier, manufacturing or quality problems with products;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	the timing of stocking orders from distributors;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	changes in our pricing policies or in the pricing policies of competitors or suppliers; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	changes in third-party payors&#146; reimbursement policies.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Because of these and other related or similar factors, it is likely that in some future period our operating results will not meet your expectations.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	19
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage26"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We may be unable to attract and retain highly qualified personnel, which could adversely and materially affect our competitive position.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our future success depends on our ability to attract and retain our executive officers and other key employees. We may be unable to attract or retain qualified management and other key personnel in the future due to the intense competition for qualified personnel among companies in the medical device business and related industries, particularly in the South Florida area where we are headquartered. The medical device industry has experienced a high rate of turnover of management personnel in recent years. Consequently, we could have difficulty attracting or retaining experienced personnel and may be required to spend
	significant time and expend significant financial resources in our employee recruitment and retention efforts. Many of the other medical device companies with which we compete for qualified personnel have greater financial and other resources and risk profiles different from ours. They also may provide more diverse opportunities and better chances for career advancement. Some of these characteristics may be more appealing to high quality candidates than that which we may offer. If we are unable to attract and retain the necessary personnel to accomplish our business objectives, we may have difficulty implementing our business strategy and achieving our business objectives.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	If we acquire other companies or businesses, we will be subject to risks that could hurt our operations in the future.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We may in the future acquire complementary businesses, products or technologies. Any acquisition may not produce the revenues, earnings or business synergies anticipated, and any acquired business, product or technology might not perform as expected. Our management could spend a significant amount of time, effort and money in identifying, pursuing and completing acquisitions. If we complete an acquisition, we may encounter significant difficulties and incur substantial expenses in integrating the operations and personnel of the acquired company into our operations. In particular, we may lose the services of key employees of
	the acquired company, and we may make changes in management that impair the acquired company&#146;s relationships with employees, vendors and customers. Additionally, we may acquire development-stage companies that are not yet profitable and require continued investment, which could decrease our future earnings or increase our futures losses. Any of these outcomes could prevent us from realizing the anticipated benefits of an acquisition.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	To pay for an acquisition, we might use equity or cash. Alternatively, we might borrow money from a bank or other lender. If we use equity, our stockholders would experience dilution of their ownership interests. If we use cash or debt financing, our financial liquidity would be reduced.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Any acquisition could result in recording significant amounts of goodwill or other intangible assets, some of which could result in significant quarterly amortization expense. Moreover, if we determine during annual reviews or otherwise that an intangible asset has been impaired, we may need to write off some or all of its carrying value, resulting in large charges to expense. Amortization charges and write-downs or write-offs of intangibles would decrease our future earnings or increase our future losses.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Product liability claims could damage our reputation and adversely affect our business.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The design, manufacture and marketing of medical devices each carry an inherent risk of product liability claims and other damage claims. In addition to the exposure we may have for defective products, physicians may misuse our products or use improper techniques, regardless of how well trained, potentially leading to injury and an increased risk of product liability. A product liability or other damages claim, product recall or product misuse could require us to spend significant time and money in litigation, regardless of the ultimate outcome, or to pay significant damages and could seriously harm our business.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We maintain liability insurance coverage that management believes to be reasonable based on our business and operations; however, our insurance may not be sufficient to cover all claims made against us. Our insurance policies generally must be renewed on an annual basis. We may be unable to maintain or increase insurance on acceptable terms or at reasonable costs. A successful claim brought against us in excess, or outside of, our insurance coverage could seriously harm our financial condition or results of operations.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	20
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage27"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We may be required to obtain additional funds in the future, and these funds may not be available on acceptable terms or at all.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our operations have consumed substantial amounts of cash since inception, and we anticipate that our expenses will increase as we continue to grow our business. We may need to seek additional capital in the future. Our growth will depend, in part, on our ability to develop variations of the SRT-100 and other products, and related technology complementary to our products. Our existing financial resources, including our existing revolving line of credit, may not allow us to conduct all of the activities that we believe would be beneficial for our future growth.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We may need to seek funds in the future. Our existing revolving line of credit restricts our ability to incur certain indebtedness or permit certain encumbrances on our assets without the prior written consent of the lender. If we are unable to raise funds on favorable terms, or at all, we may not be able to support our commercialization efforts or increase our research and development activities or meet our debt and other contractual obligations, and the growth of our business may be negatively impacted. As a result, we may be unable to compete effectively.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our cash requirements in the future may be significantly different from our current estimates and depend on many factors, including:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	the results of commercialization efforts for products;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	the need for additional capital to fund development programs;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	the costs involved in obtaining and enforcing patents or any litigation by third parties regarding intellectual property;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	the establishment of high-volume manufacturing and increased sales, marketing and distribution capabilities; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	success in entering into collaborative relationships with other parties.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We may be unable to raise funds on favorable terms, or at all, and either case would materially and adversely affect our ability to implement our strategy and meet our goals.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	To the extent that we raise additional capital through the sale of equity or convertible debt securities, stockholders&#146; ownership interest will be diluted, and the terms may include liquidation or other preferences that adversely affect common stockholders&#146; rights. Debt financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions such as incurring additional debt, making capital expenditures or declaring distributions or dividends. If we raise additional funds through collaboration and licensing arrangements with third parties, we may have to
	relinquish valuable rights to our technologies or products or grant licenses on terms that are not favorable to us. Any of these events could adversely affect our ability to declare dividends on our common stock and to achieve our product development and commercialization goals and have a material adverse effect on our business, financial condition and results of operations.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Our revolving credit facility imposes substantial restrictions on us, some of which could hinder our ability to conduct our operations effectively or otherwise in accordance with our business plan.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In March 2013, we entered into a $3.0 million revolving credit facility, which was amended in March 2015 to extend the facility and to reduce the facility to $1.5 million. The maximum borrowing is limited by our Eligible Borrowing Base, equal to 80% of eligible accounts receivable as defined in the facility agreement. Under the facility agreement, we must pay monthly interest a rate of the Prime Rate plus 1.75%, and must pay any outstanding principal and interest on or before May 12, 2017, the maturity date. The facility is secured by all of our assets and requires the maintenance of an Adjusted Quick Ratio and Minimum
	Quarterly EBITDA, as those terms are defined in the facility agreement. We were not in compliance with certain of these financial covenants as of October 31, 2015 and November 30, 2015, but we received a formal waiver from the bank in February 2016 for our noncompliance. Pursuant to our loan agreement, the March 31, 2016 covenant requirements and each quarter thereafter are based on review of our 2016 board approved plan which has not yet occurred. We are in the process of re-negotiating the terms of the loan agreement with our
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	21
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage28"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	lender and believe we are in compliance with all covenant requirements as of March 31, 2016. See &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&nbsp;&#151;&nbsp;Indebtedness.&#148;
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Additionally, the facility agreement contains a number of negative covenants that require us to seek the lender&#146;s prior written consent in order to conduct certain activities. For example, we may not, without the prior written consent of the lender:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Sell or otherwise transfer all or any part of our business or property, except for transfers in the ordinary course of business or as otherwise permitted by the facility agreement;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Change the nature of our business, liquidate or dissolve, undergo a change in management;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Add any new offices or business locations, including warehouses;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Change our jurisdiction of organization, our organizational structure or type, our legal name or any organizational number assigned to us;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Merge or consolidate with any other person or entity or acquire all or substantially all of the capital stock or property of another person or entity;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Create, incur or be liable for any indebtedness other than as permitted by the facility agreement;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Create, incur, or suffer any lien on any of our property (including receivables) other than as permitted by the facility agreement;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Maintain any operating or deposit or security accounts other than with the lender or any of its affiliates;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Pay any dividends or make any distribution or payment or redeem, retire or purchase any capital stock, except that we may pay dividends solely in common stock; or
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Directly or indirectly make any investment, including, without limitation, by the formation of any subsidiary, other than as permitted by the facility agreement.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In the event we wish to conduct any of the foregoing activities and the lender refuses to provide its prior written consent, our ability to conduct our operations effectively and in accordance with our business plan could be materially and adversely affected.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Approximately $800,000 was outstanding under the revolving credit facility as of March 31, 2016.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	If we are unable to make scheduled interest or principal payments on our present or future debt obligations, our operations could be adversely affected.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our ability to make scheduled payments on our debt obligations (including the credit facility discussed above) depends on numerous factors, including the amount of cash balances and actual and projected financial and operating performance. These amounts and performance are subject to certain financial and business factors, as well as prevailing economic and competitive conditions, some of which may be beyond our control. We may be unable to maintain a level of cash balances or cash flows from operating activities sufficient to permit ourselves to pay the principal and interest on existing or future indebtedness. If cash flows
	and capital resources are insufficient to fund debt service obligations, we may be forced to reduce or delay capital expenditures, sell assets or operations, seek additional capital or restructure or refinance our indebtedness. We may be unable to take any of these actions, and even if able, these actions may be insufficient to permit us to meet scheduled debt service obligations. In addition, in the event of our breach of any credit agreements, we may be unable to draw additional amounts under the agreements, and we may be required to repay any outstanding amounts earlier than anticipated.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	If an event of default occurs under any debt obligation, the lender may declare the outstanding principal balance and accrued but unpaid interest owed to it immediately due and payable, which would have a material adverse effect on our financial position. We may not have sufficient cash to satisfy this obligation. Also, if a default occurs under a secured loan (such as the credit facility described above), and we are unable to repay the lender, the lender could seek to enforce its rights under its security interests in our assets. In this event, we may lose or be forced to sell some or all of our assets to satisfy the debt,
	which could cause the business to fail.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	22
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage29"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our debt and other contractual obligations could have significant additional negative consequences, including, without limitation:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	increasing vulnerability to general adverse economic conditions;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	limiting ability to obtain additional funds; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Placing us or our business at a possible competitive disadvantage to less leveraged competitors and competitors that have better access to capital resources.
</TD>
</TR>
</TABLE>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	If we fail to properly manage our anticipated growth, our business could suffer.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our strategy involves substantial growth. If we experience periods of rapid growth and expansion, our limited personnel, operational infrastructure and other resources could be significantly strained. In particular, the possible internalization of manufacturing, and anticipated expansion of our direct sales force in the U.S. will require significant management, financial and other supporting resources. In addition, in order to manage expanding operations, we will need to continue to improve our operational and management controls, reporting and information technology systems and financial internal control procedures. If we are
	unable to manage our growth effectively, it may be difficult for us to execute our business strategy and our operating results and business could suffer. Any failure by us to manage our growth effectively could have an adverse effect on our ability to achieve our goals.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	To achieve our revenue goals, we must successfully increase production output to meet projected customer demand. We may be unable to increase output on the timeline anticipated, if at all. Also, we may in the future experience difficulties with production yields and quality control, component supply, and shortages of qualified personnel, among other problems. These problems could result in delays in product availability and increases in expenses. Any delay or increased expense could adversely affect our ability to increase revenues.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Cost-containment efforts of our customers, purchasing groups and governmental organizations could have a material adverse effect on our sales and profitability.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In an effort to reduce costs, many hospitals or physicians within the U.S. and abroad are members of group purchasing organizations and integrated delivery networks. Group purchasing organizations and integrated delivery networks negotiate pricing arrangements with medical device companies and distributors and offer the negotiated prices to affiliated hospitals, physicians and other members. Group purchasing organizations and integrated delivery networks typically award contracts on a category-by-category basis through a competitive bidding process. Bids are generally solicited from multiple providers with the intention of
	driving down pricing or reducing the number of vendors. Due to the highly competitive nature of the group purchasing organizations and integrated delivery networks contracting processes, we may be unable to obtain or maintain contract positions with major group purchasing organizations and integrated delivery networks. Furthermore, the increasing leverage of organized buying groups may reduce market prices for our products, thereby reducing our profitability.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	While having a contract with a group purchasing organizations or integrated delivery networks for a given product category can facilitate sales to members of that group purchasing organizations or integrated delivery networks, expected sales levels may not be achieved, as sales are typically made pursuant to purchase orders. Even when a provider is the sole contracted supplier of a group purchasing organization or integrated delivery network for a certain product category, members of the group purchasing organization or integrated delivery network generally are free to purchase from other suppliers. Furthermore, group
	purchasing organizations and integrated delivery networks contracts typically are terminable without cause by the group purchasing organizations or integrated delivery networks upon 60 to 90 days&#146; notice. Accordingly, even if we obtain contracts with any group purchasing organizations or integrated delivery networks, the members of these groups may choose to purchase from our competitors due to the price or quality offered by competitors, which could result in a decline in our sales and profitability.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	23
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage30"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We depend on information technology systems to operate our business and a cyber-attack or other breach of these systems could have a material adverse effect on our business.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We rely on information technology systems to process, transmit and store electronic information in our day-to-day operations. Our information technology systems could be vulnerable to a cyber-attack, malicious intrusion, breakdown, destruction, loss of data privacy or other significant disruption. Any successful attacks could result in the theft of intellectual property or other misappropriation of assets, or otherwise compromise our confidential or proprietary information or disrupt our operations. Cyber-attacks are becoming more sophisticated and frequent, and our systems could be the target of malware and other
	cyber-attacks. We have invested in our systems and the protection of our data to reduce the risk of an intrusion or interruption, and we monitor our systems on an ongoing basis for any current or potential threats.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	However, these measures and efforts may not prevent interruptions or breakdowns, and we may otherwise fail to maintain or protect our information technology systems and data integrity effectively. Furthermore, we may fail to anticipate, plan for or manage significant disruptions to our systems. If any of the foregoing were to occur, our competitive position could be harmed, we could lose existing customers, have difficulty preventing, detecting and controlling fraud, have disputes with customers, specialist physicians and other healthcare professionals, have regulatory sanctions or penalties imposed, incur expenses or lose
	revenues as a result of a data breach or theft of intellectual property or suffer other adverse consequences, any of which could have a material adverse effect on our business, results of operations, financial condition or cash flows.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Risks Related to our Regulatory Environment
</FONT>
</H2>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We are subject to various federal, state and foreign healthcare laws and regulations, and a finding of failure to comply with these laws and regulations could have a material adverse effect on our business.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our operations are, and will continue to be, directly and indirectly affected by various federal, state and foreign healthcare laws, including, but not limited to, those described below.
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Federal Anti-Kickback Statute (42 U.S. Code &sect;1320a-7b), which prohibits any person or entity from knowingly and willfully offering, paying, soliciting or receiving any remuneration, directly or indirectly, in cash or in kind, in return for or to induce the referring, ordering, leasing, purchasing or arranging for or recommending the referring, ordering, purchasing or leasing of any good, facility, item or service, for which payment may be made, in whole or in part, under federal healthcare programs, such as the Medicare and Medicaid programs.
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Federal &#147;Sunshine&#148; (42 U.S. Code &sect;1320a-7h) law, which requires us to track and report annually to Centers for Medicare and Medicaid Services information related to certain payments and other &#147;transfers of value&#148; provided to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals and to report annually to Centers for Medicare and Medicaid Services ownership and investment interests held by physicians, and their immediate family members. We are also subject to similar foreign &#147;sunshine&#148; laws or codes of conduct, which vary country by country.
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Federal civil and criminal false claims laws and civil monetary penalty laws, which prohibit, among other things, persons or entities from knowingly presenting, or causing to be presented, a false or fraudulent claim to, or the knowing use of false records or statements to obtain payment from, or approval by, the federal government. Suits filed under the False Claims Act, known as &#147;qui tam&#148; actions, can be brought by any individual on behalf of the government and such individuals, commonly known as &#147;whistleblowers,&#148; may share in any amounts paid by the entity to the government in fines or settlement. When an entity is determined to have violated the False Claims Act (31 U.S. Code &sect;3729-3733), it may be required to pay up to three times the actual damages sustained by the government, plus civil penalties for each separate false claim.
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, statute, which, among other things, created federal criminal laws that prohibit knowingly and willfully executing, or attempting to execute, a scheme or artifice to defraud any healthcare benefit program and knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statements in connection with the delivery of or payment for healthcare
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	24
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage31"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX; TEXT-ALIGN: LEFT">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	benefits, items or services. Additionally, HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, and applicable implementing regulations, impose certain requirements relating to the privacy, security and transmission of individually identifiable health information without appropriate authorization on entities subject to the law, such as health plans, clearinghouses, and healthcare providers and their business associates. Internationally, substantially every jurisdiction in which we operate has established its own data security and privacy legal framework with which we must comply, including the Data Protection Directive 95/46/EC and national implementation of the Directive in the member states of the European Union.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Many states have also adopted laws similar to each of the above federal laws, such as anti-kickback and false claims laws, which may be broader in scope and apply to items or services reimbursed by any third-party payor, including commercial insurers, as well as laws that restrict our marketing activities with healthcare professionals and entities, and require us to track and report payments and other transfers of value, including consulting fees, provided to healthcare professionals and entities. Some states mandate implementation of compliance programs to ensure compliance with these laws. Additionally, certain states
	require a certificate of need prior to the installation of a radiation device, such as the SRT-100. We are also subject to foreign fraud and abuse laws, which vary by country.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	If our operations are found to be in violation of any of the laws described above or any other governmental regulations that apply to us now or in the future, we may be subject to penalties, including administrative, civil and criminal penalties, damages, fines, disgorgement, individual imprisonment, contractual damages, reputational harm, exclusion from governmental healthcare programs, and the curtailment or restructuring of our operations. Any of the foregoing could adversely affect our ability to operate our business and our financial results.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Our products are subject to extensive governmental regulation that could make it more expensive and time consuming for us to introduce new or improved products.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our products must comply with regulatory requirements imposed by the U.S. Food and Drug Administration, the U.S. Department of Health and Human Services and other governmental agencies in the U.S., and similar agencies in foreign jurisdictions. These requirements involve lengthy and detailed laboratory and clinical testing procedures, sampling activities, an extensive agency review process, and other costly and time-consuming procedures. It often takes several years to satisfy these requirements, depending on the complexity and novelty of the product. If we execute on our plans to move our manufacturing function in-house, we
	will also be subject to additional licensing and regulatory requirements relating to safe working conditions, manufacturing practices, environmental protection, fire hazard control, and disposal of hazardous or potential hazardous substances. Some of the most important requirements applicable or potentially applicable to us include:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	U.S. Food and Drug Administration Regulations (Title 21 CFR, Parts 801, 803, 806, 807 and 820);
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	EU CE marking of conformity requirements depicted within the MDD (Directive 90/425/EEC);
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Health Canada requirements (SOR/98-282);
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Medical Device Quality Management System requirements (ISO 13485:2003);
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Occupational Safety and Health Administration requirements;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	China CFDA requirements; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Other similar quality, regulatory and statutory requirements in foreign jurisdictions in which we currently market or plan to market our products in the future.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Additionally, due to the nature of our products as radiation producing medical devices, we are also subject to certain state laws and regulations related to the sale of our products. Although we have taken steps to ensure our compliance with such state laws and regulations, our failure to fully comply with these requirements could result in fines or penalties and could also adversely affect our ability to sell our products.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Government regulation may impede our ability to the manufacture our existing and future products. Government regulation also could delay the marketing of new products for a considerable period of time and
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	25
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage32"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	impose costly procedures on activities. The U.S. Food and Drug Administration and other regulatory agencies may not clear or approve any future products on a timely basis, if at all. Any delay in obtaining, or failure to obtain, these approvals could negatively impact the marketing of any future products and reduce our product revenues. Regulatory bodies may review products once they are on the market and determine that they do not satisfy applicable regulatory requirements. Failure to comply with requisite requirements may lead to European Economic Area regulatory bodies ordering the suspension or withdrawal of products from
	the European Economic Area market or, as discussed below, notified bodies withdrawing certificates of conformity for devices or the underlying quality systems.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Further, regulations may change, and any additional regulation could limit or restrict our ability to use any of our technologies, which could harm our business. We could also be subject to new international, federal, state or local regulations that could affect our research and development programs and harm our business in unforeseen ways.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Product deficiencies could result in field actions, recalls, substantial costs or write-downs; these could lead to the delay or termination of ongoing trials, if any, and harm our reputation, business or financial results.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our products are subject to various regulatory guidelines and involve complex technologies. The U.S. Food and Drug Administration and similar foreign governmental authorities have the authority to require the recall of commercialized products in the event of material deficiencies or defects in design or manufacture that could affect patient safety. Manufacturers may, under their own initiative, conduct a product notification or recall to inform physicians of changes to instructions for use or if a deficiency in a device is found or suspected.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Identified quality problems, such as failure of critical components, or the failure of third parties to supply us with sufficient conforming quantities of these products or components, could impact the availability of our products in the marketplace or lead to adverse clinical events. In addition, product improvements or product redundancies could result in scrapping or expensive rework of products, and our business, financial condition or results of operations could suffer as a result. Product complaints, quality issues and necessary corrective and preventative actions could result in communications to customers or patients,
	field actions, require the scrapping, rework, recall or replacement of products, result in substantial costs or write-offs, or harm our business reputation and financial results. Further, these events could adversely affect our relationships with our customers or affect our reputation, which could materially adversely affect our earnings, results and financial viability.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	A future field action or recall announcement could harm our reputation with customers, negatively affect our sales, and subject us to U.S. Food and Drug Administration (or similar governmental authority) enforcement actions. Moreover, depending on the corrective action we take to redress a product&#146;s deficiencies or defects, the U.S. Food and Drug Administration (or similar governmental authority) may require, or we may decide, that we will need to obtain new approvals or clearances for the product before we market or distributes the corrected product. Seeking these approvals or clearances may delay our ability to replace
	the recalled products in a timely manner. If we do not adequately address problems associated with our products, we may face additional regulatory enforcement action, including U.S. Food and Drug Administration (or similar governmental authority) warning letters, product seizures, injunctions, administrative penalties, or civil or criminal fines.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Any identified quality issue can both harm our business reputation and result in substantial costs and write-offs, which in either case could materially harm our business and financial results.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The off-label use or misuse of our products may harm our image in the marketplace, result in injuries that lead to costly product liability suits, or result in costly investigations and regulatory agency sanctions under certain circumstances.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The products we currently market in the U.S. have been cleared by the U.S. Food and Drug Administration for specific indications. Our clinical support staff and marketing and sales force have been trained not to promote our products for uses outside of the cleared indications for use, known as &#147;off-label uses.&#148; However, if a physician uses our products outside the scope of the cleared indications, there may be increased risk of injury to patients. Furthermore, the use of our products for indications other than those
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	26
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage33"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	cleared by the U.S. Food and Drug Administration may not effectively treat the conditions associated with the off-label use, which could harm our reputation in the marketplace among physicians and patients, adversely affecting our operations.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	If the U.S. Food and Drug Administration determines that our promotional materials or training constitute promotion of an off-label or other improper use, it could request that we modify our training or promotional materials, or subject us to regulatory or enforcement actions, including the issuance of an untitled letter, a warning letter, injunction, seizure, civil fine or criminal penalties. It is also possible that other federal, state or foreign enforcement authorities might take action if they consider our business activities to constitute promotion of an off-label use, which could result in significant penalties,
	including, but not limited to, criminal, civil or administrative penalties, damages, fines, disgorgement, exclusion from participation in government healthcare programs, and the curtailment of our operations. Any of these events could significantly harm our business and results of operations.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The advertising and promotion of our products is subject to European Economic Area Member States governing the advertising and promotion of medical devices. In addition, voluntary European Union and national Codes of Conduct provide guidelines on the advertising and promotion of our products to the general public and may impose limitations on promotional activities with healthcare professionals. These regulations or codes may limit our ability to affectively market our products, or we could run afoul of the requirements imposed by these regulations, causing reputational harm, imposing potentially substantial costs, and
	adversely affecting our operations as a result.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We are required to comply with medical device reporting requirements and must report certain malfunctions, deaths, and serious injuries associated with our products, which can result in voluntary corrective actions or agency enforcement actions.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Under the U.S. Food and Drug Administration medical device reporting regulations (21 CFR 803), medical device manufacturers are required to submit information to the U.S. Food and Drug Administration when they receive a report or become aware that a device has or may have caused or contributed to a death or serious injury or has or may have a malfunction that would likely cause or contribute to death or serious injury if the malfunction were to recur. All manufacturers placing medical devices on the market in the European Economic Area are legally bound to report any serious or potentially serious incidents involving devices
	they produce or sell (MEDDEV 2.12-1) to the Competent Authority in whose jurisdiction the incident occurred through the European Vigilance process.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	If an event subject to medical device reporting requirements occurs, we will need to comply with the reporting requirements, which would adversely affect our reputation and subject us to actions by regulatory authorities, such as ordering recalls, imposing fines, or seizing the affected products. Furthermore, any corrective action, whether voluntary or involuntary, will require the dedication of time and capital and will distract management from operating our business. Any of the foregoing would further harm our reputation and financial results.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Healthcare policy changes, including recent federal legislation to reform the U.S. healthcare system, may have a material adverse effect on our business.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In March 2010, President Obama signed the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act. This Act includes, among other things, a deductible 2.3% excise tax on any entity that manufactures or imports medical devices offered for sale in the U.S., with limited exceptions, effective January 1, 2013. This excise tax imposed a significant increase in the tax burden on the medical device industry, and if our efforts to offset the excise tax are unsuccessful, the increased tax burden could have an adverse effect on our results of operations and cash flows. However, this
	excise tax has recently been suspended for 2016 and 2017. Other elements of this Act, including comparative effectiveness research, an independent payment advisory board, payment system reforms including shared savings pilots and other provisions, may significantly affect the payment for, and the availability of, healthcare services and may result in fundamental changes to federal healthcare reimbursement programs, any of which may materially affect numerous aspects of our business.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	27
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage34"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Other healthcare reform measures may result in more rigorous coverage criteria and in additional downward pressure on the reimbursement received for procedures utilizing our products. In addition, other legislative changes have been proposed and adopted since the Act discussed above was enacted that may adversely affect our revenues. These changes include aggregate reductions to Medicare payments to providers of up to 2% per fiscal year effective April 2013 which, due to subsequent legislative amendments to the statute, will stay in effect through 2024 unless additional Congressional action is taken. Additionally, in January
	2013, President Obama signed into law the American Taxpayer Relief Act of 2012, which, among other things, reduced Medicare payments to several providers, and increased the statute of limitations period for the government to recover overpayments to providers from three to five years. These new laws may result in additional reductions in Medicare and other healthcare funding, which could have a material adverse effect on our business and financial operations. Any reduction in reimbursement from Medicare or other government programs may result in a similar reduction in payments from private payors. The implementation of cost containment measures or other healthcare reforms may prevent us from being able to increase revenue, attain profitability, or commercialize our devices. In addition, other legislative changes may be enacted or existing regulations, guidance or interpretations may be changed, each of which may adversely affect our operations.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Risks Related to our Intellectual Property
</FONT>
</H2>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	If our patents and other intellectual property rights do not adequately protect our products, we may lose market share to competitors and be unable to operate our business profitably.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our success depends significantly on our ability to protect our proprietary rights to the technologies used in our products. We rely on the patent protection of two U.S. patents which we have acquired, as well as a combination of copyright, trade secret and trademark laws, and nondisclosure, confidentiality and other contractual restrictions to protect our proprietary technology. We also have one patent application currently pending and have filed two provisional patent applications. However, these legal means afford only limited protection and may not adequately protect our rights or permit us to gain or keep any competitive
	advantage. For example, some or all of our pending patent applications or any future pending applications may be unsuccessful. The U.S. Patent and Trademark Office may deny or require significant narrowing of claims in our pending patent applications or future patent applications, and patents issued as a result of these patent applications, if any, may not provide us with significant commercial protection or be issued in a form that is advantageous to us. We could also incur substantial costs in proceedings before the U.S. Patent and Trademark Office. These proceedings could result in adverse decisions as to the priority of our inventions and the narrowing or invalidation of claims in our issued patents. Third parties may successfully challenge our issued patents and those that may be issued in the future, which would render these patents invalidated or unenforceable, and which could limit our ability to stop competitors from marketing and selling related products. In addition, our
	pending patent applications include claims to aspects of products and procedures that are not currently protected by issued patents, and third parties may successfully patent those aspects before us or otherwise challenge our rights to these aspects.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Both the patent application process and the process of managing patent disputes can be time consuming and expensive. Competitors may be able to design around our patents or develop products that provide outcomes that are comparable to our products. Although we have entered into confidentiality agreements and intellectual property assignment agreements with certain of our employees, consultants and advisors in order to protect our intellectual property and other proprietary technology, these agreements may not be enforceable or may not provide meaningful protection for trade secrets or other proprietary information in the event
	of unauthorized use or disclosure or other breaches of the agreements. In addition, we have not sought patent protection in all countries where we sell our products. If we fail to timely file a patent application in any such country or major market, we may be precluded from doing so at a later date. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their own products and, further, may export otherwise infringing products to territories in which we have patent protection that may not be sufficient to terminate infringing activities. Furthermore, the laws of some foreign countries may not protect intellectual property rights to the same extent as the laws of the U.S., if at all.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In the event a competitor infringes upon one of our patents or other intellectual property rights, enforcing those patents and rights may be difficult and time consuming. Even if successful, litigation to defend our patents against challenges or to enforce our intellectual property rights could be expensive and time
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	28
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage35"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	consuming and could divert management&#146;s attention from managing our business. Moreover, we may not have sufficient resources to defend our patents against challenges or to enforce our intellectual property rights, any of which would adversely affect our ability to compete and our business operations as a result.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	If our trademarks or trade names are not adequately protected, then we may be unable to build name recognition in our markets of interest and our business may be adversely affected.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our registered or unregistered trademarks or trade names may be challenged, infringed, circumvented or declared generic or determined to infringe other marks. We may be unable to protect our rights to these trademarks and trade names, which we need to build name recognition by potential partners or customers in markets of interest. If our trademarks are challenged, infringed upon, circumvented, or declared generic or infringing, or if we are unable to establish name recognition based on our trademarks and trade names, then we may be unable to compete effectively and our business may be adversely affected.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The medical device industry is characterized by extensive patent litigation, and if we become subject to litigation, it could be costly, result in the diversion of management&#146;s attention, require us to pay significant damages or royalty payments, or prevent us from marketing and selling our existing or future products.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The medical device industry is characterized by extensive litigation and administrative proceedings over patent and other intellectual property rights. Determining whether a product infringes a patent involves complex legal and factual issues, the determination of which is often uncertain. Our competitors may assert that their products, the components of those products, the methods of using those products, or the methods we employ in processing those products are covered by U.S. or foreign patents held by them. In addition, they may claim that their patents have priority over us because their patents were issued first. Because
	patent applications can take many years to issue, our products that currently do not infringe on existing issued patents may later infringe on patents that are pending now or in the future. Our products might also inadvertently infringe on currently issued patents. As the number of participants in the market for skin cancer and general oncology devices and treatments increases, the possibility of patent infringement claims against us increases. Any infringement claims, litigation or other proceedings would place a significant strain on our financial resources, divert the attention of management from the core business and harm our reputation.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	A larger more established company could allege that we infringed its patent, and that we owe royalty payments on sales of certain products as a result. Any claim against us, even without merit, may cause us to incur substantial costs, and could place a significant strain on our financial resources, divert the attention of management from the core business and harm our reputation. If the appropriate authority upholds the company&#146;s patent as valid and enforceable and finds that we infringed on the patent, we could be required to pay substantial damages, including treble, or triple, damages and royalties if an infringement
	is found to be willful, and we could be prevented from selling our products unless we obtain a license or are able to redesign our products to avoid infringement. A license may not be available on reasonable terms, if at all, and we may be unable to redesign products in a way that would not infringe those patents. If we fail to obtain any required licenses or make any necessary changes to our products or technologies, we may have to withdraw existing products from the market or may be unable to commercialize one or more of our products, either of which could have a significant adverse effect on our business, financial condition and results of operations.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Any potential intellectual property litigation also could force us to do one or more of the following:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	stop selling, making, or using products that use the disputed intellectual property;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	obtain a license from the intellectual property owner to continue selling, making, licensing, or using products, which license may require substantial royalty payments and may not be available on reasonable terms, or at all;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	incur significant legal expenses;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	pay substantial damages or royalties to the party whose intellectual property rights we may be found to be infringing;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	pay the attorney fees and costs of litigation to the party whose intellectual property rights we may be found to be infringing; or
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	29
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage36"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	redesign those products that contain the allegedly infringing intellectual property, which could be costly, disruptive or infeasible.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Any of the foregoing could have a material adverse effect on our business, results of operations and financial condition.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We may indemnify our customers and international distributors with respect to infringement by our products of the proprietary rights of third parties. Third parties may assert infringement claims against customers or distributors. These claims may require us to initiate or defend protracted and costly litigation on behalf of customers or distributors, regardless of the merits of these claims. If any of these claims succeed, we may be forced to pay damages on behalf of customers or distributors or may be required to obtain licenses for the products they use, each which would adversely affect our operations. If we cannot obtain
	all necessary licenses on commercially reasonable terms, customers may be forced to stop using our products, which would materially and adversely affect our business.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We may be subject to damages resulting from claims that we, our employees or independent distributors have wrongfully used or disclosed alleged trade secrets of competitors or are in breach of non-competition or non-solicitation agreements with our competitors.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Many of our employees were previously employed at other medical device companies, including our competitors or potential competitors. Many of our independent distributors sell, or in the past have sold, products of competitors. We may be subject to claims that we, our employees or independent distributors have inadvertently or otherwise used or disclosed the trade secrets or other proprietary information of our competitors. In addition, we have been and may in the future be subject to claims that we caused an employee or independent distributor to break the terms of his or her non-competition agreement or non-solicitation
	agreement. Litigation may be necessary to defend against these claims. Even if we are successful in defending against these claims, litigation could result in substantial costs and be a distraction to management. If we fail in defending these claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel. A loss of key personnel or their work product could hamper or prevent our ability to commercialize products, which could have an adverse effect on our business, financial condition and results of operations.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Adverse outcomes in litigation or similar proceedings could adversely impact our business.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We currently are, and may in the future be, named as a party to litigation or other similar legal proceedings. Adverse outcomes in any or all of these proceedings could result in monetary damages or injunctive relief that could adversely affect our ability to continue conducting our business. While our management does not believe any of the proceedings currently pending against us are material to our business such matters are subject to inherent uncertainties and management&#146;s view of these matters may change in the future. If an unfavorable final outcome in any such matter becomes probable and reasonably estimable, our
	financial condition could be materially and adversely affected.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Risks Related to this Offering and Ownership of our Securities
</FONT>
</H2>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	There has been no public market for our common stock, warrants or units prior to this offering, and an active trading market for our securities may not develop after this offering. As a result, you may be unable to resell your shares of common stock, warrants or units at or above the price paid under this offering, or at all.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Prior to this offering, there has been no public market for our securities, and an active trading market for our securities may not develop or be sustained after this offering. Also, the initial public offering price for our units will be determined by negotiations between us and the underwriter and may bear no relationship to the market price for our securities after the offering. Furthermore, the market price of our securities may decline below the initial public offering price. As a result of any of the foregoing, you may be unable to resell your securities at or above the price you paid under this offering, or at all, and
	you may lose part or all of your investment in our securities.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	30
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage37"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We have never declared or paid cash dividends on our common stock and do not anticipate paying dividends in the foreseeable future. As a result, you must rely on price appreciation of our common stock for a return on your investment in the foreseeable future.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Except for a required tax distribution to our members in 2014 in the aggregate amount of $45,421, we have never declared or paid cash dividends on our common stock. We currently expect to retain our funds and future earnings to support the operation, growth and development of our business. We do not anticipate paying any cash dividends on our common stock in the foreseeable future, except for those related to the corporate conversion. As a result, a return on your investment in the near future will occur only if our share price appreciates. Our securities prices may not appreciate in value after this offering or maintain the
	prices at which you purchased our securities pursuant to this offering, and in either case, you would not realize a return on investment or could lose all or part of your investment in our securities.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Furthermore, any future determination to declare cash dividends will be made at the discretion of our board of directors and will be subject to compliance with applicable laws and covenants under any future credit facilities, which may restrict or limit our ability to pay dividends. For example, our current revolving line of credit restricts our ability to pay dividends or make any distributions or payments or redeem, retire or purchase any capital stock without the prior written consent of the lender, provided that we may pay dividends solely in common stock. Also, the form, frequency and amount of dividends will depend upon
	our future operations and earnings, capital requirements and surplus, general financial condition, contractual restrictions and other factors that the board of directors may deem relevant. See &#147;Dividend policy&#148; for more information. We may not pay dividends as a result of any of the foregoing, and in these cases, you will need to rely on price appreciation of our common stock for a return on your investment.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Investors in this offering will experience immediate and substantial dilution in the book value of their investment.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The initial public offering price of our units (and our common stock forming a part of our units) will be substantially higher than the net tangible book value per share of our outstanding common stock immediately prior to this offering. Therefore, if you purchase our units in this offering, you will incur an immediate dilution of $5.05 in net tangible book value per share from the price you paid, based on an assumed initial public offering price of $6.00 per share (the portion of the per unit initial public offering price attributable to the common stock based on an initial public offering price of $6.25 per unit). In
	addition, purchasers who bought units from us in this offering will have contributed 41.8% of the total consideration paid to us by our stockholders to purchase shares of our common stock, in exchange for acquiring approximately 14.1% of the outstanding shares of our capital stock as of March 31, 2016 after giving effect to this offering. The exercise of outstanding options and warrants and the issuance of additional securities by us will result in further dilution. For a further description of the dilution that you will experience immediately after this offering, see the section titled &#147;Dilution.&#148;
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The price of our securities may be volatile, and you could lose all or part of your investment.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Stock markets have experienced extreme volatility that has often been unrelated to the operating performance of particular companies. These broad market fluctuations may adversely affect the trading price of our securities. In addition, limited trading volume of our securities may contribute to its future volatility. Price declines in our securities could result from general market and economic conditions, some of which are beyond our control, and a variety of other factors, including any of the risk factors described in this prospectus. These broad market and industry factors may harm the market price of our securities,
	regardless of our operating performance, and could cause you to lose all or part of your investment in our securities since you might be unable to sell your securities at or above the price you paid in this offering. Factors that could cause fluctuations in the market price of our securities include the following:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	price and volume fluctuations in the overall stock market from time to time;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	volatility in the market prices and trading volumes of medical device company stocks;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	changes in operating performance and stock market valuations of other medical device companies generally, or those in our industry in particular;
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	31
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage38"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	sales of our securities by us or our stockholders;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	failure of securities analysts to initiate or maintain coverage of us, changes in financial estimates by securities analysts who follow our company, or our failure to meet these estimates or the expectations of investors;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	the financial projections we may provide to the public, any changes in those projections or our failure to meet those projections;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	rumors and market speculation involving us or other companies in our industry;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	actual or anticipated changes in our results of operations or fluctuations in our results of operations;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	actual or anticipated developments in our business, our competitors&#146; businesses or the competitive landscape generally;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	litigation involving us, our industry or both, or investigations by regulators into our operations or those of our competitors;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	developments or disputes concerning our intellectual property or other proprietary rights;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	announced or completed acquisitions of businesses or technologies by us or our competitors;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	new laws or regulations or new interpretations of existing laws or regulations applicable to our business;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	changes in accounting standards, policies, guidelines, interpretations or principles;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	any significant change in our management; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	general economic conditions and slow or negative growth of our markets.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In addition, in the past, following periods of volatility in the overall market and the market price of a particular company&#146;s securities, securities class action litigation has often been instituted against these companies. This litigation, if instituted against us, could result in substantial costs and a diversion of our management&#146;s attention and resources.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Holders of our warrants will have no rights as common stockholders until they acquire our common stock.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Until a warrant holder acquires shares of our common stock upon exercise of warrants, such holders will have no rights with respect to our common stock issuable upon exercise of the warrants, including the right to receive dividend payments, vote or respond to tender offers. Upon a holder&#146;s exercise of warrants, such holder will be entitled to exercise the rights of a common stockholder only as to matters for which the record date occurs after the exercise date.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The dilutive effect of our warrants could have an adverse effect on the future market price of our securities or otherwise adversely affect the interests of our stockholders.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The warrants issued in this offering as part of the units are likely to be exercised if the market price of our common stock equals or exceeds the warrant exercise price. To the extent such warrants are exercised, additional shares of common stock will be issued, which would dilute the ownership of existing stockholders. Further, if these warrants are exercised at any time in the future at a price lower than the book value per share of our common stock, existing stockholders could suffer dilution of their investment.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The warrants included in this offering may not have any value and we have the option to redeem all, but not less than all, of the warrants after the first anniversary of the date of issuance.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The warrants will expire at 5:00 p.m. on the third anniversary of the date of issuance. In the event our common stock price does not exceed the exercise price of the warrants during the period when the warrants are exercisable, the warrants may not have any value. Furthermore, regardless of any value our warrants may have, following the date that is the first anniversary of the date of issuance, we may, upon 30 days&#146; notice to the warrant agent, redeem all, but not less than all, of the outstanding warrants for $0.01 per warrant, if the closing price of one share of our common stock equals or exceeds $9.75 per share on
	each of 20 trading days within any 30 trading day period ending on the third business day prior to the date on which notice of
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	32
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage39"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	redemption is given. This redemption price may be significantly less than the value of each warrant based on the then-current trading price and such redemption could result in a loss of value for warrant holders whose warrants are redeemed.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Although we are required to use our best efforts to have an effective registration statement covering the issuance of the shares of common stock underlying the warrants at the time that holders of our warrants exercise their warrants, we cannot guarantee that a registration statement will be effective, in which case holders of our warrants will have the right to exercise the warrants via a cashless exercise feature provided for in the warrants and may not be able to receive freely tradable shares of our common stock upon exercise of the warrants.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Holders of our warrants will be able to exercise the warrants and receive freely tradable shares only if (i) a current registration statement under the Securities Act relating to the shares of our common stock underlying the warrants is then effective, or an exemption from such registration is available, and (ii) such shares of our common stock are qualified for sale or exempt from qualification under the applicable securities laws of the states in which the various holders of warrants reside. Although we have undertaken in the warrants, and therefore have a contractual obligation, to use our best efforts to maintain a current
	registration statement covering the shares of common stock underlying the warrants following completion of this offering to the extent required by federal securities laws, and we intend to comply with our undertaking, we may not be able to do so. If we fail to maintain the effectiveness of the registration statement and current prospectus relating to the common stock issuable upon exercise of the warrants, the holders of the warrants will have the right to exercise the warrants via a cashless exercise feature provided for in the warrants, until such time as there is an effective registration statement and current prospectus. In addition, we have agreed to use our best efforts to register the shares of our common stock underlying the warrants under the blue sky laws of the states of residence of the existing holders of the warrants, to the extent an exemption is not available. The value of the warrants may be greatly reduced if a registration statement covering the shares of our common
	stock issuable upon exercise of the warrants is not kept current or if the securities are not qualified, or exempt from qualification, in the states in which the holders of warrants reside.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We are an &#147;emerging growth company,&#148; and the reduced reporting requirements applicable to emerging growth companies may make our common stock less attractive to investors.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We are an &#147;emerging growth company,&#148; as defined in the Jumpstart Our Business Startups Act. For as long as we continue to be an emerging growth company, we may take advantage of exemptions from various reporting requirements that are applicable to other public companies but not to &#147;emerging growth companies,&#148; including, but not limited to:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	being permitted to provide only two years of audited financial statements, in addition to any required unaudited interim financial statements, with correspondingly reduced &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; disclosure;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	not being required to comply with the auditor attestation requirements in the assessment of our internal control over financial reporting under Section 404 of the Sarbanes-Oxley Act;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	not being required to comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor&#146;s report providing additional information about the audit and the financial statements;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We will remain an emerging growth company until the earlier of (1) the last day of the fiscal year (a) following the fifth anniversary of the completion of this offering, (b) in which we have total annual gross revenue of at least $1 billion, or (c) in which we are deemed to be a large accelerated filer, which means the market value of our common stock that is held by non-affiliates exceeds $700 million as of the prior June 30
<SUP>
	th
</SUP>
	, and (2) the date on which we have issued more than $1 billion in non-convertible debt during the
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	33
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage40"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	prior three-year period. Investors may find our common stock less attractive if we choose to rely on these exemptions. If some investors find our common stock less attractive as a result of any choices to reduce future disclosure, there may be a less active trading market for our common stock and the price of our common stock may be more volatile.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Under the Jumpstart Our Business Startups Act, emerging growth companies can also delay adopting new or revised accounting standards until such time as those standards apply to private companies. We have irrevocably elected not to avail ourselves of this exemption from new or revised accounting standards and, therefore, will be subject to the same new or revised accounting standards as other public companies that are not emerging growth companies.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Substantial future sales of our common stock or other securities in the public market, or the perception that these sales may occur, could cause the price of our common stock to decline, even if our business is doing well.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Sales of our common stock or other securities in the public market after this offering, or the perception that these sales may occur, could cause the market price of our securities to decline, even if our business is doing well. All common stock sold in this offering, other than shares acquired by our affiliates, will be freely transferable without restriction or additional registration under the Securities Act of 1933. All of the remaining common stock outstanding after this offering will be available for sale upon the expiration of the 180-day lock-up period pursuant to Rule 144 and Rule 701 under the Securities Act. See
	&#147;Shares eligible for future sale&#148; and &#147;Underwriting&#148; for a detailed description of the lock-up and Securities Act of 1933 restrictions. Any or all of our common stock may be released prior to expiration of the lock-up period at the discretion of the underwriter. To the extent this common stock is released before the expiration of the lock-up period and sold into the market, the market price of our securities could decline.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Our executive officers, directors and principal stockholders may exert control over us and may exercise influence over matters subject to stockholder approval.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our executive officers and directors, together with their respective affiliates, beneficially owned approximately 51.3% of our outstanding common stock as of May 1, 2016, and upon consummation of this offering, that same group will beneficially own approximately 41.7% of our outstanding common stock. Accordingly, these stockholders, if they act together, may exercise substantial influence over matters requiring stockholder approval, including the election of directors and approval of corporate transactions, such as a merger. This concentration of ownership could have the effect of delaying or preventing a change in control or
	otherwise discourage a potential acquirer from attempting to obtain control over us, which in turn could have a material adverse effect on the market value of our common stock. For information regarding the ownership of our common stock by our executive officers and directors and their affiliates, please see the section entitled &#147;Security ownership of certain beneficial owners and management.&#148;
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Our management will have broad discretion over the use and investment of the net proceeds received in this offering and might not apply the proceeds in ways that increase the value of your investment in our securities.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our management will have broad discretion over the use and investment of the net proceeds received from this offering, and you will be relying on, and may not agree with, the judgment of management regarding the application of these net proceeds. Management intends to use the net proceeds received from this offering as described in the section entitled &#147;Use of Proceeds.&#148; The failure by management to apply these funds effectively may result in financial losses that could have a material adverse effect on our business and cause the price of our common stock to decline. Management may invest the net proceeds received
	from this offering in a manner that does not produce income or increase value, which could have a material adverse effect on our business and cause the price of our securities to decline.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	If securities or industry analysts do not publish research or publish unfavorable or inaccurate research about our business, the price of our securities and trading volume could decline.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The trading market for our securities will depend, in part, on the research and reports that securities or industry analysts publish about us or our business. We may be unable to attract or sustain coverage by well-regarded securities and industry analysts. If either none or only a limited number of securities or industry
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	34
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage41"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	analysts cover us or our business, or if these securities or industry analysts are not widely respected within the general investment community, the trading price for our securities would be materially and negatively impacted. In the event we obtain securities or industry analyst coverage, if one or more of the analysts who cover us or our business downgrade our securities or publish inaccurate or unfavorable research about us or our business, the price of our securities would likely decline. If one or more of these analysts cease coverage of us or our business, or fail to publish reports on us or our business regularly, demand
	for our securities could decrease, which might cause the price of our securities and trading volume to decline.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Public company requirements may strain our resources and divert management&#146;s attention, which could adversely impact our ability to execute our strategy and harm operating results.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	As a public company, we will be subject to the reporting requirements of the Securities Exchange Act of 1934, the Sarbanes-Oxley Act, the Dodd-Frank Act, the listing requirements of the Nasdaq Capital Market and other applicable securities rules and regulations. Despite recent reforms made possible by the Jumpstart Our Business Startups Act, compliance with these rules and regulations will nonetheless increase our legal and financial compliance costs, make some activities more difficult, time-consuming or costly and increase demand on our systems and resources, particularly after we are no longer an &#147;emerging growth
	company.&#148; The Securities Exchange Act of 1934 requires, among other things, that we file annual, quarterly, and current reports with respect to our business and operating results.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	While the members of our board of directors and our executive officers have substantial experience relevant to our business, they have limited experience with operations as a public company upon which you can base your prediction of our future success or failure in complying with public company requirements. Our management may fail to comply with public company requirements, or may fail to do so effectively and efficiently, each would materially and adversely harm our ability to execute our strategy, and consequently, our operating results.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Furthermore, as a result of disclosure of information in this prospectus and in filings required of a public company, our business and financial condition will become more visible, which may result in threatened or actual litigation, including by competitors and other third parties. If these claims are successful, our business and operating results could be harmed, and even if the claims do not result in litigation or are resolved in our favor, these claims, and the time and resources necessary to resolve them, could divert the resources of management and adversely affect our business, brand and reputation and results of
	operations.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our new public company status and these new rules and regulations will make it more expensive for us to obtain director and officer liability insurance, and we may be required to accept reduced coverage or incur substantially higher costs to obtain coverage. These factors could also make it more difficult for us to attract and retain qualified members of the board of directors, particularly to serve on the audit committee and compensation committee, and qualified executive officers.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Our certificate of incorporation, our bylaws and Delaware law contain provisions that could discourage another company from acquiring us and may prevent attempts by our stockholders to replace or remove our current management.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Provisions of Delaware law (where we are incorporated), our certificate of incorporation and bylaws may discourage, delay or prevent a merger or acquisition that stockholders may consider favorable, including transactions in which you might otherwise receive a premium for your stock. In addition, these provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace or remove our board of directors. These provisions include:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	authorizing the issuance of &#147;blank check&#148; preferred stock without any need for action by stockholders;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	requiring supermajority stockholder voting to effect any merger or sale of all or substantially all of our stock our assets;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	eliminating the ability of stockholders to call and bring business before special meetings of stockholders;
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	35
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage42"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	prohibiting stockholder action by written consent;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	establishing advance notice requirements for nominations for election to the board of directors or for proposing matters that can be acted on by stockholders at stockholder meetings;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	dividing our board of directors into three classes so that only one third of our directors will be up for election in any given year; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	providing that our directors may be removed only by the affirmative vote of at least 75% of our then-outstanding common stock and only for cause.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In addition, we are subject to Section 203 of the Delaware General Corporation Law, which may have an anti-takeover effect with respect to transactions not approved in advance by our board of directors, including discouraging takeover attempts that could have resulted in a premium over the market price for shares of our common stock.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	These provisions will apply even if a takeover offer may be considered beneficial by some stockholders and could delay or prevent an acquisition that our board of directors determines is not in our and our stockholders&#146; best interests and could also affect the price that some investors are willing to pay for our common stock. See the section titled &#147;Description of Securities.&#148;
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Our certificate of incorporation will provide that the Court of Chancery of the State of Delaware will be the exclusive forum for substantially all disputes between us and our stockholders, which could limit our stockholders&#146; ability to obtain a favorable judicial forum for disputes with us or our directors, officers or employees.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our certificate of incorporation provides that, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware is the exclusive forum for any derivative action or proceeding brought on our behalf; any action asserting a breach of fiduciary duty; any action asserting a claim against us arising pursuant to the Delaware General Corporation Law, our certificate of incorporation or our bylaws; or any action asserting a claim against us that is governed by the internal affairs doctrine. This choice of forum provision may limit a stockholder&#146;s ability to bring a claim in a
	judicial forum that it finds favorable for disputes with us or our directors, officers or other employees, which may discourage these lawsuits against us and our directors, officers and other employees. If a court were to find the choice of forum provision contained in our certificate of incorporation to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving the action in other jurisdictions, which could harm our business and financial condition.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	If we fail to maintain proper and effective internal controls, our ability to produce accurate and timely financial statements could be impaired and investors&#146; views of us or our business could be harmed, resulting in the decrease in value of our common stock.
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	As a public company, we will be required to maintain internal control over financial reporting and to report any material weaknesses in our internal controls. In addition, beginning with our annual report on Form 10-K for our fiscal year ending December 31, 2017 to be filed in 2018, we will be required to furnish a report by management on the effectiveness of our internal control over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act. We are in the process of designing, implementing and testing the internal control over financial reporting required to comply with this obligation, which process is
	time-consuming, costly and complicated. In addition, our independent registered public accounting firm will be required to attest to the effectiveness of our internal control over financial reporting beginning with our annual report on Form 10-K following the date on which we are no longer an emerging growth company, which may be up to five full years following the date of this offering. Our compliance with Section 404 of the Sarbanes-Oxley Act will require us to incur substantial accounting expense and expend significant management efforts. If we are unable to comply with the requirements of Section 404 in a timely manner, or we or our independent registered public accounting firm identify deficiencies in our internal control over financial reporting that are deemed to be material weaknesses, the market price of our common stock could decline and we could be subject to sanctions or investigations by Nasdaq, the SEC or other regulatory authorities, which would require additional
	financial and management resources.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	36
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage43"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our ability to implement our business plan successfully and comply with Section 404 requires us to be able to prepare timely and accurate financial statements. We expect that we will need to continue to improve existing, and implement new, operational and financial systems, procedures and controls to manage our business effectively. Any delay in the implementation of, or disruption in the transition to, new or enhanced systems, procedures or controls, may cause our operations to suffer and we may be unable to conclude that our internal control over financial reporting is effective and to obtain an unqualified report on
	internal controls from our auditors when required under Section 404 of the Sarbanes-Oxley Act. Moreover, we may not implement and maintain adequate controls over our financial processes and reporting in the future. Even if we were to conclude, and, when required, our auditors were to concur, that our internal control over financial reporting provided reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles, because of our inherent limitations, internal control over financial reporting may not prevent or detect fraud or misstatements or omissions.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	37
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage44"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
</EFX_RISK_FACTORS>
<EFX_FORWARD_LOOK>
<A NAME="FIS_FORWARD_LOOK"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<A NAME="V440371_S1A_HTM_T2LI">
</A>
	CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION
</FONT>
</H1>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	This prospectus contains statements that express our opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results, in contrast with statements that reflect historical facts. Many of these statements are contained under the headings &#147;Prospectus Summary,&#148; &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; and &#147;Business.&#148; In some cases, we have identified such forward-looking statements with typical conditional words such as &#147;anticipate,&#148; &#147;intend,&#148; &#147;believe,&#148;
	&#147;estimate,&#148; &#147;plan,&#148; &#147;seek,&#148; &#147;project&#148; or &#147;expect,&#148; &#147;may,&#148; &#147;will,&#148; &#147;would,&#148; &#147;could&#148; or &#147;should,&#148; the negative of these terms or other comparable terminology.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Important factors related to forward-looking statements may include, among others, assumptions regarding:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	our ability to achieve and sustain profitability;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	market acceptance of the SRT-100 product line;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	our ability to successfully commercialize our products, including the SRT-100;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	our ability to compete effectively in selling our products and services;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	our ability to expand, manage and maintain our direct sales and marketing organizations;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	our actual financial results may vary significantly from forecasts and from period to period;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	our ability to successfully develop new products, improve or enhance existing products or acquire complementary products, technologies, services or businesses;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	our ability to obtain and maintain intellectual property of sufficient scope to adequately protect our products, including the SRT-100, and our ability to avoid infringing or otherwise violating the intellectual property rights of third parties;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	market risks regarding consolidation in the healthcare industry;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	the willingness of healthcare providers to purchase our products if coverage, reimbursement and pricing from third party payors for procedures using our products significantly declines;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	the level and availability of government and third party payor reimbursement for clinical procedures using our products;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	our ability to effectively manage our anticipated growth;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	the regulatory requirements applicable to us and our competitors;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	our ability to manufacture our products to meet demand;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	our reliance on third party manufacturers and sole- or single-source suppliers;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	our ability to reduce the per unit manufacturing cost of the SRT-100;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	our ability to efficiently manage our manufacturing processes;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	the regulatory and legal risks, and certain operating risks, that our international operations subject us to;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	the fact that product quality issues or product defects may harm our business; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	any product liability claims.
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	38
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage45"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Forward-looking statements are not a guarantee of performance, and you should not place undue reliance on such statements. We have based forward-looking statements largely on our current expectations and projections about future events. Forward-looking statements are subject to many uncertainties and other variable circumstances, including those discussed elsewhere in this prospectus under the headings &#147;Risk Factors&#148; and &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations,&#148; many of which are outside of our control, that could cause our actual results and experience to
	differ materially from any forward-looking statement. Given these risks and uncertainties, you are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements included in this prospectus are made only as of the date hereof. We do not undertake, and specifically decline, any obligation to update any such statements or to publicly announce the results of any revisions to any of such statements to reflect future events or developments, except as required by law.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	39
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage46"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
</EFX_FORWARD_LOOK>
<EFX_PROCEED_USE>
<A NAME="FIS_PROCEED_USE"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<A NAME="V440371_S1A_HTM_T3UOP">
</A>
	USE OF PROCEEDS
</FONT>
</H1>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We estimate, based upon an assumed initial public offering price of $6.25 per unit, we will receive net proceeds from this offering of approximately $9.3 million (or $10.8 million if the underwriters exercise their option to purchase additional units in full), after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. The foregoing net proceeds do not include any proceeds that we may receive from the exercise of warrants included in the units.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The principal purposes of this offering are to obtain additional capital to support our operations, create a public market for our common stock and to facilitate future access to the public equity markets. We currently expect to use the net proceeds of this offering primarily to fund the commercialization and continued development of the SRT-100 product line and other products as follows:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	approximately $3.0 million for the expansion of our sales and marketing activities, including hiring new sales representatives and a director of marketing;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	approximately $3.0 million for research and development for new products and improvements to existing products;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	up to $2.7 million to pay a dividend owed to former holders of our limited liability company units with a preferred return prior to our corporate conversion, in each case who have not elected to convert such dividend into shares of our common stock at the initial public offering price attributable to the common stock within 30 days following the closing of this offering; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	the remainder for working capital and other general corporate purposes.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Each $1.00 increase (decrease) in the assumed initial public offering price of $6.25 per unit would increase (decrease) each of cash and cash equivalents, working capital, total assets and total stockholders&#146; (deficit) equity by approximately $1.6 million, assuming that the number of units offered by us, as set forth on the cover of this prospectus, remains the same, and after deducting underwriting discounts and commissions and estimated offering expenses payable by us. We may also increase or decrease the number of units we are offering. Each increase (decrease) of 1.0 million units in the number of units offered by us
	would increase (decrease) each of cash and cash equivalents, working capital, total assets and total stockholders&#146; (deficit) equity by approximately $5.8 million, assuming that the assumed initial public offering price remains the same, and after deducting underwriting discounts and commissions and estimated offering expenses payable by us. The pro forma as adjusted information discussed above is illustrative only and will adjust based on the actual initial public offering price and other terms of this offering determined at pricing.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In addition, we may also use a portion of our net proceeds to acquire and invest in complementary products, technologies, services or businesses. We are exploring the possibility of reducing our reliance on third party manufacturers by bringing certain manufacturing, service and research and development functions in-house, which could include the acquisition of equipment and other fixed assets or the acquisition or lease of a manufacturing facility. However, we currently have no agreements or commitments to complete any such transactions nor are we involved in negotiations to do so.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our expected use of net proceeds from this offering represents our current intentions based upon our plans and business condition. As of the date of this prospectus, we cannot predict with certainty all of the particular uses for the net proceeds to be received upon the completion of this offering or the amounts that we will actually spend on the uses set forth above. The amounts and timing of our actual use of the net proceeds will vary depending on numerous factors, including the factors described under the heading &#147;Risk Factors&#148; in this prospectus. As a result, management will have broad discretion in its
	application of the net proceeds, and investors will be relying on our judgment in such application.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Pending use of the net proceeds from this offering, we may invest in short- and intermediate-term interest-bearing obligations, investment-grade instruments, certificates of deposit or direct or guaranteed obligations of the U.S. government.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	40
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage47"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
</EFX_PROCEED_USE>
<EFX_DIVIDEND_POLICY>
<A NAME="FIS_DIVIDEND_POLICY"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<A NAME="V440371_S1A_HTM_T4DP">
</A>
	DIVIDEND POLICY
</FONT>
</H1>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We currently expect to retain all future earnings, if any, for use in the operation and expansion of our business and repayment of debt. Except for a required tax distribution to our members in 2014 in the amount of $45,421, we have never declared nor paid any dividends or distributions to our securityholders and do not anticipate paying cash dividends to holders of our common stock in the foreseeable future. In addition, our secured credit facility restricts our ability to pay dividends. See &#147;Risk Factors&nbsp;&#151;&nbsp;We do not anticipate paying any dividends in the foreseeable future.&#148; Any determination to pay
	dividends in the future will be at the discretion of our Board of Directors and will depend upon, among other factors, our results of operations, financial condition, capital requirements and covenants in our existing financing arrangements and any future financing arrangements.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We expect to pay up to approximately $2.7 million to our former holders of our limited liability company units with a preferred return within 60 days following the closing of this offering. See &#147;Corporate Conversion&#148; for additional information.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	41
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage48"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<A NAME="V440371_S1A_HTM_T5CC">
</A>
	CORPORATE CONVERSION
</FONT>
</H1>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Overview
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	On January 1, 2016, Sensus Healthcare, LLC converted into a Delaware corporation pursuant to a statutory conversion and changed its name to Sensus Healthcare, Inc. In order to consummate the corporate conversion, a certificate of conversion was filed with the Secretary of State of the State of Delaware. As part of the corporate conversion, all limited liability company interests of Sensus Healthcare, LLC, which were in the form of units, were converted, on a one-for-one basis, into an aggregate of 42,852 shares of our common stock as follows (without giving effect to our expected 241.95-for-one forward stock split):
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	holders of our units without a preferred return received an aggregate of 30,101.99 shares of our common stock, par value $0.01 per share; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	holders of our units with a preferred return received an aggregate of 12,750.01 shares of our common stock, par value $0.01 per share and the right to receive payment of a dividend in cash or common stock, at the election of the holder thereof, upon a change in control in the amount of $209.74 per share (see &#147;Conversion of Cumulative Preferred Dividends into Common Stock&#148; below); and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	holders of options and warrants to purchase units of Sensus Healthcare, LLC received options and warrants to purchase an aggregate of 60 and 2,607 shares of our common stock with a weighted-average exercise price per share of $1,000 and $585, respectively, which we expect will remain outstanding following this offering except to the extent any such options or warrants are exercised prior to this offering.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Following our corporate conversion, Sensus Healthcare, Inc. continued to hold all property and assets of Sensus Healthcare, LLC and retained all of the debts and obligations of Sensus Healthcare, LLC. Sensus Healthcare, Inc. is governed by a certificate of incorporation, which was filed with the Secretary of State of the State of Delaware, and bylaws, the material provisions of which are described under the heading &#147;Description of Securities.&#148; On the effective date of the corporate conversion, the members of the board of managers of Sensus Healthcare, LLC became the members of Sensus Healthcare, Inc.&#146;s board of
	directors and the officers of Sensus Healthcare, LLC became the officers of Sensus Healthcare, Inc.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Prior to the commencement of this offering, we expect to effect a forward stock split of 241.95-for-one. The number of shares of common stock that warrants or options will be exercisable to purchase, as well as the exercise prices, will be subject to further adjustment in connection with the foregoing stock split. Following the forward stock split, we expect that our existing stockholders will hold approximately 11.0 million shares of our common stock, on a fully diluted basis.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Except as otherwise noted herein, the financial statements included elsewhere in this prospectus give retroactive effect to our corporate conversion. We expect that our conversion from a Delaware limited liability company to a Delaware corporation will not have a material effect on our financial statements, except for the effects of income taxes.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Conversion of Cumulative Preferred Dividends into Common Stock
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Pursuant to the Limited Liability Company Agreement of Sensus Healthcare, LLC, as amended (the &#147;LLC Agreement&#148;), holders of units with preferred returns were entitled to receive an 8% non-compounded preferred return. Following our corporate conversion, effective as of January 1, 2016 this preferred return ceased accumulating. Pursuant to the plan of conversion, in exchange for the termination of the preferred return, former holders of units with a preferred return are entitled to a one-time payment of approximately $0.87 per share (&#147;Dividend Payment&#148;), or a total of $2,674,197 upon the closing of this
	initial public offering or if a Change in Control occurs prior to the closing of this offering. &#147;Change in Control&#148; means (i) the sale of all or substantially all of the assets of the company or of more than 51% of the capital stock of the company; or (ii) a merger, consolidation, recapitalization or reorganization of the company that results in the inability of the then-existing stockholders to designate or elect a majority of the members of the company&#146;s board of directors (or equivalent governing body) of the resulting entity or its parent company. Each holder of units with a preferred return has been given a one-time right, which must be exercised within 30 days after the closing of this offering, to elect to convert all or a portion of their Dividend Payment into shares of our
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	42
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage49"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	common stock at the same price of our common stock in this offering. We will mail an election form to each holder of units with a preferred return to allow them to elect whether to receive all or a portion of their Dividend Payment in shares of our common stock. If a holder does not make an election before the expiration of the 30-day period following the closing of this offering, then the holder will receive his or her Dividend Payment solely in cash. We plan to pay each Dividend Payment, whether in cash, common stock or a combination of cash and common stock, within 60 days following the closing of this offering.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	43
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage50"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
</EFX_DIVIDEND_POLICY>
<EFX_CAPITALIZATION>
<A NAME="FIS_CAPITALIZATION"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<A NAME="V440371_S1A_HTM_T6CA">
</A>
	CAPITALIZATION
</FONT>
</H1>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The following table sets forth our cash and cash equivalents and our capitalization as of March 31, 2016:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	on an actual basis;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	on a pro forma basis to give effect to the accrual of the dividend payable to the former holders of units with a preferred return that was declared upon our conversion from a Delaware limited liability company to a Delaware corporation, effective January 1, 2016; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	on a pro forma as adjusted basis to additionally give effect to the 241.95-for-one forward stock split and issuance of shares of our common stock in this offering at an assumed initial public offering price of $6.25 per unit, after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	You should read the following information together with the information contained under the &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; and our financial statements and the accompanying notes appearing elsewhere in this prospectus.
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_12"></A>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="346">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="77">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="64">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="72">
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=11>
	As of March 31, 2016
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Actual
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Pro forma
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Pro forma
<BR>
	as adjusted
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Cash and cash equivalents
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	4,746,539
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	4,746,539
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	14,918,414
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Total debt
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	800,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	800,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	800,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Stockholders&#146; equity (deficit):
<BR>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Preferred stock, $0.01 par value per share (5,000,000 shares authorized, none issued and outstanding, actual and pro forma; 5,000,000 shares authorized, none issued and outstanding, pro forma as adjusted)
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Common stock, $0.01 par value per share (50,000,000 authorized and 42,852 issued and outstanding at March 31, 2016, actual and pro forma; 50,000,000 authorized and 12,438,041 issued and outstanding at March 31, 2016, pro forma adjusted)
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	428
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	428
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	124,380
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Additional paid-in capital
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	13,364,229
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	13,364,229
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	22,519,944
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Accumulated deficit
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(7,443,728
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(10,117,925
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(10,117,925
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Total stockholders&#146; equity
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	5,920,929
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	3,246,732
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	12,526,399
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 30PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Total capitalization
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	6,720,929
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	4,046,732
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	13,326,399
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Pro forma as adjusted common stock outstanding incudes (i) 1,750,000 shares of common stock to be issued in this offering; (ii) 320,000 shares of restricted common stock estimated to be issued to certain employees assuming our offering price is $6.00 per share (the portion of the per unit initial offering price attributable to the common stock based on an initial public offering price of $6.25 per unit).
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The table does not reflect as of such date:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	as of March 31, 2016, 14,517 shares issuable upon the exercise of outstanding stock options at a weighted-average exercise price of $4.13 per share;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	as of March 31, 2016, 630,763 shares issuable upon the exercise of warrants at a weighted-average exercise price of $2.42 per share following the corporate conversion;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	262,500 additional units issuable upon the underwriters&#146; exercise of the over-allotment option;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	120,750 units issuable upon exercise of warrants to be issued to the representatives of the underwriters in connection with this offering, at an exercise price per unit equal to $7.80 per unit, as described in the &#147;Underwriting&nbsp;&#151;&nbsp;Representatives&#146; Warrants&#148; section of this prospectus; or
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	2,133,250 shares of our common stock issuable upon the exercise of warrants issued and sold in this offering.
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	44
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage51"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
</EFX_CAPITALIZATION>
<EFX_DILUTION>
<A NAME="FIS_DILUTION"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<A NAME="V440371_S1A_HTM_T7DI">
</A>
	DILUTION
</FONT>
</H1>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	If you invest in our common stock, your ownership interest will be diluted to the extent of the difference between $6.00 per share (the portion of the per unit initial offering price attributable to the common stock based on an initial public offering price of $6.25 per unit) and the pro forma as adjusted net tangible book value per share of our common stock after the consummation of this offering. Net tangible book value per share represents the book value of our total tangible assets less the book value of our total liabilities divided by the number of shares of common stock then issued and outstanding. As of March 31, 2016,
	our net tangible book value was $5,222,131, or $121.86 per share of common stock, which represents the amount of our total tangible assets less total liabilities, divided by 42,852, the number of shares outstanding at March 31, 2016 (without giving effect to our expected 241.95-for-one forward stock split).
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	After giving effect to the corporate conversion and our expected 241.95-for-one forward stock split, pro forma net tangible book value as of March 31, 2016 would have been $5,222,131, or $0.49 per share based on the shares of common stock issued and outstanding after the corporate conversion. After giving effect to our sale of common stock in this offering at the initial public offering price of $6.00 per share (the portion of the per unit initial offering price attributable to the common stock based on an initial public offering price of $6.25 per unit), and after deducting estimated underwriting discounts and commissions and
	estimated offering expenses payable by us, our pro forma as adjusted net tangible book value as of March 31, 2016 would have been $11,827,601, or $0.95 per share (assuming no exercise of the underwriters&#146; option to purchase additional units). This represents an immediate and substantial dilution of $5.05 per share to new investors purchasing common stock in this offering. The following table illustrates this dilution per share:
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_13"></A>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="554" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="442">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="40">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="40">
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Assumed initial public offering price attributable to common stock
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	6.00
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Net tangible book value per share before this offering
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	0.49
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Increase in net tangible book value per share attributable to this offering
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	0.46
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Pro forma as adjusted net tangible book value per share after giving effect to this offering
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	0.95
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Dilution per share to new investors in this offering
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	5.05
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	If the underwriters&#146; option to purchase additional units in this offering is exercised in full, the pro forma as adjusted net tangible book value would be $13,353,382, or $1.05 per share, and the dilution to new investors participating in this offering would be $4.95 per share.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The pro forma information discussed above is illustrative only and will change based on the actual initial public offering price, number of shares and other terms of this offering determined at pricing.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The following table summarizes, on a pro forma as adjusted basis as of March 31, 2016, the differences between the number of shares of common stock purchased from us, the total price and the average price per share paid by existing stockholders and by the new investors in this offering, before deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us, at an assumed initial public offering price of $6.00 per share (the portion of the per unit initial offering price attributable to the common stock based on an initial public offering price of $6.25 per unit).
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<EFX_BENEFICIAL_OWNERS>
<A NAME="FIS_BENEFICIAL_OWNERS"></A>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="256">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="56">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="44">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="76">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="44">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="52">
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=7>
	Shares purchased
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=7>
	Total consideration
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=2>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=2 COLSPAN=3>
	Average
<BR>
	price per
<BR>
	share
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Number
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Percent
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Amount
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Percent
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=19>
	(in millions)
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Existing investors
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	10,688,041
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	85.9
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	%
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	14,601,500
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	58.2
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	%
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1.37
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	New investors
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,750,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	14.1
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	%
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	10,500,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	41.8
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	%
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	6.00
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Total
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	12,438,041
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	100.0
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	%
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	25,101,500
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	100.0
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	%
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	2.02
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_BENEFICIAL_OWNERS>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In addition, if the underwriters&#146; option to purchase additional units is exercised in full, the number of shares held by existing stockholders will be reduced to 84.2% of the total number of shares of common stock to be outstanding upon completion of this offering, and the number of shares of common stock held by new investors participating in this offering will be further increased to 15.8% of the total number of shares of common stock to be outstanding upon completion of the offering.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	45
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage52"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The discussion and tables above are based on 10,688,041 shares of our common stock outstanding as of March 31, 2016 and assumes no exercise of stock options outstanding and the expected issuance of 320,000 shares of restricted stock under our equity incentive plans. The tables do not reflect as of such date:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	as of March 31, 2016, 14,517 shares issuable upon the exercise of outstanding stock options at a weighted-average exercise price of $4.13 per share;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	as of March 31, 2016, 630,763 shares issuable upon the exercise of warrants at a weighted-average exercise price of $2.42 per share following the corporate conversion;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	77,473 additional shares reserved for future issuance under our 2016 Equity Incentive Plan;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	262,500 additional units issuable upon the underwriters&#146; exercise of the over-allotment option;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	no exercise of the warrants included in the units issued and sold in this offering; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	shares issuable upon the election of former holders of units with a preferred return, within 30 days of the closing of this offering to convert all or a portion of the cumulative preferred dividend into shares of common stock at the initial public offering price.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	If, after giving effect to the corporate conversion, all of our then outstanding options and warrants were exercised, our pro forma as adjusted net tangible book value as of March 31, 2016 would have been $0.52 per share and our pro forma as adjusted net tangible book value after giving effect to this offering would have been $1.03 per share, causing dilution to new investors purchasing shares in this offering of $4.97 per share. Shares purchased by new investors would then represent 13.4% of the shares purchased from us for 39.3% of the total consideration.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	To the extent that options are exercised or we issue additional shares of common stock in the future, there will be further dilution to investors participating in this offering. In addition, we may choose to raise additional capital because of market conditions or strategic considerations, even if we believe that we have sufficient funds for our current or future operating plans. If we raise additional capital through the sale of equity or convertible debt securities, the issuance of these securities could result in further dilution to our stockholders.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	46
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage53"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
</EFX_DILUTION>
<EFX_MANAGEMENTS_DISCUSSION>
<A NAME="FIS_MANAGEMENTS_DISCUSSION"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<A NAME="V440371_S1A_HTM_T8MDA">
</A>
	MANAGEMENT&#146;S DISCUSSION AND ANALYSIS OF
<BR>
	FINANCIAL CONDITION AND RESULTS OF OPERATIONS
</FONT>
</H1>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<I>
	The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our financial statements and the accompanying notes and other financial information appearing elsewhere in this prospectus. In addition to historical information, this discussion contains forward-looking statements that involve risks, uncertainties and assumptions that could cause actual results to differ materially from management&#146;s expectations. Factors that could cause such differences include, but are not limited to, those identified below and those described under the heading &#147;Risk
	Factors&#148; appearing elsewhere in this prospectus.
</I>
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Overview
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Sensus Healthcare, LLC, a Delaware limited liability company, was formed on May 7, 2010, to design, manufacture and market proprietary medical devices specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy. In June 2010, Sensus Healthcare, LLC, a Florida limited liability company (&#147;Sensus (FL)&#148;) acquired all the assets associated with our primary product, the SRT-100, from Topex, Inc. for $1.3 million. Following this acquisition, we relaunched the SRT-100 under the Sensus Healthcare brand. In December 2011, we merged with Sensus (FL),
	with the Delaware limited liability company surviving the merger for the purpose of changing our domicile from Florida to Delaware.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	On January 1, 2016, Sensus Healthcare, LLC converted into a Delaware corporation pursuant to a statutory conversion and we changed our name to Sensus Healthcare, Inc. As a result of the corporate conversion, all holders of units of Sensus Healthcare, LLC became holders of common stock of Sensus Healthcare, Inc. Holders of warrants and options to purchase units of Sensus Healthcare, LLC became holders of warrants and options to purchase common stock of Sensus Healthcare, Inc., respectively.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The SRT-100 is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 is especially effective in treating primary lesions that would otherwise be difficult or require extensive surgery involving sensitive areas of the head and neck regions, such as the fold in the nose, eyelids, lips, corner of the mouth, and the lining of the ear, that would otherwise lead to a less than desirable cosmetic outcome. Superficial radiation therapy
	treatment procedures do not require the use of anesthetics and eliminates the need for skin grafting. The SRT-100 provides healthcare providers and patients with a safe, virtually painless, and substantially non-scarring treatment option for non-melanoma skin cancer and other skin conditions, such as keloids. It allows dermatologists to retain non-melanoma skin cancer patients, rather than referring them to specialists, while offering radiation oncologists an alternative to costly linear accelerator&#150;based treatments with a process that is less invasive, more time-efficient, and improves practice economics. Our revenue is primarily derived from sales of our SRT-100 product line.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Corporate conversion
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The purpose of the corporate conversion was to reorganize our corporate structure so that we are a corporation rather than a limited liability company and so that our existing investors own our common stock rather than equity interests in a limited liability company. For further information regarding the corporate conversion, see &#147;Corporate Conversion.&#148; References elsewhere in this prospectus to our capitalization and other matters pertaining to our equity and shares prior to the corporate conversion relate to the capitalization and equity and shares of Sensus Healthcare, LLC, and after the corporate conversion, to
	Sensus Healthcare, Inc.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The financial statements included elsewhere in this prospectus give retroactive effect to the corporate conversion. Effective January 1, 2016, we are subject to corporate income taxes.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Components of our results of operations
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We manage our business globally within one reportable segment, which is consistent with how our management reviews our business, prioritizes investment and resource allocation decisions and assesses operating performance.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	47
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage54"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Revenue
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our revenue primarily relates to sales of our devices. We recognize product revenue upon shipment provided that there is persuasive evidence of an arrangement, there are no uncertainties regarding customer acceptance, the sales price is fixed and determinable, and collection of the resulting receivable is reasonably assured. We do not provide a right of return related to product sales. Revenues for service contracts are recognized over the service contract period on a straight-line basis. Revenue for rentals of equipment is recognized over the lease term on a straight-line basis.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We sell products and services under multiple-element arrangements with separate units of accounting; in these situations, total consideration is allocated to the identified units of accounting based on their relative selling prices and revenue is then recognized for each unit based on its specific characteristics. A deliverable in an arrangement qualifies as a separate unit of accounting if the delivered item has value to the customer on a stand-alone basis. The principal deliverables in our multiple deliverable arrangements that qualify as separate units of accounting consist of (i) sales of medical devices and accessories
	and (ii) service contracts. Performance obligations, including installation and customer training, are considered inconsequential and are combined with the product as one unit of accounting. Selling prices are established using vendor-specific objective evidence (VSOE). If VSOE does not exist, we use our best estimate of the selling prices for the deliverables.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We operate in a highly regulatory environment and are continually entering into new markets in which state or foreign approval is sometimes required prior to the customer being able to use the product. In these cases, where regulatory approval is pending, revenue is deferred until such time regulatory approval is obtained and customer acceptance becomes certain.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Deferred revenue consists of payments from customers for separately priced service contracts, sales pending regulatory approval and deposits on products.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We provide warranties, generally one year, in conjunction with the sale of our product. These warranties are short term in nature and entitle the customer to repair, replacement, or modification of a defective product subject to the terms of the respective warranty. We record an estimate of future warranty claims at the time we recognize revenue from the sale of the product based upon management&#146;s estimate of the future claims rate.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Shipping and handling costs are expensed as incurred and are included in cost of sales.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We expect revenue to increase in the future as we expand our sales, marketing and distribution capabilities to support growth in the U.S. and internationally and the SRT-100 becomes more widely adopted and new products are introduced. Revenue for the year 2015 significantly increased from 2014 levels due to the resolution of the CMS reimbursement uncertainty discussed below in &#147;Significant trends and uncertainties impacting our business.&#148;
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Cost of sales
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Since July 2010, we have used a third party manufacturer for the production and manufacture of our main products, the SRT-100 product line, in accordance with our product specifications. Cost of sales consists primarily of direct material, direct labor, overhead, depreciation and amortization. A significant portion of our cost of sales consists of costs paid to our third party manufacturer.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Gross profit
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We calculate gross profit as net revenue less cost of sales. Our gross profit has been and will continue to be affected by a variety of factors, including production volumes, manufacturing costs, product reliability and the implementation over time of cost-reduction strategies. Our gross profit may fluctuate from quarter to quarter.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Selling and marketing
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We focus on two primary markets, private dermatology practices and radiation oncologists in both private and hospital settings. We currently employ a multi-tier sales strategy in an attempt to optimize geographic coverage and focus on what we perceive to be our key markets. This multi-tier sales model uses a direct sales
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	48
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage55"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	force, international dealers and distributors, and, to a lesser degree, regional independent sales representatives compensated on a commission-only basis. We expect the amount of our sales and marketing expense to increase as we continue to expand our sales force and marketing activities.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	General and administrative
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	General and administrative expense, or G&amp;A, consists primarily of salaries, employee benefits, bonuses, and related costs for personnel who support our general operations such as executive management, finance, accounting and administrative functions, as well as legal and other professional fees. We expect the amount of G&amp;A expenses to continue to increase following the public offering as we employ additional personnel and incur additional legal, accounting, insurance and other professional service fees associated with being a public company.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Research and development
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We expect the amount of our research and development, or R&amp;D, expense to increase as we continue to innovate and introduce new products and technologies.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Other income (expense)
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Other income (expense) primarily consists of interest payments made pursuant to our secured credit facility with Silicon Valley Bank. Our interest expense will fluctuate in future periods to the extent we incur additional, or pay down, indebtedness.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Income taxes
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Until December 31, 2015, the Company was a limited liability corporation (LLC) that had elected to be taxed as a pass-through entity and accordingly, we did not recognize a federal or state income tax provision for the years ended December 31, 2013, 2014 and 2015. Beginning in 2016, as a result of the conversion from an LLC to a Delaware corporation, income tax (benefit) expense will consist of income taxes in jurisdictions in which we conduct business. We will be taxed at the rates applicable within each jurisdiction in which we operate or generate revenue. The composite income tax rate, tax provisions, deferred tax assets
	and deferred tax liabilities will vary according to the jurisdiction in which profits arise. Tax laws are complex and subject to different interpretations by management and the respective governmental taxing authorities, and require us to exercise judgment in determining our income tax provision, our deferred tax assets and liabilities and the valuation allowance recorded against our net deferred tax assets. Deferred tax assets and liabilities are determined using the enacted tax rates in effect for the years in which those tax assets are expected to be realized. A valuation allowance is established when it is more likely than not that the future realization of all or some of the deferred tax assets will not be achieved.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Significant trends and uncertainties impacting our business
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Many third-party payors follow coverage decisions and payment amounts determined by the Centers for Medicare and Medicaid Services, or CMS, which administers the U.S. Medicare program, in setting their coverage and reimbursement policies. Beginning in 2013, the AMA CPT&reg; Editorial Panel, or the AMA, commenced a review of the reportable codes during an episode of superficial radiation therapy, including a recommendation to eliminate several reportable codes used for superficial radiation therapy. During this review, future reimbursement levels became uncertain. This uncertainty significantly impacted sales of our products in
	2014 as many of our customers delayed purchasing decisions until the reimbursement review was completed. At the conclusion of the review at the end of 2014, and effective January 1, 2015, the total reimbursement for an episode of care remained similar to the reimbursement prior to the review; however, we believe that the uncertainty during 2014 regarding the final rates for 2015 had a significant negative impact on our 2014 sales. While a number of codes used for superficial radiation therapy were no longer reportable in 2015, the AMA indicated alternative codes could be reported for a common episode of care, therefore compensating for the impact of the eliminated codes. As the uncertainty of the reimbursement has subsided, our sales in 2015 returned to 2013 levels. In 2015, CMS reviewed the value of the superficial radiation therapy treatment delivery code value for 2016 and made a slight increase.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	49
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage56"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Results of operations
</FONT>
</H2>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_14"></A>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="200">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="64">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="64">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="64">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="64">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="72">
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=11>
	For the Years Ended
<BR>
	December 31,
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=7>
	For the Three Months Ended
<BR>
	March 31,
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2013
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2014
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2015
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2015
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2016
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=3>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=3>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=3>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=7>
	(unaudited)
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Revenues
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	10,478,920
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	5,810,205
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	10,273,094
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,929,649
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	3,035,204
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Cost of Sales
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	3,600,348
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	2,054,798
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	3,698,687
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	724,179
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,102,370
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Gross Profit
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	6,878,572
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	3,755,407
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	6,574,407
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,205,470
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,932,834
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Operating Expenses
<BR>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Selling and marketing
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	3,965,276
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	4,208,241
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	3,742,535
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	916,350
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	944,122
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	General and administrative
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,453,344
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,650,651
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,586,401
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	329,745
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	685,720
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Research and development
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,333,111
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,576,775
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,466,728
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	439,804
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	293,404
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Total Operating Expenses
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	6,751,731
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	7,435,667
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	6,795,664
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,685,899
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,923,246
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Income (Loss) From Operations
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	126,841
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(3,860,260
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(221,257
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(480,429
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	9,588
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Other Income (Expense)
<BR>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Interest expense
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(20,467
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(20,030
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(17,786
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(5,119
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(9,626
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Interest income
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,253
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	820
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,776
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	288
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	2,755
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Total Other Income (Expense)
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(19,214
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(19,210
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(16,010
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(4,831
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(6,871
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Income (Loss) Before Income Taxes
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	107,627
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(3,699,470
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(237,267
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(485,260
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	2,717
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Income Taxes
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	636
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Net Income (Loss)
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	107,627
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(3,699,470
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(237,267
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(485,260
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	2,081
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Three months ended March 31, 2016 compared to the three months ended March 31, 2015
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Total revenue.
</I>
</B>
	&nbsp;&nbsp;Total revenue was $3,035,204 for the three months ended March 31, 2016 compared to $1,929,649 for the three months ended March 31, 2015, an increase of $1,105,555, or 57.3%. The growth in revenue was primarily attributable to significantly more SRT-100 systems sold during the first three months of 2016. Average selling price did not change significantly in 2016 compared to 2015.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Total cost of sales.
</I>
</B>
	&nbsp;&nbsp;Cost of sales was $1,102,370 for the three months ended March 31, 2016 compared to $724,179 for the three months ended March 31, 2016, an increase of $378,191, or 52.2%. The increase in costs was due to a greater number of SRT-100 systems sold the first three months of 2016 compared to the corresponding period in 2015.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Gross profit.
</I>
</B>
	&nbsp;&nbsp;Gross profit was $1,932,834 for the three months ended March 31, 2016 compared to $1,205,470 for the three months ended March 31, 2015, an increase of $727,364, or 60.3%, for the reasons discussed above. Our overall gross profit percentage was 63.7% in the three months ended March 31, 2016 compared to 62.5% in the corresponding period in 2015.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Selling and marketing.
</I>
</B>
	&nbsp;&nbsp;Selling and marketing expense was $944,122 for the three months ended March 31, 2016 compared to $916,350 for the three months ended March 31, 2015, an increase of $27,772, or 3.0%. The increase was primarily attributable to an increase in payroll cost of $80,000 related to new hires offset by a reduction in trade show attendance ($44,000). We expect selling and marketing costs to increase in the future as we increase our sales force and our marketing activities.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	General and administrative.
</I>
</B>
	&nbsp;&nbsp;General and administrative expense was $685,720 for the three months ended March 31, 2016 compared to $329,745 for the three months ended March 31, 2015, an increase of $355,975, or 108.0%. The increase was due primarily to increases in legal and professional fees ($115,000), settlement of litigation ($112,000), payroll cost ($63,000) and travel ($26,000). We expect the amount of G&amp;A expenses to continue to increase following the public offering as we employ additional personnel and incur additional legal, accounting, insurance and other professional service fees
	associated with being a public company.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	50
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage57"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Research and development.
</I>
</B>
	&nbsp;&nbsp;Research and development expense was $293,404 for the three months ended March 31, 2016 compared to $439,804 for the three months ended March 31, 2015, a decrease of $146,400, or 33.3%. The decrease in research and development spending was primarily attributable to the completion of research and development for the enhanced SRT-100 Vision product. We expect that research and development costs will increase in the future as we invest in improvements to existing products as well as development of new products.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Other income (expense).
</I>
</B>
	&nbsp;&nbsp;We incur interest expense in connection with our secured credit facility with Silicon Valley Bank.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Income taxes.
</I>
</B>
	&nbsp;&nbsp;We recognized income tax expense of $636 for the three months ended March 31, 2016, with an effective tax rate of 23.4%. Prior to January 1, 2016, we were a limited liability company taxed as a partnership and therefore did not incur income tax expense.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Year ended December 31, 2015 compared to the year ended December 31, 2014
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Total revenue.
</I>
</B>
	&nbsp;&nbsp;Total revenue was $10,273,094 for the year ended December 31, 2015 compared to $5,810,205 for the year ended December 31, 2014, an increase of $4,462,889, or 76.8%. The growth in revenue was primarily attributable to significantly more systems sold during 2015 as we have substantially overcome the uncertainty regarding customer reimbursement for use of our products that had negatively impacted sales in 2014. Average selling price did not change significantly compared to 2014.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Total cost of sales.
</I>
</B>
	&nbsp;&nbsp;Cost of sales was $3,698,687 for the year ended December 31, 2015 compared to $2,054,798 for the year ended December 31, 2014, an increase of $1,643,889, or 80.0% due to the higher sales in 2015 compared to 2014.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Gross profit.
</I>
</B>
	&nbsp;&nbsp;Gross profit was $6,574,407 for the year ended December 31, 2015 compared to $3,755,407 for the year ended December 31, 2014, an increase of $2,819,000, or 75.1%, for the reasons discussed above. Our gross profit percentage was 64.0% in 2015 compared to 64.6% in 2014.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Selling and marketing.
</I>
</B>
	&nbsp;&nbsp;Selling and marketing expense was $3,742,535 for the year ended December 31, 2015 compared to $4,208,241 for the year ended December 31, 2014, a decrease of $465,706, or 11.1%. The net decrease was mainly due to lower spending on trade shows ($180,000), marketing consultants ($150,000) and reduction in sales payroll ($130,000).
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	General and administrative.
</I>
</B>
	&nbsp;&nbsp;General and administrative expense was $1,586,401 for the year ended December 31, 2015 compared to $1,650,651 for the year ended December 31, 2014, a decrease of $64,250, or 3.9%. The net decrease was due primarily to lower legal expenses ($141,000) and bad debt expense ($182,000), offset by an increase in payroll of ($114,000), travel expense ($59,000), training and education expense ($24,000), information technology expenses ($25,000) and other professional fees of ($49,000).
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Research and development.
</I>
</B>
	&nbsp;&nbsp;Research and development expense was $1,466,728 for the year ended December 31, 2015 compared to $1,576,775 for the year ended December 31, 2014, a decrease of $110,047, or 7.0%. The net decrease in research and development spending was attributable to lower expenses in 2015 related to the enhanced SRT-100 Vision product as well as foreign registrations of the SRT-100 ($195,000), offset by an increase in payroll expense of $97,000.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Other income (expense).
</I>
</B>
	&nbsp;&nbsp;We incur interest expense in connection with our secured credit facility with Silicon Valley Bank.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Year ended December 31, 2014 compared to the year ended December 31, 2013
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Total revenue.
</I>
</B>
	&nbsp;&nbsp;Total revenue was $5,810,205 for the year ended December 31, 2014 compared to $10,478,920 for the year ended December 31, 2013, a decrease of $4,668,715, or 44.6%. The decrease in revenue was primarily due to significantly fewer systems sold in 2014 due to uncertainty regarding reimbursement to our customers for the use of our products. Average selling price in 2014 did not change significantly compared to 2013.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Total cost of sales.
</I>
</B>
	&nbsp;&nbsp;Cost of sales was $2,054,798 for the year ended December 31, 2014 compared to $3,600,348 for the year ended December 31, 2013, a decrease of $1,545,550, or 42.9% due to the lower sales in 2014 compared to 2013.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	51
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage58"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Gross profit.
</I>
</B>
	&nbsp;&nbsp;Gross profit was $3,755,407 for the year ended December 31, 2014 compared to $6,878,572 for the year ended December 31, 2013, a decrease of $3,123,165, or 45.4%, for the reasons discussed above. Our gross profit percentage was 64.6% in 2014 compared to 65.6% in 2013.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Selling and marketing.
</I>
</B>
	&nbsp;&nbsp;Selling and marketing expense was $4,208,241 for the year ended December 31, 2014 compared to $3,965,276 for the year ended December 31, 2013, an increase of $242,965, or 6.1%. The net increase was mainly due to higher spending on trade shows ($448,000) and marketing consultants ($256,000), offset by lower payroll ($416,000) due to headcount reductions during 2014 and lower travel ($51,000).
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	General and administrative.
</I>
</B>
	&nbsp;&nbsp;General and administrative expense was $1,650,651 for the year ended December 31, 2014 compared to $1,453,344 for the year ended December 31, 2013, an increase of $197,307, or 13.6%. The net increase was due primarily to higher legal expenses ($251,000) and bad debt expense ($128,000), offset by lower payroll ($146,000).
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Research and development.
</I>
</B>
	&nbsp;&nbsp;Research and development expense was $1,576,775 for the year ended December 31, 2014 compared to $1,333,111 for the year ended December 31, 2013, an increase of $243,664, or 18.3%. The increase was mostly research and development ($116,000) attributable to the enhanced SRT-100 Vision product and foreign registrations ($126,000).
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Other income (expense).
</I>
</B>
	&nbsp;&nbsp;We incur interest expense in connection with our secured credit facility with Silicon Valley Bank.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Seasonality
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We do not believe our business to be seasonal in nature.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Liquidity and capital resources
</FONT>
</H2>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Overview
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	As of March 31, 2016, we had cash and cash equivalents of $4,476,539 and an accumulated deficit of $(7,443,728) compared to cash and cash equivalents of $5,065,068 and an accumulated deficit of $(7,445,809) as of December 31, 2015.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our liquidity position and capital requirements may be impacted by a number of factors, including the following:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	our ability to generate and increase revenue;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	fluctuations in gross margins, operating expenses and net results; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	fluctuations in working capital.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our primary short-term capital needs, which are subject to change, include expenditures related to:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	expansion of our sales, marketing and distribution activities;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	expansion of our research and development activities;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	payment of accumulated dividends to stockholders.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We regularly evaluate our cash requirements for current operations, commitments, capital requirements and business development transactions, and we may elect to raise additional funds for these purposes in the future.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We may need to raise additional funds to finance future cash needs through public or private equity offerings, debt financings, receivables or royalty financings or corporate collaboration and licensing arrangements. The covenants under our credit facilities limit our ability to obtain additional debt financing. We cannot be certain that additional funding will be available on acceptable terms, or at all. Any failure to raise capital in the future could have a negative impact on our financial condition and our ability to pursue our business strategies.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	If we raise additional funds by issuing equity securities or convertible debt, our stockholders will experience dilution. Debt financing, if available, would result in increased fixed payment obligations and may
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	52
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage59"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. Any debt financing or additional equity that we raise may contain terms, such as liquidation and other preferences, which are not favorable to us or our stockholders. If we raise additional funds through collaboration and licensing arrangements with third parties, it may be necessary to relinquish valuable rights to our products, future revenue streams or product candidates or to grant licenses on terms that may not be favorable to us.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Cash flows
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The following table provides a summary of our cash flows for the periods indicated:
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_15"></A>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="200">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="64">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="64">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="64">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="64">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="72">
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=11>
	For the Years Ended
<BR>
	December 31,
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=7>
	For the Three Months Ended
<BR>
	March 31,
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2013
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2014
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2015
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2015
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2016
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=3>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=3>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=3>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=7>
	(unaudited)
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Net cash provided by (used in):
<BR>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Operating activities
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(128,693
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(1,867,682
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(1,339,343
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(467,471
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(458,546
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Investing activities
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(251,004
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(123,959
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(196,190
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(11,801
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(232,906
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Financing activities
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	3,245,854
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(45,421
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	2,061,888
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	__
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	372,923
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Total
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	2,866,157
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(2,037,062
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	526,355
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(479,272
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(318,529
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Cash flows from operating activities
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Net cash used in operating activities was $458,546 for the three months ended March 31, 2016, consisting of net income of $2,081 and an increase in net operating assets of $547,775, offset by non-cash charges of $87,148. The increase in net operating assets was primarily due to the increase in sales resulting in an increase in accounts receivable as well as increase in prepaid expense and deposits and a decrease in deferred revenue, offset by an increase in inventory. Non-cash charges consisted primarily of depreciation and amortization. Net cash used in operating activities was $467,471 for the three months ended March 31,
	2015.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Net cash used in operating activities for 2015 was $1,339,343, consisting of a net loss of $237,267 and an increase in net operating assets of $1,432,418, offset by non-cash charges of $330,342. The increase in net operating assets was primarily due to the increase in sales resulting in an increase in accounts receivable as well as increase in inventory, prepaid expense and deposits and a decrease in deferred revenue, offset by an increase in accounts payable and accrued expenses. Non-cash charges consisted primarily of depreciation and amortization.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Net cash used in operating activities for 2014 was $1,867,682, consisting of a net loss of $3,699,470, offset by a decrease in net operating assets of $1,335,992 and non-cash charges of $475,796. The decrease in net operating assets was primarily due to cash collections and lower sales in 2014 resulting in a decrease in accounts receivable as well as an increase in deferred revenue, offset by an increase in inventories and decrease in accounts payable and accrued expenses. Non-cash charges consisted primarily of depreciation and amortization and provision for bad debts.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Net cash used in operating activities for 2013 was $128,693, consisting primarily of net income of $107,627 and non-cash charges of $444,429 offset by an increase in net operating assets of $680,749. The increase in net operating assets was primarily due to the increase in sales resulting in increases in accounts receivable as well as increase in inventory, offset by increases in accounts payable and accrued expenses and deferred revenue. Non-cash charges consisted primarily of depreciation and amortization, product warranties and provision for bad debts.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Cash flows from investing activities
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Net cash used in investing activities was $232,906 and $11,801 during the three months ended March 31, 2016 and 2015, respectively, and $196,190, and $123,959 and $251,004 for the years ended December 31, 2015, 2014 and 2013, respectively, with the expenditures in all years for acquisition of property and equipment.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	53
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage60"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Cash flows from financing activities
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Net cash provided by financing activities was $372,923 during the three months ended March 31, 2016 mostly from proceeds from the revolving credit facility. There was no cash provided by or used in financing activities during the three months ended March 31, 2015.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Net cash provided by financing activities was $2,061,888 during the year ended December 31, 2015, primarily attributable to an increase of $2,014,186 from common stock issuance, net of offering costs.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Net cash used in financing activities was $45,421 during the year ended December 31, 2014 from distributions to shareholders.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Net cash provided by financing activities was $3,245,854 during the year ended 2013, from common stock issuance, net of offering costs.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Indebtedness
</FONT>
</H2>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Silicon Valley Bank Secured Credit Facility
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	On March 12, 2013, we entered into a 2-year $3 million revolving credit facility. The credit facility was amended and extended effective March 12, 2015. The maximum borrowing was reduced to $1,500,000 and is limited by our eligible borrowing base of 80% of eligible accounts receivable.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Interest, at Prime plus 1.75% (5.25% at March 31, 2015) is payable monthly with outstanding principal and interest due on May 12, 2017, the maturity date. The facility is secured by all of our assets and limits the amount of additional indebtedness, restricts the sale, disposition or transfer of assets of our and requires the maintenance of a certain monthly adjusted quick ratio restrictive covenant and minimum quarterly EBITDA restrictive covenant, as defined in the agreement. At December 31, 2014, we were not in compliance our minimum EBITDA requirement and received a waiver from our lender. We were not in compliance with
	our adjusted quick ratio requirement for October and November 2015 and received a waiver from our lender. Pursuant to our loan agreement, the March 31, 2016 covenant requirements and each quarter thereafter are based on review of our 2016 board approved plan which has not yet occurred. We are in the process of re-negotiating the terms of the loan agreement with our lender and believe we are in compliance with all covenant requirements as of March 31, 2016. Approximately $375,000 and $423,000 was outstanding under the revolving credit facility at December 31, 2014 and 2015, respectively, and $800,000 at March 31, 2016 (unaudited). We pay commitment fees of 0.25% per annum on the average unused portion of the line of credit.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Off-balance sheet arrangements
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We do not have during the period presented, and do not currently have, any off-balance sheet arrangements.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Critical accounting policies
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our discussion and analysis of our financial condition and results of operations are based on our financial statements, which have been prepared in accordance with generally accepted accounting principles in the U.S., or GAAP. We have identified the accounting policies below as critical to understanding our financial condition and results of our operations. For a detailed discussion on the application of these and other accounting policies, see the notes to our financial statements.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Revenue recognition
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our revenue is primarily derived from sales of our devices, including the SRT-100. We recognize product revenue upon shipment provided that there is persuasive evidence of an arrangement, there are no uncertainties regarding customer acceptance, the sales price is fixed and determinable, and collection of the resulting receivable is reasonably assured. We generally do not provide a right of return related to product sales. We consider the service contracts as a separate deliverable and as a separate unit of accounting in our product offering. Revenue for service contracts is recognized over the service contract period on a
	straight-line basis. Revenue for rentals of equipment is recognized over the lease term on a straight-line basis.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Accounts receivable and allowance for doubtful accounts
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We do business and extend credit based on an evaluation of our customers&#146; financial condition, generally without requiring collateral. Exposure to losses on receivables is expected to vary by customer due to the
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	54
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage61"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	financial condition of each customer. We monitor exposure to credit losses and maintain allowances for anticipated losses considered necessary under the circumstances. To date, we have not experienced significant credit-related losses.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Inventories
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Inventories consist of finished product and components and are stated at the lower of cost and net realizable value, determined using the first-in first-out method, or market. Cost includes labor and overhead incurred to prepare the product for sale.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Intangible assets and long-lived assets
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Intangible assets are comprised of our patent rights and are amortized over the patents&#146; estimated useful life of 13 years.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We evaluate our long-lived assets for possible impairment whenever circumstances indicate that the carrying amount of the asset, or related group of assets, may not be recoverable from estimated future cash flows in accordance with accounting guidance. If circumstances suggest the recorded amounts cannot be recovered, based upon estimated future undiscounted cash flows, we reduce the carrying values of such assets to fair value.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Equity based compensation
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Pursuant to accounting guidance related to accounting for equity-based compensation, we are required to recognize all share-based payments to non-employees and employees in the financial statements based on fair values on the grant date. We have accounted for issuance of units, options, and warrants in accordance with the guidance, which requires the recognition of expense, based on grant-date fair values, over the service period, generally periods over which the shares, options and warrants vest.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Income taxes
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Through December 31, 2015, we were not subject to income taxes in any jurisdiction. Each member was responsible for the tax liability, if any, related to their proportionate share of our taxable income. Effective January 1, 2016, we are subject to corporate income taxes and a provision for income taxes is included in the statement of operations.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	JOBS Act
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We qualify as an &#147;emerging growth company&#148; pursuant to the provisions of the JOBS Act. For as long as we are an &#147;emerging growth company,&#148; we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not &#147;emerging growth companies,&#148; including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404(b) of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, reduced disclosure obligations relating
	to the presentation of financial statements in Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations, exemptions from the requirements of holding advisory &#147;say-on-pay&#148; votes on executive compensation and shareholder advisory votes on golden parachute compensation. We have availed ourselves of the reduced reporting obligations and executive compensation disclosure in this prospectus, and expect to continue to avail ourselves of the reduced reporting obligations available to emerging growth companies in future filings.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In addition, an emerging growth company can delay its adoption of certain accounting standards until those standards would otherwise apply to private companies. However, we are choosing to &#147;opt out&#148; of such extended transition period, and as a result, we plan to comply with any new or revised accounting standards on the relevant dates on which non-emerging growth companies must adopt such standards. Section 107 of the JOBS Act provides that our decision to opt out of the extended transition period for complying with new or revised accounting standards is irrevocable.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Recently issued accounting pronouncements
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	See Note 1 to our audited financial statements included elsewhere in this prospectus for a description of recently issued accounting pronouncements.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	55
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage62"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
</EFX_MANAGEMENTS_DISCUSSION>
<EFX_BUSINESS>
<A NAME="FIS_BUSINESS"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<A NAME="V440371_S1A_HTM_T9BU">
</A>
	BUSINESS
</FONT>
</H1>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Overview
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We are a medical device company, headquartered in Boca Raton, Florida, specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy. Superficial radiation therapy is based on a technology with decades of successful clinical use treating various benign and malignant skin conditions. Prior to the introduction of Mohs surgery and linear accelerators in the late 1960s and early 1970s, the predecessor of superficial radiation therapy, orthovoltage, was the standard of care in treating several skin conditions, including skin cancer. When Mohs surgery was
	developed and linear accelerators, or LINACS, were introduced to treat cancer, the manufacturers of the orthovoltage devices abandoned manufacturing these products believing that Mohs surgery and linear accelerators would ultimately become the standard of care in treating skin cancer. We believe that orthovoltage device manufacturers may have perceived these newer procedures and technology as being superior to orthovoltage for a number of reasons, including (i) the fact that Mohs surgery did not require significant capital investment, other than specialized medical training, (ii) that higher-powered LINACS offered the ability to treat a wider variety of conditions because of its deeper x-ray penetration, and (iii) the perceived impracticalities of orthovoltage machines due to their large size. As a result, the orthovoltage technology became largely dormant.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Recently, healthcare providers are recognizing the benefits of superficial radiation therapy and there is a resurgence of this technology. Based on an independent retrospective analysis (with 95% confidence intervals) published in
<I>
	the Journal of the American Academy of Dermatology
</I>
	in 2012, recurrence rates for all tumors at two and five years were 1.9% and 5.0%, respectively, for cases of cutaneous basal cell carcinoma and squamous cell carcinoma treated using our superficial radiation therapy products, matching the recurrence rates for Mohs surgery. We believe this peer-reviewed study illustrates the effectiveness of
	superficial radiation therapy in the treatment of non-melanoma skin cancer. Superficial radiation therapy is also an effective treatment modality for keloids, which are firm, rubbery lesions or shiny, fibrous nodules, that can vary from pink to the color of the patient&#146;s flesh or red to dark brown in color, in conjunction with surgical removal. One recent study has indicated that surgical excision combined with platelet rich plasma and post-operative in-office superficial radiation therapy can achieve a non-recurrence rate of 100% at the fourth and eleventh month follow-up. No other treatment modality known to us leads to a greater non-recurrence rate.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We believe that modern superficial radiation therapy technology has improved over its orthovoltage predecessor. With modern technology, such as that found in the SRT-100, an equipment system manufactured by us, there is very low radiation scatter, which is significantly below the threshold defined by the American Association of Physicists in Medicine and the Conference of Radiation Control Program Directors, Inc. Our technologies preserve healthy tissue while attacking only the cancer cells because the SRT-100, unlike LINACS, uses low energy photon x-rays, which are only capable of penetrating skin up to approximately five
	millimeters. Moreover, our superficial radiation therapy products incorporate new digital and diagnostic systems that represent significant technological advancements over the orthovoltage predecessors. Further, while orthovoltage devices were very large (requiring a dedicated room), the SRT-100 is a mobile unit with a 30" x 30" footprint. Additionally, with a shift in the demographics of skin cancer patients due to an aging population, we believe superficial radiation therapy offers certain benefits that may not have been relevant decades ago when skin cancer patients were generally younger. For example, patients with certain health conditions or who have been proscribed certain medications may not be good candidates for surgical procedures, such as Mohs surgery, due to the additional health risks these procedures present.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Although Mohs surgery, a procedure involving the progressive removal of microscopic layers of cancer-containing skin until all cancer cells are removed, is one of the leading methods to treat non-melanoma skin cancer, there are significant downsides to this procedure. For example, patients often experience pain following the procedure. In addition to the inconvenience and pain involved with undergoing Mohs surgery, there are several other potential unpleasant aspects that may affect the surgical area, such as temporary or permanent numbness, temporary or permanent weakness, itching, enlarged scarring, and other post-surgical
	complications.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We believe that our products provide patients with a safe and virtually pain-free alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell carcinoma, and other skin
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	56
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage63"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	conditions, including keloids. Our products also allow dermatologists to retain non-melanoma skin cancer patients, rather than referring them to other specialists, while offering radiation oncologists an alternative to costly linear accelerator-based treatments with a process that is less invasive, more time-efficient, and which improves practice economics. Superficial radiation therapy treatments typically take less than one minute per treatment, and therapy frequently requires multiple visits. Often, patients undergoing superficial radiation therapy treatment will need three to four treatments per week for up to four
	consecutive weeks to achieve the desired results. Additionally, superficial radiation therapy is typically limited to the treatment of surface-based skin cancers because of the limited penetrating ability of the radiation used. Therefore, while safe and effective for many skin cancers, superficial radiation therapy typically is ineffective in treated skin cancer in advanced stages.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The SRT-100 system is designed for effectiveness and ease of use. The current features include specific x-ray and automatic filtering technique factors for accurate skin cancer treatment, visual verification of the treated area, a compact design for device mobility, connectivity to digital systems, reduced space requirements, and integrated safety controls for both the patient and the clinician.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We own two patents in the U.S. (U.S. Patent Nos. 7,372,940 and 7,263,170) related to the SRT-100 system and a third patent application pending in the U.S., China and Russia. We have also filed two provisional patent applications in the U.S. We have received 510(k) marketing clearance from the FDA, European CE marking certification, CFDA (the Chinese equivalent of the FDA), and Health Canada approval. We also received regulatory clearance for Russia in the fourth quarter of 2015. These governmental clearances and approvals are required to market and sell medical devices to customers located in the countries or areas covered by
	these agencies. We are currently marketing our SRT-100 in both the U.S. and abroad to private dermatology practices and private and hospital-based radiation oncology practices. We have been active in bringing this system to the global marketplace since the fourth quarter of 2010 and have begun establishing a distribution network to sell the SRT-100 to healthcare providers in the U.S. and internationally.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Sensus Healthcare, LLC, a Delaware limited liability company, was formed on May 7, 2010, to design, manufacture and market proprietary medical devices specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy. In June 2010, Sensus Healthcare, LLC, a Florida limited liability company (&#147;Sensus (FL)&#148;) acquired all the assets associated with our primary product, the SRT-100, from Topex, Inc. for $1.3 million. Following this acquisition, we relaunched the SRT-100 under the Sensus Healthcare brand. In December 2011, to change our domicile from
	Florida to Delaware, we merged with Sensus (FL), with the Delaware limited liability company surviving the merger. Effective as of January 1, 2016, we converted to a Delaware corporation.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Industry overview
</FONT>
</H2>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Non-melanoma skin cancer
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our products have received FDA-clearance to treat:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Basal Cell Carcinoma;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Squamous Cell Carcinoma;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Kaposi&#146;s Sarcoma;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Metatyptic Carcinoma;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Cutaneous Appendage Carcinoma; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Other primary malignant epithelial neoplasms of the skin.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Based on estimates by the U.S. Surgeon General and analysis by the Agency for Healthcare Research and Quality, of the approximately five million U.S. adults treated for skin cancer on average each year, approximately 4.3 million (or 86%) are treated for non-melanoma skin cancer (basal and squamous cell carcinoma and other rare skin cancers).
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Skin cancer is a growing epidemic. We believe that increased exposure to the sun without skin protection, a decreasing natural ozone layer, and the increase in the aging population demographic are chief
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	57
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage64"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	causes of this increase. Over the last three decades, the number of people experiencing skin cancer has grown at a higher rate than that of all other cancers combined. According to the Skin Cancer Foundation, one in five Americans is at risk for developing some form of skin cancer during their lifetime. MD Anderson has said that half of all Americans will have skin cancer at least once by the time they are 65. The U.S. Surgeon General has reported that approximately five million new skin cancer cases are diagnosed annually in the U.S., with an estimated annual treatment cost of over $8 billion, and that these numbers are
	projected to dramatically increase in the future.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Other skin conditions, including keloids
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our products have received FDA-clearance to treat keloids. Keloids are disfiguring, often benign, tumors, which are more common in people with skin of color. For such affected groups, typical prevalence rates can be as high as 6% to 16%. Keloids commonly form on skin areas where previous trauma has been experienced. Most frequently, keloids form after knee and hip replacement, cesarean-section procedures, bypass surgery and piercings. A large keloid formed near a joint may interfere with joint function. We estimate that the incidence rates of keloids to be three to four times greater than non-melanoma skin cancer, and expect
	this market will continue to grow as the population increases.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In addition to keloids, we are exploring the use of superficial radiation therapy for other indications, including psoriasis, eczema, and systemic scleroderma.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Existing alternatives to our products
</FONT>
</H2>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Mohs surgery
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Mohs surgery, which began replacing orthovoltage technology in the 1970s, is currently the standard of care for the most difficult to treat types of skin cancer. This procedure involves the progressive removal of microscopic layers of cancer-containing skin until all cancer cells are removed. The goal is to remove the skin cancer while minimizing the damage to surrounding healthy tissue. Mohs surgery is usually done on an outpatient basis using a local anesthetic.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	While Mohs surgery is generally recognized as an improvement to traditional surgery, which involves removing the visible cancer and a small margin of surrounding healthy tissue all at once, patients often experience some degree of pain following the procedure. In addition to the inconvenience and pain involved with undergoing Mohs surgery, there are several other potential unpleasant aspects, such as disfigurement, co-morbid complications, lifestyle disruption, and post-surgical complications. According to the American Society of Plastic Surgeons, 87% of facial plastic surgeons surveyed see patients for reconstructive work
	related to skin cancer. In 2014, the nose (68%) was the most common site on the face for skin cancer facial reconstruction followed by cheeks (16%), ears (6%) and forehead (4%).
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	It can take several weeks or even several months for patients to recover from Mohs surgery. The extent of any residual scarring varies with each patient, but there is often a facial disfiguring scar and permanent nerve-numbness in and around the site of the surgery, which can have long-term impact on the patient&#146;s quality of life. As many patients discover, usually only after electing to have Mohs surgery, the extent and size of the remaining scar is often much larger than what they were led to believe.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Other treatment options for non-melanoma skin cancer
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In addition to Mohs surgery, other treatment options for non-melanoma skin cancer include surgical excision, high dose rate brachytherapy, linear accelerators, topical creams and photodynamic therapy. These alternatives have non-recurrence rates that range from approximately 65% to 95%, below the non-recurrence rates for Mohs surgery and superficial radiation therapy, which range from approximately 95% to 98%. In addition to the generally lower non-recurrence rates among all of these alternatives, we believe there are other considerations that may make them less appealing. For example, surgical excision is an expensive,
	invasive and painful procedure that often yields poor cosmetic results and has a non-recurrence rate of only approximately 80%. Linear accelerator treatments use more powerful radiation that can potentially cause collateral damage to healthy tissue. Only high dose rate brachytherapy has a comparable cure rate to Mohs surgery and superficial radiation therapy, at approximately 95% to 98%, but, based on our experience, this procedure is limited to treating small lesions. Brachytherapy generally involves the permanent or temporary
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	58
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage65"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	placement of a radioactive source in close proximity to a cancerous tumor, which is intended to treat the condition with radiation. The effective dose received by a patient treated with bracytherapy is generally higher than a patient treated with superficial radiation therapy. In addition, due to the use of radioactive sources in brachytherapy equipment, only radiation oncologists may provide this type of treatment, limiting the potential market for these devices.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Alternative treatment options for keloids
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The current treatment options for keloids include antihistamines, corticosteroid injections, surgical excision, pressure therapy and silicone occlusive dressings. Many of these options will only reduce the size of the keloid or treat the symptoms (itching, pain, and general discomfort), but will not permanently cure the condition. Recurrence is common following these procedures.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The superficial radiation therapy alternative
</FONT>
</H2>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Non-melanoma skin cancer
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We believe our products provide a compelling alternative to existing treatment methods for non-melanoma skin cancer. Aware of the complexities, costs (direct and indirect), inferior cosmetic outcomes and post-procedural complications associated with Mohs surgery, more dermatology and radiation oncology clinical centers around the world are recognizing the benefits and advantages of superficial radiation therapy for patients, physicians, and healthcare systems. Specifically, the precise and targeted treatment that can be accomplished through superficial radiation therapy offers a compelling alternative treatment option for
	treating lesions, particularly those located in these sensitive regions of the body. Given that over 80% of skin cancers occur on the head and neck regions of the body, we believe our products compare favorably against traditional invasive surgical procedures, such as Mohs surgery.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Superficial radiation treatments usually take less than a minute, as opposed to up to three hours for Mohs surgery. The number of treatments received by patients electing to receive treatment will depend on the particular patient, the physician, the clinical evaluation and the location of the skin condition.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Based on a retrospective analysis published in the
<I>
	Journal of the American Academy of Dermatology
</I>
	in 2012, recurrence rates for all tumors at two and five years were 1.9% and 5.0%, respectively, for cases of cutaneous basal cell carcinoma and squamous cell carcinoma treated with superficial radiation therapy, matching non-recurrence rates for Mohs surgery. We believe this study illustrates the effectiveness of superficial radiation therapy in the treatment of non-melanoma skin cancer.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	As the world grows older and lives longer, other health conditions have become a factor in determining a course of treatment. For example, diabetes and heart conditions can add to the risk of complications with surgical procedures. Moreover, skin cancers that are located on certain areas of the body, such as the shin and head regions, can make surgical procedures less desirable because skin areas that are located in close proximity to bone may not heal as quickly or effectively. Consequently, superficial radiation therapy may offer a better alternative. Finally, we believe there is a growing population that would prefer to
	avoid surgery, especially when it is to be performed on the head or neck areas, for cosmetic and other reasons. Studies have indicated that the SRT-100 is effective in treating primary lesions that would otherwise be difficult to treat or require extensive surgery involving sensitive areas of the head and neck regions, such as the fold in the nose, eyelids, lips, corner of the mouth, and the lining of the ear, and would lead to a less than desirable cosmetic outcome. Because superficial radiation therapy penetrates the skin only a few millimeters, our treatment procedures do not require the use of anesthetics and eliminates the need for skin grafting.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We believe superficial radiation therapy is one of the most viable and effective treatment modalities for non-melanoma skin cancer. The superior cosmetic outcomes and high non-recurrence rates of superficial radiation therapy (in excess of 95% based on certain studies) are significant factors which make superficial radiation therapy a preferable treatment modality. In addition, temporary side effects of superficial radiation therapy are generally minor, which may include skin redness and blistering similar to mild sunburn. However, the affected areas are usually small due to the typically small treatment area and side effects
	typically clear up when treatment stops. Superficial radiation therapy has a decades-long successful track record treating skin cancer, and delivers high quality clinical outcomes, reduced cost of treatment and excellent patient satisfaction.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	59
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage66"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Keloids
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Superficial radiation therapy is an effective treatment modality for keloids, in conjunction with surgical removal. One recent study indicated that surgical excision combined with platelet rich plasma and post-operative in-office superficial radiation therapy can achieve a non-recurrence rate of 100% at the fourth to eleventh month follow-up. No other treatment modality known to us leads to a greater non-recurrence rate. In fact, some studies have shown that existing treatment options commonly see recurrence at rates between 50% and 90%, depending on the treatment.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Other applications of superficial radiation therapy
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In addition to the treatment of non-melanoma skin cancer and keloids, we believe superficial radiation therapy can be beneficial in the treatment of other skin conditions and we plan to continue our research and development efforts with the goal of expanding our indications into new areas of treatment.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Our Strengths
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Cost effective products for a global market.
</I>
</B>
	&nbsp;&nbsp;Our products offer a solution for today&#146;s cost conscious healthcare market. Our products rely on superficial radiation therapy, which we believe is an effective, yet less expensive procedure for payors for the treatment of non-melanoma skin cancer and other skin conditions than existing treatment options. The productivity and reliability associated with our products, along with our related service offerings, allow our customers to quickly and easily install and deploy our products in their respective practices while reducing downtime. Our products offer
	reduced treatment times, yet provide similar, or better, outcomes when compared with other treatment modalities for non-melanoma skin cancer and keloids. We believe that we are ideally positioned to meet the demands of the reforming healthcare systems by providing higher quality care at a lower cost with a better patient experience.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Exclusive focus on a large, growing market.
</I>
</B>
	&nbsp;&nbsp;The U.S. Surgeon General estimates that the skin cancer market represents an over $8 billion opportunity in the U.S. alone, which we expect will continue to grow. This growth is being driven by increased incidence of skin cancer and other skin conditions among the general population. We also estimate that the potential market for the treatment of keloids is even larger than the skin cancer market. Because our products offer an effective alternative treatment option, we believe that we are positioned as one of a limited number of companies exclusively focused
	on the use of superficial radiation therapy for the treatment of non-melanoma skin cancer and other skin conditions, such as keloids.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Highly experienced management and medical advisory team.
</I>
</B>
	&nbsp;&nbsp;We have assembled a senior management team and medical advisory board with significant experience in the healthcare industry. Our leadership team has a long track record in introducing numerous disruptive technologies and products to the healthcare market in the field of radiology, oncology and interventional medicine. Members of our management team also have experience in product development, launching new products into the healthcare market and selling medical devices and technology to hospitals and private healthcare practices through direct
	sales organizations, distributors and manufacturers. We also collaborate with a network of leading medical advisors in the design and use of our products.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Extensive product support network.
</I>
</B>
	&nbsp;&nbsp;In addition to the SRT-100 product line, we offer a unique and dedicated superficial radiation therapy support network for clinicians and therapists, which includes site planning and preparation, system deployment and installation, a national and global network of medical physicists for system commissioning and calibration, a dedicated service network, a dedicated clinical applications and education network and service, SRT University, and online and live customer support. We believe that by offering these dedicated and tailored services we have enhanced our brand and
	gained market presence.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Relationships with the medical community.
</I>
</B>
	&nbsp;&nbsp;We are actively involved in scientific, medical, and commercial organizations and communities. We are a member of the American Cutaneous Oncology Society (ACOS), which is a dedicated superficial radiation therapy scientific and medical society that promotes the betterment and further education on all superficial radiation therapy-related subject matter and topics, across multi-disciplinary fields, such as radiation oncology, dermatology, medical physics, plastic surgery, physician
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	60
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage67"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	assistants, and radiation therapy technologists. We anticipate that we will be able to leverage our involvement in these organizations to increase awareness of the benefits of radiation therapy and increase sales of our products.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Our Strategy
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our goal is to be a leading medical device company providing innovative, noninvasive solutions for the treatment of non-melanoma skin cancer and other skin conditions. The key elements of our strategy include:
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Increase acceptance of superficial radiation therapy as the standard of care for non-melanoma skin cancer, keloids and other skin conditions.&nbsp;&nbsp;
</I>
</B>
	We believe a great opportunity exists in creating an awareness of our treatment options for consumers. We believe dermatologists are now recognizing that surgery is not the only solution, or necessarily the best solution, for treating skin cancer or other skin conditions, such as keloids, and superficial radiation therapy can now be recognized as a valuable modality in their toolbox. The 95% non-melanoma skin cancer non-recurrence rate at the five-year follow-up
	(according to one study with 95% confidence intervals) achieved with superficial radiation therapy, combined with the benefit of a better cosmetic outcome and what we believe to be a more certain reimbursement environment, creates a significant opportunity for us to expand our market share. Focused consumer and practitioner educational awareness of the benefits of superficial radiation therapy is a key for our success. We are seeking to leverage our relationships with medical and other organizations to increase public awareness of superficial radiation therapy treatment options.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Drive adoption and awareness of SRT-100 among specialists, physicians, administrators and patients
</I>
</B>
<B>
	.&nbsp;&nbsp;
</B>
	We intend to educate specialists, physicians, administrators and patients on the compelling case for the treatment of non-melanoma skin cancer with the SRT-100. We believe that increased awareness of the benefits of superficial radiation therapy will favorably impact sales of the SRT-100. Additionally, we believe that our products will allow dermatologists to treat patients without having to refer them to specialists for treatment and will free-up larger, higher power equipment, such as linear
	accelerators, for oncologists to treat other patients whose treatment requires the use of these other devices.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Develop new technology products and services.&nbsp;&nbsp;
</I>
</B>
	Since acquiring the SRT-100, we have developed optional add-on technology products and service options which have enhanced the operational capabilities of our SRT-100, including the SRT-100 Vision and SRT-100 Lynx. We believe continued research and development of both new and existing technology will be critical to our success.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Pursue opportunities to enhance our product offerings.
</I>
</B>
	&nbsp;&nbsp;We intend to continue to expand applications of our superficial radiation therapy technology and vigorously protect those innovations through patent applications. We may also opportunistically pursue the licensing or acquisition of complementary products and technologies to strengthen our market position or improve product margins.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Expand our sales organization to support growth.
</I>
</B>
	&nbsp;&nbsp;We intend to expand our highly-trained direct sales organization and broaden our relationships with distributor partners to increase sales and drive revenues.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Lessen our dependency on third party manufacturers.
</I>
</B>
	&nbsp;&nbsp;We are exploring the possibility of reducing our reliance on third party manufacturers by bringing certain manufacturing, service and research and development functions in-house, which could include the acquisition of equipment and other fixed assets or the acquisition or lease of a manufacturing facility.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Our products and services
</FONT>
</H2>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	SRT-100
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We offer the SRT-100 product family, which we anticipate will be complemented by additional models and options in the future. With over 220 installations in 12 countries, we believe our SRT-100 product family to be a global leader in the superficial radiation therapy space.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our technology is based on several key needs and requirements, including the need for a dedicated and cost-effective device for the treatment of skin cancer, keloids, and other skin conditions. The SRT-100 provides the following clinical and functional advantages:
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	61
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage68"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Easy touch automatic set-up procedure with specific kV and mA time technique factors and filter designed for effective skin cancer treatment, including automatic x-ray tube warm-up procedures;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Specially designed control console for medical physicists and service technicians providing integrated safety and back-up timer controls, automatic system conditioning procedures, calibration, x-ray output verification and system parameters including last treatment status information;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Advanced patient record management with integrated enterprise workflow management;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Compact mobile design with a small 30&#148; x 30&#148; footprint and unique scissor x-ray tube arm movements providing a large range of motion for patient access and treatment; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	High reliability and MTBF (mean time between maintenance) performance that assure availability for the patients and practitioners and lower the total cost of ownership.
</TD>
</TR>
</TABLE>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	SRT-100 Vision
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The SRT-100 Vision provides customers with additional options compared to the SRT-100 base model. These additional options allow for dedicated treatment planning and full treatment progression documentation in a patient&#146;s record. The SRT-100 Vision provides the user with a unique superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and comprehensive dosimetry parameters. This allows the user to precisely and more accurately plan and prescribe the patient-specific treatment course to
	maximize patient outcomes and workflow efficiency. The SRT-100 Vision also offers a comprehensive control console and workflow management control console that provides full record and verify treatment tracing, operator-level access and functional control, audio-visual patient and treated lesion monitoring, and advanced dosimetry setting and tracing.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	SRT-100 Lynx
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The SRT-100 Lynx is an added hardware and software option for the SRT-100 system that adds full patient record creation, maintenance, and exporting capabilities. This option provides the SRT-100 the capability to be fully integrated in an enterprise environment and communicate via Health Level Seven (HL7) with other clinical data repositories, such as electronic medical records (EMR) and Hospital Information System/Radiology Information System (HIS/RIS), and other planning systems. We accomplish this integration through the use of HL7 interfaces, which are standard in healthcare information technology systems. The HL7
	interface allows systems written in different languages and running on different platforms to be able to talk to each other through the use of an abstracted data layer. This allows our customers to easily integrate the SRT-100 with electronic health records systems or other healthcare software systems.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We engineered and deployed this solution as a quick response to recent market dynamics and the Health Information Technology for Economic and Clinical Health (HITECH) Act, a federal law enacted as part of the American Recovery and Reinvestment Act of 2009 to promote the adoption and meaningful use of health information technology. The SRT-100 Vision offers embedded, and even more advanced, electronic patient record connectivity and functions.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Sentinel service program
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We offer the Sentinel service program, which provides our customers comprehensive protection for their SRT-100 and SRT-100 Vision systems at an annual price of approximately 10% of the system&#146;s list price. The Sentinel program covers all parts and labor for the period of the contract and one annual preventive maintenance session that includes cooling system maintenance, high voltage loop maintenance, filters and system cleaning, and system touch-ups, should they be required during the preventative maintenance session.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Through our Sentinel service program, we also provide turn-key pre- and post-sale services that include the following:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Providing a pre-install kit for the contractors to prepare the treatment room;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Room retrofit and shielding;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	System shipping coordination and installation;
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	62
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage69"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	System commissioning by a medical physicist (through a national physics network);
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	System registration with the state and daily workflow documentation preparation;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Clinical applications training with the customer&#146;s superficial radiation therapy staff; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Treating the first scheduled patients with our customers (onsite applications training).
</TD>
</TR>
</TABLE>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Consumables
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We also believe that there is an opportunity for additional revenue through the sale of consumables. We sell disposable lead shielding replacements, disposable radiation safety items, such as aprons, and eye shields, and disposable applicator tips, which are used to treat various sized lesions and different areas of the body.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Third party coverage and reimbursement
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Based on our experience to date, third party payors generally reimburse for superficial radiation therapy procedures in which our products are used, as long as the patient meets the established medical necessity criteria. Reimbursement decisions by particular third party payors may depend upon a number of factors, including each payor&#146;s determination that use of a product is:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	a covered benefit under its health plan;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	appropriate and medically necessary for the specific indication;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	cost effective; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	neither experimental nor investigational.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The Centers for Medicare &amp; Medicaid Services, or CMS, the agency responsible for administering the Medicare program, sets coverage and reimbursement policies for the Medicare program in the U.S. CMS policies may alter coverage and payment related to our product portfolio in the future. These changes may occur as the result of national coverage determinations issued by CMS or as the result of local coverage determinations by contractors under contract with CMS to review and make coverage and payment decisions. Medicaid programs are funded by both federal and state governments, may vary from state to state and from year to
	year and will likely play an even larger role in healthcare funding pursuant to the recently enacted Patient Protection and Affordable Care Act, as amended by the Healthcare and Education Affordability Reconciliation Act, collectively, the Affordable Care Act.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	A key component in ensuring whether the appropriate payment amount is received for physician and other services, including those procedures using our products, is the existence of a Current Procedural Terminology, or CPT&reg;, code. To receive payment, healthcare practitioners must submit claims to insurers using these codes for payment for medical services. CPT&reg; codes are assigned, maintained and annually updated by the American Medical Association and its CPT&reg; Editorial Panel. The AMA Relative Value Scale Update Committee also establishes relative code values, which is often a basis for payment. If the CPT&reg; codes
	or the codes values that apply to the procedures performed using our products are changed, reimbursement for performances of these procedures may be adversely affected.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In the U.S., some insured individuals enroll in managed care programs, which monitor and often require pre-approval of the services that an insured individual will receive. Some managed care programs pay their providers on a per capita (patient) basis, which puts the providers at financial risk for the services provided to their patients by paying these providers a predetermined payment per member per month and, consequently, may limit the willingness of these providers to use our products.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We believe that the overall escalating cost of medical products and services being paid for by the government and private health insurance has led to, and will continue to lead to, increased pressures on the healthcare and medical device industry to reduce the costs of products and services. All third party reimbursement programs are developing increasingly sophisticated methods of controlling healthcare costs through, for example, prospective reimbursement and capitation programs, group purchasing, redesign of benefits, second opinions and prior authorizations, benefit management, utilization review, careful review of bills,
	encouragement of healthier lifestyles and other preventative services and exploration of more cost-effective methods of delivering healthcare.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	63
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage70"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In international markets, reimbursement and healthcare payment systems vary significantly by country, and many countries have instituted price ceilings on specific product lines and procedures. There can be no assurance that procedures using our products will be considered medically reasonable and necessary for a specific indication, that our products will be considered cost-effective by third party payors, that an adequate level of reimbursement will be available or that the third-party payors&#146; reimbursement policies will not adversely affect our ability to sell our products profitably. More and more, local, product
	specific reimbursement law is applied as an overlay to medical device regulation, which has provided an additional layer of clearance requirement.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	While the Medicare reimbursement rates for a number of treatment delivery codes for other radiation oncology modalities are expected to decrease in 2016, the Medicare rates for the radiation therapy treatment delivery code is expected to increase in 2016.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Sales and marketing
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We focus on two primary markets, private dermatology practices and radiation oncologists in both private and hospital settings. We currently employ a multi-tier sales strategy in an attempt to optimize geographic coverage and focus on what we perceive to be our key markets. This multi-tier sales model uses a direct sales force (currently nine people), as well as international dealers and distributors.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our dermatology market sales are directed by Stephen Cohen, our Senior Vice President, Strategic Initiatives and Dermatology, capitalizing on his prior experience in executive capacities at Technicare (now Johnson &amp; Johnson), Diasonics, and Xoft. Our direct sales force for radiation oncology is led by Richard Golin, our Executive Vice President of Sales, Oncology and Dermatology, who has prior experience in sales at Toshiba Medical Systems, Siemens, and Hologic. We plan to continue selling and marketing our products to both the dermatology and radiation oncology markets concurrently.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Dermatology Market
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The estimated 7,000 private dermatology practices in the U.S. represent the point of entry for most non-melanoma skin cancer patients. We believe the SRT-100 offers dermatologists a competitive advantage by allowing them to retain patients for the treatment of non-melanoma skin cancer, rather than referring them out to specialists for Mohs surgery or other radiation procedures. In addition to non-melanoma skin cancers, our FDA-approved indications include, among others, keloids, Kaposi&#146;s Sarcoma, Actinic Keratosis, Metatypic Carcinoma, Cutaneous Appendage Carcinoma and other malignant skin tumors. We are continuing to
	drive our research and development to expand our indications into new areas of treatment.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Radiation Oncology Market
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	For the estimated 4,400 licensed radiation oncologists in the U.S., we believe the SRT-100 offers a simpler, faster method of treatment with a better overall patient experience. Our SRT-100 system offers the ability to free up more expensive radiation equipment, such as linear accelerators, for more complex procedures while providing patients with effective, non-invasive treatment options for non-melanoma skin cancer.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Other Markets
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We also believe that both plastic and general surgery markets present growth opportunities for our product offerings. With FDA clearance to treat keloids through superficial radiation therapy, many plastic surgeons are recognizing the opportunity to be able to provide an effective treatment solution for this benign tumor. Additionally, we believe that plastic surgeons view the non-melanoma skin cancer market as a growth opportunity that can supplement their existing services. We believe there is an opportunity to also provide superficial radiation therapy in a prophylactic manner for various surgical procedures to reduce the
	formation of keloids. Within the new healthcare reform environment, superficial radiation therapy can provide hospitals and surgery centers with a direct measurable impact on clinical outcomes for certain procedures, including joint replacement procedures, bypass surgery, and OBGYN/C-section procedures, among others.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	64
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage71"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Global Focus
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We currently have an installed base of over 220 units in 12 countries. Our customer list includes leading cancer centers, dermatology practices, hospitals and plastic surgery clinics, which we believe further validates our targeted marketing approach led by our direct sales teams and our global distribution partners.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Product Development and Research
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We offer the SRT-100 as our base product. The SRT-100 has successfully treated over 200,000 patients around the world in approximately 220 locations. The SRT-100 serves as a conduit to the dermatology and radiation oncology market segments and with approximately 220 units installed worldwide; we believe the SRT-100 has proven itself as a reliable, safe, and effective superficial radiation therapy solution.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We developed the second generation SRT-100 (Gen 2) product through the implementation of a number of engineering and design changes to the original SRT-100. Following the development of the Gen 2 SRT-100, we introduced the SRT-100 Lynx, which combined our clinical indications in treating keloids with a technology solution that allows customers to create and export patient records in an integrated EMR/enterprise environment.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Building on the clinical and commercial success of the SRT-100, we embarked on the development and launch of the SRT-100 Vision. This evolution of the SRT-100 combines the existing computing platform with imaging modalities that create a &#147;search and destroy&#148; therapy platform. The SRT-100 Vision platform provides many advancements and benefits for our customers, including a flexible platform that is capable of treating several different indications, new and advanced workflow management methodologies, and addresses many of the new healthcare environment requirements, such as system integration capabilities with
	electronic medical record systems. We plan to continue the development of the SRT-100 Vision by integrating additional imaging modalities to make it a single cohesive hybrid system. We believe the SRT-100 Vision will also allow us to increase our footprint in the enterprise and teaching hospital radiation oncology market segment. By adding image-guidance with high frequency ultrasound and advanced treatment therapy planning, together with advanced record and verify and workflow management tools, the SRT-100 Vision should be ideally positioned to open new opportunities for us in the domestic and international academic and large-scale hospital environments.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We plan to conduct additional research and development for product line expansions to address a broader and more diversified market and to provide additional solutions to the existing and future customer base. The SRT-100 (Gen 3) will be a more modular platform that will include some of the technologies developed for the SRT-100 Vision, and at the same time, can be competitively configured to compete in other global value markets.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We anticipate that we will continue developing our technology with the goal of optimizing workflow for users and positively impacting patients&#146; quality of life and outcomes. We believe our focus will allow us to provide advanced and seamless data portability in enterprise and cloud environments to make data readily available and interchangeable for practitioners, payors, and patients, while delivering products with very high levels of reliability and efficacy. As a result, we expect our products and services will achieve commercial and clinical success worldwide and thus bolster our global market leadership and financial
	viability. As new features and capabilities are added to our product portfolio, our users will gain access to a broader patient population, expanded reimbursement potential, and that our offerings will directly address the requirements and needs of accountable care organizations and the trend toward bundling of payments. We believe that this will allow us to increase list prices as our product line is enhanced and improved, which should positively impact our future margins.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We anticipate launching subsequent generations for the SRT-100 (Gen 3) and SRT-100 Vision (Gen 2), which will provide our customers with additional indications for use. These subsequent generations may expand the types of oncological conditions that can be treated with our product family, enhancing scalability and cost effectiveness (enhancing margins), and expanding our market segments. Since our expanded product family may treat various other oncological and dermatologic conditions, we believe many hospital departments will recognize the benefits of our product line. We believe that our new product generations will transform
	the
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	65
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage72"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	field of superficial radiation therapy with ground-breaking technology that will open brand new business opportunities for us and create new disruptive functionalities and clinical services.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	During 2014 and 2015, we spent approximately $1,256,000 and $1,129,000, respectively, on research and development of our products and services.
</P>
<EFX_COMPETITION>
<A NAME="FIS_COMPETITION"></A>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Competition
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The medical device industry is highly competitive, subject to rapid technological change and significantly affected by new product introductions and market activities of other participants. Our currently marketed products, and any future products we commercialize, will compete against healthcare providers who use traditional surgical treatment options, such as Mohs surgery, as well as medical device companies that offer other treatment options for the conditions our products are designed to treat. We currently have three primary medical device company competitors:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Xstrahl Medical (formerly Gulmay, headquartered in the United Kingdom)
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Xoft (a subsidiary of iCad, headquartered in New Hampshire)
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Elekta (headquartered in Georgia)
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Xstrahl Medical is an engineering company focused on industrial and research x-ray therapy devices. We believe most of Xstrahl Medical&#146;s installed base is comprised of legacy orthovoltage machines made up of higher energy devices located in Europe.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Both Xoft and Elekta offer products that are considered Electronic Brachytherapy (&#147;eBx&#148;) devices. Due to this classification, both companies may face challenges in the U.S. and certain other international markets where laws and regulations require that a radiation oncologist, medical physicist, or radiation therapist be involved with every treatment. Additionally, the CPT&reg; Editorial Panel has established two new treatment delivery codes for eBx for 2016, including a specific skin code. In addition, in early 2015, a large Medicare contractor issued guidance precluding the reporting of the existing eBx treatment
	delivery code for skin. The 2016 payments rates for the eBx treatment delivery skin code is currently being established by the various Medicare contractors. The new skin only code and payment rates may make this technology a challenge for dermatology in-office applications. Based on typical treatment practices, it appears that both eBx products also have limited capabilities as to size of lesions that can be treated and require expensive consumables. Furthermore, eBx products have very limited clinical studies.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Many of our current and potential competitors have significantly greater financial, technical, marketing and other resources than we do and may be able to devote greater resources to the development, promotion, sale and support of their products. Our competitors may also have more extensive customer bases and broader customer relationships than we do, including relationships with our potential customers. In addition, many of these companies and healthcare providers have longer operating histories and greater brand recognition than we do. Because of the size of the skin cancer treatment market and the high growth profile of the
	segments in which we compete, we anticipate that companies will dedicate significant resources to developing competing products. Additionally, we may also face competition from smaller companies that have developed or are developing similar technologies for our addressable markets. We believe that the principal competitive factors in our markets include:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	improved outcomes for medical conditions;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	acceptance by doctors treating non-melanoma skin cancer and keloids;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	potential greater acceptance by the patient community;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	potential greater ease of use and reliability;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	product price and qualification for reimbursement;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	technical leadership and superiority;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	effective marketing and distribution; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	speed to market.
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	66
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage73"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We may be unable to compete effectively against our competitors in regard to any one or all of these factors. Our ability to compete effectively will depend on the acceptance of our products by dermatologists, radiation oncologists, hospitals and patients, and our ability to achieve better clinical outcomes than products developed by our existing or future competitors. In addition, certain of our competitors could use their superior financial resources to develop products that have features or clinical outcomes similar or superior to our products, which would harm our ability to successfully compete.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Intellectual property
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We actively seek to protect the intellectual property we believe is important to our business, including seeking and maintaining patents that cover our products. We also rely on trademarks to build and maintain the integrity of our brand.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We own two issued patents, both of which are U.S. patents. We own one pending patent application and have filed two provisional patent applications and additional applications are in the process of being completed. All of our issued U.S. patents expire in 2025. Our patents pertain to technology in the specialized field of superficial radiotherapy treatment. The following two U.S. patents were issued between August 2007 and September 2008 and were assigned to us when we acquired the technology from Topex.
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	U.S. Patent No. 7,372,940: Radiation therapy system with risk mitigation
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	U.S. Patent No. 7,263,170: Radiation therapy system featuring rotatable filter assembly
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The following patent application is pending in the U.S., China and Russia and was submitted in 2013:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	U.S. Patent Application No. 13/740,181: Hybrid Ultrasound-Guided Superficial Radiotherapy System and Method (published as U.S. Patent Application No. 2013/0217947 A1)
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	As of December 31, 2015, we also owned three U.S. trademark registrations.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We also rely on trade secrets and other unpatented proprietary rights to develop and maintain our competitive position. We seek to protect our unpatented proprietary rights through a variety of methods, including confidentiality agreements with employees, consultants and others who may have access to our proprietary information. We also require our employees to execute invention assignment agreements with respect to inventions arising from their employment.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We acquired the photon x-ray low energy or superficial x-ray therapy system, dubbed the SRT-100 and developed a next generation system&nbsp;&#151;&nbsp;the SRT-100 Vision, which are each designed specifically to treat skin cancer and keloids as an alternative to surgery. Since first introduced in May 2007 by Topex, over 200,000 patients have been successfully treated with the SRT-100 system. The treatment of keloids has now begun at several sites throughout the world, including the U.S. and China. We are in the process of authoring and preparing additional forward-looking patents.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	No patents or trademarks may ever be issued or be registered from our pending or future applications for such intellectual property. Even if such patents or trademarks are respectively issued or registered, they, or any of our other intellectual property, may not provide us with any meaningful protection or competitive advantage. Our intellectual property could be challenged, invalidated, circumvented, infringed or misappropriated. In addition, third parties have claimed, and in the future may claim, that we, our customers, licensees or other parties indemnified by us are infringing upon their intellectual property rights. For
	a discussion of these risks, please see &#147;Risk factors&nbsp;&#151;&nbsp;Risks related to our intellectual property.&#148;
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Manufacturing and supply
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We currently use a third party located in the U.S. to manufacture our products. In July 2010, we entered into a manufacturing agreement with RbM Services, LLC (&#147;RbM&#148;) pursuant to which RbM agreed to manufacture our SRT-100 products based on an annual 12-month sales forecast and rolling six-month sales forecast. We pay a fixed price per unit under the terms of this agreement, subject to annual adjustments due to changes in the costs of materials. The initial term of this agreement was three years with successive one-year renewals thereafter. We continue to do business with RbM, although we or RbM may terminate the
	agreement with 90 days&#146; written notice or upon at least 60 days&#146; notice prior to the end of each additional one-year renewal period. We believe our third party manufacturer meets FDA, International Organization for
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	67
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage74"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Standardization, or ISO, and other quality standards. We maintain internal policies, procedures and supplier management processes to ensure that our third party manufacturer is meeting applicable quality standards. To date, we have not experienced any difficulty in locating and obtaining the materials necessary to meet demand for our products, and we believe manufacturing capacity is sufficient to meet global market demand for our products for the foreseeable future.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We believe this third party manufacturing relationship initially allowed us to work with a supplier that has well-developed specific competencies while minimizing our capital investment, controlling costs and shortening cycle times, all of which we believe allowed us to compete with our competitors. However, as discussed elsewhere in this prospectus, we are exploring the possibility of reducing our reliance on third party manufacturers by bringing certain manufacturing, service and research and development functions in-house, which could include the acquisition of equipment and other fixed assets or the acquisition or lease of
	a manufacturing facility.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We have a single preferred supplier for the x-ray tubes used in our products. We believe our preferred supplier has a superior product; however, we believe that the products of alternate suppliers would be adequate for our products. We do not have a contractual relationship with our preferred supplier; however, we do not anticipate any material disruptions to our supply of x-ray tubes. Adequate x-ray tubes are readily accessible from alternate suppliers.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Government regulation
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our business is subject to extensive federal, state, local and foreign laws and regulations including those relating to the protection of the environment, health and safety. Some of the pertinent laws have not been definitively interpreted by the regulatory authorities or the courts, and their provisions are open to a variety of subjective interpretations. In addition, these laws and their interpretations are subject to change or new laws may be enacted.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Both federal and state governmental agencies continue to subject the healthcare industry to intense regulatory scrutiny, including heightened civil and criminal enforcement efforts. We believe that we have structured our business operations and relationships with our customers to comply with all applicable legal requirements. However, it is possible that governmental entities or other third parties could interpret these laws differently and assert otherwise. We discuss below the statutes and regulations that are most relevant to our business. For the years ended December 31, 2014 and 2015, we incurred approximately $326,000
	and $330,000, respectively, in expenses related to regulatory compliance and quality standards.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	U.S. Food and Drug Administration (FDA) regulation of medical devices
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The Federal Food, Drug and Cosmetic Act, or FDCA, and FDA regulations establish a comprehensive system for the regulation of medical devices intended for human use. Our products include medical devices that are subject to these, as well as other federal, state, and local laws and regulations. FDA is responsible for the overall enforcement of quality, regulatory and statutory requirements governing medical devices. Our regulated medical devices include our SRT-100 product line.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	FDA classifies medical devices into one of three classes&nbsp;&#151;&nbsp;Class I, Class II, or Class III&nbsp;&#151;&nbsp;depending on their level of risk and the types of controls that are necessary to assure device safety and effectiveness. The class assignment determines the type of premarketing submission or application, if any, that will be required before marketing in the U.S.
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Class I devices present a low risk and are not life-sustaining or life-supporting. The majority of Class I devices are subject only to &#147;general controls&#148;&nbsp;&#151;&nbsp;e.g., prohibition against adulteration and misbranding, registration and listing, good manufacturing practices, labeling, and adverse event reporting. General controls are baseline requirements that apply to all classes of medical devices.
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Class II devices present a moderate risk and are devices for which general controls alone are not sufficient to provide a reasonable assurance of safety and effectiveness. Devices in Class II are subject to both general controls and &#147;special controls&#148;&nbsp;&#151;&nbsp;e.g., special labeling, compliance with
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	68
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage75"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX; TEXT-ALIGN: LEFT">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	industry standards, and postmarket surveillance. Unless exempted, Class II devices typically require FDA clearance before marketing, through the premarket notification (510(k)) process, in accordance with 21 CFR, Part 807 requirements.
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Class III devices present the highest risk. These devices generally are life-sustaining, life-supporting, or for a use that is of substantial importance in preventing impairment of human health, or present a potential unreasonable risk of illness or injury. Class III devices are devices for which general controls, by themselves, are insufficient and for which there is insufficient information to establish special controls to provide a reasonable assurance of safety and effectiveness. Class III devices are subject to general controls and typically require approval of a premarket approval application, or PMA in accordance with 21 CFR, Part 814, before marketing.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Unless it is exempt from premarket review requirements, a medical device must receive marketing authorization from the FDA prior to being commercially distributed in the U.S. The most common pathways for obtaining marketing authorization are 510(k) clearance and PMA. With the enactment of the Food and Drug Administration Safety and Innovation Act, or the FDASIA, the availability of a
<I>
	de novo
</I>
	pathway was facilitated for certain low- to moderate-risk devices that do not qualify for the 510(k) pathway due to the absence of a predicate device.
</P>
<H4 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	510(k) pathway
</FONT>
</H4>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Currently, all of our products are subject to the 510(k) requirement or are exempt from the 510(k) requirement. The 510(k) review process compares a new device to a legally marketed device. Through the 510(k) process, FDA determines whether a new medical device is &#147;substantially equivalent&#148; to a legally marketed device (i.e., predicate device) that is not subject to PMA requirements. &#147;Substantial equivalence&#148; means that the proposed device: (a) has the same intended use as the predicate device; (b) the same or similar technological characteristics; (c) the information submitted in the 510(k) demonstrates
	that the proposed device is as safe and effective as the predicate device; and (d) the proposed device does not raise different questions of safety and effectiveness than the predicate device.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	To obtain 510(k) clearance, we must submit a 510(k) application containing sufficient information and data to demonstrate that our proposed device is substantially equivalent to a legally marketed predicate device. These data generally include non-clinical performance testing (e.g., software validation, bench testing electrical safety testing), but may also include clinical data. Typically, it takes approximately four months for FDA to complete its review of a 510(k) submission; however, it can take significantly longer and clearance is never assured. During its review of a 510(k), FDA may request additional information,
	including clinical data, which may significantly prolong the review process. After completing its review of a 510(k), FDA may issue an order, in the form of a letter, that finds the device to be either (1) substantially equivalent and states that the device can be marketed in the U.S., or (2) not substantially equivalent and states that device cannot be marketed in the U.S. Depending upon the reasons for the not substantially equivalent finding, the device may need to be approved through the PMA pathway (discussed below) prior to commercialization. A new medical device for which there is no substantially equivalent device is automatically designated a Class III device. Depending on the nature of the new device, the manufacturer may ask the FDA to make a risk-based determination of the new device and reclassify it in Class I or Class II. This process is referred to as the
<I>
	de novo
</I>
	process. If the FDA agrees, the new device will be reassigned to the appropriate other class. If the
	FDA does not agree, the manufacturer will have to submit a PMA. We have received FDA clearances for our SRT-100 and SRT-100 Vision.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	After a device receives 510(k) clearance, any modification that could significantly affect the safety or effectiveness of the device, or that would constitute a major change in its intended use, including significant modifications to any of our products, requires submission and clearance of a new 510(k). FDA relies on each manufacturer to make and document this determination initially, but FDA can review any such decision and can disagree with a manufacturer&#146;s determination. We have made and plan to continue to make minor product enhancements that we believe do not require new 510(k) clearances. However, we expect to
	confer with FDA on planned changes that may require a special, abbreviated or traditional 510(k) submission. If FDA disagrees with our determination regarding whether a new 510(k) clearance was required for these modifications, we may need to cease marketing or recall the modified device. FDA may also subject us to other enforcement
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	69
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage76"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	actions, including, but not limited to, issuing a warning letter or untitled letter to us, seizing our products, imposing civil penalties, or initiating criminal prosecution.
</P>
<H4 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Premarket approval pathway
</FONT>
</H4>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We currently do not market any devices that are subject to PMA requirements. Unlike the comparative standard of the 510(k) pathway, the PMA approval process requires an independent demonstration of the safety and effectiveness of a device. PMA is the most stringent type of device marketing application required by FDA. PMA approval is based on a determination by FDA that the PMA contains sufficient valid scientific evidence to assure that the device is safe and effective for its intended use(s). A PMA application generally includes extensive information about the device including the results of clinical testing conducted on the
	device and a detailed description of the manufacturing process.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	After a PMA application is accepted for review, FDA begins an in-depth review of the submitted information. FDA regulations provide 180 days to review the PMA and make a determination; however, in reality, the review time is normally longer (e.g., 1&nbsp;&#150;&nbsp;3 years). During this review period, FDA may request additional information or clarification of information already provided. Also during the review period, an advisory panel of experts from outside FDA may be convened to review and evaluate the data supporting the application and provide recommendations to FDA as to whether the data provide a reasonable assurance
	that the device is safe and effective for its intended use. In addition, FDA generally will conduct a preapproval inspection of the manufacturing facility to ensure compliance with the Quality System Regulation, or QSR, which imposes comprehensive development, testing, control, documentation and other quality assurance requirements for the design and manufacturing of a medical device.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Based on its review, FDA may (1) issue an order approving the PMA, (2) issue a letter stating the PMA is &#147;approvable&#148; (e.g., minor additional information is needed), (3) issue a letter stating the PMA is &#147;not approvable,&#148; or (4) issue an order denying PMA. A company may not market a device subject to PMA review until FDA issues an order approving the PMA. As part of a PMA approval, FDA may impose post-approval conditions intended to ensure the continued safety and effectiveness of the device including, among other things, restrictions on labeling, promotion, sale and distribution, and requiring the
	collection of additional clinical data. Failure to comply with the conditions of approval can result in materially adverse enforcement action, including withdrawal of the approval.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Most modifications to a PMA approved device, including changes to the design, labeling, or manufacturing process, require prior approval before being implemented. Prior approval is obtained through submission of a PMA supplement. The type of information required to support a PMA supplement and FDA&#146;s time for review of a PMA supplement vary depending on the nature of the modification.
</P>
<H4 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Clinical trials
</FONT>
</H4>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Clinical trials of medical devices in the U.S. are governed by FDA&#146;s Investigational Device Exemption regulation, in accordance with 21 CFR, Part 812. This regulation places significant responsibility on the sponsor of the clinical study including, but not limited to, choosing qualified investigators, monitoring the trial, submitting required reports, maintaining required records, and assuring investigators obtain informed consent, comply with the study protocol, control the disposition of the investigational device, submit required reports, etc.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Clinical trials of significant risk devices (e.g., implants, devices used in supporting or sustaining human life, devices of substantial importance in diagnosing, curing, mitigating or treating disease or otherwise preventing impairment of human health) require FDA and Institutional Review Board approval prior to starting the trial. FDA approval is obtained through submission of an Investigational Device Exemption application. Clinical trials of non-significant risk devices (i.e. devices that do not meet the regulatory definition of a significant risk device) only require Institutional Review Board approval before starting.
	The clinical trial sponsor is responsible for making the initial determination of whether a clinical study is significant risk or non-significant risk; however, a reviewing Institutional Review Board or the FDA may review this decision and disagree with the determination.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	An Investigational Device Exemption application must be supported by appropriate data, such as performance data, animal and laboratory testing results, showing that it is safe to evaluate the device in
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	70
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage77"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	humans and that the clinical study protocol is scientifically sound. There is no assurance that submission of an Investigational Device Exemption will result in the ability to commence clinical trials. Additionally, after a trial begins, FDA may place it on hold or terminate it if, among other reasons, it concludes that the clinical subjects are exposed to an unacceptable health risk.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	As noted above, FDA may require a company to collect clinical data on a device in the postmarket setting. The collection of such data may be required as a condition of PMA approval. FDA also has the authority to order, via a letter, a postmarket surveillance study, in accordance with 21 CFR, Part 822, for certain devices at any time after they have been cleared or approved. We do not expect to launch clinical trials subject to the Investigational Device Exemption regulations for future products. Also, our products are not currently subject to any required postmarket surveillance studies.
</P>
<H4 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Pervasive and continuing FDA regulation
</FONT>
</H4>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	After a device is entered into commerce in the U.S., regardless of its classification or premarket pathway, numerous additional FDA requirements generally apply. These include:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Establishment registration and device listing requirements, in accordance with 21 CFR, Part 807;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Quality System Regulation requirements, which govern the methods used in, and the facilities and controls used for, the design, manufacture, packaging, labeling, storage, installation, and servicing of finished devices, in accordance with 21 CFR, Part 820;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Labeling requirements, which mandate the inclusion of certain content in device labels and labeling, and which also prohibit the promotion of products for uncleared or unapproved, i.e., &#147;off-label,&#148; uses;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Medical Device Reporting regulation, which requires that manufacturers and importers report to FDA if their device may have caused or contributed to a death or serious injury or malfunctioned in a way that would likely cause or contribute to a death or serious injury if it were to recur, in accordance with 21 CFR, Part 803; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Reports of Corrections and Removals regulation, which requires that manufacturers and importers report to FDA recalls (i.e., corrections or removals) if undertaken to reduce a risk to health posed by the device or to remedy a violation of the FDCA that may present a risk to health; manufacturers and importers must keep records of recalls that they determine to be not reportable, in accordance with 21 CFR, Part 806.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	FDA enforces these requirements by inspection and market surveillance. Failure to comply with applicable regulatory requirements can result in enforcement action by FDA, which may include, but is not limited to, the following sanctions:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Issuance of Form 483 observations during a facilities inspection;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Untitled letters or warning letters;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Fines, injunctions and civil penalties;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Consent Decree, which forces improvements in the quality management system through the use of the federal courts;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Recall or seizure of our products;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Operating restrictions, partial suspension or total shutdown of production;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Refusing our request for 510(k) clearance or premarket approval of new products;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Withdrawing 510(k) clearance or premarket approvals that are already granted; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Criminal prosecution.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We are subject to unannounced establishment inspections by FDA, as well as other regulatory agencies overseeing the implementation of and compliance with applicable state public health regulations. These inspections may include our suppliers&#146; facilities.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	71
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage78"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	International
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	International sales of medical devices are subject to foreign government regulations, which vary substantially from country to country. In order to market our products in other countries, we must obtain regulatory approvals and comply with extensive safety and quality regulations in other countries. The time required to obtain approval by a foreign country may be longer or shorter than that required for FDA clearance or approval, and the requirements may differ. The European Union/European Economic Area, or EU/EEA, requires a CE conformity mark in order to market medical devices. Many other countries, such as Australia, India,
	New Zealand, Pakistan and Sri Lanka, accept CE or FDA clearance or approval, although others, such as China, Brazil, Canada and Japan require separate regulatory filings.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In the EEA, our devices are required to comply with the essential requirements of the EU Medical Devices Directive (93/42/EEC). Compliance with these requirements entitles us to affix the CE marking of conformity to our medical devices, without which they cannot be commercialized in the EEA. To demonstrate compliance with the essential requirements and obtain the right to affix the CE marking of conformity we must undergo a conformity assessment procedure, which varies according to the type of medical device and its classification. Except for low risk medical devices (Class I), where the manufacturer can issue an EC
	Declaration of Conformity based on a self-assessment of the conformity of its products with the essential requirements of the Medical Devices Directive, a conformity assessment procedure requires the intervention of a Notified Body, which is an organization accredited by a Member State of the EEA to conduct conformity assessments. The Notified Body would typically audit and examine the quality system for the manufacture, design and final inspection of our devices before issuing a certification demonstrating compliance with the essential requirements. Based on this certification we can draw up an EC Declaration of Conformity which allows us to affix the CE mark to our products.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Further, the advertising and promotion of our products in the EEA is subject to the laws of individual EEA Member States implementing the EU Medical Devices Directive, Directive 2006/114/EC concerning misleading and comparative advertising, and Directive 2005/29/EC on unfair commercial practices, as well as other EEA Member State laws governing the advertising and promotion of medical devices. These laws may limit or restrict the advertising and promotion of our products to the general public and may impose limitations on our promotional activities with healthcare professionals.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Sales and marketing commercial compliance
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Federal anti-kickback laws and regulations prohibit, among other things, persons from knowingly and willfully soliciting, receiving, offering or paying remuneration, directly or indirectly, in exchange for, or to induce either the referral of an individual, or the purchase, order or recommendation of, any good or service paid for under federal healthcare programs such as the Medicare and Medicaid programs. Possible sanctions for violation of these anti-kickback laws include monetary fines, civil and criminal penalties, exclusion from Medicare and Medicaid programs and forfeiture of amounts collected in violation of such
	prohibitions.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In addition, federal false claims laws prohibit any person from knowingly presenting, or causing to be presented, a false claim for payment to the federal government, or knowingly making, or causing to be made, a false statement to get a false claim paid. Off-label promotion has been pursued as a violation of the federal false claims laws. Pursuant to FDA regulations, we can only market our products for cleared or approved uses. Although surgeons are permitted to use medical devices for indications other than those cleared or approved by FDA based on their medical judgment, we are prohibited from promoting products for such
	off-label uses. Additionally, the majority of states in which we market our products have similar anti-kickback, false claims, anti-fee splitting and self-referral laws, which may apply to items or services reimbursed by any third party payor, including commercial insurers, and violations may result in substantial civil and criminal penalties.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	To enforce compliance with the federal laws, the U.S. Department of Justice, or DOJ, has increased its scrutiny of interactions between healthcare companies and healthcare providers which has led to an unprecedented level of investigations, prosecutions, convictions and settlements in the healthcare industry. Dealing with investigations can be time- and resource-consuming. Additionally, if a healthcare company settles an investigation with the DOJ or other law enforcement agencies, the company may be required to agree to additional compliance and reporting requirements as part of a consent decree or corporate integrity
	agreement.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	72
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage79"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The U.S. and foreign government regulators have increased regulation, enforcement, inspections and governmental investigations of the medical device industry, including increased U.S. government oversight and enforcement of the Foreign Corrupt Practices Act. Whenever a governmental authority concludes that we are not in compliance with applicable laws or regulations, that authority can impose fines, delay or suspend regulatory clearances, institute proceedings to detain or seize our products, issue a recall, impose operating restrictions, enjoin future violations and assess civil penalties against us or our officers or
	employees and can recommend criminal prosecution. Moreover, governmental authorities can ban or request the recall, repair, replacement or refund of the cost of devices we distribute.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Additionally, the commercial compliance environment is continually evolving in the healthcare industry as some states, including California, Massachusetts and Vermont, mandate implementation of corporate compliance programs, along with the tracking and reporting of gifts, compensation and other remuneration to physicians. The Affordable Care Act also imposes reporting and disclosure requirements on device manufacturers for any &#147;transfer of value&#148; made or distributed to prescribers and other healthcare providers. Device manufacturers are also required to report and disclose any investment interests held by physicians
	and their family members during the preceding calendar year. Failure to submit required information may result in civil monetary penalties of up to an aggregate of $150,000 per year (and up to an aggregate of $1 million per year for &#147;knowing failures&#148;), for all payments, transfers of value or ownership or investment interests not reported in an annual submission. The shifting compliance environment and the need to build and maintain robust and expandable systems to comply in multiple jurisdictions with different compliance or reporting requirements increases the possibility that a healthcare company may run afoul of one or more of the requirements.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Healthcare fraud and abuse
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Healthcare fraud and abuse laws apply to our business when a customer submits a claim for an item or service that is reimbursed under Medicare, Medicaid or most other federally-funded healthcare programs. The federal Anti-Kickback Statute prohibits unlawful inducements for the referral of business reimbursable under federally-funded healthcare programs, such as remuneration provided to physicians to induce them to use certain tissue products or medical devices reimbursable by Medicare or Medicaid. The Anti-Kickback Statute is subject to evolving interpretations. For example, the government has enforced the Anti-Kickback
	Statute to reach large settlements with healthcare companies based on sham consultant arrangements with physicians. The majority of states also have anti-kickback laws which establish similar prohibitions that may apply to items or services reimbursed by any third party payor, including commercial insurers. Further, recently enacted amendments to the Affordable Care Act, among other things, amend the intent requirement of the federal anti-kickback and criminal healthcare fraud statutes. A person or entity no longer needs to have actual knowledge of this statute or specific intent to violate it. In addition, the Affordable Care Act provides that the government may assert that a claim including items or services resulting from a violation of the federal anti-kickback statute constitutes a false or fraudulent claim for purposes of the false claims statutes. If a governmental authority were to conclude that we are not in compliance with applicable laws and regulations, we and our officers
	and employees could be subject to severe criminal and civil penalties including, for example, exclusion from participation as a supplier of product to beneficiaries covered by Medicare or Medicaid.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In addition to the Anti-Kickback Statute, the federal physician self-referral statute, commonly known as the Stark Law, prohibits physicians who have a financial relationship with an entity, including an investment, ownership or compensation relationship, from referring Medicare patients for designated health services, which include clinical pathology services, unless an exception applies. Similarly, entities may not bill Medicare or any other party for services furnished pursuant to a prohibited referral. Many states have their own self-referral laws as well, which in some cases apply to all third party payors, not just
	Medicare and Medicaid. If a governmental authority were to conclude that we are not in compliance with the Stark Law or state self-referral laws and regulations, our pathology laboratory business could be subject to severe financial consequences, including the obligation to refund amounts billed to third party payors in violation of such laws, civil penalties and potentially also exclusion from participation in government healthcare programs like Medicare and Medicaid. The Stark Law often is enforced through lawsuits brought under the Federal False Claims Act, violations of which trigger significant monetary penalties and treble damages.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	73
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage80"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Additionally, the civil False Claims Act prohibits knowingly presenting or causing the presentation of a false, fictitious or fraudulent claim for payment to the U.S. government. Actions under the False Claims Act may be brought by the Attorney General or as a qui tam action by a private individual in the name of the government. Violations of the False Claims Act can result in very significant monetary penalties and treble damages. The federal government is using the False Claims Act, and the accompanying threat of significant liability, in its investigations of healthcare providers and suppliers throughout the country for a
	wide variety of Medicare billing practices, and has obtained multi-million and multi-billion dollar settlements in addition to individual criminal convictions. Given the significant size of actual and potential settlements, it is expected that the government will continue to devote substantial resources to investigating healthcare providers&#146; and suppliers&#146; compliance with the healthcare reimbursement rules and fraud and abuse laws.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Health information privacy
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH, and their respective implementing regulations, impose requirements on certain covered healthcare providers, health plans and healthcare clearinghouses, known as covered entities, as well as their business associates that perform services for them that involve individually identifiable health information. The HIPAA privacy and security regulations, including the expanded requirements under HITECH, establish comprehensive federal standards with
	respect to the use and disclosure of protected health information by covered entities and their business associates, in addition to setting standards to protect the confidentiality, integrity and security of protected health information.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We have implemented policies and procedures related to compliance with the HIPAA privacy and security regulations, as required by law. The privacy and security regulations establish a &#147;floor&#148; and do not supersede state laws that are more stringent. Therefore, we are required to comply with both federal privacy and security regulations and varying state privacy and security laws. In addition, for healthcare data transfers from other countries relating to citizens of those countries, we must comply with the laws of those other countries. The federal privacy regulations restrict our ability to use or disclose patient
	identifiable laboratory data, without patient authorization, for purposes other than payment, treatment or healthcare operations (as defined by HIPAA), except for disclosures for various public policy purposes and other permitted purposes outlined in the privacy regulations. HIPAA, as amended by HITECH, provides for significant fines and other penalties for wrongful use or disclosure of protected health information in violation of the privacy and security regulations, including potential civil and criminal fines and penalties. If we do not comply with existing or new laws and regulations related to protecting the privacy and security of health information, we could be subject to monetary fines, civil penalties or criminal sanctions. In addition, other federal and state laws that protect the privacy and security of patient information may be subject to enforcement and interpretations by various governmental authorities and courts resulting in complex compliance issues. For example, we
	could incur damages under state laws pursuant to an action brought by a private party for the wrongful use or disclosure of confidential health information or other private personal information. If we were to experience a breach of protected health information, we could be subject to significant adverse publicity in addition to possible enforcement sanctions and civil damages lawsuits. Finally, we may be required to incur additional costs related to ongoing HIPAA compliance as may be necessary to address evolving interpretations and enforcement of HIPAA and other health information privacy and security laws, the enactment of new laws or regulations, emerging cybersecurity threats and other factors.
</P>
</EFX_COMPETITION>
<EFX_EMPLOYEES>
<A NAME="FIS_EMPLOYEES"></A>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Employees
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	As of April 30, 2016, we had 28 employees, all in the U.S. None of our employees is represented by a labor union or covered by a collective bargaining agreement. We consider our relationship with our employees to be good.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Facilities
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our corporate headquarters and principal office is located in Boca Raton, Florida. Our corporate headquarters and principal office occupies approximately 4,500 square feet of leased space. The lease term expires in 2017. Our lease contains escalating rent clauses. Our rental expense in 2015 was approximately $98,000 and our estimated minimum rent in 2016 is approximately $101,000. We believe that our current
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	74
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage81"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	facilities are suitable and adequate to meet our current needs and that suitable additional space will be available as and when needed on acceptable terms. Our manufacturing and service functions are physically located at our third party manufacturer&#146;s facility. We are planning to review the feasibility of bringing certain manufacturing, service and research and development functions in-house, which may require the purchase or lease of a manufacturing facility. See &#147;Use of Proceeds.&#148;
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Legal proceedings
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We are party to certain legal proceedings in the ordinary course of business. We assess, in conjunction with our legal counsel, the need to record a liability for litigation and related contingencies. Please see Note 6 to the Financial Statements.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Seasonality
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We do not believe our business to be seasonal in nature.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	75
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage82"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
</EFX_EMPLOYEES>
</EFX_BUSINESS>
<EFX_MANAGEMENT>
<A NAME="FIS_MANAGEMENT"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<A NAME="V440371_S1A_HTM_T10M">
</A>
	MANAGEMENT
</FONT>
</H1>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The following table sets forth the name, age, and position of the individuals who currently serve as executive officers and directors of Sensus Healthcare, Inc. as of May 1, 2016. The following also includes certain information regarding our directors&#146; and officers&#146; individual experience, qualifications, attributes and skills and brief statements of those aspects of our directors&#146; backgrounds that led us to conclude that they are qualified to serve as directors.
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<EFX_NAME_AND_TITLE>
<A NAME="FIS_NAME_AND_TITLE"></A>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="152">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="32">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="392">
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	Name
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	Age
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	Position(s)
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; FONT-STYLE: ITALIC" ROWSPAN=1 COLSPAN=1>
	Executive officers:
<BR>
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	&nbsp;&nbsp;
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT" ROWSPAN=1 COLSPAN=1>
	Joseph C. Sardano
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: CENTER">
	63
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Chief Executive Officer and Chairman
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT" ROWSPAN=1 COLSPAN=1>
	Kalman Fishman
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: CENTER">
	45
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Chief Technology Officer and Chief Operating Officer
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT" ROWSPAN=1 COLSPAN=1>
	Arthur Levine
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: CENTER">
	58
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Chief Financial Officer
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT" ROWSPAN=1 COLSPAN=1>
	Richard Golin
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: CENTER">
	63
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Executive Vice President of Sales, Oncology and International
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT" ROWSPAN=1 COLSPAN=1>
	Stephen Cohen
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: CENTER">
	56
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Senior Vice President, Strategic Initiatives and Dermatology
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; FONT-STYLE: ITALIC" ROWSPAN=1 COLSPAN=1>
	Non-executive directors:
<BR>
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: CENTER">
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	&nbsp;&nbsp;
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT" ROWSPAN=1 COLSPAN=1>
	John Heinrich
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: CENTER">
	69
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Director
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT" ROWSPAN=1 COLSPAN=1>
	William McCall
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: CENTER">
	69
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Director
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT" ROWSPAN=1 COLSPAN=1>
	Samuel O&#146;Rear
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: CENTER">
	68
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Director
</TD>
</TR>
</TABLE>
</DIV>
</EFX_NAME_AND_TITLE>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Executive officers
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Joseph C. Sardano
</I>
</B>
	.&nbsp;&nbsp;Mr. Sardano is a co-founder and has served as our President, Chief Executive Officer and Chairman of the Board since our inception in June 2010. From July 2008 to February 2009, Mr. Sardano served as Chief Commercial Officer of Xoft, Inc., an electronic brachytherapy medical device company. From 2005 to 2008, Mr. Sardano served as managing partner and healthcare consultant for Molecular Imaging Ventures. From May 2005 to November 2005, Mr. Sardano served as Vice President of Siemens Medical Systems. Mr. Sardano served from September 2002 to May 2005 as Sr. Vice President of Global
	Sales and Marketing of CTI Molecular Imaging and Pet Net Pharmaceuticals, a developer of imaging and isotope solutions for the healthcare industry which was acquired by and now operates as a subsidiary of Siemens Medical Solutions. From August 1998 to September 2002 Mr. Sardano served as Americas Sales Manager for Functional Imaging at GE Medical Systems. From July 1997 to August 1998, Mr. Sardano served as Vice President of Sales and Marketing for Elscint Inc., a developer and manufacturer of medical imaging solutions, including nuclear medicine, computed tomography magnetic resonance imaging and x-ray scanners, the imaging activities of which were sold to GE Medical Systems in 1999. From June 1991 to December 1995, Mr. Sardano served as Region Sales Manager of Toshiba America Medical Systems. Mr. Sardano has a Bachelor of Arts degree from Concordia University in Montreal, Canada, as well as several Business Certificates from McGill University, School of Management. Our board of
	directors believes that Mr. Sardano&#146;s breadth of experience with and leadership of the introduction and commercialization of new technologies and services within the healthcare industry qualifies him to serve as our President, Chief Executive Officer and Chairman of the Board.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Kalman Fishman
</I>
</B>
	.&nbsp;&nbsp;Mr. Fishman is a co-founder and has served as our Chief Technology Officer and Chief Operating Officer since our inception in June 2010. Prior to our inception, Mr. Fishman served as Vice President of Sales &amp; Business Development for Rcadia Medical Imaging from August 2008 to September 2009, Vice President of Sales &amp; Marketing of Positron Medical Systems from August 2007 to July 2008, Director of Strategic Outsourcing &amp; Business Development from December 2006 to July 2007, and Director, Sales and Marketing at Siemens Medical Systems from September 2004 to December 2006.
	Prior to that, Mr. Fishman served as Global Product Manager and Six Sigma Black Belt from January 2000 to February 2004 at GE Medical Systems. Mr. Kalman holds an associate&#146;s degree in computer science from the Ort Singalowski Technological Institute in Tel Aviv, Israel and also attended the Milwaukee School of Engineering.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Arthur Levine
</I>
</B>
	.&nbsp;&nbsp;Mr. Levine has served as our Chief Financial Officer since August 2014. Prior to joining us, Mr. Levine served as Chief Accounting Officer of Trade Street Residential, a publicly traded real estate investment trust, from June 2012 to June 2014. From April 2010 to May 2012, Mr. Levine served as
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	76
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage83"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Chief Financial Officer of IVAX Diagnostics, a publicly traded in vitro diagnostics company. Mr. Levine previously served in various finance roles at several technology companies and worked at Ernst &amp; Young in the U.S. and abroad. He is a graduate of the Wharton School of the University of Pennsylvania and is a Certified Public Accountant.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Richard Golin
</I>
</B>
	.&nbsp;&nbsp;Mr. Golin is a co-founder and has served as our Executive Vice President of Sales, Oncology and International, since our inception in June 2010. Prior to our inception, Mr. Golin served as Vice President of Sales, East, for Xoft, Inc. from August 2008 to August 2009, Regional Sales Manager for Biospace Med USA from August 2007 to August 2008, Director of Sales Skeletal Health for Hologlc, a developer, manufacturer and supplier of diagnostic and medical imaging systems related to women&#146;s health, from 2006 to 2007 and as Region Sales Manager at Siemens Medical Systems from 2005 to
	2006. From 2003 to 2005, Mr. Golin served as Region Vice President of Sales for CTI Molecular Imaging, a developer of imaging solutions for the healthcare industry which was acquired by and now operates as a subsidiary of Siemens Medical Solutions under the name Siemens Molecular Imaging. Mr. Golin&#146;s other previous experience related to medical device sales and marketing includes having served as Region Sales Manager for Toshiba Medical Systems from 1992 to 2003 and as the Vice President of Sales &amp; Marketing at Ausonics, a developer of ultrasonic technology from 1986 to 1989.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Stephen Cohen
</I>
</B>
	.&nbsp;&nbsp;Mr. Cohen is a co-founder and has served as our Senior Vice President, Strategic Initiatives and Dermatology, since our inception in June 2010. Prior to our inception, Mr. Cohen served as Regional Sales Manager for Xoft Inc., a medical device company that develops and commercializes miniaturized electronic brachytherapy (eBx) technology for radiation oncology applications, from October 2008 to June 2009. Prior to that, Mr. Cohen&#146;s medical device sales and marketing experience includes having served as Regional Sales Manager for Diasonics, a developer and manufacturer of ultrasound
	and other medical imaging equipment, from 1985 to 1988, and from 1983 to 1985, as Regional Sales Manager for Technicare, a developer of CT, DR and MRI scanners and other medical imaging equipment that was acquired by Johnson and Johnson in 1986. Mr. Cohen has a bachelor&#146;s degree from the University of Texas at Austin.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Non-executive directors
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	John Heinrich
</I>
</B>
	.&nbsp;&nbsp;Dr. Heinrich has served as director since February 2012. His experience over the past 25 years includes having served as Chief Executive Officer of PhoenixNMR, a provider of probes for solid state NMR, from November 2014 to present, Managing Partner of Kansas Analytical Services, a provider of analytical services, from April 2007 to present, Chief Executive Officer of Acuitas Medical Ltd., a developer of MRI software, from May 2006 to December 2010 and April 2013 to present, a partner in Revolution NMR LLC, a provider of components and accessories for solid state NMR from May 2004 to
	present, President and Chief Operating Officer of Meretek Diagnostics Inc., a developer and marketer of medical diagnostics, from July 2001 to July 2004; President and Chief Executive Officer of Otsuka Electronics USA Inc., a developer and marketer of medical and scientific equipment, from February 1994 to December 1999; President and Chief Operating Officer of Summit World Trade, a diversified group of healthcare and technology companies, from January 1991 to January 1994; and President and Chief Operating Officer of Technomed International USA Inc., a developer and marketer of therapeutic technology, from January 1988 to December 1990. Mr. Heinrich has a Ph.D. in Metallurgical Engineering from the University of Notre Dame. Given Dr. Heinrich&#146;s substantial involvement in the development and management of a wide range of diagnostic imaging, therapeutic, medical diagnostic, and scientific instrument companies for more than 25 years, our board of directors believes that he is
	qualified to serve as a director.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	William McCall
</I>
</B>
	.&nbsp;&nbsp;Mr. McCall has served as director since October 2015. Mr. McCall is currently Managing Director of Heritage Advisory Group, a financial advisory practice of Ameriprise Financial Services Inc. and has worked in such capacity since January 2014. Mr. McCall's also currently serves as Managing Partner of Investors Capital Alliance LLC (since June 2009), a consulting company; Chief Executive Officer of WMW Partners LLC (since March 2009), an SEC-registered investment adviser; member of Pandora Mineral Resources LLC (since June 2015), and Board member of Cherokee Farm Partners Inc. (since
	January 2015), an entity of the University of Tennessee Research Foundation. Mr. McCall has a B.S. in business administration and received a Chartered Wealth Advisor&reg; designation from the Michigan State University Estate and Wealth Management Institute. Mr. McCall has a B.S. in business administration from the University of Tennessee and also earned his Chartered Wealth Advisor&reg; designation through the Michigan
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	77
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage84"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	State University Estate and Wealth Management Institute. In light of Mr. McCall's substantial experience as a financial advisor and portfolio manager for over 43 years, our board of directors believes that he is qualified to serve as a director.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
<I>
	Samuel O&#146;Rear
</I>
</B>
	.&nbsp;&nbsp;Mr. O&#146;Rear has served as director since February 2012. Mr. O&#146;Rear is the founder of The Innovation Group, Inc., which provides commercialization services to healthcare companies. Since June 1990, Mr. O&#146;Rear has been the CEO and Senior Partner of Total Innovation Group, Inc. and is currently an Investor/Principal/Board Member in several start-ups in the healthcare industry (Data Advantage&nbsp;&#151;&nbsp;Investor &amp; Advisor to CEO, Remcare&nbsp;&#151;&nbsp;Investor, UP Labs&nbsp;&#151;&nbsp;Investor&nbsp;&#151;&nbsp;Advisor to BOD). From June 1, 1990 to June 1,
	1991, Mr. O&#146;Rear served as the Chief Operating Officer of Medical Imaging Centers of America. Before then, Mr. O&#146;Rear worked for GE Healthcare, from October 1976 to June 1990 where he was promoted from sales management, financing/asset management, and marketing positions to Vice President, General Manager of X-Ray Business, and for Siemens Medical Systems Jan 1974 to October 1976, as sales representative. Mr. O&#146;Rear also served as the clinician in the ancillary services of three hospitals, primarily in the UAB Health System during the years March 1970 to January 1974. Mr. O&#146;Rear has a Bachelor of Science from the University of Alabama and attended the Marketing Development Program at Northwestern University. In light of Mr. O&#146;Rear&#146;s 40 years of experience in the healthcare industry as a clinician, a sales and marketing director, general manager, and as the owner or principal in several healthcare services businesses, our board of directors believes that he
	is qualified to serve as a director.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Board of directors and committees
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our board of directors currently consists of four directors. Our board of directors has determined that each of our directors, other than Mr. Sardano, is an &#147;independent director&#148; as defined under the Nasdaq listing standards. Under our bylaws, the number of directors will be determined from time to time by our board of directors.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We have a classified board of directors, which consists of three classes of directors. At each annual meeting of stockholders, directors of one class are elected for a three-year term. The terms of the directors identified above will expire upon the election and qualification of successor directors at the annual meeting of stockholders in the calendar year in which their terms expire.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The director class assignments are as follows:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Class I director (with a term expiring at the 2016 annual meeting)&nbsp;&#151;&nbsp;Mr. Heinrich;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Class II director (with a term expiring at the 2017 annual meeting)&nbsp;&#151;&nbsp;Mr. McCall;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Class III directors (with terms expiring at the 2018 annual meeting)&nbsp;&#151;&nbsp;Messrs. O&#146;Rear and Sardano.
</TD>
</TR>
</TABLE>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Audit committee
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our audit committee currently consists of Messrs. O&#146;Rear, Heinrich and McCall, with Mr. O&#146;Rear serving as chairman. Our board of directors has affirmatively determined that each member of the audit committee meets the definition of &#147;independent director&#148; for purposes of the Nasdaq rules and the independence requirements of Rule 10A-3 under the Exchange Act. Mr. O&#146;Rear qualifies as an &#147;audit committee financial expert&#148; under SEC rules.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our audit committee is responsible for, among other matters:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	appointing, compensating, retaining, evaluating, terminating and overseeing our independent registered public accounting firm;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	discussing with our independent registered public accounting firm their independence from management;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	reviewing with our independent registered public accounting firm the scope and results of their audit;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	approving all audit and permissible non-audit services to be performed by our independent registered public accounting firm;
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	78
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage85"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	overseeing the financial reporting process and discussing with management and our independent registered public accounting firm the interim and annual financial statements that we file with the SEC;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	reviewing and monitoring our accounting principles, accounting policies, financial and accounting controls and compliance with legal and regulatory requirements;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	establishing procedures for the confidential anonymous submission of concerns regarding questionable accounting, internal control or auditing matters; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	reviewing and approving related person transactions.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our board of directors adopted a new written charter for the audit committee, which will be available on our website.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Compensation committee
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our compensation committee currently consists of Messrs. Heinrich and McCall, with Mr. Heinrich serving as chairman. Our board of directors has affirmatively determined that each member of the compensation committee meets the heightened definition of &#147;independent director&#148; for purposes of the rules applicable to members of the compensation committee, and the definition of &#147;non-employee director&#148; for purposes of Section 16 of the Exchange Act.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The compensation committee is responsible for, among other matters:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	annually reviewing and approving our goals and objectives for executive compensation;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	annually reviewing and approving for the chief executive officer and other executive officers (1) the annual base salary level, (2) the annual cash incentive opportunity level, (3) the long-term incentive opportunity level, and (4) any special or supplemental benefits or perquisites;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	reviewing and approving employment agreements, severance arrangements and change of control agreements for the chief executive officer and other executive officers, as appropriate;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	making recommendations and reports to the board of directors concerning matters of executive compensation;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	reviewing compensation plans, programs and policies;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	handling such other matters that are specifically delegated to the compensation committee by the board of directors from time to time.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our board of directors adopted a new written charter for the compensation committee, which will be available on our website.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Compensation committee interlocks and insider participation
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	None of our executive officers currently serve on the compensation committee or board of directors of any other company of which any member or proposed member of our compensation committee is an executive officer.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Nominating and corporate governance committee
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our nominating and corporate governance committee consists of Messrs. Heinrich, McCall and O&#146;Rear, with Mr. McCall serving as chairman. Our board of directors has affirmatively determined that each member of the nominating and corporate governance committee meets the definition of &#147;independent director&#148; for purposes of the Nasdaq rules.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The nominating and corporate governance committee will be responsible for, among other matters:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	identifying the requisite skills and characteristics to be found in individuals qualified to serve as members of the board of directors;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	conducting inquiries into the background and qualifications of possible candidates;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	recruiting of qualified candidates for membership on the board of directors;
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	79
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage86"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	recommending for selection by the board of directors, (1) nominees to the board of directors and (2) committee members for each committee of the board of directors;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	overseeing the corporate governance of the company;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	evaluating the performance of the committee and its charter on an annual basis;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	handling such other matters that are specifically delegated to the nominating and corporate governance committee by the board of directors from time to time.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our board of directors adopted a new written charter for the nominating and corporate governance committee, which will be available on our website.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Role of the board in risk oversight
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	One of the key functions of our board of directors is informed oversight of our risk management process. The board of directors does not have a standing risk management committee, but rather administers this oversight function directly through the board of directors as a whole, as well as through various standing committees of our board of directors that address risks inherent in their respective areas of oversight. In particular, our board of directors is responsible for monitoring and assessing strategic risk exposure and our audit committee has the responsibility to consider and discuss our major financial risk exposures
	and the steps our management has taken to monitor and control these exposures, including guidelines and policies to govern the process by which risk assessment and management is undertaken. The nominating and corporate governance committee monitors compliance with legal and regulatory requirements and the effectiveness of our corporate governance practices, including whether they are successful in preventing illegal or improper liability-creating conduct. Our nominating and corporate governance committee is also responsible for overseeing our risk management efforts generally, including the allocation of risk management functions among our board of directors and its committees. Our compensation committee assesses and monitors whether any of our compensation policies and programs has the potential to encourage excessive risk-taking. Our audit committee periodically reviews the general process for the oversight of risk management by our board of directors.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	80
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage87"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
</EFX_MANAGEMENT>
<EFX_EXECUTIVE_COMPENSATION>
<A NAME="FIS_EXECUTIVE_COMPENSATION"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<A NAME="V440371_S1A_HTM_T11EAM">
</A>
	EXECUTIVE AND DIRECTOR COMPENSATION
</FONT>
</H1>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Introduction
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	This section provides an overview of our executive compensation program, including a narrative description of the material factors necessary to understand the information disclosed in the summary compensation table below. For 2015, our named executive officers, or NEOs, were:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Joseph C. Sardano, who was our founder and has served as our Chief Executive Officer and a member of our board of directors, since our inception in 2010;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Kalman Fishman, who has served as our Chief Technology Officer since our inception in 2010; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Arthur Levine, who has served as our Chief Financial Officer since 2014.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The objective of our compensation program is to provide a total compensation package to each named executive officer that will enable us to attract, motivate and retain outstanding individuals, reward named executive officers for performance and align the financial interests of each named executive officer with the interests of our stockholders to encourage each named executive officer to contribute to our long-term performance and success.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The compensation program for our named executive officers consists of the following elements: base salary; performance-based discretionary cash bonus; equity-based incentive compensation; and severance and change-in-control benefits.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our compensation committee, with input from the board, determines the compensation for our named executive officers. Upon completion of this offering, we will have an independent compensation committee that meets the enhanced independence standards applicable to compensation committees and that will be responsible for determining the compensation for our named executive officers and administering our equity compensation plans and awards.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Employment arrangements and agreements
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We have entered into written employment agreements with each of our named executive officers. These agreements were negotiated on an arms-length basis and establish the key elements of compensation, as set forth below. The terms of the agreements with our named executive officers are described in further detail below.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Mr. Sardano&#146;s employment
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We entered into an employment agreement with Mr. Sardano with an effective date of February 8, 2016. The initial base salary set forth in the agreement is $300,000, which may be increased from time to time (but never decreased) pursuant to the determination of our Compensation Committee. Under his employment agreement, Mr. Sardano will serve as our President and Chief Executive Officer. His agreement is for an initial term that ends December 31, 2020; however, the agreement provides for continuously renewing one-year periods thereafter unless either he or we provide written notice of the intent not to renew the agreement for a
	new term at least six months in advance of the end of the initial term or any one-year renewal term.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In addition to his salary, Mr. Sardano is entitled to participate in our incentive compensation programs. Mr. Sardano is entitled to an annual cash incentive bonus based on a plan established by our Compensation Committee. Mr. Sardano&#146;s target annual bonus must be at least $100,000, which may be increased from time to time (but never decreased) pursuant to the determination of our Compensation Committee. Mr. Sardano is also eligible to participate in and receive equity compensation or other long-term incentive compensation as may be granted by our Compensation Committee pursuant to a plan that the Compensation Committee
	may adopt from time to time. For Mr. Sardano, any annual cycle equity awards will be determined in discretion of our Compensation Committee; however, his agreement requires that the Compensation Committee base their decision on a basis at least as favorable as the basis for making grants to other senior executive officers of the company.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Mr. Sardano is entitled to certain severance benefits if his employment is terminated upon his death or Disability, change-in-control, without cause (as defined in the agreement) or if he resigns within 120 days
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	81
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage88"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	after the occurrence of any of the following (&#147;Good Reason&#148;): (a) reduction by us of his base salary or target bonus; (b) material reduction, other than during any period of illness or incapacity, of his authority, responsibilities, or duties such that he no longer has the title of, or serves or functions as Chief Executive Officer, (c) failure of our Board of Directors to nominate him for election as a member of the board of directors or failure to be re-elected to our Board (other than due to legal or exchange requirements that would prohibit him from serving on our Board of Directors); (d) relocation of principal
	place of employment more than 50 miles from our current principal executive offices; (e) our failure to obtain the written assumption of our obligations under the employment agreement by a successor; (f) our failure to renew the employment agreement (not as a result of death, Disability, or for cause); or (g) any other material breach of his employment agreement by us, including termination of Mr. Sardano for any other reason that is not a &#147;for cause&#148; termination. For the severance benefits to which he may be entitled, please see the section entitled &#147;Severance benefits under employment agreements.&#148;
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Mr. Sardano is entitled to participate in all of the employee benefit programs and perquisites generally available to our senior executive officers. The agreement contains customary business expense reimbursement, indemnification, confidentiality, non-compete and non-solicitation provisions.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Prior to entering into this employment agreement, we did not have a written agreement with Mr. Sardano. In 2015, we paid Mr. Sardano a base salary of $272,475 per year. Mr. Sardano was also eligible to receive discretionary cash bonuses in addition to his base salary and received a non-accountable car allowance of approximately $1,100 per month. Mr. Sardano was also eligible to participate in the employment benefit plans, programs and policies maintained by us from time to time.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Mr. Fishman&#146;s employment agreement
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We entered into an employment agreement with Mr. Fishman with an effective date of February 8, 2016. The initial base salary set forth in the agreement is $200,000, which may be increased from time to time (but never decreased) pursuant to the determination of our Compensation Committee. Under his employment agreement, Mr. Fishman will serve as our Chief Technology Officer and Chief Operating Officer. His agreement is for an initial term that ends December 31, 2020; however, the agreement provides for continuously renewing one-year periods thereafter unless either he or we provide written notice of the intent not to renew the
	agreement for a new term at least six months in advance of the end of the initial term or any one-year renewal term.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In addition to his salary, Mr. Fishman is entitled to participate in our incentive compensation programs. Mr. Fishman is entitled to an annual cash incentive bonus based on a plan established by our Compensation Committee. Mr. Fishman&#146;s target annual bonus must be at least $50,000, which may be increased from time to time (but never decreased) pursuant to the determination of our Compensation Committee. Mr. Fishman is also eligible to participate in and receive equity compensation or other long-term incentive compensation as may be granted by our Compensation Committee pursuant to a plan that the Compensation Committee
	may adopt from time to time.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Mr. Fishman is entitled to certain severance benefits if his employment is terminated upon his death or Disability, change-in-control, without cause (as defined in the agreement) or if he resigns within 120 days after the occurrence of any of the following (&#147;Good Reason&#148;): (a) reduction by us of his base salary or target bonus; (b) material reduction, other than during any period of illness or incapacity, of his authority, responsibilities, or duties such that he no longer has the title of, or serves or functions as Chief Technology Officer and Chief Operating Officer, (c) relocation of principal place of employment
	more than 50 miles from our current principal executive offices; (d) our failure to obtain the written assumption of our obligations under the employment agreement by a successor; (e) our failure to renew the employment agreement (not as a result of death, Disability, or for cause); or (f) any other material breach of his employment agreement by us, including termination of Mr. Fishman for any other reason that is not a &#147;for cause&#148; termination. For the severance benefits to which he may be entitled, please see the section entitled &#147;Severance benefits under employment agreements.&#148;
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Mr. Fishman is entitled to participate in all of the employee benefit programs and perquisites generally available to our senior executive officers. The agreement contains customary business expense reimbursement, indemnification, confidentiality, non-compete and non-solicitation provisions.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	82
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage89"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Prior to entering into this employment agreement, we did not have a written agreement with Mr. Fishman. In 2015, we paid Mr. Fishman a base salary of $189,000 per year. Mr. Fishman was also eligible to receive discretionary cash bonuses in addition to his base salary and received a non-accountable car allowance of approximately $1,100 per month. Mr. Fishman was also eligible to participate in the employment benefit plans, programs and policies maintained by us from time to time.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Mr. Levine&#146;s employment agreement
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We entered into an employment agreement with Mr. Levine with an effective date of February 8, 2016. This agreement supersedes our original employment agreement with Mr. Levine, which was dated August 12, 2014. Under Mr. Levine&#146;s new agreement, his initial base salary is $200,000, which may be increased from time to time (but never decreased) pursuant to the determination of our Compensation Committee. Under his employment agreement, Mr. Levine will serve as our Chief Financial Officer. His agreement is for an initial term that ends December 31, 2020; however, the agreement provides for continuously renewing one-year
	periods thereafter unless either he or we provide written notice of the intent not to renew the agreement for a new term at least six months in advance of the end of the initial term or any one-year renewal term.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In addition to his salary, Mr. Levine is entitled to participate in our incentive compensation programs. Mr. Levine is entitled to an annual cash incentive bonus based on a plan established by our Compensation Committee. Mr. Levine&#146;s target annual bonus must be at least $50,000, which may be increased from time to time (but never decreased) pursuant to the determination of our Compensation Committee. Mr. Levine is also eligible to participate in and receive equity compensation or other long-term incentive compensation as may be granted by our Compensation Committee pursuant to a plan that the Compensation Committee may
	adopt from time to time.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Mr. Levine is entitled to certain severance benefits if his employment is terminated upon his death or Disability, change-in-control, without cause (as defined in the agreement) or if he resigns within 120 days after the occurrence of any of the following (&#147;Good Reason&#148;): (a) reduction by us of his base salary or target bonus; (b) material reduction, other than during any period of illness or incapacity, of his authority, responsibilities, or duties such that he no longer has the title of, or serves or functions as Chief Financial Officer, (c) relocation of principal place of employment more than 50 miles from our
	current principal executive offices; (d) our failure to obtain the written assumption of our obligations under the employment agreement by a successor; (e) our failure to renew the employment agreement (not as a result of death, Disability, or for cause); or (f) any other material breach of his employment agreement by us, including termination of Mr. Levine for any other reason that is not a &#147;for cause&#148; termination. For the severance benefits to which he may be entitled, please see the section entitled &#147;Severance benefits under employment agreements.&#148;
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Mr. Levine is entitled to participate in all of the employee benefit programs and perquisites generally available to our senior executive officers. The agreement contains customary business expense reimbursement, indemnification, confidentiality, non-compete and non-solicitation provisions.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In 2015, we paid Mr. Levine a base salary of $160,000 per year pursuant to his now-superseded employment agreement, dated as of August 12, 2014. Under his prior employment agreement, Mr. Levine was also eligible to receive discretionary cash bonuses with a targeted payout of 20% of his base salary pursuant to the annual bonus plan determined and adopted by the board from time to time. Mr. Levine also received a non-accountable car allowance of approximately $1,100 per month and was eligible to participate in the employment benefit plans, programs and policies maintained by us from time to time.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Base salary
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We pay base salaries to attract, recruit and retain qualified employees. The base salaries of each of the named executive officers, pursuant to their respective employment agreements, is as follows: Mr. Sardano&nbsp;&#151;&nbsp;$300,000 Mr. Fishman&nbsp;&#151;&nbsp;$200,000; and Mr. Levine&nbsp;&#151;&nbsp;$200,000. Following the consummation of this offering, our compensation committee will review and set base salaries of our named executive officers annually consistent with their employment agreements.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	83
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage90"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Performance-based cash bonus compensation
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our executive compensation program includes an annual performance-based discretionary cash bonus. Our board of directors approves the terms and conditions of these awards on an annual basis. We intend to continue an annual performance-based cash bonus program for the named executive officers.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Equity incentive compensation
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Since 2013, we have granted options under our 2013 Option Plan. The option award agreements for all participants in the 2013 Option Plan are substantially similar. The awards provide for a five-year vesting period, with 100% of the options vesting on the fifth anniversary of the grant date. The plan also provides for accelerated vesting in the event of a change in control or termination of employment by us other than for cause and such termination occurs within 90 days prior to a change in control. Historically, we have not provided option awards to any of our named executive officers. For information about the equity awards
	held by the named executive officers at December 31, 2015, see &#147;Outstanding equity awards at Fiscal Year-End&#148; below.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In connection with the corporate conversion, outstanding options were converted into options to purchase our common stock at a one for one basis. Upon a change in control, which includes the closing of an initial public offering, all outstanding options will become immediately vested and will be automatically exercised pursuant to a cashless exercise feature, as set forth in our 2013 Option Plan.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In July 2015, we granted Mr. Levine 105,248 shares, equal to approximately one percent of the then-issued and outstanding shares of the company, which shares will vest upon the expiration of contractual lock-ups following the occurrence of a Liquidity Event (as defined in his equity grant agreement), which will include the successful completion of this offering.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Immediately following the pricing of this offering, our Compensation Committee expects to grant an aggregate of $1.92 million in restricted stock awards, or 320,000 shares, based on $6.00 per share (the portion of the per unit initial offering price attributable to the common stock based on an initial public offering price of $6.25 per unit), to certain of our officers and employees. Of these 320,000 shares, we expect to issue 156,666 shares to Arthur Levine, our Chief Financial Officer. The remaining shares are expected to be issued to our non-executive officer employees. The actual number of shares issued will depend on the
	final price per share of the common stock sold in this offering. All of the shares of restricted stock issued will vest in equal annual installments over a 4-year vesting period beginning on the date of grant. These grants will be subject to customary restrictions and other terms and conditions contained in each recipient&#146;s respective restricted stock grant agreement.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Benefits and perquisites
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We offer health and welfare benefits and life insurance to our named executive officers on the same basis that these benefits are offered to our other eligible employees, except that we pay the employee contribution toward the cost of health insurance for our named executive officers and we provide our named executive officers the opportunity for an executive physical. We offer a 401(k) plan to all eligible employees. In addition, Messrs. Sardano, Fishman and Levine each receive a non-accountable monthly car allowance.
</P>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Summary compensation table
</FONT>
</H1>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The following table sets forth information concerning the total compensation awarded to, earned by or paid to the named executive officers for the fiscal year ended December 31, 2015, calculated in accordance with SEC rules and regulations.
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<EFX_COMPENSATION_TABLE>
<A NAME="FIS_COMPENSATION_TABLE"></A>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="225">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="32">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="64">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="64">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="70">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="72">
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	Name and Principal Position
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Year
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Salary
<BR>
	($)
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Bonus
<BR>
	($)
<SUP>
	&#040;1&#041;
</SUP>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	All other
<BR>
	compensation
<BR>
	($)
<SUP>
	&#040;2&#041;
</SUP>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Total
<BR>
	($)
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-TOP" ROWSPAN=1 COLSPAN=1>
	Joseph C. Sardano
<BR>
<I>
	Chief Executive Officer
</I>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	2015
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	272,475
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	55,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	31,372
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	358,847
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-TOP" ROWSPAN=1 COLSPAN=1>
	Kalman Fishman
<BR>
<I>
	Chief Technology Officer
</I>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	2015
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	189,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	57,800
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	32,560
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	279,360
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-TOP" ROWSPAN=1 COLSPAN=1>
	Arthur Levine
<BR>
<I>
	Chief Financial Officer
</I>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	2015
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	160,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	48,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	36,672
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	244,672
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_COMPENSATION_TABLE>
<P STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 1PX">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_LINE.GIF" STYLE="WIDTH: 72PX; HEIGHT: 1PT">
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 1PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	(1)
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	For Mr. Fishman, his 2015 bonus includes $20,000 in sales commissions.
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	84
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage91"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 1PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	(2)
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	All other compensation includes the following:
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_16"></A>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="554" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="306">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="64">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="64">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="72">
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Life
<BR>
	insurance
<BR>
	($)
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Health
<BR>
	insurance
<BR>
	($)
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Car
<BR>
	allowance
<BR>
	($)
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Mr. Sardano
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	5,940
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	12,438
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	12,994
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Mr. Fishman
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,350
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	18,216
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	12,994
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Mr. Levine
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	3,612
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	20,066
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	12,994
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Outstanding equity awards at fiscal year-end
</FONT>
</H1>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The following table sets forth information with respect to outstanding option awards and incentive stock awards for each of the named executive officers as of December 31, 2015.
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_17"></A>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="340">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="70">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="70">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="78">
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=11>
	Stock awards
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	Name
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Incentive
<BR>
	share grant
<BR>
	date
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Equity
<BR>
	incentive plan
<BR>
	awards:
<BR>
	number of
<BR>
	unearned
<BR>
	shares
<BR>
	(#)
<SUP>
	&#040;1&#041;
</SUP>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Equity
<BR>
	incentive plan
<BR>
	awards:
<BR>
	market or
<BR>
	payout value of
<BR>
	unearned shares
<BR>
	($)
<SUP>
	&#040;2&#041;
</SUP>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Joseph C. Sardano
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Kalman Fishman
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Arthur Levine
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	7/30/15
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	105,248
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 1PX">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_LINE.GIF" STYLE="WIDTH: 72PX; HEIGHT: 1PT">
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 1PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	(1)
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Represents a grant of 105,248 shares which shares will vest upon the expiration of contractual lock-ups in connection with this initial public offering in accordance with the terms of the award agreement.
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 1PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	(2)
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	In accordance with U.S. GAAP, compensation costs for awards with performance conditions should be recorded in the Company&#146;s financial statements at the time that it is probable the performance condition is achieved, which is the closing of an initial public offering. As of December 31, 2015, the performance condition had not been probable and accordingly no compensation cost was recorded.
</TD>
</TR>
</TABLE>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Potential payments upon termination or change in control
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Mr. Levine&#146;s employment agreement provides that stock issued to Mr. Levine in connection with his employment shall vest upon his involuntary termination or upon the occurrence of a Liquidity Event (as defined in his equity grant agreement), which includes the closing of this initial public offering.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Severance benefits under employment agreements
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We have agreed to pay severance benefits to our named executive officers in the event of their termination by us under certain circumstances as follows:
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<I>
	In connection with a change in control.
</I>
	&nbsp;&nbsp;In the event of that the employment of Mr. Sardano, Mr. Fishman, or Mr. Levine terminates without cause or due to a resignation for good reason in connection with a change in control, the executive is entitled to receive any salary earned but unpaid prior to termination, any business expenses that were incurred but not reimbursed as of the date of termination, a separation allowance, payable in equal installments over a 12-month period, equal to two times the sum of (x) the executive&#146;s then base salary and (y) the executive&#146;s then target bonus, if termination
	occurs prior to the end of any fiscal year, a pro rata annual incentive bonus, the ability to participate (through COBRA or otherwise), on the same terms and conditions as in effect for the executive immediately prior to termination, in the medical, dental, disability, and life insurance programs until the earlier of (i) expiration of a 24-month period or (ii) such time the executive is covered by the benefits of a subsequent employer. In addition, all of the executive&#146;s then-outstanding equity awards, if any, shall vest in full immediately upon termination.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<I>
	Termination without cause or resignation for good reason,
</I>
	&nbsp;&nbsp;In the event of that the employment of Mr. Sardano, Mr. Fishman, or Mr. Levine terminates without cause or due to a resignation for good reason (other than in connection with a change in control), the executive is entitled to receive any salary earned but unpaid prior to termination, any business expenses that were incurred but not reimbursed as of the date of termination, a separation allowance, payable in equal installments over a 12-month period, equal to one times the sum of (x) the executive&#146;s then base salary and (y) the executive&#146;s
	then target bonus, if termination occurs prior to the end of any fiscal year, a pro rata annual incentive bonus, the ability to participate (through
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	85
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage92"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	COBRA or otherwise), on the same terms and conditions as in effect for the executive immediately prior to termination, in the medical, dental, disability, and life insurance programs until the earlier of (i) expiration of a 12-month period or (ii) such time the executive is covered by the benefits of a subsequent employer. In addition, all of the executive&#146;s then-outstanding equity awards, if any, shall vest in full immediately upon termination.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<I>
	Termination due to death or disability.
</I>
	&nbsp;&nbsp;In the event of that the employment of Mr. Sardano, Mr. Fishman, or Mr. Levine terminates due to death or Disability, the executive is entitled to receive any salary earned but unpaid prior to termination, any business expenses that were incurred but not reimbursed as of the date of termination, any earned benefits to which executive was entitled as of the date of termination pursuant to the terms of any compensation or benefit plans to the extent permitted by such plans, any annual incentive bonuses earned but not yet paid for any completed full fiscal year immediately
	preceding the date of termination, and, if termination occurs prior to the end of any fiscal year, a pro rata annual incentive bonus.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<I>
	For voluntary resignation without good reason.
</I>
	&nbsp;&nbsp;In the event that any of Mr. Sardano, Mr. Fishman, or Mr. Levine voluntarily terminates his employment for any reason other than good reason, no further payments are due, except that the executive will be entitled to any salary earned but unpaid prior to termination, any benefits accrued prior to termination and any business expenses that were incurred but not reimbursed as of the date of termination.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<I>
	Termination for Cause
</I>
	.&nbsp;&nbsp;In the event that we terminate Mr. Sardano, Mr. Fishman, or Mr. Levine for cause, no further payments are due, except that the executive will be entitled to any salary earned but unpaid prior to termination and any business expenses that were incurred but not reimbursed as of the date of termination.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Accelerated vesting of option awards
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Pursuant to our 2013 Option Plan, (i) options shall fully vest as of the time of a Change in Control (as such term is defined in our 2013 Option Plan) if the participant is, and has been, continuously employed by or providing services to the company as of such time; (ii) options shall fully vest and be deemed outstanding as of the time of a Change in Control if the participant is, and has been, continuously employed by or providing services to the company as of the date that is within 90 days prior to a Change in Control and the participant&#146;s employment and any other service with the company was terminated by the company
	without cause.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2013 Option Plan
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In October 2013, we adopted the Sensus Healthcare, LLC 2013 Option Plan to provide a means to attract, retain and motivate our directors, employees and consultants upon whose judgment, initiative and efforts our continued success, growth and development are dependent.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The plan provides for the grant of options to employees, directors and consultants. The plan is administered by the compensation committee of our board of directors. The maximum number of shares that may be granted under the plan is equal to 1% of our outstanding shares from time to time. The compensation committee has the discretion to grant option awards and set the vesting terms for awards, provided that the exercise price for such option awards may not be less than fair market value.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Except as otherwise provided in the applicable award agreement, in the event of termination of a participant&#146;s employment and other services, the participant&#146;s unvested options will expire, unless the termination occurs within 90 days prior to a change in control and other conditions are met, in which case the options will vest as of the date of the Change in Control. In the event of any termination (including termination due to death or disability) other than termination by us without cause: (i) all of the participant&#146;s options (vested or unvested) will expire; and (ii) any option interests acquired by the
	participant through option exercise that took place within thirty (30) days immediately preceding the date of such termination of employment and services, will be forfeited to us and the exercise price paid by the participant (other than the exercise price paid by virtue of our withholding option interests) will be returned to the participant. Our board of directors expects to terminate the 2013 Option Plan prior to the closing of this offering.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	86
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage93"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2016 Equity Incentive Plan
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In February 2016, we adopted the Sensus Healthcare, Inc. 2016 Equity Incentive Plan (the &#147;2016 Plan&#148;). A summary of the material terms of the 2016 Plan is set forth below.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Purpose and administration
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Pursuant to the 2016 Plan, our directors, officers and other key employees who have been selected as participants are eligible to receive awards of various forms of equity-based incentive compensation, including incentive and nonqualified stock options, stock appreciation rights, restricted stock awards, performance shares and phantom stock, and awards consisting of combinations of such incentives. The 2016 Plan is administered by the Compensation Committee of the Board of Directors. Under the 2016 Plan, the Compensation Committee has the authority to establish, adopt, revise or rescind such rules and regulations and to make
	all such determinations relating to the 2016 Plan as it may deem necessary or advisable for the administration of the 2016 Plan.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Subject to the provisions of the 2016 Plan, the Compensation Committee has sole discretionary authority to interpret the 2016 Plan and to determine the type of awards to grant, when, if, and to whom awards are granted, the number of shares covered by each award and the terms and conditions of the award. The term of the 2016 Plan is 10 years from the effective date, after which no further securities may be granted thereunder.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Types of awards
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Options granted under the 2016 Plan may be incentive stock options, within the meaning of Section 422 of the Internal Revenue Code of 1986, or nonqualified stock options. The exercise price of the incentive options is the fair market value of the common stock on the date of grant. The exercise price of the nonqualified options is determined by the Compensation Committee when the options are granted, subject to a minimum price of the fair market value of the common stock on the date of grant. In the discretion of the Compensation Committee, the option exercise price may be paid in cash or in shares of stock or other property
	having a fair market value on the date of exercise equal to the option exercise price, or by delivering to us a copy of irrevocable instructions to a stockbroker to deliver promptly to us an amount of sale or loan proceeds sufficient to pay the exercise price.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	A stock appreciation right granted under the 2016 Plan option, will entitle its holder to be paid an amount equal to the fair market value of our common stock subject to the stock appreciation right as of an appreciation date selected by the holder of the stock appreciation right, less the exercise price of the related stock option, if any, or such other price as the Compensation Committee may determine at the time of the grant of the stock appreciation right (which may not be less than the fair market value of one share of our common stock on the date of grant).
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Restricted stock will be issued to the recipient at the time the award is granted, but will be subject to forfeiture to the extent set forth in the applicable restricted stock award agreement.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	A performance share or phantom stock award will provide for the future payment of cash or the issuance of shares of common stock to the participant if continued employment or other performance objectives established by the Compensation Committee at the time of grant are attained. Performance share awards will be payable in common stock based on the fair market value of such shares on the valuation date, provided, however, that the Compensation Committee may, at its discretion, vary such form of payment in whole or partial consideration of the performance share upon the specific request of a participant, which form may include
	cash.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We have limited the aggregate number of shares of common stock to be awarded under the 2016 Plan to 397,473 shares and no more than 397,473 shares of common stock in the aggregate may be granted in connection with incentive stock options. In addition, unless the Compensation Committee specifically determines otherwise, the maximum number of shares available under the 2016 Plan and the awards granted under the 2016 Plan will be subject to appropriate adjustment in the case of any stock dividends, stock splits, recapitalizations, reorganizations, mergers, consolidations, exchanges or other changes in capitalization affecting our
	common stock. Any shares granted in connection with options and stock appreciation rights shall be counted against this limit as one share for every one share allotted in connection with the awarded option or stock appreciation right. Any shares granted
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	87
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage94"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	in connection with awards other than options and stock appreciation rights shall be counted against this limit as two shares for every one share granted in connection with such award or by which the award is valued by reference.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Minimum vesting periods
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	All options, restricted stock, or stock appreciation rights granted to executive officers that are subject to vesting solely based on such executive officers continuing as employees may not vest in full or be issued earlier than the three-year anniversary of the grant date (except if accelerated pursuant to (i) a change in control, (ii) the death of the holder, (iii) the disability of the holder, or (iv) the holder&#146;s termination of employment without &#147;cause&#148;). All restricted stock grants to executive officers that are subject to vesting or issuance based in whole or in part on performance conditions or the level
	of achievement versus performance goals will be evaluated over an award period of not less than one year.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Prohibition on repricing
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The 2016 Plan permits the Compensation Committee to amend, terminate, or modify the 2016 Plan from time to time, provided that, without shareholder approval, the Compensation Committee may not, among other things, materially increase the number of shares available for issuance under the 2016 Plan, reprice outstanding options or stock appreciation rights, expand the types of awards available under the 2016 Plan, materially expand the class of participants eligible to participate under the 2016 Plan or otherwise materially increase benefits to any participants.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Limited recycling policy
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	To the extent that shares of common stock subject to an award are not issued or delivered by reason of (i) the expiration, termination, cancellation, or forfeiture of such award or (ii) the settlement of such award in cash rather than the issuance of shares of common stock, then such shares of common stock shall again be available under the 2016 Plan, provided, however, that such shares will not again be available if such shares are (x) shares that were subject to a stock-settled stock appreciation right and were not issued or delivered upon the net settlement of such stock appreciation right, (y) shares delivered to, or
	withheld by, us to pay the exercise price or the withholding taxes related to an outstanding award, or (z) shares repurchased by us on the open market with the proceeds of an option exercise.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Clawback, forfeiture and reductions of awards
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	To comply with applicable law (including the Dodd-Frank Wall Street Reform and Consumer Protection Act) and any risk management requirements or policies adopted by us, the Compensation Committee retains the right to decrease or terminate any awards or payments under the 2016 Plan. Furthermore, any and all amounts paid or payable under the 2016 Plan will be subject to clawback, forfeiture, and reductions to the extent necessary to comply with applicable law, as determined by the Compensation Committee.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Effect of change in control
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In the event of a &#147;Change in Control,&#148; all awards of options, stock appreciation rights, phantom stock and restricted stock will become fully exercisable or vested, as applicable, subject to certain limitations. The exercise of incentive stock options following a change in control will be subject to a $100,000 limitation under the 2016 Plan or any other similar plan of the Company. &#147;Change in Control&#148; means, unless the Committee otherwise directs by resolution adopted prior thereto, the occurrence of any of the following after the effective date of the 2016 Plan: (a) the date any &#147;person&#148; is or
	becomes the beneficial owner, directly or indirectly, of 50% or more of the combined voting power of our then outstanding voting securities entitled to vote generally in the election of directors; (b) the date when individuals who, at the beginning of any two-year period during the duration of the 2016 Plan, constitute the Board of Directors, plus new directors whose election or nomination for election by our shareholders is approved by a vote of at least two-thirds of the directors still in office who were directors at the beginning of such two-year period, cease for any reason during such two-year period to constitute at least a majority of the members of our Board of Directors; (c) the date a reorganization, merger or consolidation of us with any other corporation or entity is consummated regardless of which entity is the survivor, other than a merger, share exchange or consolidation which would result in our voting securities outstanding immediately prior thereto continuing to
	represent (either by remaining outstanding or being converted into voting securities of the surviving or acquiring entity) at least 50% of the combined voting power of the voting securities of us or such surviving or acquiring entity
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	88
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage95"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	outstanding immediately after such merger, share exchange or consolidation; (d) the date our stockholders approve a plan of complete liquidation or dissolution of us; or (e) the date a sale or disposition by us of all or substantially all of our assets is consummated.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Director compensation
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In 2015, we did not pay any cash fees or grant any equity or equity-based awards to our directors in connection with their service on our board of directors. We anticipate adopting a compensation program for non-employee directors following the closing of our initial public offering.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	89
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage96"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
</EFX_EXECUTIVE_COMPENSATION>
<EFX_STOCKHOLDERS>
<A NAME="FIS_STOCKHOLDERS"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<A NAME="V440371_S1A_HTM_T12PS">
</A>
	PRINCIPAL STOCKHOLDERS
</FONT>
</H1>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The following table sets forth information as of May 1, 2016 regarding the beneficial ownership of our common stock, giving effect to our conversion from a Delaware limited liability company to a Delaware corporation, by:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	each person or group known by us to beneficially owns more than 5% of our outstanding shares of common stock;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	each of our named executive officers;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	each of our directors; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	all of our current executive officers and directors as a group.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Beneficial ownership for the purposes of the following table is determined in accordance with the rules and regulations of the SEC. These rules generally provide that a person is the beneficial owner of securities if such person has or shares the power to vote or direct the voting of securities, or to dispose or direct the disposition of securities or has the right to acquire such powers within 60 days. For purposes of calculating each person&#146;s percentage ownership, common stock issuable pursuant to options exercisable within 60 days are included as outstanding and beneficially owned for that person or group, but are not
	deemed outstanding for the purposes of computing the percentage ownership of any other person. Except as disclosed in the footnotes to this table and subject to applicable community property laws, we believe that each beneficial owner identified in the table possesses sole voting and investment power over all common stock shown as beneficially owned by the beneficial owner.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The percentage of beneficial ownership is based on 10,368,041 shares of common stock outstanding prior to this offering after giving effect to our conversion from a Delaware limited liability company to a Delaware corporation and our expected 241.95-for-one forward stock split, shares of common stock to be outstanding after the completion of this offering, assuming no exercise of the underwriters&#146; option to purchase additional shares of our common stock and shares of common stock to be outstanding after the completion of this offering, assuming exercise of the underwriters&#146; option to purchase additional shares of our
	common stock in full.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The address for each beneficial owner is c/o Sensus Healthcare, Inc., 851 Broken Sound Pkwy. NW #215, Boca Raton, Florida 33487.
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<EFX_BENEFICIAL_OWNERS>
<A NAME="FIS_BENEFICIAL_OWNERS_2"></A>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 9PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="173">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="66">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="66">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="66">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="66">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="66">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="69">
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=3>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=3>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=15>
	After this offering
<SUP>
	&#040;1&#041;
</SUP>
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=7>
	Prior to this offering
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=7>
	Assuming underwriters&#146;
<BR>
	option to purchase additional
<BR>
	units is not exercised
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=7>
	Assuming underwriters&#146;
<BR>
	option to purchase additional
<BR>
	units is exercised in full
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=7>
	Number of shares
<BR>
	beneficially owned
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=7>
	Number of shares
<BR>
	beneficially owned
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=7>
	Number of shares
<BR>
	beneficially owned
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	Name
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Number
<BR>
	of shares
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Percentage
<BR>
	of shares
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Number
<BR>
	of shares
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Percentage
<BR>
	of shares
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Number
<BR>
	of shares
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Percentage
<BR>
	of shares
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	5% Stockholders
<BR>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Richard Golin
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	994,329
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	9.6
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	%
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	994,329
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	7.7
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	%
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	994,329
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	7.6
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	%
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Stephen Cohen
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	994,329
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	9.6
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	%
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	994,329
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	7.7
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	%
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	994,329
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	7.6
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	%
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Named executive officers and directors
<BR>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Joseph C. Sardano
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,642,668
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	15.8
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	%
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,642,668
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	12.7
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	%
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,642,668
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	12.5
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	%
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Kalman Fishman
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	994,329
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	9.6
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	%
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	994,329
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	7.7
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	%
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	994,329
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	7.6
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	%
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Arthur Levine
<SUP>
	&#040;2&#041;
</SUP>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	261,914
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	2.5
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	%
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	261,914
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	2.0
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	%
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	261,914
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	2.0
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	%
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	John Heinrich
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	30,002
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	*&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	30,002
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	*&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	30,002
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	*&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	William McCall
<SUP>
	&#040;3&#041;
</SUP>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	544,387
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	5.0
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	%
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	544,387
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	4.1
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	%
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	544,387
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	4.0
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	%
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Samuel O&#146;Rear
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	133,314
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1.3
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	%
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	133,314
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1.0
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	%
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	133,314
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1.0
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	%
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Current executive officers
<BR>
	and directors as a group
<BR>
	(8 persons)
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
<B>
	5,595,273
</B>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
<B>
	51.3
</B>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
<B>
	%
</B>
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
<B>
	5,595,273
</B>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
<B>
	41.7
</B>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
<B>
	%
</B>
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
<B>
	5,595,273
</B>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
<B>
	40.9
</B>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
<B>
	%
</B>
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_BENEFICIAL_OWNERS>
<P STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 1PX">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_LINE.GIF" STYLE="WIDTH: 72PX; HEIGHT: 1PT">
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 11PT; FONT-SIZE: 9PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 1PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	*
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Represents less than 1%.
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	90
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage97"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 11PT; FONT-SIZE: 9PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 1PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	(1)
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Assumes that each stockholder entitled to receive a Dividend Payment in connection with our corporate conversion elects to receive such Dividend Payment in the form of our common stock. See &#147;Corporate Conversion.&#148;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 11PT; FONT-SIZE: 9PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 1PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	(2)
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Includes 156,666 shares of restricted stock (based on $6.00 per share&nbsp;&#150;&nbsp;the portion of the per unit initial offering price attributable to the common stock based on an initial public offering price of $6.25 per unit) expected to be issued to Mr. Levine under our 2016 Equity Incentive Plan immediately following the pricing of this offering. See &#147;Executive and Director Compensation&nbsp;&#150;&nbsp;Equity incentive compensation.&#148;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 11PT; FONT-SIZE: 9PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 1PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	(3)
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Represents 544,387 shares issuable upon exercise of warrants held by Investors Capital Alliance, LLC, for which Mr. McCall serves as managing partner and over which Mr. McCall has voting and dispositive authority.
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	91
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage98"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
</EFX_STOCKHOLDERS>
<EFX_CERTAIN_TRANSACTIONS>
<A NAME="FIS_CERTAIN_TRANSACTIONS"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<A NAME="V440371_S1A_HTM_T13CRA">
</A>
	CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
</FONT>
</H1>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Prior to the completion of this offering, we expect to adopt a written policy on transactions with related persons. Under SEC rules, a related person is an officer, director, nominee for director or beneficial owner of more than 5% of any class of our voting securities (our 5% Security Holders) or an immediate family member of any of the foregoing. Pursuant to our related party transaction written policy and our code of ethics and business conduct, directors (including director nominees), executive officers and employees will be required to report any transactions or circumstances that may create or appear to create a conflict
	between the personal interests of the individual and our interests, regardless of the amount involved.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The audit committee of the board of directors is responsible for evaluating each related party transaction and making a determination as to whether the transaction at issue is fair, reasonable and within our policy and whether it should be ratified and approved. In the course of its review and approval of related party transactions, our audit committee will consider the relevant facts and circumstances to decide whether to approve such transactions. Our audit committee will approve only those transactions that it determines are in our best interest. In particular, our policy on related party transactions will require our audit
	committee to consider, among other factors it deems appropriate:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	whether the related party transaction is on terms no less favorable than terms generally available to an unaffiliated third party under the same or similar circumstances; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	the extent of the related party&#146;s interest in the transaction.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Pursuant to our policy on related party transactions, our audit committee will identify the following categories of transactions as deemed to be preapproved by the audit committee, even if the aggregate amount involved exceeds the lesser of (i) $120,000 or (ii) one percent of the Company&#146;s average assets as of the last day of the Company&#146;s two most recent fiscal years:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	our employment of any executive officer or compensation paid by us to any executive officer if, among other conditions, our compensation committee approved (or recommended that our board of directors approve) such compensation;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	any compensation paid to a director if the compensation is required to be reported in our proxy statement under Item 402 of the SEC&#146;s compensation disclosure requirements;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	any transaction with another company at which a related person&#146;s only relationship is as an employee (other than an executive officer), director or beneficial owner of less than 10% of that company&#146;s shares, if the aggregate amount involved does not exceed the lesser of $120,000 or one percent of the average of the Company&#146;s total assets at year-end for the last two completed fiscal years;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	any charitable contribution, grant or endowment made by us to a charitable organization, foundation or university at which a related person&#146;s only relationship is as an employee (other than an executive officer) or a director, if the aggregate amount involved does not exceed the lesser of $120,000 or one percent of the average of the Company&#146;s total assets at year-end for the last two completed fiscal years;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	any transaction where the related person&#146;s interest arises solely from the ownership of our common stock and all holders of our common stock received the same benefit on a pro rata basis; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	any transaction involving a related person where the rates or charges involved are determined by competitive bids.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In addition, our code of business conduct and ethics requires that each of our employees and directors inform our corporate counsel or the audit committee of any material transaction or relationship that comes to their attention that could reasonably be expected to create a conflict of interest. Further, at least annually, each director and executive officer will complete a detailed questionnaire that asks questions about any business relationship that may give rise to a conflict of interest and all transactions in which we are involved and in which the executive officer, a director or a related person has a direct or indirect
	material interest.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Other than compensation agreements and other arrangements which are described under &#147;Executive and Director Compensation&#148; and the transactions described below, since January 1, 2013, there has not been, and there is not currently proposed, any transaction or series of similar transactions to which we were or will be a
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	92
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage99"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	party in which the amount involved exceeded or will exceed $82,894 (our current threshold for reporting related party transactions) and in which any related person had or will have a direct or indirect material interest.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Relationship of certain employees
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	James Sardano, the brother of our President and Chief Executive Officer Joseph C. Sardano, is currently employed as a member of our sales team and received compensation in the amount of $120,080 and $180,577 during 2014 and 2013, respectively.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Conversion to corporate form
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	On January 1, 2016, we converted from a Delaware limited liability company to a Delaware corporation under the name Sensus Healthcare, Inc. Existing holders, including our 5% Security Holders, executive officers and directors, of (1) units and (2) options and warrants to purchase units, received the number of shares of common stock or the number of options described in this prospectus as a result of the corporate conversion. The existing securities held by our officers, directors, nominees for director and 5% Security Holders, executive officers and directors will be converted on the same basis as all other holders of such
	securities. See &#147;Corporate Conversion&#148; and &#147;Principal Stockholders&#148; for additional information.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Amendment of warrant agreement
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	On March 30, 2016, our board of directors approved an amendment to the warrant agreement with Investors Capital Alliance, LLC, dated as of March 31, 2011, to extend the expiration date of the warrant agreement from March 31, 2016 until April 30, 2016. On April 27, 2016, our board of directors approved a second amendment to the warrant agreement to further extend the expiration date until May 30, 2016. William McCall, a current member of our board of directors, serves as the managing partner of Investors Capital Alliance, LLC and abstained from voting on each of the proposals to amend the warrant agreement. Investors Capital
	Alliance, LLC may exercise the warrant agreement, as amended, on or before May 30, 2016 for an aggregate exercise price of $1,132,539 and would receive 544,387 shares of our common stock upon such exercise.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Limitation of liability and indemnification
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	As permitted by Delaware law, we adopted provisions in our certificate of incorporation, which will be effective as of the closing date of this offering, that limit or eliminate the personal liability of our directors. Our certificate of incorporation limits the liability of directors to the maximum extent permitted by Delaware law. Delaware law provides that directors of a corporation will not be personally liable for monetary damages for breaches of their fiduciary duties as directors, except liability for:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	any breach of the director&#146;s duty of loyalty to us or our stockholders;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	any unlawful payments related to dividends or unlawful stock repurchases, redemptions or other distributions; or
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	any transaction from which the director derived an improper personal benefit.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	These limitations do not apply to liabilities arising under federal securities laws and do not affect the availability of equitable remedies, including injunctive relief or rescission. If Delaware law is amended to authorize the further elimination or limiting of a director, then the liability of our directors will be eliminated or limited to the fullest extent permitted by Delaware law as so amended.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	As permitted by Delaware law, our certificate of incorporation or bylaws, as applicable, that will be effective as of the closing date of this offering also provide that:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	we will indemnify our directors and officers to the fullest extent permitted by law; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	we will advance expenses to our directors and officers in connection with a legal proceeding for which indemnification is required.
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	93
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage100"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Pursuant to Delaware law, we may, by action of our board of directors, also indemnify our other employees and other agents to the same extent that we may indemnify our officers and directors.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We anticipate entering into indemnification agreements with our directors and officers to provide such officers and directors with additional contractual assurances regarding the scope of their indemnification. We expect that each of these indemnification agreements will provide that we will indemnify the director or officer to the fullest extent permitted by law for claims arising in his capacity as a director or officer, provided that he acted in good faith and in a manner that he reasonably believed to be in, or not opposed to, our best interests and, with respect to any criminal proceeding, had no reasonable cause to
	believe that his conduct was unlawful. We expect that each of these indemnification agreements will provide that in the event that we do not assume the defense of a claim against a director or officer, we will be required to advance his expenses in connection with his defense, provided that he undertakes to repay all amounts advanced if it is ultimately determined that he is not entitled to be indemnified by us.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We also intend to purchase and maintain insurance on behalf of any person who is or was a director or officer against any loss arising from any claim asserted against him or her and incurred by him or her in any such capacity, subject to certain exclusions.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We believe that these provisions and agreements are necessary to attract and retain qualified persons as directors and officers. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling our company pursuant to the foregoing provisions, we understand that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.
<B>
</B>
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Other transactions
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The Compensation Committee of our Board of Directors expects to approve grants of restricted stock under our 2016 Equity Incentive Plan to Arthur Levine, our Chief Financial Officer, and certain other non-executive officer employees, effective upon the pricing of this offering. The value of the shares to be issued to Mr. Levine is approximately $940,000 (based on $6.00 per share&nbsp;&#151;&nbsp;the portion of the per unit initial offering price attributable to the common stock based on an initial public offering price of $6.25 per unit). For a description of these grants, see &#147;Executive and Director
	Compensation&nbsp;&#150;&nbsp;Equity incentive compensation.&#148;
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	94
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage101"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
</EFX_CERTAIN_TRANSACTIONS>
<EFX_SECURITIES_DESCRIPTION>
<A NAME="FIS_SECURITIES_DESCRIPTION"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<A NAME="V440371_S1A_HTM_T14DOC">
</A>
	DESCRIPTION OF SECURITIES
</FONT>
</H1>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<I>
	The following description summarizes important terms of our securities. For a complete description, you should refer to our certificate of incorporation and bylaws, copies of which have been filed as exhibits to the registration statement of which this prospectus is a part, as well as the relevant portions of the Delaware General Corporation Law, or the DGCL.
</I>
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Units
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Each unit consists of one share of common stock, $0.01 par value per share, and a warrant to purchase one share of our common stock. The common stock and warrants comprising each unit are not immediately separable. The units are expected to begin trading on or promptly after the date of this prospectus. The common stock and warrants comprising the units will begin trading separately on the seventh day following the expiration of the underwriters&#146; 45-day over-allotment option, or such earlier date as may be determined by the representatives of the underwriters, at which time trading of the units will be suspended, the
	units will be de-listed and only our common stock and warrants will continue to be listed for trading on Nasdaq.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Common stock
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<I>
	General
</I>
	.&nbsp;&nbsp;Our certificate of incorporation authorizes the issuance of up to 50,000,000 shares of our common stock, and there were 42,852 shares of our common stock outstanding following our corporate conversion on January 1, 2016. Prior to the commencement of this offering, we expect to effect a 241.95-for-one forward stock split after which 10,368,041 shares of our common stock will be outstanding. Following this offering, 12,700,541 shares of common stock will be outstanding, assuming the underwriters fully exercise their over-allotment option.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<I>
	Voting rights
</I>
	.&nbsp;&nbsp;The holders of our common stock are entitled to one vote for each share held of record on all matters submitted to a vote of the stockholders, including the election of directors, and will not have cumulative voting rights. Unless otherwise required by law, matters submitted to a vote of our stockholders require the approval of a majority of votes cast by stockholders represented in person or by proxy and entitled to vote on such matter, except that (1) the affirmative vote of the holders of at least seventy-five percent (75%) of the total voting power of the shares of the then-outstanding
	common stock is required to remove directors for cause, approve a change of control transaction, amend any provision of the bylaws, or amend certain provisions of the certificate of incorporation; and (2) if the number of nominees for director exceeds the number of directors to be elected, directors will be elected by a plurality of the votes cast. Accordingly, the holders of a majority of the shares of common stock entitled to vote in any election of directors will be able to elect all of the directors standing for election, if they so choose.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<I>
	Dividend rights
</I>
	.&nbsp;&nbsp;Holders of common stock will be entitled to receive ratably dividends if, as and when dividends are declared from time to time by our board of directors out of funds legally available for that purpose, subject to any preferential dividend rights of any then outstanding preferred stock.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<I>
	Other matters
</I>
	.&nbsp;&nbsp;Upon our liquidation, dissolution or winding up, the holders of common stock are entitled to share ratably in the net assets legally available for distribution to stockholders after the payment of all of our debts and other liabilities, subject to any liquidation preference granted to holders of any outstanding preferred stock. Holders of common stock will have no preemptive or conversion rights or other subscription rights, and no redemption or sinking fund provisions will be applicable to our common stock. All outstanding shares of common stock are, and the shares of common stock to be
	outstanding upon completion of this offering will be, fully paid and nonassessable.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Warrants
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The material terms and provisions of the warrants being issued as part of the units in this offering are summarized below. The following description is subject to, and qualified in its entirety by, the form of warrant, which is filed as an exhibit to the registration statement, of which this prospectus is a part. You should review a copy of the form of warrant for a complete description of the terms and conditions applicable to the warrants.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<I>
	Term
</I>
	.&nbsp;&nbsp;The warrants are exercisable during the period beginning upon separation and ending at 5:00 P.M. on the third anniversary of the issuance date.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	95
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage102"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<I>
	Exercise Price
</I>
	.&nbsp;&nbsp;The exercise price of the warrants will be $7.80 per share. The exercise price is subject to adjustment in the event of certain share dividends and distributions, share splits, share combinations, share issuances, reclassifications or similar events affecting our common stock.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<I>
	Exercisability
</I>
	.&nbsp;&nbsp;Holders may exercise the warrants upon issuance and at any time during the applicable term of the warrant. The warrants will be exercisable, at the option of each holder, in whole or in part, by delivering to us a duly executed exercise notice accompanied by payment in full in cash for the number of shares of our common stock purchased upon such exercise. If and only if a registration statement covering the issuance of common stock upon exercise of warrants is not available for the issuance of such shares, the warrants may be exercised, in whole or in part and in the warrant holder&#146;s sole
	discretion, through a cashless exercise feature as set forth in the warrant.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<I>
	Beneficial Ownership Limitation on Exercises
</I>
	.&nbsp;&nbsp;We will not effect the exercise of any warrants to the extent that after giving effect to such exercise, the warrant holder (together with their affiliates, and any persons acting as a group together with such holder and their affiliates) would beneficially own in excess of 4.99% of the common stock outstanding immediately after giving effect to such exercise.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<I>
	Call Provision
</I>
	.&nbsp;&nbsp; All, but not less than all, of the outstanding warrants may be redeemed, at our sole option, at any time on or after the first anniversary of the issuance date and prior to the expiration (so long as there is a current registration statement in effect with respect to the shares of common stock underlying the warrants), at the office of the warrant agent, upon 30 days&#146; written notice, at the price of $0.01 per warrant, provided that the last sales price of our common stock equals or exceeds $9.75 per share on each of the 20 trading days within any 30 trading day period ending on the third
	business day prior to the date on which notice of redemption is given.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<I>
	No Fractional Shares
</I>
	.&nbsp;&nbsp;No fractional shares or scrip representing fractional shares shall be issued upon the exercise of the warrants. As to any fraction of a share which the holder would otherwise be entitled to purchase upon such exercise, we shall, at our election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the exercise price of the warrant or round up to the next whole share.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<I>
	Transferability
</I>
	.&nbsp;&nbsp;Subject to applicable laws, the warrant may be transferred at the option of the holder upon surrender of the warrant to the warrant agent together with the appropriate instruments of transfer.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<I>
	Authorized Shares
</I>
	.&nbsp;&nbsp;During the period the warrants are outstanding, we will reserve from our authorized and unissued shares of common stock a sufficient number of shares to provide for the issuance of common stock underlying the warrants upon the exercise of the warrants.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<I>
	Exchange Listing
</I>
	.&nbsp;&nbsp;The warrants are a part of the units being sold in this offering. Each unit is comprised of one share of common stock and one warrant to purchase one share of common stock. The units will begin trading on or promptly after the date of this prospectus on the Nasdaq Capital Market under the symbol &#147;SRTSU.&#148; We expect that the warrants will begin trading separately on the seventh trading day following the expiration of the underwriters&#146; 45-day over-allotment option under the symbol &#147;SRTSW,&#148; or such earlier date as may be determined by the representatives of the
	underwriters, at which time trading of the units will be suspended and the units will be de-listed and only our common stock and warrants will continue to be listed for trading on the Nasdaq Capital Market.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<I>
	Right as a Stockholder
</I>
	.&nbsp;&nbsp;Except as otherwise provided in the warrants or by virtue of such holder&#146;s ownership of our common stock, the holders of the warrants do not have the rights or privileges of holders of our common stock, including any voting rights, until they exercise their warrants.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<I>
	Waivers and Amendments
</I>
	.&nbsp;&nbsp;Any term of the warrants issued in the offering may be amended or waived with our written consent and the written consent of holders representing 65% of the common stock issuable upon exercise of the warrants then outstanding.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<I>
	Fundamental Transactions.
</I>
	&nbsp;&nbsp;In the event of any fundamental transaction, as described in the warrant agreement and generally including any merger with or into another entity, sale of all or substantially all of our assets, tender offer or exchange offer, or recapitalization of our common stock, then upon any subsequent exercise of a warrant the holder shall have the right to receive for each share of common stock that would
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	96
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage103"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	have been issuable upon such exercise immediately prior to the occurrence of such fundamental transaction, the number of shares of capital stock of the successor or acquiring entity or of us, if we are the surviving entity, and any additional consideration receivable upon or as a result of such transaction by a holder of the number of shares of common stock for which the warrant is exercisable immediately prior to such event. Alternatively, in the event of a Fundamental Transaction that is approved by our board of directors or that occurs as a result of an event that was within our sole control, we will, at the warrant
	holder&#146;s option exercisable at any time prior to the consummation of the Fundamental Transaction, purchase such holder&#146;s warrants immediately prior to the consummation of such Fundamental Transaction for cash in an amount equal to the Black Scholes Value (as defined in the warrant agreement) of the remaining unexercised portion of such holder&#146;s warrants immediately prior to the consummation of such Fundamental Transaction.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Preferred stock
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	As of April 30, 2016, no shares of preferred stock were outstanding. Our certificate of incorporation permits our board of directors to issue up to 5,000,000 shares of preferred stock from time to time in one or more classes or series. The board also may fix the relative rights and preferences of those shares, including dividend rights, conversion rights, voting rights, redemption rights, terms of sinking funds, liquidation preferences, the number of shares constituting any class or series and the designation of the class or series. Terms selected by our board of directors in the future could decrease the amount of earnings
	and assets available for distribution to holders of common stock or adversely affect the rights and powers, including voting rights, of the holders of common stock without any further vote or action by the stockholders. As a result, the rights of holders of our common stock will be subject to, and may be adversely affected by, the rights of the holders of any preferred stock that may be issued by us in the future, which could have the effect of decreasing the market price of our common stock.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Anti-takeover effects of provisions of our certificate of incorporation and bylaws and Delaware law
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The provisions of the DGCL and our certificate of incorporation and bylaws could have the effect of discouraging others from attempting an unsolicited offer to acquire our company. Such provisions may also have the effect of preventing changes in our management. It is possible that these provisions could make it more difficult to accomplish transactions that stockholders may otherwise deem to be in their best interests.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<I>
	Election and removal of directors
</I>
	.&nbsp;&nbsp;Our board of directors is divided into three classes with initial terms ending at our annual meetings of stockholders in 2016, 2017 and 2018, respectively. Following their initial terms, each class of directors will be elected for a three-year term. Our directors may be removed only by the affirmative vote of at least 75% of our then outstanding common stock and only for cause. For more information on the terms of our directors, see the section entitled &#147;Management&nbsp;&#151;&nbsp;Board of directors and committees.&#148; This system of electing and removing directors
	generally makes it more difficult for stockholders to replace a majority of our directors.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<I>
	Authorized but unissued shares.
</I>
	&nbsp;&nbsp;The authorized but unissued shares of our common stock and our preferred stock will be available for future issuance without any further vote or action by our stockholders. These additional shares may be utilized for a variety of corporate purposes, including future public offerings to raise additional capital, corporate acquisitions and employee benefit plans. The existence of authorized but unissued shares of our common stock and our preferred stock could render more difficult or discourage an attempt to obtain control over us by means of a proxy contest, changes in our
	management, tender offer, merger or otherwise.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<I>
	Stockholder action; advance notification of stockholder nominations and proposals.
</I>
	&nbsp;&nbsp;Our certificate of incorporation and bylaws require that any action required or permitted to be taken by our stockholders must be effected at a duly called annual or special meeting of stockholders and may not be effected by written consent. Our certificate of incorporation also requires that special meetings of stockholders be called only by a majority of our board of directors. In addition, our bylaws provide that candidates for director may be nominated and other business brought before an annual meeting only by the board of
	directors or by a stockholder who gives written notice to us no later than 90 days prior to nor earlier than 120 days prior to the first anniversary of the last annual meeting of stockholders. These provisions may have the effect of deterring unsolicited offers to acquire our company or delaying changes in our management, which could depress the market price of our common stock.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	97
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage104"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<I>
	Amendment of certain provisions in our organizational documents
</I>
	.&nbsp;&nbsp;The amendment of any of the above provisions would require approval by holders of at least 75% of the voting power of all of the then outstanding shares of the capital stock entitled to vote generally in the election of directors, voting together as a single class.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<I>
	No cumulative voting
</I>
	.&nbsp;&nbsp;The DGCL provides that stockholders are not entitled to the right to cumulate votes in the election of directors unless our certificate of incorporation provides otherwise.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<I>
	Delaware anti-takeover law.
</I>
	&nbsp;&nbsp;Section 203 of the DGCL, an anti-takeover law, applies to us. In general, Section 203 prohibits a publicly held Delaware corporation from engaging in a &#147;business combination&#148; with an &#147;interested stockholder&#148; for a period of three years following the date the person became an interested stockholder, unless the &#147;business combination&#148; or the transaction in which the person became an interested stockholder is approved in a prescribed manner. Generally, a &#147;business combination&#148; includes a merger, asset or stock sale, or other transaction resulting
	in a financial benefit to the interested stockholder. Generally, an &#147;interested stockholder&#148; is a person who, together with affiliates and associates, owns or, within three years prior to the determination of interested stockholder status, did own, 15% or more of a corporation&#146;s voting stock.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Limitation of liability and indemnification
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our certificate of incorporation provides that no director will be personally liable for monetary damages for breach of any fiduciary duty as a director, except with respect to liability:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	for any breach of the director&#146;s duty of loyalty to us or our stockholders;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	for acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	under Section 174 of the DGCL (governing distributions to stockholders); or
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	for any transaction from which the director derived any improper personal benefit.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	If the DGCL is amended to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of our directors will be eliminated or limited to the fullest extent permitted by the DGCL, as so amended. The modification or repeal of this provision of our certificate of incorporation will not adversely affect any right or protection of a director existing at the time of such modification or repeal.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Our certificate of incorporation will provide that we will, to the fullest extent permitted by law, indemnify our directors and officers against all liabilities and expenses in any suit or proceeding or arising out of their status as an officer or director or their activities in these capacities. We will also indemnify any director or officer who, at our request, is or was serving as a director, officer, employee, agent or trustee of another corporation or of a partnership, limited liability company, joint venture, trust or other enterprise. We may, by action of our board of directors, provide indemnification to our employees
	and agents within the same scope and effect as the foregoing indemnification of directors and officers.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Listing
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We have been approved to list our common stock on the Nasdaq Capital Market under the symbol &#147;SRTS.&#148; We have applied to list our units and the warrants on the Nasdaq Capital Market under the symbols &#147;SRTSU&#148; and &#147;SRTSW,&#148; respectively.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Transfer agent and registrar and warrant agent
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The transfer agent and registrar for our units and common stock and the warrant agent for our warrants is American Stock Transfer &amp; Trust Company, LLC.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	98
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage105"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
</EFX_SECURITIES_DESCRIPTION>
<EFX_FUTURE_SALE>
<A NAME="FIS_FUTURE_SALE"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<A NAME="V440371_S1A_HTM_T15SEF">
</A>
	SHARES ELIGIBLE FOR FUTURE SALE
</FONT>
</H1>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Based upon the number of shares outstanding as of April 30, 2016, and after giving effect to the proposed 241.95-for-one forward stock split, we will have 12,438,041 shares of common stock outstanding upon the closing of this offering and separation of the units, assuming the underwriters fully exercise their over-allotment option. All the shares of our common stock sold in this offering are freely tradable without restriction or further registration under the Securities Act, except for any such shares which may be held or acquired by our &#147;affiliates,&#148; as that term is defined in Rule 144 promulgated under the
	Securities Act, which shares will be subject to the volume limitations and other restrictions of Rule 144 described below. The remaining shares of common stock will be &#147;restricted securities,&#148; as that term is defined in Rule 144. These restricted securities will be eligible for public sale only if they are registered under the Securities Act, or if they qualify for an exemption from registration, for example, under Rule 144.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Rule 144
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In general, under Rule 144 as in effect on the date of this prospectus, a person who is not one of our affiliates at any time during the three months preceding a sale, and who has beneficially owned shares of our common stock for at least six months, would be entitled to sell an unlimited number of shares of our common stock provided current public information about us is available and, after owning such shares for at least one year, would be entitled to sell an unlimited number of shares of our common stock without restriction. Our affiliates who have beneficially owned restricted securities within the meaning of Rule 144 for
	at least six months would be entitled to sell within any three-month period a number of shares that does not exceed the greater of:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	1% of the number of shares of our common stock then outstanding; or
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	the average weekly trading volume of our common stock on the during the four calendar weeks preceding the filing of a notice on Form 144 with respect to the sale.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Sales under Rule 144 by our affiliates are also subject to manner of sale provisions and notice requirements and to the availability of current public information about us.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Rule 701
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Rule 701 generally allows a member who acquired shares of our common stock pursuant to a written compensatory plan or contract and who is not deemed to have been an affiliate of our company during the immediately preceding 90 days to sell these shares in reliance upon Rule 144, but without being required to comply with the public information, holding period, volume limitation or notice provisions of Rule 144. Rule 701 also permits affiliates of our company to sell their Rule 701 shares under Rule 144 without complying with the holding period requirements of Rule 144. All holders of Rule 701 shares, however, are required by
	that rule to wait until 90 days after the date of this prospectus before selling those shares pursuant to Rule 701.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Options
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Following the date of this prospectus, we may file one or more registration statements on Form S-8 under the Securities Act to register the issuance of up to shares of common stock under our stock plans. These registration statements will become effective upon filing. All of the shares issued or to be issued upon the exercise of stock options or settlement of other awards under our stock plans are or will be eligible for resale in the public market without restrictions, subject to Rule 144 limitations applicable to affiliates and the lock-up agreements described below.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Lock-up agreements
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Notwithstanding the foregoing, we and substantially all of the holders of our equity prior to this offering have agreed with the underwriters, subject to limited exceptions, not to dispose of or hedge any of their common stock or securities convertible into or exchangeable for shares of common stock during the 180-day lock-up period after the date of this prospectus without the prior written consent of the underwriters. For an additional description of the lock-up agreements, please refer to the section entitled &#147;Underwriting&nbsp;&#151;&nbsp;Lock-Up Agreements.&#148;
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	99
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage106"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
</EFX_FUTURE_SALE>
<EFX_TAXATION>
<A NAME="FIS_TAXATION"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<A NAME="V440371_S1A_HTM_T16SF">
</A>
	MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS
</FONT>
</H1>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Overview
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The following is a summary of the material U.S. federal income tax consequences of the purchase, ownership and disposition of our securities to a non-U.S. holder that purchases securities in this offering. For purposes of this summary, a &#147;non-U.S. holder&#148; means a beneficial owner of our securities that is not a &#147;U.S. person&#148; or a partnership for U.S. federal income tax purposes. A U.S. person is any of the following:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	an individual citizen or resident of the U.S.;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	a corporation (or other entity treated as a corporation for U.S. federal income tax purposes) created or organized under the laws of the U.S., any state thereof or the District of Columbia;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	an estate the income of which is subject to U.S. federal income tax regardless of its source; or
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	a trust (1) whose administration is subject to the primary supervision of a U.S. court and which has one or more U.S. persons who have the authority to control all substantial decisions of the trust, or (2) that has a valid election in effect under applicable Treasury regulations to be treated as a U.S. person for U.S. federal income tax purposes.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In the case of a holder that is classified as a partnership for U.S. federal income tax purposes, the tax treatment of a partner in such partnership generally will depend upon the status of the partner and the activities of the partnership. If you are a partner in a partnership holding our securities, then you should consult your own tax advisor.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	This summary is based upon the provisions of the U.S. Internal Revenue Code of 1986, as amended, which we refer to as the Code, the Treasury regulations promulgated thereunder and administrative and judicial interpretations thereof, all as of the date hereof. Those authorities may be changed, perhaps retroactively, so as to result in U.S. federal income tax consequences different from those summarized below. We cannot assure you that a change in law, possibly with retroactive application, will not alter significantly the tax consequences described in this summary. We have not sought and do not plan to seek any ruling from the
	U.S. Internal Revenue Service, which we refer to as the IRS, with respect to the statements and conclusions set forth in the following summary, and there can be no assurance that the IRS or a court will agree with such statements and conclusions.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	This summary does not address all aspects of U.S. federal income taxes that may be relevant to non-U.S. holders in light of their personal circumstances, and does not deal with federal taxes other than the U.S. federal income tax, or with state, local or non-U.S. tax considerations. Special rules, not discussed here, may apply to certain non-U.S. holders, including (without limitation):
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	U.S. expatriates;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	controlled foreign corporations;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	passive foreign investment companies; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	pass-through entities (or investors in such entities) that are subject to special treatment under the Code.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Such non-U.S. holders should consult their own tax advisors to determine the U.S. federal, state, local and other tax consequences that may be relevant to them.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	This summary applies only to a non-U.S. holder that holds our securities as a capital asset (within the meaning of Section 1221 of the Code).
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	If you are considering the purchase of our securities, you should consult your own tax advisor concerning the particular U.S. federal income tax consequences to you of the purchase, ownership and disposition of our common stock, as well as the consequences to you arising under U.S. tax laws other than the federal income tax laws or under the laws of any other taxing jurisdiction.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	100
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage107"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Allocation of purchase price and characterization of a unit
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	There is no authority directly addressing the treatment, for U.S. federal income tax purposes, of securities with terms substantially the same as our units, and, therefore, that treatment is not entirely clear. Each unit should be treated for U.S. federal income tax purposes as an investment unit consisting of one share of our common stock and one warrant, each warrant representing the right to acquire one share of our common stock. Each holder of a unit must allocate the purchase price paid by such holder for such unit between the common stock and the warrant based on their respective relative fair market values. A
	holder&#146;s initial tax basis in the common stock and warrant included in each unit should equal the portion of the purchase price of the unit allocated thereto.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We intend to treat the warrants as options to purchase our common stock and not as current interests in our common stock until the warrants are exercised by the holders.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The foregoing treatment of the common stock and warrants are not binding on the IRS or any court. Because there are no authorities that directly address instruments that are similar to the units, no assurance can be given that the IRS or any court will agree with the characterization described above or the discussion below. Accordingly, each prospective investor should consult its own tax advisors regarding the U.S. federal, state, local and any non-U.S. tax consequences of an investment in a unit (including alternative characterizations of a unit). Unless otherwise stated, the following discussions are based on the assumption
	that our intended characterization of the common stock and warrants described above is accepted for U.S. federal income tax purposes.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Dividends
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	As discussed under the section entitled &#147;Dividend policy&#148; above, we do not currently anticipate paying any dividends in the foreseeable future. If we make a distribution of cash or property (other than certain distributions of our common stock) with respect to our common stock, such distribution will be treated as a dividend for U.S. federal income tax purposes to the extent paid from our current or accumulated earnings and profits (as determined under U.S. federal income tax principles). Dividends paid to you generally will be subject to withholding of U.S. federal income tax at a 30% rate or such lower rate as may
	be specified by an applicable income tax treaty. However, dividends that are effectively connected with the conduct of a trade or business by you within the U.S. and, in cases in which certain tax treaties apply, are attributable to a U.S. permanent establishment maintained by you, are not subject to the withholding tax, but instead are subject to U.S. federal income tax on a net income basis at applicable graduated individual or corporate rates. Certain certification and disclosure requirements including delivery of a properly executed IRS Form W-8ECI must be satisfied for effectively connected income to be exempt from U.S. federal withholding tax. Any such effectively connected dividends received by a foreign corporation may be subject to an additional &#147;branch profits tax&#148; at a 30% rate or such lower rate as may be specified by an applicable income tax treaty.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	If the amount of a distribution paid on our common stock exceeds our current and accumulated earnings and profits, such excess will be allocated ratably among each share of common stock with respect to which the distribution is paid and treated first as a tax-free return of capital to the extent of your adjusted tax basis in each such share, and thereafter as capital gain from a sale or other disposition of such share of common stock that is taxed to you as described below under the heading &#147;Gain on disposition of common stock.&#148; Your adjusted tax basis in a share of our common stock is generally the purchase price of
	such share, reduced by the amount of any such tax-free returns of capital.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	If you wish to claim the benefit of an applicable income tax treaty to avoid or reduce withholding of U.S. federal income tax on dividends, then you must (i) provide the withholding agent with a properly completed IRS Form W-8BEN or W-8BEN-E (or other applicable form) and certify under penalties of perjury that you are not a U.S. person and are eligible for treaty benefits, or (ii) if our common stock is held through certain foreign intermediaries, satisfy the relevant certification requirements of applicable U.S. Treasury regulations. Special certification and other requirements apply to certain non-U.S. holders that act as
	intermediaries (including partnerships).
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	101
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage108"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	If you are eligible for a reduced rate of U.S. federal income tax pursuant to an income tax treaty, then you may obtain a refund or credit of any excess amounts withheld by timely filing an appropriate claim with the IRS.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Gain on disposition of common stock
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Subject to the discussion below under &#147;Information reporting and backup withholding tax&#148; and &#147;Additional withholding tax,&#148; you generally will not be subject to U.S. federal income tax with respect to gain realized on the sale or other taxable disposition of our common stock (other than a redemption that is treated as a distribution for U.S. federal income tax purposes and taxed as described above), unless:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	the gain is effectively connected with a trade or business you conduct in the U.S., and, in cases in which certain tax treaties apply, is attributable to a U.S. permanent establishment maintained by you;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	if you are an individual, you are present in the U.S. for 183 days or more in the taxable year of the sale or other taxable disposition, and you have a &#147;tax home&#148; (as defined in the Code) in the U.S.; or
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	we are or have been a &#147;U.S. real property holding corporation&#148; for U.S. federal income tax purposes at any time within the shorter of (i) the five-year period ending on the date of the sale or other taxable disposition of our common stock and (ii) your holding period for our common stock.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	If you are a non-U.S. holder described in the first bullet point above, you generally will be subject to tax on the net gain derived from the disposition under regular graduated U.S. federal income tax rates. If you are a foreign corporation described in the first bullet point above, you may also be subject to a branch profits tax equal to 30% of your effectively connected earnings and profits or such lower rate as may be specified by an applicable income tax treaty. If you are an individual described in the second bullet point above, you will generally be subject to a flat 30% tax on the gain derived from the disposition,
	which may be offset by certain U.S. source capital losses (even though you are not considered a resident of the U.S.) but may not be offset by any capital loss carryovers.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	With respect to the third bullet point above, we believe that we are not currently, and we do not anticipate becoming, a U.S. real property holding corporation. However, because the determination of whether we are a U.S. real property holding corporation depends on the fair market value of our U.S. real property interests relative to the fair market value of our global real property interests and other business assets, there can be no assurance that we will not become a U.S. real property holding corporation in the future. In the event we do become a U.S. real property holding corporation, as long as our common stock is
	regularly traded on an established securities market, gain on a sale or disposition of our common stock will generally be subject to taxation pursuant to the third bullet point above only with respect to a non-U.S. holder that actually or constructively held more than 5% of our common stock at any time during the shorter of (i) the five-year period ending on the date of the sale or disposition of our common stock or (ii) the non-U.S. holder&#146;s holding period for our common stock. If gain on the sale or other taxable disposition of our common stock were subject to taxation under the third bullet point above, the non-U.S. holder would be subject to regular U.S. federal income tax with respect to such gain in generally the same manner as a U.S. person and may be subject to withholding tax.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Information reporting and backup withholding tax
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We must report annually to the IRS and to you the amount of dividends paid to you and the amount of tax, if any, withheld with respect to such dividends. The IRS may make this information available to the tax authorities in the country in which you are resident.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Additional information returns may be filed and you may be subject to backup withholding (currently at a rate of 28%) with respect to dividends paid on, and the proceeds from the disposition of, shares of our common stock, unless, generally, you certify under penalties of perjury (usually on IRS Form W-8BEN or W-8BEN-E) that you are not a U.S. person or you otherwise establish an exemption.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Any amounts withheld under the backup withholding rules may be allowed as a refund or a credit against your U.S. federal income tax liability, provided the required information is timely furnished by you to the IRS.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	102
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage109"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Additional withholding tax
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Sections 1471 through 1474 of the Code (commonly referred to as &#147;FATCA&#148;) generally will impose a 30% withholding tax on (i) dividends paid on our common stock and (ii) gross proceeds from the sale or other disposition of our common stock that occurs after December 31, 2018, in each case if the common stock is held by or through:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	certain foreign financial institutions (including investment funds), unless the institution otherwise qualifies for an exemption or enters into an agreement with the U.S. Treasury (i) to collect and report, on an annual basis, information with respect to accounts in the institution held by certain U.S. persons and by certain non-U.S. entities that are wholly or partially owned by U.S. persons, and (ii) to withhold on certain payments; or
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	a non-financial non-U.S. entity, unless the entity (i) either certifies to the applicable withholding agent or the IRS that the entity does not have any &#147;substantial United States owners&#148; or provides certain information regarding the entity&#146;s &#147;substantial United States owners&#148; or (ii) otherwise establishes an exemption from such withholding tax.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The rules described above may be modified by an intergovernmental agreement entered into between the United States and an applicable foreign country, or by future Treasury regulations or other guidance. Non-U.S. holders are encouraged to consult their tax advisors regarding the possible implications of these rules on their investment in our common stock.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<B>
	POTENTIAL PURCHASERS OF OUR COMMON STOCK ARE URGED TO CONSULT THEIR OWN TAX ADVISORS TO DETERMINE THE U.S. FEDERAL, STATE, LOCAL AND NON-U.S. TAX CONSIDERATIONS OF PURCHASING, OWNING AND DISPOSING OF OUR COMMON STOCK.
</B>
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	103
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage110"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
</EFX_TAXATION>
<EFX_UNDERWRITING>
<A NAME="FIS_UNDERWRITING"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<A NAME="V440371_S1A_HTM_T17U">
</A>
	UNDERWRITING
</FONT>
</H1>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Northland Securities, Inc. and Neidiger, Tucker, Bruner, Inc. are acting as the joint book-running managers and the representatives of the underwriters of the offering. We have entered into an underwriting agreement dated &nbsp;&nbsp;, 2016 with the representatives. Subject to the terms and conditions of the underwriting agreement, we have agreed to sell to each underwriter named below and each underwriter named below has severally agreed to purchase, at the public offering price set forth on the cover page of this prospectus, less the underwriting discounts and commissions, the number of units listed next to its name in the
	following table:
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_18"></A>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="554" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="466">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="72">
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	Name of Underwriter
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Number of Units
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Northland Securities, Inc.
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Neidiger, Tucker, Bruner, Inc.
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Total
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The underwriters are committed to purchase all the units offered by us other than those covered by the option to purchase additional units described below, if they purchase any units. The obligations of the underwriters may be terminated upon the occurrence of certain events specified in the underwriting agreement. Furthermore, pursuant to the underwriting agreement, the underwriters&#146; obligations are subject to customary conditions, representations and warranties contained in the underwriting agreement, such as receipt by the underwriters of officers&#146; certificates and legal opinions.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We have agreed to indemnify the underwriters against specified liabilities, including liabilities under the Securities Act, and to contribute to payments the underwriters may be required to make in respect thereof.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The underwriters are offering the units, subject to prior sale, when, as and if issued to and accepted by them, subject to approval of legal matters by their counsel and other conditions specified in the underwriting agreement. The underwriters reserve the right to withdraw, cancel or modify offers to the public and to reject orders in whole or in part.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We have granted a 45-day option to the underwriters to purchase up to 262,500 additional units solely to cover over-allotments, if any. The representatives may exercise this option for 45 days from the date of this prospectus, but in no event after separation of the units, solely to cover sales of units by underwriters in excess of the total number of units set forth in the table above. If any of these additional units are purchased, the underwriters will offer the additional units on the same terms as those on which the units are being offered. We will pay the expenses associated with the exercise of the over-allotment
	option. If this option is exercised in full, the total price to the public will be $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; and the total net proceeds, before expenses, to us will be $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_19"></A>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Discounts and Commissions
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The following table shows the public offering price, underwriting discounts and commissions and proceeds, before expenses, to us. The information assumes either no exercise or full exercise by the underwriters of their over-allotment option.
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="344">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="56">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="76">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="84">
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=3>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=7>
	Total
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Per Unit
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Without
<BR>
	Over-Allotment
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	With
<BR>
	Over-Allotment
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Public offering price
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Underwriting discounts and commissions
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Proceeds, before expenses, to us
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The underwriters propose to offer the units offered by us to the public at the public offering price set forth on the cover of this prospectus. In addition, the underwriters may offer some of the units to other securities dealers at such price less a concession of $&nbsp;&nbsp;&nbsp;&nbsp; per unit. If all of the units offered by us are not sold at the public offering price, the underwriters may change the offering price and other selling terms by means of a further supplement to this prospectus supplement.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We have paid an expense deposit of $50,000 to the representatives, which will be applied against the out-of-pocket accountable expenses that will be paid by us to the underwriters in connection with this offering.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	104
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage111"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The underwriting agreement, however, provides that in the event the offering is terminated, the $50,000 out-of-pocket expense deposit paid to the representatives will be returned to the extent such expenses are not actually incurred in accordance with FINRA Rule 5110(f)(2)(C).
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We have also agreed to pay the underwriters&#146; expenses relating to the offering, including (a) all fees, expenses and disbursements relating to background checks of our officers and directors in an amount not to exceed $10,000 in the aggregate; (b) all fees incurred in clearing this offering with FINRA; (c) all fees, expenses and disbursements relating to registration, qualification or exemption of securities offered under the securities laws of foreign jurisdictions designated by the representative; (d) all fees, expenses and disbursements relating to registration, qualification or exemption of securities offered under
	the &#147;blue sky&#148; securities laws of such states and jurisdictions designated by the representative (including, without limitation, all filing and registration fees, and the reasonable fees and disbursements of &#147;blue sky&#148; counsel, it being agreed that such fees and expenses will be limited to a payment of $15,000 to such counsel upon the commencement of &#147;blue sky&#148; work by such counsel and an additional $5,000 at closing, if the offering is commenced on the Over-the-Counter Bulletin Board, or an aggregate of $5,000 at closing if the offering is consummated on a national exchange; (e) the $29,500 cost associated with the use of Ipreo&#146;s book building, prospectus tracking and compliance software for the offering, (f) the fees and expenses of the underwriters&#146; legal counsel not to exceed $50,000; (g) up to $20,000 of the representatives actual accountable &#147;road show&#148; expenses for the offering, (h) the costs associated with bound volumes of the
	public offering materials as well as commemorative mementos and Lucite tombstones, not to exceed $2,500, and (i) up to $10,000 in costs associated with post-closing advertisement of the offering in the
<I>
	Wall Street Journal
</I>
	and
<I>
	New York Times.
</I>
	In addition, we have agreed to reimburse the representatives for their actual out-of-pocket expenses, up to $200,000.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We estimate that the total expenses of the offering payable by us, excluding the total underwriting discounts and commissions and expense reimbursement, will be approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Discretionary Accounts
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The underwriters do not intend to confirm sales of the securities offered hereby to any accounts over which they have discretionary authority.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Lock-Up Agreements
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Pursuant to certain &#147;lock-up&#148; agreements, we, our officers and directors, and substantially all of our stockholders have agreed, subject to certain exceptions, not to offer, sell, assign, transfer, pledge, contract to sell, or otherwise dispose of or announce the intention to otherwise dispose of, or enter into any swap, hedge or similar agreement or arrangement that transfers, in whole or in part, the economic risk of ownership of, directly or indirectly, engage in any short selling of any common stock or securities convertible into or exchangeable or exercisable for any common stock, whether currently owned or
	subsequently acquired, without the prior written consent of the representatives, for a period of 180 days from the date of this prospectus.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The lock-up period described in the preceding paragraphs will be automatically extended if: (1) during the last 17 days of the restricted period, we issue an earnings release or announce material news or a material event; or (2) prior to the expiration of the lock-up period, we announce that we will release earnings results during the 16-day period beginning on the last day of the lock-up period, in which case the restrictions described in the preceding paragraph will continue to apply until the expiration of the 18-day period beginning on the date of the earnings release, unless the representatives waive this extension in
	writing.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Representatives&#146; Warrants
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We have agreed to issue warrants to the representatives of the underwriters, or the Representatives&#146; Warrants, to purchase up to a total of 120,750 units (6% of the units sold in this offering), each unit consisting of one share of common stock and a warrant to purchase one share of common stock at an exercise price of $7.80 per share. The shares of common stock included in the units are identical to the shares of common stock sold pursuant to the offering. Other than the expiration date and the exercise date, the warrants to purchase common stock included in the units are substantially similar to the warrants to purchase
	common stock sold pursuant to the offering. The warrants are exercisable at a per unit price equal to $7.80 per unit, at
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	105
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage112"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	any time, and from time to time, in whole or in part, during the four-year period commencing one year from the effective date of the offering, which period shall not extend further than five years from the effective date of the offering in compliance with FINRA Rule 5110(f)(2)(G)(i). The warrants have been deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant to Rule 5110(g)(1) of FINRA. These underwriters (or permitted assignees under Rule 5110(g)(1)) will not sell, transfer, assign, pledge, or hypothecate these warrants or the securities underlying these warrants, nor will they engage in any
	hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the warrants or the underlying securities for a period of 180 days from the effective date of the offering. In addition, the warrants provide for registration rights upon request, in certain cases. The demand registration right provided will not be greater than five years from the effective date of the offering in compliance with FINRA Rule 5110(f)(2)(G)(iv). The piggyback registration right provided will not be greater than seven years from the effective date of the offering in compliance with FINRA Rule 5110(f)(2)(G)(v). We will bear all fees and expenses attendant to registering the securities issuable on exercise of the warrants other than underwriting commissions incurred and payable by the holders. The exercise price and number of securities issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend,
	extraordinary cash dividend or our recapitalization, reorganization, merger or consolidation. However, the warrant exercise price or underlying units will not be adjusted for issuances of units at a price below the warrant exercise price.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Right of First Refusal
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Until 24 months from the closing of the offering, Northland Securities, Inc. and Neidiger, Tucker, Bruner, Inc. have a right of first refusal to act as exclusive co-investment bankers, exclusive co-book-runners or exclusive co-placement agents, at their sole discretion, for each and every future public and private equity and debt offering, which we or any subsidiary or successor may seek to sell in public or private equity and public debt offerings during such 24-month period. These underwriters will not have more than one opportunity to waive or terminate the right of first refusal in consideration of any payment or fee.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Electronic Offer, Sale and Distribution of Securities
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	A prospectus in electronic format may be made available on the websites maintained by one or more of the underwriters participating in this offering and one or more of the underwriters participating in this offering may distribute prospectuses electronically. The representatives may agree to allocate a number of shares to underwriters for sale to their online brokerage account holders. Internet distributions will be allocated by the underwriters and selling group members that will make internet distributions on the same basis as other allocations. Other than the prospectus in electronic format, the information on these
	websites is not part of, nor incorporated by reference into, this prospectus or the registration statement of which this prospectus forms a part, has not been approved or endorsed by us or any underwriter in its capacity as underwriter, and should not be relied upon by investors.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Stabilization
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In connection with this offering, the underwriters may engage in stabilizing transactions, over-allotment transactions, syndicate-covering transactions, penalty bids and purchases to cover positions created by short sales.
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Stabilizing transactions permit underwriters to purchase securities so long as the stabilizing bids do not exceed a specified maximum, and are engaged in for the purpose of preventing or retarding a decline in the market price of the securities while the offering is in progress.
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Over-allotment transactions involve sales by the underwriters of securities in excess of the number of securities the underwriters are obligated to purchase. This creates a syndicate short position which may be either a covered short position or a naked short position. In a covered short position, the number of securities over-allotted by the underwriters is not greater than the number of securities that they may purchase in the over-allotment option. In a naked short position, the number of securities involved is greater than the number of securities in the over-allotment option. The underwriters may close out any short position by exercising their over-allotment option or purchasing securities in the open market.
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	106
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage113"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Syndicate covering transactions involve purchases of securities in the open market after the distribution has been completed in order to cover syndicate short positions. In determining the source of securities to close out the short position, the underwriters will consider, among other things, the price of securities available for purchase in the open market as compared with the price at which they may purchase securities through exercise of the over-allotment option. If the underwriters sell more securities than could be covered by exercise of the over-allotment option and, therefore, have a naked short position, the position can be closed out only by buying securities in the open market. A naked short position is more likely to be created if the underwriters are concerned that after pricing there could be downward pressure on the price of the securities in the open market that could adversely affect investors who purchase in the offering.
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Penalty bids permit the representatives to reclaim a selling concession from a syndicate member when the securities originally sold by that syndicate member are purchased in stabilizing or syndicate covering transactions to cover syndicate short positions.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	These stabilizing transactions, syndicate covering transactions and penalty bids may have the effect of raising or maintaining the market price of our securities or preventing or retarding a decline in the market price of our securities. As a result, the price of our securities in the open market may be higher than it would otherwise be in the absence of these transactions. Neither we nor the underwriters make any representation or prediction as to the effect that the transactions described above may have on the price of our securities. These transactions may be effected on the Nasdaq Capital Market, in the over-the-counter
	market or otherwise and, if commenced, may be discontinued at any time.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Passive market making
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In connection with this offering, underwriters and selling group members may engage in passive market making transactions in our securities on the Nasdaq Capital Market in accordance with Rule 103 of Regulation M under the Exchange Act, during a period before the commencement of offers or sales of the securities and extending through the completion of the distribution. A passive market maker must display its bid at a price not in excess of the highest independent bid of that security. However, if all independent bids are lowered below the passive market maker&#146;s bid, then that bid must then be lowered when specified
	purchase limits are exceeded.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Other relationships
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Certain of the underwriters and their affiliates have engaged, and may in the future engage, in investment banking transactions with us in the ordinary course of their business. They have received, and expect to receive, customary compensation and expense reimbursement for these commercial and investment banking transactions. Neidiger, Tucker, Bruner, Inc. served as the placement agent of our offering of units we consummated on December 28, 2015, for which it received a transaction fee of approximately $154,000 in cash. Neidiger, Tucker, Bruner, Inc. also served as placement agent of our offering of units that closed on
	January 3, 2013, for which it received a transaction fee of approximately $400,000. In addition, warrants to acquire 86,376 shares with an exercise price of $4.55 per share were issued to certain associated persons and employees of Neidiger, Tucker, Bruner, Inc. in connection with the private placement we closed on January 3, 2013. Certain associated persons of Neidiger, Tucker, Bruner, Inc. hold an aggregate of 42,048 shares of our common stock that were purchased in the 2013 offering. Except as disclosed in this prospectus, we have no present arrangements with any of the underwriters for any further services. Additionally, Anthony Petrelli, President and Managing Director of Neidiger, Tucker, Bruner, Inc. serves as an advisor to our board of directors. Mr. Petrelli is not compensated for these services but regularly attends meetings of our board of directors.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Additional information
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Northland Capital Markets is the trade name for certain capital markets and investment banking services of Northland Securities, Inc., member FINRA/SIPC.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Offer restrictions outside the U.S.
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Other than in the U.S., no action has been taken by us or the underwriters that would permit a public offering of the securities offered by this prospectus in any jurisdiction where action for that purpose is
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	107
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage114"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	required. The securities offered by this prospectus may not be offered or sold, directly or indirectly, nor may this prospectus or any other offering material or advertisements in connection with the offer and sale of any such securities be distributed or published in any jurisdiction, except under circumstances that will result in compliance with the applicable rules and regulations of that jurisdiction. Persons into whose possession this prospectus comes are advised to inform themselves about and to observe any restrictions relating to the offering and the distribution of this prospectus. This prospectus does not constitute
	an offer to sell or a solicitation of an offer to buy any securities offered by this prospectus in any jurisdiction in which such an offer or a solicitation is unlawful.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Canada
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The securities may be sold in Canada only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National Instrument 45-106 Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the securities must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities laws.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser&#146;s province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#146;s province or territory for particulars of these rights or consult with a legal advisor.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Pursuant to section 3A.3 of National Instrument 33-105 Underwriting Conflicts (NI 33-105), the underwriters are not required to comply with the disclosure requirements of NI 33-105 regarding underwriter conflicts of interest in connection with this offering.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Australia
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	This prospectus is not a disclosure document under Chapter 6D of the Australian Corporations Act, has not been lodged with the Australian Securities and Investments Commission and does not purport to include the information required of a disclosure document under Chapter 6D of the Australian Corporations Act. Accordingly, (i) the offer of the securities under this prospectus is only made to persons to whom it is lawful to offer the securities without disclosure under Chapter 6D of the Australian Corporations Act under one or more exemptions set out in section 708 of the Australian Corporations Act, (ii) this prospectus is made
	available in Australia only to those persons as set forth in clause (i) above, and (iii) the offeree must be sent a notice stating in substance that by accepting this offer, the offeree represents that the offeree is such a person as set forth in clause (i) above, and, unless permitted under the Australian Corporations Act, agrees not to sell or offer for sale within Australia any of the securities sold to the offeree within 12 months after its transfer to the offeree under this prospectus.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	China
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The information in this document does not constitute a public offer of the securities, whether by way of sale or subscription, in the People&#146;s Republic of China (excluding, for purposes of this paragraph, Hong Kong Special Administrative Region, Macau Special Administrative Region and Taiwan). The securities may not be offered or sold directly or indirectly in the PRC to legal or natural persons other than directly to &#147;qualified domestic institutional investors.&#148;
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	European Economic Area&nbsp;&#151;&nbsp;Belgium, Germany, Luxembourg and Netherlands
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The information in this document has been prepared on the basis that all offers of securities will be made pursuant to an exemption under the Directive 2003/71/EC (&#147;Prospectus Directive&#148;), as implemented in Member States of the European Economic Area (each, a &#147;Relevant Member State&#148;), from the requirement to produce a prospectus for offers of securities.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	108
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage115"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	An offer to the public of securities has not been made, and may not be made, in a Relevant Member State except pursuant to one of the following exemptions under the Prospectus Directive as implemented in that Relevant Member State:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	to legal entities that are authorized or regulated to operate in the financial markets or, if not so authorized or regulated, whose corporate purpose is solely to invest in securities;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	to any legal entity that has two or more of (i) an average of at least 250 employees during its last fiscal year; (ii) a total balance sheet of more than &#8364;43,000,000 (as shown on its last annual unconsolidated or consolidated financial statements) and (iii) an annual net turnover of more than &#8364;50,000,000 (as shown on its last annual unconsolidated or consolidated financial statements);
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	to fewer than 100 natural or legal persons (other than qualified investors within the meaning of Article 2(1)(e) of the Prospectus Directive) subject to obtaining the prior consent of Sensus Healthcare, Inc. or any underwriter for any such offer; or
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	in any other circumstances falling within Article 3(2) of the Prospectus Directive, provided that no such offer of common stock shall result in a requirement for the publication by Sensus Healthcare, Inc. of a prospectus pursuant to Article 3 of the Prospectus Directive.
</TD>
</TR>
</TABLE>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	France
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	This document is not being distributed in the context of a public offering of financial securities (offre au public de titres financiers) in France within the meaning of Article L.411-1 of the French Monetary and Financial Code (Code mon&eacute;taire et financier) and Articles 211-1 et seq. of the General Regulation of the French Autorit&eacute; des march&eacute;s financiers (&#147;AMF&#148;). The securities have not been offered or sold and will not be offered or sold, directly or indirectly, to the public in France.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	This document and any other offering material relating to the securities have not been, and will not be, submitted to the AMF for approval in France and, accordingly, may not be distributed or caused to distributed, directly or indirectly, to the public in France.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Such offers, sales and distributions have been and shall only be made in France to (i) qualified investors (investisseurs qualifi&eacute;s) acting for their own account, as defined in and in accordance with Articles L.411-2-II-2&#176; and D.411-1 to D.411-3, D. 744-1, D.754-1 and D.764-1 of the French Monetary and Financial Code and any implementing regulation or (ii) a restricted number of non-qualified investors (cercle restreint d&#146;investisseurs) acting for their own account, as defined in and in accordance with Articles L.411-2-II-2&#176; and D.411-4, D.744-1, D.754-1 and D.764-1 of the French Monetary and Financial
	Code and any implementing regulation.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Pursuant to Article 211-3 of the General Regulation of the AMF, investors in France are informed that the securities cannot be distributed (directly or indirectly) to the public by the investors otherwise than in accordance with Articles L.411-1, L.411-2, L.412-1 and L.621-8 to L.621-8-3 of the French Monetary and Financial Code.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Ireland
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The information in this document does not constitute a prospectus under any Irish laws or regulations and this document has not been filed with or approved by any Irish regulatory authority as the information has not been prepared in the context of a public offering of securities in Ireland within the meaning of the Irish Prospectus (Directive 2003/71/EC) Regulations 2005 (the &#147;Prospectus Regulations&#148;). The securities have not been offered or sold, and will not be offered, sold or delivered directly or indirectly in Ireland by way of a public offering, except to (i) qualified investors as defined in Regulation 2(l)
	of the Prospectus Regulations and (ii) fewer than 100 natural or legal persons who are not qualified investors.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Israel
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In the State of Israel, the securities offered hereby may not be offered to any person or entity other than the following:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	(a)
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	a fund for joint investments in trust (i.e., mutual fund), as such term is defined in the Law for Joint Investments in Trust, 5754-1994, or a management company of such a fund;
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	109
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage116"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	(b)
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	a provident fund as defined in Section 47(a)(2) of the Income Tax Ordinance of the State of Israel, or a management company of such a fund;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	(c)
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	an insurer, as defined in the Law for Oversight of Insurance Transactions, 5741-1981, a banking entity or satellite entity, as such terms are defined in the Banking Law (Licensing), 5741-1981, other than a joint services company, acting for their own account or for the account of investors of the type listed in Section 15A(b) of the Securities Law 1968;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	(d)
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	a company that is licensed as a portfolio manager, as such term is defined in Section 8(b) of the Law for the Regulation of Investment Advisors and Portfolio Managers, 5755-1995, acting on its own account or for the account of investors of the type listed in Section 15A(b) of the Securities Law 1968;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	(e)
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	a company that is licensed as an investment advisor, as such term is defined in Section 7(c) of the Law for the Regulation of Investment Advisors and Portfolio Managers, 5755-1995, acting on its own account;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	(f)
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	a company that is a member of the Tel Aviv Stock Exchange, acting on its own account or for the account of investors of the type listed in Section 15A(b) of the Securities Law 1968;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	(g)
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	an underwriter fulfilling the conditions of Section 56(c) of the Securities Law, 5728-1968;
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	(h)
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	a venture capital fund (defined as an entity primarily involved in investments in companies which, at the time of investment, (i) are primarily engaged in research and development or manufacture of new technological products or processes and (ii) involve above-average risk);
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	(i)
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	an entity primarily engaged in capital markets activities in which all of the equity owners meet one or more of the above criteria; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	(j)
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	an entity, other than an entity formed for the purpose of purchasing securities in this offering, in which the shareholders equity (including pursuant to foreign accounting rules, international accounting regulations and U.S. generally accepted accounting rules, as defined in the Securities Law Regulations (Preparation of Annual Financial Statements), 1993) is in excess of NIS 250 million.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Any offeree of the securities offered hereby in the State of Israel shall be required to submit written confirmation that it falls within the scope of one of the above criteria. This prospectus will not be distributed or directed to investors in the State of Israel who do not fall within one of the above criteria.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Italy
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The offering of the securities in the Republic of Italy has not been authorized by the Italian Securities and Exchange Commission (Commissione Nazionale per le Societ&agrave; e la Borsa, &#147;CONSOB&#148;) pursuant to the Italian securities legislation and, accordingly, no offering material relating to the securities may be distributed in Italy and such securities may not be offered or sold in Italy in a public offer within the meaning of Article 1.1(t) of Legislative Decree No. 58 of 24 February 1998 (&#147;Decree No. 58&#148;), other than:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	to Italian qualified investors, as defined in Article 100 of Decree no. 58 by reference to Article 34-ter of CONSOB Regulation no. 11971 of 14 May 1999 (&#147;Regulation no. 1197l&#148;) as amended (&#147;Qualified Investors&#148;); and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	in other circumstances that are exempt from the rules on public offer pursuant to Article 100 of Decree No. 58 and Article 34-ter of Regulation No. 11971 as amended.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Any offer, sale or delivery of the securities or distribution of any offer document relating to the securities in Italy (excluding placements where a Qualified Investor solicits an offer from the issuer) under the paragraphs above must be:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	made by investment firms, banks or financial intermediaries permitted to conduct such activities in Italy in accordance with Legislative Decree No. 385 of 1 September 1993 (as amended), Decree No. 58, CONSOB Regulation No. 16190 of 29 October 2007 and any other applicable laws; and
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	110
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage117"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	in compliance with all relevant Italian securities, tax and exchange controls and any other applicable laws.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Any subsequent distribution of the securities in Italy must be made in compliance with the public offer and prospectus requirement rules provided under Decree No. 58 and the Regulation No. 11971 as amended, unless an exception from those rules applies. Failure to comply with such rules may result in the sale of such securities being declared null and void and in the liability of the entity transferring the securities for any damages suffered by the investors.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Japan
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The securities have not been and will not be registered under Article 4, paragraph 1 of the Financial Instruments and Exchange Law of Japan (Law No. 25 of 1948), as amended (the &#147;FIEL&#148;) pursuant to an exemption from the registration requirements applicable to a private placement of securities to Qualified Institutional Investors (as defined in and in accordance with Article 2, paragraph 3 of the FIEL and the regulations promulgated thereunder). Accordingly, the securities may not be offered or sold, directly or indirectly, in Japan or to, or for the benefit of, any resident of Japan other than Qualified Institutional
	Investors. Any Qualified Institutional Investor who acquires securities may not resell them to any person in Japan that is not a Qualified Institutional Investor, and acquisition by any such person of securities is conditional upon the execution of an agreement to that effect.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Portugal
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	This document is not being distributed in the context of a public offer of financial securities (oferta p&uacute;blica de valores mobili&aacute;rios) in Portugal, within the meaning of Article 109 of the Portuguese Securities Code (C&oacute;digo dos Valores Mobili&aacute;rios). The securities have not been offered or sold and will not be offered or sold, directly or indirectly, to the public in Portugal. This document and any other offering material relating to the securities have not been, and will not be, submitted to the Portuguese Securities Market Commission (Comissao do Mercado de Valores Mobili&aacute;rios) for approval
	in Portugal and, accordingly, may not be distributed or caused to distributed, directly or indirectly, to the public in Portugal, other than under circumstances that are deemed not to qualify as a public offer under the Portuguese Securities Code. Such offers, sales and distributions of securities in Portugal are limited to persons who are &#147;qualified investors&#148; (as defined in the Portuguese Securities Code). Only such investors may receive this document and they may not distribute it or the information contained in it to any other person.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Sweden
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	This document has not been, and will not be, registered with or approved by Finansinspektionen (the Swedish Financial Supervisory Authority). Accordingly, this document may not be made available, nor may the securities be offered for sale in Sweden, other than under circumstances that are deemed not to require a prospectus under the Swedish Financial Instruments Trading Act (1991:980) (Sw. lag (1991:980) om handel med finansiella instrument). Any offering of securities in Sweden is limited to persons who are &#147;qualified investors&#148; (as defined in the Financial Instruments Trading Act). Only such investors may receive
	this document and they may not distribute it or the information contained in it to any other person.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Switzerland
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The securities may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange (&#147;SIX&#148;) or on any other stock exchange or regulated trading facility in Switzerland. This document has been prepared without regard to the disclosure standards for issuance prospectuses under art. 652a or art. 1156 of the Swiss Code of Obligations or the disclosure standards for listing prospectuses under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in Switzerland. Neither this document nor any other offering material relating to the
	securities may be publicly distributed or otherwise made publicly available in Switzerland.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Neither this document nor any other offering material relating to the securities have been or will be filed with or approved by any Swiss regulatory authority. In particular, this document will not be filed with, and the offer of securities will not be supervised by, the Swiss Financial Market Supervisory Authority (&#147;FINMA&#148;).
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	This document is personal to the recipient only and not for general circulation in Switzerland.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	111
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage118"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	United Arab Emirates
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Neither this document nor the securities have been approved, disapproved or passed on in any way by the Central Bank of the United Arab Emirates or any other governmental authority in the United Arab Emirates, nor has Sensus Healthcare, Inc. received authorization or licensing from the Central Bank of the United Arab Emirates or any other governmental authority in the United Arab Emirates to market or sell the securities within the United Arab Emirates. This document does not constitute and may not be used for the purpose of an offer or invitation. No services relating to the securities, including the receipt of applications
	or the allotment or redemption of such securities, may be rendered within the United Arab Emirates by Sensus Healthcare, Inc.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	No offer or invitation to subscribe for securities is valid or permitted in the Dubai International Financial Centre.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	United Kingdom
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Neither the information in this document nor any other document relating to the offer has been delivered for approval to the Financial Services Authority in the United Kingdom and no prospectus (within the meaning of section 85 of the Financial Services and Markets Act 2000, as amended (&#147;FSMA&#148;)) has been published or is intended to be published in respect of the securities. This document is issued on a confidential basis to &#147;qualified investors&#148; (within the meaning of section 86(7) of FSMA) in the United Kingdom, and the securities may not be offered or sold in the United Kingdom by means of this document,
	any accompanying letter or any other document, except in circumstances which do not require the publication of a prospectus pursuant to section 86(1) FSMA. This document should not be distributed, published or reproduced, in whole or in part, nor may its contents be disclosed by recipients to any other person in the United Kingdom.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Any invitation or inducement to engage in investment activity (within the meaning of section 21 of FSMA) received in connection with the issue or sale of the securities has only been communicated or caused to be communicated and will only be communicated or caused to be communicated in the United Kingdom in circumstances in which section 21(1) of FSMA does not apply to Sensus Healthcare, Inc.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In the United Kingdom, this document is being distributed only to, and is directed at, persons (i) who have professional experience in matters relating to investments falling within Article 19(5) (investment professionals) of the Financial Services and Markets Act 2000 (Financial Promotions) Order 2005 (&#147;FPO&#148;), (ii) who fall within the categories of persons referred to in Article 49(2)(a) to (d) (high net worth companies, unincorporated associations, etc.) of the FPO or (iii) to whom it may otherwise be lawfully communicated (together &#147;relevant persons&#148;). The investments to which this document relates are
	available only to, and any invitation, offer or agreement to purchase will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this document or any of its contents.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	112
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage119"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
</EFX_UNDERWRITING>
<EFX_LEGAL_MATTERS>
<A NAME="FIS_LEGAL_MATTERS"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<A NAME="V440371_S1A_HTM_T18LM">
</A>
	LEGAL MATTERS
</FONT>
</H1>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The validity of the securities offered by this prospectus will be passed upon for us by our counsel, Gunster, Yoakley &amp; Stewart, P.A., Fort Lauderdale, FL. Certain legal matters will be passed upon for the underwriters by Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., New York, NY.
</P>
</EFX_LEGAL_MATTERS>
<EFX_EXPERTS>
<A NAME="FIS_EXPERTS"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<A NAME="V440371_S1A_HTM_T19EX">
</A>
	EXPERTS
</FONT>
</H1>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The financial statements of Sensus Healthcare, Inc. as of December 31, 2014 and 2015, and for each of the years in the three-year period ended December 31, 2015, have been included herein and in the registration statement in reliance upon the report of Marcum LLP, independent registered public accounting firm, appearing elsewhere herein, and upon the authority of said firm as experts in accounting and auditing.
</P>
</EFX_EXPERTS>
<EFX_MORE_INFORMATION>
<A NAME="FIS_MORE_INFORMATION"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<A NAME="V440371_S1A_HTM_T20WYC">
</A>
	WHERE YOU CAN FIND MORE INFORMATION
</FONT>
</H1>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We have filed with the SEC a registration statement on Form S-1, including exhibits and schedules, under the Securities Act with respect to the securities to be sold in this offering. This prospectus does not contain all of the information set forth in the registration statement and exhibits and schedules to the registration statement. For further information with respect to our company and the securities to be sold in this offering, reference is made to the registration statement, including the exhibits and schedules to the registration statement. Statements contained in this prospectus as to the contents of any contract is
	an exhibit to the registration statement, each statement is qualified in all respects by the exhibit to which the reference relates. In addition, as a result of this offering, we will become subject to the information and periodic reporting requirements of the Exchange Act, and will file annual, quarterly and current reports and other information with the SEC. Our SEC filings, including the registration statement on Form S-1 and all filed exhibits and schedules thereto, are available to the public on the SEC&#146;s website at
<I>
	http://www.sec.gov
</I>
	. To receive copies of public records not posted to the SEC&#146;s website at prescribed rates, you may complete an online form at
<I>
	http://www.sec.gov
</I>
	, send a fax to (202) 772-9337 or submit a written request to the SEC, Office of FOIA/PA Operations, 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for further information.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	113
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage120"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_20"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<A NAME="V440371_S1A_HTM_TOC1">
</A>
	FINANCIAL STATEMENTS OF SENSUS HEALTHCARE, INC.
<BR>
	CONTENTS
</FONT>
</H1>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<A NAME="V440371_S1A_HTM_T21FSO">
</A>
</P>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="552">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="40">
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_TFRI">
	Report of Independent Registered Public Accounting Firm
</A>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_TFRI">
	F-2
</A>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Financial Statements
<BR>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_TFBS">
	Balance Sheets as of March 31, 2016 (unaudited) and December 31, 2015 and 2014
</A>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_TFBS">
	F-3
</A>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_TFSO">
	Statements of Operations for the three months ended March 31, 2016 (unaudited) and 2015 (unaudited) and for the years ended December 31, 2015, 2014 and 2013
</A>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_TFSO">
	F-4
</A>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_TFSSE">
	Statements of Stockholders&#146; Equity for the years ended December 31, 2015, 2014 and 2013 and for the three months ended March 31, 2016 (unaudited)
</A>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_TFSSE">
	F-5
</A>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_TFSC">
	Statements of Cash Flows for the three months ended March 31, 2016 (unaudited) and 2015 (unaudited) and for the years ended December 31, 2015, 2014 and 2013
</A>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_TFSC">
	F-6
</A>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_TFNFS">
	Notes to financial statements
</A>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
<A HREF="#V440371_S1A_HTM_TFNFS">
	F-7
</A>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	F-1
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage121"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<EFX_AUDITORS_OPINION>
<A NAME="FIS_AUDITORS_OPINION"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<A NAME="V440371_S1A_HTM_TFRI">
</A>
	REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
</FONT>
</H1>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	To the Audit Committee of the
<BR>
	Board of Directors and Members
<BR>
	of Sensus Healthcare, Inc.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We have audited the accompanying balance sheets of Sensus Healthcare, Inc. (the &#147;Company&#148;) as of December 31, 2015 and 2014, and the related statements of operations, stockholders&#146; equity and cash flows for each of the years in the three-year period ended December 31, 2015. These financial statements are the responsibility of the Company&#146;s management. Our responsibility is to express an opinion on these financial statements based on our audits.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the
	effectiveness of the Company&#146;s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Sensus Healthcare, Inc., as of December 31, 2015 and 2014, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2015 in conformity with accounting principles generally accepted in the United States of America.
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	/s/ Marcum LLP
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	West Palm Beach, FL
<BR>
	February 9, 2016
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	F-2
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage122"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<EFX_BALANCE_SHEET>
<A NAME="FIS_BALANCE_SHEET"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<A NAME="V440371_S1A_HTM_TFBS">
</A>
	SENSUS HEALTHCARE, INC.
<BR>
	&nbsp;
<BR>
	BALANCE SHEETS
</FONT>
</H1>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="328">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="80">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="80">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="72">
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=2 COLSPAN=1>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=7>
	As of December 31,
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=2>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=2 COLSPAN=3>
	As of
<BR>
	March 31,
<BR>
	2016
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: NORMAL; FONT-SIZE: 10PT; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- NEW-GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2014
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2015
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=3>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=3>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=3>
	(unaudited)
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Assets
<BR>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Current Assets
<BR>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Cash and cash equivalents
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	4,538,713
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	5,065,068
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	4,746,539
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Accounts receivable, net
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	407,592
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	2,071,572
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	2,321,940
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Inventories
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	844,074
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	998,861
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	815,738
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Deferred offering costs and other prepaids
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	48,312
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	432,787
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	844,309
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Total Current Assets
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	5,838,691
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	8,568,288
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	8,728,526
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Property and Equipment, Net
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	260,497
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	320,699
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	537,761
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Patent Rights, Net
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	819,281
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	722,895
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	698,798
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Deposits
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	24,272
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	24,272
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	24,272
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Total Assets
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	6,942,741
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	9,636,154
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	9,989,357
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Liabilities and Stockholders&#146; Equity
<BR>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Current Liabilities
<BR>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Accounts payable and accrued expenses
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,081,039
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	2,307,465
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	2,377,905
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Product warranties
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	47,614
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	48,363
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	40,242
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Revolving credit facility
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	375,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	422,702
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	800,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Deferred revenue, current portion
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,249,880
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	890,234
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	820,906
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Total Current Liabilities
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	2,753,533
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	3,668,764
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	4,039,053
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Deferred Revenue, Net of Current Portion
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	51,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	45,786
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	29,375
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Total Liabilities
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	2,804,533
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	3,714,550
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	4,068,428
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Commitments and Contingencies
<BR>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Stockholders&#146; Equity
<BR>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Preferred stock, 5,000,000 shares authorized at March 31, 2016
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Common stock, $0.01 par value &#150; 1,000,000 authorized and 40,835 issued and outstanding at December 31, 2014; 1,000,000 authorized and 42,852 issued and outstanding at December 31, 2015; 50,000,000 authorized and 42,852 issued and outstanding at March 31, 2016.
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	408
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	428
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	428
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Additional paid-in capital
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	11,346,342
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	13,366,985
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	13,364,229
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Accumulated deficit
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(7,208,542
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(7,445,809
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(7,443,728
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Total Stockholders&#146; Equity
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	4,138,208
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	5,921,604
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	5,920,929
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Total Liabilities and Stockholders&#146; Equity
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	6,942,741
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	9,636,154
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	9,989,357
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_BALANCE_SHEET>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	&nbsp;
<BR>
	&nbsp;
<BR>
	The accompanying footnotes are an integral part of these financial statements.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	F-3
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage123"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<EFX_INCOME_STATEMENT>
<A NAME="FIS_INCOME_STATEMENT"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<A NAME="V440371_S1A_HTM_TFSO">
</A>
	SENSUS HEALTHCARE, INC.
<BR>
	&nbsp;
<BR>
	STATEMENTS OF OPERATIONS
</FONT>
</H1>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="193">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="78">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="78">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="78">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="74">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="77">
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=11>
	For the Years Ended December 31,
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=7>
	For the Three Months Ended March 31,
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2013
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2014
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2015
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2015
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2016
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=3>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=3>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=3>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=7>
	(unaudited)
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Revenues
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	10,478,920
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	5,810,205
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	10,273,094
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,929,649
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	3,035,204
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Cost of Sales
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	3,600,348
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	2,054,798
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	3,698,687
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	724,179
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,102,370
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Gross Profit
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	6,878,572
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	3,755,407
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	6,574,407
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,205,470
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,932,834
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Operating Expenses
<BR>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Selling and marketing
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	3,965,276
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	4,208,241
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	3,742,535
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	916,350
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	944,122
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	General and administrative
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,453,344
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,650,651
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,586,401
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	329,745
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	685,720
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Research and development
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,333,111
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,576,775
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,466,728
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	439,804
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	293,404
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Total Operating Expenses
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	6,751,731
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	7,435,667
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	6,795,664
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,685,899
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,923,246
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Income (Loss) From
<BR>
	Operations
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	126,841
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(3,860,260
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(221,257
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(480,429
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	9,588
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Other Income (Expense)
<BR>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Interest expense
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(20,467
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(20,030
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(17,786
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(5,119
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(9,626
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Interest income
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,253
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	820
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,776
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	288
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	2,755
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Total Other Income (Expense)
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(19,214
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(19,210
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(16,010
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(4,831
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(6,871
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Income (Loss) Before Income Taxes
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	107,627
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(3,699,470
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(237,267
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(485,260
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	2,717
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Provision for income taxes
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	636
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Net Income (Loss)
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	107,627
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(3,699,470
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(237,267
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(485,260
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	2,081
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Preferential distribution
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(513,332
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(537,693
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(513,332
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(128,333
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Net Income (Loss) Attributable to Common Stockholders
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(405,705
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(4,237,163
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(750,599
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(613,593
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	2,081
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Net income (Loss) Attributable to Common Stockholders per share &#150; basic
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(10.02
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(103.76
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(18.37
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(15.03
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	0.05
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 30PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	diluted
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(10.02
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(103.76
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(18.37
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(15.03
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	0.05
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Weighted average number of shares used in computing net income (loss) per share &#150;
<BR>
	basic
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	40,482
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	40,835
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	40,857
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	40,835
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	42,852
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 30PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	diluted
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	40,482
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	40,835
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	40,857
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	40,835
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	44,070
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_INCOME_STATEMENT>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	&nbsp;
<BR>
	&nbsp;
<BR>
	The accompanying footnotes are an integral part of these financial statements.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	F-4
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage124"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<EFX_STOCKHOLDERS_EQUITY>
<A NAME="FIS_STOCKHOLDERS_EQUITY"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<A NAME="V440371_S1A_HTM_TFSSE">
</A>
	SENSUS HEALTHCARE, INC.
<BR>
	&nbsp;
<BR>
	STATEMENTS OF STOCKHOLDERS&#146; EQUITY
<BR>
	&nbsp;
<BR>
	FOR THE YEARS ENDED DECEMBER 31, 2015, 2014 AND 2013 AND
<BR>
	FOR THE THREE MONTHS ENDED MARCH 31, 2016 (UNAUDITED)
</FONT>
</H1>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="205">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="48">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="48">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="80">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="74">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="72">
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=2 COLSPAN=1>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=7>
	Common Stock
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=2>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=2 COLSPAN=3>
	Additional
<BR>
	Paid-In Capital
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=2>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=2 COLSPAN=3>
	Accumulated Deficit
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=2>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=2 COLSPAN=3>
	Total
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: NORMAL; FONT-SIZE: 10PT; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- NEW-GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Shares
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Amount
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	December 31, 2012
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	37,260
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	372
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	8,138,388
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(3,616,699
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	4,522,061
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Issuance of common stock for cash, net of offering costs
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	3,575
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	36
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	3,245,818
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	3,245,854
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Stock based compensation
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,080
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,080
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Net income
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	107,627
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	107,627
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	December 31, 2013
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	40,835
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	408
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	11,385,286
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(3,509,072
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	7,876,622
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Stock based compensation
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	6,477
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	6,477
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Distributions paid
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(45,421
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(45,421
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Net loss
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(3,699,470
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(3,699,470
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	December 31, 2014
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	40,835
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	408
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	11,346,342
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(7,208,542
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	4,138,208
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Stock based compensation
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	6,477
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	6,477
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Issuance of common stock for cash, net of offering costs
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	2,017
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	20
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	2,014,166
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	2,014,186
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Net loss
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(237,267
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(237,267
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	December 31, 2015
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	42,852
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	428
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	13,366,985
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(7,445,809
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	5,921,604
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Stock based compensation
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,619
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,619
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Offering costs
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(4,375
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(4,375
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Net income
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	2,081
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	2,081
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	March 31, 2016 (unaudited)
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	42,852
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	428
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	13,364,229
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	(7,443,728
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	5,920,929
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_STOCKHOLDERS_EQUITY>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	&nbsp;
<BR>
	&nbsp;
<BR>
	The accompanying footnotes are an integral part of these financial statements.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	F-5
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage125"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<EFX_CASH_FLOW>
<A NAME="FIS_CASH_FLOW"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<A NAME="V440371_S1A_HTM_TFSC">
</A>
	SENSUS HEALTHCARE, INC.
<BR>
	&nbsp;
<BR>
	STATEMENTS OF CASH FLOWS
</FONT>
</H1>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="240">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="69">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="69">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="69">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="65">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="68">
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=11>
<FONT STYLE="FONT-SIZE: 7PT">
	For the Years Ended December 31,
</FONT>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=7>
<FONT STYLE="FONT-SIZE: 7PT">
	For the Three Months
<BR>
	Ended March 30,
<BR>
	(unaudited)
</FONT>
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
<FONT STYLE="FONT-SIZE: 7PT">
	2013
</FONT>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
<FONT STYLE="FONT-SIZE: 7PT">
	2014
</FONT>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
<FONT STYLE="FONT-SIZE: 7PT">
	2015
</FONT>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
<FONT STYLE="FONT-SIZE: 7PT">
	2015
</FONT>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
<FONT STYLE="FONT-SIZE: 7PT">
	2016
</FONT>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Cash Flows From Operating Activities
<BR>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Net income (loss)
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	107,627
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(3,699,470
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(237,267
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(485,260
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	2,081
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Adjustments to reconcile net income (loss) to net cash and cash equivalents used in operating activities:
<BR>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 30PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Depreciation and amortization
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	265,557
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	272,649
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	315,599
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	72,798
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	84,795
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 30PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Provision for product warranties
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	122,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	13,024
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	7,189
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	13,500
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	734
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 30PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Provision for bad debt
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	55,792
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	183,646
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,077
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 30PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Stock based compensation
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,080
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	6,477
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	6,477
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,619
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,619
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 30PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	(Increase) decrease in:
<BR>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 40PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Accounts receivable
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(1,368,941
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	2,118,715
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(1,665,057
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(858,312
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(250,368
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 40PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Inventories
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(342,934
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(327,350
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(238,011
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	388,201
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	138,269
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 40PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Deferred offering costs and other prepaids
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	13,963
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(28,707
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(384,475
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	15,579
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(411,522
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 30PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Increase (decrease) in:
<BR>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 40PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Accounts payable and accrued expenses
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	807,482
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(607,958
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,226,425
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	35,075
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	70,440
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 40PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Deferred revenue
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	288,991
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	267,826
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(364,860
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	349,329
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(85,739
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 40PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Product warranties
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(79,310
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(66,534
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(6,440
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(8,855
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Total Adjustments
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(236,320
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,831,788
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(1,102,076
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	17,789
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(460,627
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Net Cash Used In Operating
<BR>
	Activities
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(128,693
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(1,867,682
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(1,339,343
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(467,471
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(458,546
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Cash Flows from Investing Activities
<BR>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Acquisition of property and equipment
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(251,004
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(123,959
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(196,190
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(11,801
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(232,906
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Net Cash Used In Investing Activities
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(251,004
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(123,959
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(196,190
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(11,801
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(232,906
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Cash Flows from Financing Activities
<BR>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Issuance of common stock
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	3,575,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	2,200,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Proceeds from revolving credit facility, net
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	47,702
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	377,298
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Distributions to members
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(45,421
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Offering costs related to issuance
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(329,146
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(185,814
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(4,375
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Net Cash Provided By (Used In) Financing Activities
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	3,245,854
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(45,421
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	2,061,888
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	372,923
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Net Increase (Decrease) in Cash and Cash Equivalents
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	2,866,157
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(2,037,062
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	526,355
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(479,272
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(318,529
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Cash and Cash Equivalents &#150;
<BR>
	Beginning
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	3,709,618
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	6,575,775
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	4,538,713
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	4,538,713
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	5,065,068
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Cash and Cash Equivalents &#150; Ending
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	6,575,775
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	4,538,713
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	5,065,068
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	4,059,441
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	4,746,539
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Supplemental Disclosure of Cash Flow Information
<BR>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 30PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Interest Paid
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	20,748
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	20,031
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	17,814
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	3,414
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	7,916
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Non Cash Investing and Financing Activities
<BR>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Transfer of inventory unit to property and equipment
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	44,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	83,224
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	44,854
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_CASH_FLOW>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	&nbsp;
<BR>
	&nbsp;
<BR>
	The accompanying footnotes are an integral part of these financial statements.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	F-6
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage126"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	SENSUS HEALTHCARE, INC.
<BR>
	&nbsp;
</EFX_AUDITORS_OPINION>
<EFX_NOTES_TO_FINANCIAL_STATEMENT>
<A NAME="FIS_NOTES_TO_FINANCIAL_STATEMENT"></A>
<BR>
	NOTES TO FINANCIAL STATEMENTS
</H1>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Note 1&nbsp;&#151;&nbsp;Summary of Significant Accounting Policies
</FONT>
</H2>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
<A NAME="V440371_S1A_HTM_TFNFS">
</A>
	Description of the Business
</FONT>
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Sensus Healthcare, Inc. (the &#147;Company&#148;) is a manufacturer of superficial radiation therapy devices and has established a distribution and marketing network to sell the devices to healthcare providers globally. The Company operates as a corporation under the laws of the State of Delaware and was organized on May 7, 2010. The Company operates as one segment from its corporate headquarters located in Boca Raton, Florida.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	On January 1, 2016, Sensus Healthcare, LLC converted into a Delaware corporation pursuant to a statutory conversion and changed its name to Sensus Healthcare, Inc (&#147;corporate conversion&#148;). As a result of the corporate conversion, the holders of the different classes of units of Sensus Healthcare, LLC became holders of common stock of Sensus Healthcare, Inc. Holders of warrants and options, respectively, to purchase units of Sensus Healthcare, LLC became holders of warrants and options to purchase common stock of Sensus Healthcare, Inc., respectively. Each unit converted to one share of common stock. Preferential
	distributions no longer accrue as of January 1, 2016. In the event of an initial public offering or change in control (as defined) the accumulated distribution of $2,674,000 as of December 31, 2015 will be paid. The corporate conversion has been reflected retroactively for all periods presented.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Unaudited Interim Financial Statements
</FONT>
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The accompanying balance sheet as of March 31, 2016, the statements of operations and cash flows for the three months ended March 31, 2015 and 2016, and the statement of stockholders&#146; equity for the three months ended March 31, 2016, are unaudited. The financial data and other information disclosed in these notes to the financial statements related to March 31, 2016, and the three months ended March 31, 2015 and 2016, are also unaudited. The unaudited interim financial statements have been prepared on the same basis as the annual financial statements and, in the opinion of management, reflect all adjustments, which
	include only normal recurring adjustments, necessary to state fairly the Company&#146;s financial position as of March 31, 2016, and the results of its operations and cash flows for the three months ended March 31, 2015 and 2016. The results for the three months ended March 31, 2016, are not necessarily indicative of results to be expected for the year ending December 31, 2016, or for any other interim period or for any future year.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Use of Estimates
</FONT>
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates to which it is reasonably possible that a change could occur in the near term include, revenue recognition, inventory reserves, receivable allowances, recoverability of long lived assets and estimation of
	the Company&#146;s product warranties. Actual results could differ from those estimates.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Revenue Recognition
</FONT>
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The Company&#146;s sales primarily relate to sales of the Company&#146;s devices. The Company recognizes product revenue upon shipment provided that there is persuasive evidence of an arrangement, there are no uncertainties regarding customer acceptance, the sales price is fixed and determinable, and collection of the resulting receivable is reasonably assured. The Company does not provide a right of return related to product sales. Revenues for service contracts are recognized over the service contract period on a straight-line basis. Revenue for rentals of equipment is recognized over the lease term on a straight-line basis.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The Company sells products and services under multiple-element arrangements with separate units of accounting; in these situations, total consideration is allocated to the identified units of accounting based on their relative selling prices and revenue is then recognized for each unit based on its specific characteristics. A deliverable in an arrangement qualifies as a separate unit of accounting if the delivered item has value to the customer on a stand-alone basis. The principal deliverables in our multiple deliverable arrangements that
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	F-7
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage127"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	SENSUS HEALTHCARE, INC.
<BR>
	&nbsp;
<BR>
	NOTES TO FINANCIAL STATEMENTS
</H1>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Note 1&nbsp;&#151;&nbsp;Summary of Significant Accounting Policies
</FONT>
	&nbsp;&#150;&nbsp;(continued)
</H2>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	qualify as separate units of accounting consist of (i) sales of medical devices and accessories and (ii) service contracts. Performance obligations, including installation and customer training, are considered inconsequential and are combined with the product as one unit of accounting. Selling prices are established using vendor-specific objective evidence (VSOE).
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	If VSOE does not exist, the Company uses its best estimate of the selling prices for the deliverables. The Company operates in a highly regulated environment and is continually entering into new markets in which state or foreign approval is sometimes required prior to the customer being able to use the product. In these cases, where regulatory approval is pending, revenue is deferred until such time regulatory approval is obtained and customer acceptance becomes certain.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Deferred revenue consists of payments from customers for long term separately priced service contracts, sales pending regulatory approval and deposits on products. Deferred revenue as of December 31, 2014 and 2015 and March 31, 2016 (unaudited) was as follows:
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_21"></A>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="554" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="306">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="64">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="64">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="72">
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=7>
	As of December 31,
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=2>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=2 COLSPAN=3>
	March 31,
<BR>
	2016
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2014
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2015
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=7>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=3>
	(unaudited)
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Service contracts
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	519,445
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	669,717
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	639,544
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Sales pending regulatory approval
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	465,916
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	155,517
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	156,362
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Deposits on products
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	264,519
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	65,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	25,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Total deferred revenue, current portion
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	1,249,880
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	890,234
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	820,906
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Service contracts, net of current portion
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	51,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	45,786
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	29,375
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Total deferred revenue
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,300,880
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	936,020
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	850,281
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The Company provides warranties, generally one year, in conjunction with the sale of its product. These warranties are short term in nature and entitle the customer to repair, replacement, or modification of the defective product subject to the terms of the respective warranty. The Company records an estimate of future warranty claims at the time the Company recognizes revenue from the sale of the product based upon management&#146;s estimate of the future claims rate.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Shipping and handling costs are expensed as incurred and are included in cost of sales.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Concentration of Credit Risk
</FONT>
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of cash and cash equivalents and accounts receivable.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Segment and Geographical Information
</FONT>
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The Company&#146;s revenue is generated primarily from customers in the United States, which represented approximately 96%, 94% and 82% of its net revenues for the years ended December 31, 2013, 2014 and 2015, respectively, and approximately 87% and 45% for the three months ended March 31, 2015 and 2016, respectively. Customers in China accounted for approximately 2%, 5% and 14% of revenues for the years ended December 31, 2013, 2014 and 2015 and approximately 8% and 20% for the three months ended March 31, 2015 and 2016, respectively. One new customer in Costa Rica and one existing customer in Israel accounted for
	approximately 24% and 11%, respectively, of revenues for the three months ended March 31, 2016.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Fair Value of Financial Instruments
</FONT>
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Carrying amounts of cash equivalents, accounts receivable, accounts payable, accrued liabilities and revolving credit facility approximate fair value due to their relative short maturities.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	F-8
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage128"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	SENSUS HEALTHCARE, INC.
<BR>
	&nbsp;
<BR>
	NOTES TO FINANCIAL STATEMENTS
</H1>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Note 1&nbsp;&#151;&nbsp;Summary of Significant Accounting Policies
</FONT>
	&nbsp;&#150;&nbsp;(continued)
</H2>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Cash and Cash Equivalents
</FONT>
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The Company maintains its cash and cash equivalents with financial institutions which balances exceed the federally insured limits. Federally insured limits are $250,000 for deposits. As of December 31, 2014 and 2015 and March 31, 2016 (unaudited), the Company had approximately $4,289,000, $4,782,000 and $4,497,000, respectively in excess of federally insured limits.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	For purposes of the statement of cash flows, the Company considers all highly liquid financial instruments with a maturity of three months or less when purchased to be a cash equivalent.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Accounts Receivable
</FONT>
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The Company does business and extends credit based on an evaluation of the customers&#146; financial condition, generally without requiring collateral. Exposure to losses on receivables is expected to vary by customer due to the financial condition of each customer. The Company monitors exposure to credit losses and maintains allowances for anticipated losses considered necessary under the circumstances. The allowance for doubtful accounts was approximately $42,000 and $27,000 as of December 31, 2014 and 2015, receptively, and approximately $27,000 as of March 31, 2016 (unaudited). To date, the Company has not experienced
	significant credit-related losses.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Inventories
</FONT>
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Inventories consist of finished product and components and are stated at the lower of cost and net realizable value, determined using the first-in-first-out method. Cost includes labor and overhead incurred to prepare the product for sale.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Property and Equipment
</FONT>
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Property and equipment are stated at cost. Depreciation on property and equipment is calculated on the straight-line basis over the estimated useful lives of the assets. Maintenance and repairs are expensed as incurred; expenditures that enhance the value of property or extend their useful lives are capitalized. When assets are sold or returned, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss is included in income.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Inventory units designated for customer demonstrations, as part of the sales process, are reclassified to property and equipment and the depreciation is recorded to selling and marketing expense. The inventory used for demonstrations that was reclassified to property and equipment for the years ended December 31, 2013 and 2015 was approximately $44,000 and $44,000, respectively. No inventory was reclassified for the year ended December 31, 2014 and for the three months ended March 31, 2015 and 2016.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Inventory units designated for customer rental agreements are reclassified to property and equipment and the depreciation is recorded to cost of sales. The inventory under rental agreements reclassified to property and equipment for the year ended December 31, 2015 was approximately $39,000. No inventory was reclassified for the years ended December 31, 2013 and 2014. The inventory under rental agreements reclassified to property and equipment for the three months ended March 31, 2016 (unaudited) was approximately $45,000. No inventory was reclassified for the three months ended March 31, 2015.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Intangible Assets
</FONT>
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Intangible assets are comprised of the Company&#146;s patent rights and are amortized over the patents&#146; estimated useful life of approximately 13 years. As of March 31, 2016 (unaudited) the remaining useful life was 87 months.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Long-Lived Assets
</FONT>
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The Company evaluates its long-lived assets, including intangible assets, for possible impairment whenever circumstances indicate that the carrying amount of the asset, or related group of assets, may not be
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	F-9
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage129"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	SENSUS HEALTHCARE, INC.
<BR>
	&nbsp;
<BR>
	NOTES TO FINANCIAL STATEMENTS
</H1>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Note 1&nbsp;&#151;&nbsp;Summary of Significant Accounting Policies
</FONT>
	&nbsp;&#150;&nbsp;(continued)
</H2>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	recoverable from estimated future cash flows in accordance with accounting guidance. If circumstances suggest the recorded amounts cannot be recovered, based upon estimated future undiscounted cash flows, the carrying values of such assets are reduced to fair value. No impairment charges were recorded for long-lived assets for the years ended December 31, 2013, 2014 and 2015, and for the three months ended March 31, 2015 and 2016 (unaudited).
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Research and Development
</FONT>
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Research and development costs relate to products under development by the Company and quality and regulatory costs and are expensed as incurred.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Income Taxes
</FONT>
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Through December 31, 2015, the Company was not subject to income taxes in any jurisdiction. Each member was responsible for the tax liability, if any, related to their proportionate share of the Company&#146;s taxable income.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Effective January 1, 2016, the Company is subject to corporate income taxes. The unaudited supplemental pro forma income tax expense (benefit) gives effect to the tax treatment of the Company as if it had been subject to federal and state income taxes for the years ended December 31, 2013, 2014 and 2015. See note 9.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	There are no uncertain tax positions that would require recognition in the financial statements. If the Company incurs an income tax liability in the future, interest on any income tax liability would be reported as interest expense and penalties on any income tax liability would be reported as income taxes. The Company&#146;s conclusions regarding uncertain tax positions may be subject to review and adjustment at a later date based upon ongoing analyses of tax laws, regulations and interpretations thereof as well as other factors.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The Company accounts for income taxes in accordance with ASC 740, Income Taxes, which prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC 740 also provides guidance on de-recognition, classification, interest and penalties, accounting in interim period, disclosure and transition.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	As of March 31, 2016, the tax years 2013, 2014 and 2015 were subject to examination.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Earnings Per Share
</FONT>
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Basic net income (loss) per share attributable to common stockholders is calculated by dividing the net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding for the period using the treasury stock method for options and warrants. The diluted net income per share attributable to common stockholders is computed by giving effect to all potential dilutive common share equivalents outstanding for the period. In periods when the Company has incurred a net loss, options and warrants to purchase common shares are considered common share equivalents but have been excluded from
	the calculation of diluted net loss per share attributable to common stockholders as their effect is antidilutive. For the three months ended March 31, 2016 (unaudited), the weighted average number of shares used in computing diluted net income per share includes 1,213 warrants and 5 options. Shares excluded were computed under the treasury stock method as follows:
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<EFX_UNIDENTIFIED_TABLE>
<TR>
<TD>
<A NAME="FIS_UNIDENTIFIED_TABLE_22"></A>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="232">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="64">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="64">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="64">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="120">
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=11>
	For the Years Ended December 31,
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=2>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=2 COLSPAN=3>
	For the Three Months
<BR>
	Ended March 31, 2015
<BR>
	(unaudited)
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2013
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2014
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2015
</TD>
</TR>
</EFX_UNIDENTIFIED_TABLE>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Warrants
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,118
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,118
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,213
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,118
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Options
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	5
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Equity-Based Compensation
</FONT>
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Pursuant to accounting guidance related to accounting for equity-based compensation, the Company is required to recognize all share-based payments to non-employees and employees in the financial statements
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	F-10
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage130"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	SENSUS HEALTHCARE, INC.
<BR>
	&nbsp;
<BR>
	NOTES TO FINANCIAL STATEMENTS
</H1>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Note 1&nbsp;&#151;&nbsp;Summary of Significant Accounting Policies
</FONT>
	&nbsp;&#150;&nbsp;(continued)
</H2>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	based on fair values on the grant date. The Company has accounted for issuance of units, options, and warrants in accordance with the guidance, which requires the recognition of expense, based on grant-date fair values, over the service period, generally periods over which the shares, options and warrants vest.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Advertising Costs
</FONT>
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Advertising and promotion expenses are charged to expense as incurred. Advertising and promotion expense included in selling expense in the accompanying statements of operations amounted to approximately $463,000, $973,000 and $773,000 for the years ended December 31, 2013, 2014 and 2015, respectively, and $235,000 and $232,000 for the three months ended March 31, 2015 and 2016 (unaudited), respectively.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Operating Leases
</FONT>
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Rent expense for operating leases which contain escalating rental clauses is recorded on a straight-line basis over the lease term.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Deferred Initial Public Offering Costs
</FONT>
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Deferred offering costs, which consist of direct incremental legal, accounting and other fees relating to the IPO, are capitalized. The deferred offering costs will be offset against IPO proceeds upon the consummation of the offering. In the event the offering is terminated, deferred offering costs will be expensed. As of December 31, 2015 and March 31, 2016 (unaudited), approximately $310,000 and $809,000 of deferred offering costs were capitalized and included in prepaid expenses and other on the balance sheets. No deferred offering costs were capitalized as of December 31, 2014.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Recently issued accounting pronouncements
</FONT>
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606). ASU 2014-09 will eliminate transaction- and industry-specific revenue recognition guidance under current GAAP and replace it with a principle based approach for determining revenue recognition. ASU 2014-09 will require that companies recognize revenue based on the value of transferred goods or services as they occur in the contract. The ASU also will require additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in
	judgments and assets recognized from costs incurred to obtain or fulfill a contract. ASU 2014-09 is effective for reporting periods beginning after December 15, 2017. Entities can transition to the standard either retrospectively or as a cumulative-effect adjustment as of the date of adoption. The Company is currently evaluating the impact of the future adoption of this standard.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In June 2014, the FASB has issued ASU 2014-12, Compensation&nbsp;&#151;&nbsp;Stock Compensation (Topic 718): Accounting for Shared-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period. This ASU requires that a performance target that affects vesting, and that could be achieved after the requisite service period, be treated as a performance condition. As such, the performance target should not be reflected in estimating the grant date fair value of the award. This update further clarifies that compensation cost should be recognized in the period in
	which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the period(s) for which the requisite service has already been rendered. The amendments in this ASU are effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. The Company adopted this standard in the first quarter of 2016 and it did not have an impact on its financial statements.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In July 2015, the FASB issued ASU 2015-11, Inventory (Topic 330), Simplifying the Measurement of Inventory, which changes the measurement principle for inventory from the lower of cost or market to the lower of cost and net realizable value. ASU 2015-11 defines net realizable value as estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. The new guidance must be applied on a prospective basis and is effective for fiscal years beginning after
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	F-11
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage131"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	SENSUS HEALTHCARE, INC.
<BR>
	&nbsp;
<BR>
	NOTES TO FINANCIAL STATEMENTS
</H1>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Note 1&nbsp;&#151;&nbsp;Summary of Significant Accounting Policies
</FONT>
	&nbsp;&#150;&nbsp;(continued)
</H2>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	December 15, 2015, and interim periods within those years, with early adoption permitted. The Company adopted this standard in the first quarter of 2016 and it did not have a material impact on its financial statements.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In November 2015, the FASB issued ASU 2015-17, Balance Sheet Classification of Deferred Taxes (Topic 740). Under the new guidance, companies are required to classify all deferred tax assets and liabilities as noncurrent on the balance sheet instead of separating deferred taxes into current and noncurrent amounts. In addition, companies will no longer allocate valuation allowances between current and noncurrent deferred tax assets because those allowances will also be classified as noncurrent. This guidance is effective for financial statements issued for annual periods beginning after December 15, 2016. The Company is
	currently evaluating the impact of the future adoption of this standard but it does not expect the adoption to have a material effect on our financial statements.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In April 2016, the FASB issued ASU 2016-09, Compensation&nbsp;&#151;&nbsp;Stock Compensation (Topic 718), which requires that the income tax effect of share-based awards be recognized in the income statement when the awards vest or are settled. The guidance will also allow an employer to repurchase more of an employee&#146;s shares for tax withholding purposes without triggering liability accounting and to make a policy election to account for forfeitures as they occur. The guidance is effective for fiscal years beginning after December 15, 2016 and interim periods within those years. The Company is currently evaluating the
	impact of the future adoption of this standard.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In April 2016, the FASB issued ASU 2016-10, Identifying Performance Obligations and Licensing, implementation guidance on principal versus agent, identifying performance obligations, and licensing. The Company is currently evaluating the new guidance to determine the impact it may have on its financial statements. ASU 2016-10 is effective for reporting periods beginning after December 15, 2017. Entities can transition to the standard either retrospectively or as a cumulative-effect adjustment as of the date of adoption. The Company is currently evaluating the impact of the future adoption of this standard.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Reclassification
</FONT>
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Depreciation and amortization for the years ended December 31, 2013 and 2014, which had been previously presented in the Statement of Operations as a separate line item, have been reclassified to cost of sales, selling and marketing, and general and administrative expense. The Company believes this is a more meaningful presentation.
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_23"></A>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Note 2&nbsp;&#151;&nbsp;
<B>
	Property and Equipment
</FONT>
</B>
</H2>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="253">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="70">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="70">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="70">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="78">
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=7>
	As to December 31,
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=2>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=2 COLSPAN=3>
	As to
<BR>
	March 31,
<BR>
	2016
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=2>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=2 COLSPAN=3>
	Estimated
<BR>
	Useful Lives
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2014
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2015
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=3>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=3>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=3>
	(unaudited)
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=3>
	&nbsp;&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Operations and rental equipment
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	290,364
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	504,786
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	585,397
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	3 years
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Tradeshow and demo equipment
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	392,002
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	397,325
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	569,995
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	3 years
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Computer equipment
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	72,894
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	88,451
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	112,930
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	3 years
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	755,260
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	990,562
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,268,322
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Less accumulated depreciation
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(494,763
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(669,863
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(730,561
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Property and Equipment, Net
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	260,497
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	320,699
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	537,761
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Depreciation expense was approximately $169,000, $176,000 and $219,000 for the years ended December 31, 2013, 2014 and 2015, respectively, and $49,000 and $61,000, for the three months ended March 31, 2015 and 2016 (unaudited), respectively.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	F-12
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage132"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_24"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	SENSUS HEALTHCARE, INC.
<BR>
	&nbsp;
<BR>
	NOTES TO FINANCIAL STATEMENTS
</H1>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Note 3&nbsp;&#151;&nbsp;Patent Rights
</FONT>
</H2>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="360">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="64">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="64">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="72">
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=7>
	As to December 31,
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=2>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=2 COLSPAN=3>
	As of
<BR>
	March 31,
<BR>
	2016
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2014
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2015
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=3>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=3>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=3>
	(unaudited)
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Gross carrying amount
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,253,018
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,253,018
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,253,018
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Less accumulated depreciation
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(433,737
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(530,123
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(554,220
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Net Carrying Amount
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	819,281
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	722,895
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	698,798
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Amortization expense was approximately $96,000 for each of the years ended December 31, 2013, 2014 and 2015, and $24,000 for each of the three-month periods ended March 31, 2015 and 2016 (unaudited). As of December 31, 2015 and March 31, 2016, future remaining amortization expense is as follows:
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_25"></A>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="554" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="370">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="80">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="72">
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	For the Year Ending December 31,
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	As of
<BR>
	December 31,
<BR>
	2015
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	As of
<BR>
	March 31,
<BR>
	2016
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	2016
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	96,386
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	72,289
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	2017
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	96,386
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	96,386
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	2018
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	96,386
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	96,386
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	2019
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	96,386
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	96,386
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	2020
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	96,386
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	96,386
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Thereafter
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	240,965
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	240,965
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Total
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	722,895
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	698,798
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Note 4&nbsp;&#151;&nbsp;Revolving Credit Facility
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	On March 12, 2013, the Company entered into a 2-year $3 million revolving credit facility. The credit facility was amended and extended effective March 12, 2015. The maximum borrowing was reduced to $1,500,000 and is limited by the Company&#146;s eligible borrowing base of 80% of eligible accounts receivable.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Interest, at Prime plus 1.75% (5.25% at March 31, 2016), is payable monthly with outstanding principal and interest due on May 12, 2017, the maturity date. The facility is secured by all of the Company&#146;s assets and limits the amount of additional indebtedness, restricts the sale, disposition or transfer of assets of the Company and requires the maintenance of a certain monthly adjusted quick ratio restrictive covenant and minimum quarterly EBITDA restrictive covenant, as defined in the agreement. At December 31, 2014, the Company was not in compliance with its minimum EBITDA requirement and received a waiver from its
	lender. The Company was not in compliance with its adjusted quick ratio requirement for October and November 2015 and received a waiver from its lender. Pursuant to our loan agreement, the March 31, 2016 covenant requirements and each quarter thereafter are based on review of our 2016 board approved plan which has not yet occurred. We are in the process of re-negotiating the terms of the loan agreement with our lender and believe we are in compliance with all covenant requirements as of March 31, 2016. Approximately $375,000, and $423,000 was outstanding under the revolving credit facility at December 31, 2014 and 2015, respectively, and $800,000 at March 31, 2016 (unaudited). The Company pays commitment fees of 0.25% per annum on the average unused portion of the line of credit.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	F-13
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage133"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_26"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	SENSUS HEALTHCARE, INC.
<BR>
	&nbsp;
<BR>
	NOTES TO FINANCIAL STATEMENTS
</H1>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Note 5&nbsp;&#151;&nbsp;Product Warranties
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Changes in product warranty liability were as follows for the years ended December 31, 2014 and 2015 and for the three-month period ended March 31, 2016 (unaudited).
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="340">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="70">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="70">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="78">
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=7>
	For the Years Ended
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=2>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=2 COLSPAN=3>
	For the
<BR>
	Three Months
<BR>
	Ended
<BR>
	March 31,
<BR>
	2016
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2014
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2015
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=3>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=3>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=3>
	(unaudited)
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Balance, beginning of period
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	101,124
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	47,614
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	48,363
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Warranties accrued during the period
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	13,024
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	7,189
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	734
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Payments on warranty claims
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(66,534
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(6,440
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(8,855
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Balance, end of period
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	47,614
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	48,363
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	40,242
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_27"></A>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Note 6&nbsp;&#151;&nbsp;Commitment and Contingencies
</FONT>
</H2>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Operating Lease Agreements
</FONT>
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The Company maintains a lease requiring monthly payments with an unrelated third party to lease approximately 4,500 square feet of office space, which lease is guaranteed by the founding members. The lease expires on July 31, 2017 and lease payments increase by 3% annually.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Future minimum payments as of December 31, 2015 and March 31, 2016 are as follows:
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="554" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="386">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="64">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="72">
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	Year
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	As of
<BR>
	December 31,
<BR>
	2015
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	As of
<BR>
	March 31,
<BR>
	2016
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	2016
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	101,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	76,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	2017
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	60,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	60,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	161,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	136,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Rental expense for the years ended December 31, 2013, 2014 and 2015 was approximately $83,000, $89,000 and $98,000, respectively, and for the three months ended March 31, 2015 and 2016 (unaudited) was approximately $25,000 and $25,000, respectively.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Manufacturing Agreement
</FONT>
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In July 2010, the Company entered into a three-year contract manufacturing agreement with an unrelated third party for the production and manufacture of the Company&#146;s main product in accordance with the Company&#146;s product specifications. The Company continues to do business with the contract manufacturer in accordance with the July 2010 agreement. The Company or the manufacturer has the option to terminate the agreement with 90 days written notice. Any change in the relationship with the manufacturer could have an adverse effect on the Company&#146;s business.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Purchases from this manufacturer totaled approximately $2,973,000, $1,459,000 and $2,871,000 for the years ended December 31, 2013, 2014 and 2015, respectively and $12,000 and $1,180,000 for the three months ended March 31, 2015 and 2016 (unaudited), respectively. As of December 31, 2014 and 2015 and March 31, 2016 (unaudited) approximately $95,000, $1,079,000 and $859,000, respectively, was due to this manufacturer, which is presented in accounts payable and accrued expenses in the accompanying balance sheets.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	F-14
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage134"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	SENSUS HEALTHCARE, INC.
<BR>
	&nbsp;
<BR>
	NOTES TO FINANCIAL STATEMENTS
</H1>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Note 6&nbsp;&#151;&nbsp;Commitment and Contingencies
</FONT>
	&nbsp;&#150;&nbsp;(continued)
</H2>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Legal contingencies
</FONT>
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The Company is party to certain legal proceedings in the ordinary course of business. The Company assesses, in conjunction with its legal counsel, the need to record a liability for litigation and related contingencies. The Company has accrued $112,500 related to the expected settlement of a lawsuit involving a customer seeking, among other things, to return and obtain a refund for one of the Company&#146;s devices. The Company does not believe that any other legal proceedings are likely to have a material effect on the business, financial condition, or results of operations.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Note 7&nbsp;&#151;&nbsp;Stockholders&#146; Equity
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The Company has authorized 50,000,000 shares of common stock, of which 40,835 and 42,852 shares were issued and outstanding as of December 31, 2014 and 2015, respectively, and 42,852 shares as of March 31, 2016 (unaudited).
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	During the year ended December 31, 2014, distributions were paid of approximately $45,000. During the years ended December 31, 2013 and 2015 and the three months ended in March 31, 2016 (unaudited) there were no distributions relating to the common stock.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Stock Issuances
</FONT>
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	During 2011, the Company offered to a limited number of investors (the &#147;investor members&#148;) preferred membership interests (the &#147;interests&#148;) consisting of (i) cumulative, non-compounded, 8% per annum preferential return, payable annually, if and when such distributions are made by the Company&#146;s board of directors and (ii) participation in the Company&#146;s net profits, net losses and distributions of the Company&#146;s assets pursuant to the operating agreement. The offering raised approximately $6.4 million in gross proceeds ($6.0 million net of offering costs), utilizing a private placement
	memorandum. As of December 31, 2013, 2014 and 2015, accumulated unpaid preferential distributions were approximately $1,648,000 ($129.22 per share), $2,161,000 ($169.49 per share) and $2,674,000 ($209.74 per share), respectively. Preferential distributions no longer accrue after December 31, 2015.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In March 2012, the Company offered non-preferred equity interests to qualified investors (the &#147;1
<SUP>
	st
</SUP>
	Common Offering&#148;). All interests were common membership interests in the Company and did not bear a preferred rate of return. The placement agent was entitled to transaction fees of 7.5% of the gross proceeds of the offering including reimbursement of certain costs not to exceed $50,000. The Company raised approximately $2.4 million in gross proceeds ($2.1 million net of offering costs) from the sale of these interests. No warrants were granted related to this offering.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In December 2012, the Company offered non-preferred equity interests to qualified investors (the &#147;2
<SUP>
	nd
</SUP>
	Common Offering&#148;). All interests were common membership interests in the Company and did not bear a preferred rate of return. The placement agent received transaction fees equal to 7.5% of the gross proceeds of the offering including reimbursement of certain costs not to exceed 1% of the gross proceeds of the offering. In addition, the placement agent received investor rights to 5 year warrants. The Company raised approximately $3.6 million in gross proceeds ($3.2 million net of offering costs) from the
	successful completion of the private placement in 2013.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	On December 28, 2015, the Company issued 2,017 common membership interests to qualified investors and raised approximately $2.2 million in gross proceeds (approximately $2.0 million net of offering costs). Additional offering costs of $4,375 were incurred during the quarter ended March 31, 2016.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The placement agent in this offering received transaction fees equal to 7.0% of the gross proceeds of the offering. No warrants were granted related to this offering.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	On January 1, 2016, Sensus Healthcare, LLC converted into a Delaware corporation pursuant to a statutory conversion and changed its name to Sensus Healthcare, Inc. As a result of the corporate conversion,
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	F-15
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage135"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	SENSUS HEALTHCARE, INC.
<BR>
	&nbsp;
<BR>
	NOTES TO FINANCIAL STATEMENTS
</H1>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Note 7&nbsp;&#151;&nbsp;Stockholders&#146; Equity
</FONT>
	&nbsp;&#150;&nbsp;(continued)
</H2>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	the holders of the different classes of units of Sensus Healthcare, LLC became holders of common stock of Sensus Healthcare, Inc. Holders of warrants and options, respectively, to purchase units of Sensus Healthcare, LLC became holders of warrants and options to purchase common stock of Sensus Healthcare, Inc., respectively. Each unit converted to one share of common stock. In the event of an initial public offering or change in control (as defined) the accumulated unpaid distribution as of December 31, 2015 will be paid in cash or shares, at the option of each stockholder with a preferential distribution.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Warrants
</FONT>
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In March 2011, the closing date of the preferred offering, the Company&#146;s placement agent was granted investor rights to 5 year warrants (the &#147;placement agent warrants&#148;) to purchase 2,250 preferred units of the Company at an exercise price of approximately $503 per unit. Dividends on the preferred interest do not accumulate until the warrants are exercised. The expiration of the warrants was extended through May 30, 2016.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	In April 2013, the closing date of the 2
<SUP>
	nd
</SUP>
	Common Offering, the placement agent received investor rights to 5 year warrants to purchase 357 common units of the Company at an exercise price of $1,100 per unit which was equal to 110% of the offering price.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	All warrants were fully vested as of December 31, 2014 and 2015 and March 31, 2016. The following table summarizes the Company&#146;s warrant activity:
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_28"></A>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="210">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="58">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="53">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="69">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="58">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="53">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="72">
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=11>
	Preferred Unit Warrants
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=11>
	Common Unit Warrants
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Number
<BR>
	of Warrants
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Weighted
<BR>
	Average
<BR>
	Exercise
<BR>
	Price
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Weighted
<BR>
	Average
<BR>
	Remaining
<BR>
	Contractual
<BR>
	Term
<BR>
	(In Years)
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Number
<BR>
	of Warrants
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Weighted
<BR>
	Average
<BR>
	Exercise
<BR>
	Price
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Weighted
<BR>
	Average
<BR>
	Remaining
<BR>
	Contractual
<BR>
	Term
<BR>
	(In Years)
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Outstanding&nbsp;&#150;&nbsp;December 31, 2012
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	2,250
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	503
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	3.17
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Granted
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	357
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,100
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	5.00
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Exercised
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Cancelled (forfeited)
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Outstanding&nbsp;&#150;&nbsp;December 31, 2013
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	2,250
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	503
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	2.17
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	357
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	1,100
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	4.26
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Granted
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Exercised
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Cancelled (forfeited)
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Outstanding&nbsp;&#150;&nbsp;December 31, 2014
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	2,250
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	503
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	1.17
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	357
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	1,100
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	3.26
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Granted
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Exercised
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Cancelled (forfeited)
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Outstanding&nbsp;&#150;&nbsp;December 31, 2015
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	2,250
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	503
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	0.17
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	357
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	1,100
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	2.26
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Granted
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Exercised
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Cancelled (forfeited)
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Outstanding&nbsp;&#150;&nbsp;March 31, 2016 (unaudited)
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	2,250
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	503
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	0.00
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	357
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	1,100
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	2.01
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Exercisable&nbsp;&#150;&nbsp;March 31, 2016 (unaudited)
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	2,250
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	503
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	0.00
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	357
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	1,100
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	2.01
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	2013 Option Plan
</FONT>
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The Company&#146;s 2013 option plan (the &#147;Plan&#148;) permits the grant of 375 shares of common interests to its employees. Option awards are generally granted with an exercise price equal to the fair value of the Company&#146;s common shares at the date of grant and those option awards generally vest based on 5 years of
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	F-16
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage136"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	SENSUS HEALTHCARE, INC.
<BR>
	&nbsp;
<BR>
	NOTES TO FINANCIAL STATEMENTS
</H1>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Note 7&nbsp;&#151;&nbsp;Stockholders&#146; Equity
</FONT>
	&nbsp;&#150;&nbsp;(continued)
</H2>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	continuous service. The awards provide for accelerated vesting if there is a change in control as defined in the Plan. Upon the closing of an initial public offering, all options issued under the Plan will automatically be exercised using a cashless exercise feature.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	2013 Options Granted
</FONT>
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	On November 1, 2013, the Company granted two employees, options to each purchase 30 units of common interest at an exercise price of $1,000 per unit. In lieu of cash exercise, the options also contain certain cashless exercise provisions however the net settlement amount remains fixed. The options expire 10 years from the grant date and vest 5 years from the grant date. No options were granted during the years ended December 31, 2014 and 2015 and the three months ended March 31, 2015 and 2016.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The fair value of each option is estimated on the date of grant using the Black-Scholes Option Pricing Model (&#147;Black-Scholes Model) that uses the assumptions noted in the following table. Expected volatilities are based on historical volatilities of comparable companies, industry indexes and other factors. Because the Company has no historical exercise data and alternative information, such as exercise data relating to employees of other companies, is not easily obtainable, the Company concluded that its historical share option exercise experience does not provide a reasonable basis upon which to estimate expected term.
	Accordingly, the Company utilized the &#147;simplified&#148; method for &#147;plain vanilla&#148; options equal to the average of the term of the option and the vesting period. The risk-free rate represents the yield on U.S. Treasury bonds with a maturity equal to the expected term of the warrant. The weighted average grant date fair value of the options granted during the year ended December 31, 2013 was approximately $40,000 using the following assumptions:
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_29"></A>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="554" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="466">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="72">
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Expected volatility
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	64&#37;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Expected term
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	7.5 years
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Risk free interest rate
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	2.01&#37;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Dividend rate
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	0&#37;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	A summary of option activity under the Plan is as follows:
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_30"></A>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="554" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="322">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="58">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="58">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="66">
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Number of Options
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Weighted
<BR>
	Average
<BR>
	Exercise
<BR>
	Price
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Weighted
<BR>
	Average
<BR>
	Remaining
<BR>
	Contractual
<BR>
	Term
<BR>
	(In Years)
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Outstanding&nbsp;&#150;&nbsp;December 31, 2012
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Granted
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	60
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	1,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	10.00
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Exercised
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Cancelled (forfeited)
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Outstanding&nbsp;&#150;&nbsp;December 31, 2013
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	60
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	1,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	9.83
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Granted
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Exercised
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Cancelled (forfeited)
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Outstanding&nbsp;&#150;&nbsp;December 31, 2014
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	60
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	1,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	8.83
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Granted
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Exercised
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Cancelled (forfeited)
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Outstanding&nbsp;&#150;&nbsp;December 31, 2015
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	60
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	1,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	7.83
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Exercisable&nbsp;&#150;&nbsp;December 31, 2015
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Granted
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Exercised
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Cancelled (forfeited)
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Outstanding&nbsp;&#150;&nbsp;March 31, 2016
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	60
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	1,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	7.58
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Exercisable&nbsp;&#150;&nbsp;March 31, 2016
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	F-17
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage137"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	SENSUS HEALTHCARE, INC.
<BR>
	&nbsp;
<BR>
	NOTES TO FINANCIAL STATEMENTS
</H1>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Note 7&nbsp;&#151;&nbsp;Stockholders&#146; Equity
</FONT>
	&nbsp;&#150;&nbsp;(continued)
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Total intrinsic value of vested and non-vested units of common interests was approximately $0 as of December 31, 2013 and 2014, and approximately $5,000 as of December 31, 2015 and March 31, 2016 (unaudited). The Company recognized approximately $1,000, $6,000 and $6,000 of stock based compensation related to the grant of the options to its employees for the years ended December 31, 2013, 2014 and 2015, and approximately $2,000 for the three months ended March 31, 2015 and 2016 (unaudited). Total stock based compensation related to nonvested awards not yet recognized as of December 31, 2013, 2014 and 2015, and March 31, 2016
	(unaudited) is approximately $39,000, $32,000, $25,000 and $23,000, respectively, which will be recognized over the remaining vesting period through November 30, 2019.
</P>
<H3 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: ITALIC; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Equity Interest Awarded to an Executive
</FONT>
</FONT>
</H3>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	During the year ended December 31, 2014, the Company granted a 1% ownership interest in the Company to an executive which vests upon a change in control of the Company. During 2015, the terms were amended such that the ownership interest will vest in the event of involuntary termination or a liquidity event, as defined. In accordance with accounting principles generally accepted in the United States, compensation cost for awards with performance conditions should be recorded in the Company&#146;s financial statements at which time that it is probable the performance condition is achieved. As of December 31, 2014 and 2015, and
	March 31, 2016 the performance condition was not probable and accordingly no compensation cost was recorded.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Note 8&nbsp;&#151;&nbsp;Income Taxes
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Through December 31, 2015, the Company was not subject to income taxes in any jurisdiction. Each member of the LLC was responsible for the tax liability, if any, related to their proportionate share of the Company&#146;s taxable income. Effective January 1, 2016, the Company is subject to corporate income taxes. The unaudited supplemental pro forma income tax expense (benefit) gives effect to the tax treatment of the Company as if it had been subject to federal and state income taxes for the years ended December 31, 2013, 2014 and 2015&nbsp;&#151;&nbsp;see note 9.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The Company recognized an increase in valuation allowance equal to 100% of the pro forma deferred tax expense (benefit) attributable to the years ended December 31, 2013, 2014 and 2015.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The Company recognized income tax expense of $636 for the three months ended March 31, 2016 (unaudited), based on an effective tax rate of 23.4%.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	There are no uncertain tax positions that would require recognition in the financial statements. If the Company incurs an income tax liability in the future, interest on any income tax liability would be reported as interest expense and penalties on any income tax liability would be reported as income taxes. The Company&#146;s conclusions regarding uncertain tax positions may be subject to review and adjustment at a later date based upon ongoing analyses of tax laws, regulations and interpretations thereof as well as other factors.
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Note 9&nbsp;&#151;&nbsp;Corporate Conversion
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	On January 1, 2016, Sensus Healthcare, LLC converted into a Delaware corporation pursuant to a statutory conversion and changed its name to Sensus Healthcare, Inc. As a result of the corporate conversion, the holders of the different classes of units of Sensus Healthcare, LLC became holders of common stock of Sensus Healthcare, Inc. Holders of warrants and options, respectively, to purchase units of Sensus Healthcare, LLC became holders of warrants and options to purchase common stock of Sensus Healthcare, Inc., respectively. Each unit converted to one share of common stock. Preferential distributions no longer accrue as of
	January 1, 2016. In the event of an initial public offering or change in control (as defined) the accumulated unpaid distribution as of December 31, 2015 will be paid in cash or shares, at the option of each stockholder with a preferential distribution.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	F-18
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage138"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_31"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	SENSUS HEALTHCARE, INC.
<BR>
	&nbsp;
<BR>
	NOTES TO FINANCIAL STATEMENTS
</H1>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Note 9&nbsp;&#151;&nbsp;Corporate Conversion
</FONT>
	&nbsp;&#150;&nbsp;(continued)
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Following is an unaudited pro forma balance sheet to reflect the accrual of the dividend payable to the former holders of units with a preferred return:
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="554" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="386">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="64">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="72">
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=7>
	As of March 31, 2016
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Actual
<BR>
	(unaudited)
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	Pro Forma
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Balance sheet data:
<BR>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Cash and cash equivalents
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	4,746,539
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	4,746,539
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Working capital
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	4,689,473
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	2,015,276
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Total assets
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	9,989,357
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	9,989,357
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Total liabilities
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	4,068,428
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	6,742,625
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Total stockholders&#146; equity
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	5,920,929
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	3,246,732
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Total liabilities and stockholders&#146; equity
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	9,989,357
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	9,989,357
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The pro forma net income tax expense (benefit) is comprised of the following:
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_32"></A>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="554" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="306">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="64">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="64">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="72">
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=11>
	Year ended December 31,
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2013
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2014
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2015
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Current income tax benefit
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Deferred income tax expense (benefit) before valuation allowance
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	37,486
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(1,400,125
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(90,281
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Net income tax expense (benefit) before valuation allowance
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	37,486
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(1,400,125
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(90,281
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Increase (decrease) in valuation allowance
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(37,486
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,400,125
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	90,281
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1 COLSPAN=1>
	Net Income Tax Expense
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 3PT DOUBLE WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 3PT DOUBLE BLACK" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 3PT DOUBLE WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The Company&#146;s pro forma income tax rates vary from statutory federal income tax rates due to the following:
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_33"></A>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="554" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="306">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="64">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="64">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="72">
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=11>
	Year ended December 31,
</TD>
</TR>
<TR>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: LEFT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2013
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2014
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=3>
	2015
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Income (loss) before income tax expense (benefit)
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	107,627
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(3,699,470
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(237,267
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Income tax expense (benefit) at statutory federal rate
<BR>
	of 34%
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	36,593
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(1,257,820
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(80,671
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Tax effect of:
<BR>
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Non-deductible expenses
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	23,125
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	20,016
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	17,320
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	State income taxes
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	6,376
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(132,154
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(4,915
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Research and development credit
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(28,608
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(30,167
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(22,015
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Pro Forma Income Tax Benefit before change in Valuation Allowance
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	37,486
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(1,400,125
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	(90,281
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Change in valuation allowance
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	(37,486
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
	)
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	1,400,125
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	90,281
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Pro Forma Income Tax Expense
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	&#151;
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	F-19
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage139"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_V430231_IBC.JPG" WIDTH="604" ALIGN="MIDDLE" ALT="[GRAPHIC MISSING]">
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage140"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	&nbsp;
</P>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: RIGHT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	&nbsp;
</H2>
<DIV STYLE="WIDTH: 100%; DISPLAY: INLINE-BLOCK; *DISPLAY:INLINE; VERTICAL-ALIGN: MIDDLE; BORDER-TOP: 4PT BLACK DOUBLE">
	&nbsp;
</DIV>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 16PT; LINE-HEIGHT: 18PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	1,750,000 Units
<BR>
	Each Unit Consisting of One Share of Common Stock and
<BR>
	a Warrant to Purchase One Share of Common Stock
</FONT>
</H1>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_LOGO_SENSUS.JPG" WIDTH="337" ALIGN="MIDDLE" ALT="[GRAPHIC MISSING]">
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	&nbsp;
<BR>
	&nbsp;
<BR>
	&nbsp;
<BR>
</P>
<DIV ALIGN="CENTER">
<BR>
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_LINE.GIF" ALIGN="MIDDLE" STYLE="WIDTH: 180PX; HEIGHT: 1PT; TEXT-ALIGN: CENTER">
<BR>
	&nbsp;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_34"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 12PT; LINE-HEIGHT: 14PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	PROSPECTUS
</FONT>
</H1>
<DIV ALIGN="CENTER">
<BR>
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_LINE.GIF" ALIGN="MIDDLE" STYLE="WIDTH: 180PX; HEIGHT: 1PT; TEXT-ALIGN: CENTER">
<BR>
	&nbsp;
</DIV>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	&nbsp;
<BR>
	&nbsp;
<BR>
	&nbsp;
<BR>
	&nbsp;&nbsp;
<BR>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<I>
	Joint Book-Running Managers
</I>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="672" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 18PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="328">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="328">
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; FONT-WEIGHT: BOLD" ROWSPAN=1 COLSPAN=1>
	Northland Capital Markets
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: RIGHT">
<B>
	Neidiger, Tucker, Bruner, Inc.
</B>
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	&nbsp;
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	&nbsp;&nbsp;
<BR>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	&nbsp;
<BR>
	&nbsp;
<BR>
	&nbsp;
<BR>
	&nbsp;&nbsp;
<BR>
	&nbsp;
<BR>
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Through and including &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016 (the 25
<SUP>
	th
</SUP>
	day after the date of this offering), all dealers effecting transactions in these securities, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to a dealer&#146;s obligation to deliver a prospectus when acting as an underwriter and with respect to an unsold allotment or subscription.
</P>
<DIV STYLE="WIDTH: 100%; DISPLAY: INLINE-BLOCK; *DISPLAY:INLINE; VERTICAL-ALIGN: MIDDLE; BORDER-TOP: 4PT BLACK DOUBLE">
	&nbsp;
</DIV>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	&nbsp;
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage141"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	PART II: INFORMATION NOT REQUIRED IN THE PROSPECTUS
</FONT>
</H1>
</EFX_NOTES_TO_FINANCIAL_STATEMENT>
<EFX_OFFERING_EXPENSE>
<A NAME="FIS_OFFERING_EXPENSE"></A>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Item 13. Other expenses of issuance and distribution.
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The following table sets forth all fees and expenses, other than underwriting discounts and commissions, payable solely by the registrant in connection with the offer and sale of the securities being registered. All amounts shown are estimated except for the registration fee of the SEC, the FINRA filing fee and the Nasdaq listing fee.
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_35"></A>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="554" STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="476">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD COLSPAN="3">
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="62">
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	SEC registration fee
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	3,038
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	FINRA filing fee
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	5,024
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Nasdaq listing fee
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	55,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Accounting fees and expenses
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	125,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Legal fees and expenses
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	500,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Printing fees and expenses
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	70,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Transfer agent and registrar fees and expenses
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	5,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: TEXT-BOTTOM" ROWSPAN=1 COLSPAN=1>
	Blue sky fees and expenses
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT" ROWSPAN=1 COLSPAN=1>
	5,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: WHITE">
<TD STYLE="PADDING-LEFT: 10PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Miscellaneous
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	&nbsp;
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	125,000
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-LEFT: 20PT; TEXT-INDENT: -10PT; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1 COLSPAN=1>
	Total
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID WHITE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1>
<!-- $ -->
	$
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	893,062
</TD>
<TD STYLE="WHITE-SPACE: NOWRAP; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; BORDER-BOTTOM: 1PT SOLID WHITE">
<!-- PERCENT -->
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
</EFX_OFFERING_EXPENSE>
<EFX_INDEMNIFICATION>
<A NAME="FIS_INDEMNIFICATION"></A>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Item 14. Indemnification of directors and officers.
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	On January 1, 2016, Sensus Healthcare, LLC converted into a Delaware corporation pursuant to a statutory conversion and change its name to Sensus Healthcare, Inc. Section 145(a) of the Delaware General Corporation Law (the &#147;DGCL&#148;) provides that a Delaware corporation may indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, other than an action by or in the right of the corporation, by reason of the fact that such person is or was a director, officer, employee or agent
	of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys&#146; fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection with such action, suit or proceeding if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe the person&#146;s conduct was unlawful.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Section 145(b) of the DGCL provides that a Delaware corporation may indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason of the fact that such person acted in any of the capacities set forth above, against expenses (including attorneys&#146; fees) actually and reasonably incurred by such person in connection with the defense or settlement of such action or suit if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed
	to the best interests of the corporation, except that no indemnification shall be made in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable to the corporation, unless and only to the extent that the Court of Chancery or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the court shall deem proper.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Further subsections of DGCL Section 145 provide that:
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	to the extent a present or former director or officer of a corporation has been successful on the merits or otherwise in the defense of any action, suit or proceeding referred to in subsections (a) and (b) of Section 145 or in the defense of any claim, issue or matter therein, such person shall be indemnified against expenses, including attorneys&#146; fees, actually and reasonably incurred by such person in connection therewith;
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	II-1
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage142"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	the indemnification and advancement of expenses provided for pursuant to Section 145 shall not be deemed exclusive of any other rights to which those seeking indemnification or advancement of expenses may be entitled under any bylaw, agreement, vote of stockholders or disinterested directors or otherwise; and
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	the corporation shall have the power to purchase and maintain insurance of behalf of any person who is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against any liability asserted against such person and incurred by such person in any such capacity, or arising out of such person&#146;s status as such, whether or not the corporation would have the power to indemnify such person against such liability under Section 145.
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	As used in this Item 14, the term &#147;proceeding&#148; means any threatened, pending, or completed action, suit, or proceeding, whether or not by or in the right of Registrant, and whether civil, criminal, administrative, investigative or otherwise.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Section 145 of the DGCL makes provision for the indemnification of officers and directors in terms sufficiently broad to indemnify officers and directors of each of the registrants incorporated in Delaware under certain circumstances from liabilities (including reimbursement for expenses incurred) arising under the Securities Act of 1933, as amended (the &#147;Act&#148;). Sensus Healthcare, Inc. may, in its discretion, similarly indemnify its employees and agents.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The certificate of incorporation and bylaws of Sensus Healthcare, Inc. provide that, to the fullest extent and under the circumstances permitted by Section 145 of the DGCL, Sensus Healthcare, Inc. will indemnify directors and officers from and against any and all of the expenses, liabilities or other maters referred to in Section 145 of the DGCL. In addition, the certificate of incorporation of Sensus Healthcare, Inc. relieves its directors from monetary damages to it or its stockholders for breach of such director&#146;s fiduciary duty as a director to the fullest extent permitted by the DGCL. Under Section 102(b)(7) of the
	DGCL, a corporation may relieve its directors from personal liability to such corporation or its stockholders for monetary damages for any breach of their fiduciary duty as directors except (i) for a breach of the duty of loyalty, (ii) for failure to act in good faith, (iii) for intentional misconduct or knowing violation of law, (iv) for willful or negligent violations of certain provisions in the DGCL imposing certain requirements with respect to stock repurchases, redemptions and dividends, or (v) for any transactions from which the director derived an improper personal benefit.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Sensus Healthcare, Inc. also intends to purchase and maintain insurance on behalf of any person who is or was a director or officer against any loss arising from any claim asserted against him or her and incurred by him or her in any such capacity, subject to certain exclusions.
</P>
</EFX_INDEMNIFICATION>
<EFX_SALE_OF_UNREGISTERED_SECURITIES>
<A NAME="FIS_SALE_OF_UNREGISTERED_SECURITIES"></A>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Item 15. Recent sales of unregistered securities.
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The following list sets forth information as to all securities we have sold or exchanged since January 1, 2013, which were not registered under the Securities Act. Amounts in parentheses below in this Item 15 give effect to our corporate conversion and our expected 241.95-for-one forward stock split.
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	(1)
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Since January 1, 2013, we have issued units in the following transactions:
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 41PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	On January 3, 2013, we issued an aggregate of 3,575 units without preferred returns (864,925 shares) to certain investors in a private placement at a price per unit of $1,000 ($4.13 per share) for aggregate gross consideration of approximately $3.6 million. In addition, we issued warrants to acquire an aggregate of 357 units (86,376 shares), with an exercise price of $1,100 per unit ($4.55 per share) and which were exercisable for a five-year term. In connection with this private placement we paid placement agent commissions and fees in the aggregate amount of approximately $0.4 million.
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	II-2
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage143"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 41PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	On December 28, 2015, we issued an aggregate of 2,017 units (487,981 shares) without preferred returns to certain investors in a private placement at a price per unit of $1,090.73 ($4.51 per share) for aggregate gross consideration of $2.2 million. In connection with this private placement we paid placement agent commissions and fees in the aggregate amount of approximately $0.2 million.
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 21PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	(2)
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Since January 1, 2013, we have issued units in the following transactions to certain of our employees:
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 41PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	On July 30, 2015, we issued 435 units (105,248 shares) without preferred returns to Arthur Levine, our Chief Financial Officer, as equity compensation. These units will vest upon the expiration of the contractual lock-up agreements in connection with a Liquidity Event (as defined in his equity grant agreement), which includes this initial public offering.
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 41PX">
</TD>
<TD STYLE="WIDTH: 24PX; TEXT-ALIGN: LEFT">
	&#149;
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	We have granted options to employees under our 2013 Option Plan to acquire 60 units (14,517 shares) with a weighted-average exercise price of $1,000 per unit ($4.13 per share).
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We claimed exemption from registration under the Securities Act for the sale and issuance of securities in the transactions described in paragraph (1) by virtue of Section 4(a)(2) and Regulation D promulgated thereunder as transactions not involving any public offering. All of the purchasers of unregistered securities for which we relied on Section 4(a)(2) and Regulation D represented that they were accredited investors as defined under the Securities Act. We claimed such exemption on the basis that (a) the purchasers in each case represented that they intended to acquire the securities for investment only and not with a view
	to the distribution thereof and that they either received adequate information about the registrant or had access, through employment or other relationships, to such information and (b) appropriate legends were affixed to the unit certificates issued in such transactions.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	We claimed exemption from registration under the Securities Act for the sales and issuances of securities in the transactions described in paragraph (2) above under Section 4(a)(2) of the Securities Act in that such sales and issuances did not involve a public offering or under Rule 701 promulgated under the Securities Act, in that they were offered and sold either pursuant to written compensatory plans or pursuant to a written contract relating to compensation, as provided by Rule 701.
</P>
</EFX_SALE_OF_UNREGISTERED_SECURITIES>
<EFX_EXHIBITS>
<A NAME="FIS_EXHIBITS"></A>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Item 16. Exhibits and financial statement schedules.
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	(a) The exhibits listed below in the &#147;Index to exhibits&#148; are part of this Registration Statement on Form S-1 and are numbered in accordance with Item 601 of Regulation S-K.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	(b) Financial statement schedules. Schedules have been omitted because the information required to be set forth therein is not applicable or is shown in the financial statements or notes thereto.
</P>
</EFX_EXHIBITS>
<EFX_UNDERTAKINGS>
<A NAME="FIS_UNDERTAKINGS"></A>
<H2 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 5PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Item 17. Undertakings.
</FONT>
</H2>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	The undersigned registrant hereby undertakes that:
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	(1) For purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of this Registration Statement in reliance upon Rule 430A and contained in a form of prospectus filed by the Registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this Registration Statement as of the time it was declared effective.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	(2) For the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed to be a new Registration Statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial
<I>
	bona fide
</I>
	offering thereof.
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	(3) The undersigned will provide to the underwriters, at the closing specified in the underwriting agreement, certificates in such denominations and registered in such names as required by the underwriters to permit prompt delivery to each purchaser.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	II-3
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage144"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action,
	suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.
</P>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	II-4
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage145"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
</EFX_UNDERTAKINGS>
</EFX_MORE_INFORMATION>
<EFX_SIGNATURES>
<A NAME="FIS_SIGNATURES"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	SIGNATURES
</FONT>
</H1>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this Amendment No. 4 to the Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Boca Raton, State of Florida, on May 19, 2016.
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 244PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Sensus Healthcare, Inc.
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 241PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	By:
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	/s/ Joseph C. Sardano
<BR>
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_LINE.GIF" STYLE="WIDTH: 100%; HEIGHT: 1PT">
<BR>
	Joseph C. Sardano
<BR>
<I>
	Chief Executive Officer
</I>
</TD>
</TR>
</TABLE>
<P STYLE="TEXT-INDENT:20PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities set forth opposite their names and on the date indicated above.
</P>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="232">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="224">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="120">
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	Signature
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	Title
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	Date
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	/s/ Joseph C. Sardano
<BR>
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_LINE.GIF" STYLE="WIDTH: 100%; HEIGHT: 1PT">
<BR>
	Joseph C. Sardano
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Chief Executive Officer and Director
<BR>
	(Principal Executive Officer)
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	May 19, 2016
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	/s/ Arthur Levine
<BR>
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_LINE.GIF" STYLE="WIDTH: 100%; HEIGHT: 1PT">
<BR>
	Arthur Levine
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Chief Financial Officer
<BR>
	(Principal Financial Officer and Principal Accounting Officer)
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	May 19, 2016
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	*
<BR>
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_LINE.GIF" STYLE="WIDTH: 100%; HEIGHT: 1PT">
<BR>
	John Heinrich
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Director
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	May 19, 2016
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	*
<BR>
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_LINE.GIF" STYLE="WIDTH: 100%; HEIGHT: 1PT">
<BR>
	William McCall
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Director
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	May 19, 2016
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	*
<BR>
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_LINE.GIF" STYLE="WIDTH: 100%; HEIGHT: 1PT">
<BR>
	Samuel O&#146;Rear
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Director
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	May 19, 2016
</TD>
</TR>
</TABLE>
</DIV>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 1PX">
</TD>
<TD STYLE="WIDTH: 25PX; TEXT-ALIGN: LEFT">
	*By:
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
<U>
	/s/ Arthur Levine&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</U>
<BR>
	Attorney-in-Fact
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	II-5
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage146"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
</EFX_SIGNATURES>
<EFX_EXHIBIT_INDEX>
<A NAME="FIS_EXHIBIT_INDEX"></A>
<H1 STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD; TEXT-TRANSFORM: NONE; PADDING-TOP: 9PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	INDEX TO EXHIBITS
</FONT>
</H1>
<P STYLE="TEXT-INDENT:0PT; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 4PX; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_36"></A>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="72">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="520">
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	Exhibit No.
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	Description
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;1.1&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Form of Underwriting Agreement.
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;2.1*&nbsp;
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Agreement and Plan of Merger, dated as of December 12, 2011, by and between Sensus Healthcare, LLC and Sensus Healthcare, LLC.
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;2.2*&nbsp;
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Plan of Conversion of Sensus Healthcare, LLC.
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;3.1*&nbsp;
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Amended and Restated Certificate of Incorporation of Sensus Healthcare, Inc.
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;3.2*&nbsp;
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Bylaws of Sensus Healthcare, Inc., effective as of January 1, 2016.
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;3.3*&nbsp;
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Limited Liability Company Agreement, dated as of September 30, 2010, by and among Sensus Healthcare, LLC and the members party thereto.
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;3.4*&nbsp;
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Amendment to Operating Agreement of Sensus Healthcare, LLC, dated as of February 28, 2012.
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;3.5*&nbsp;
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Second Amendment to Operating Agreement of Sensus Healthcare, LLC, dated as of April 5, 2013.
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;4.1*&nbsp;
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Warrant Agreement of Sensus Healthcare, LLC, dated as of March 31, 2011, by and between Sensus Healthcare, LLC and Anderson Strudwick, Inc.
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;4.2*&nbsp;
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Assignment of Warrant Agreement, dated as of March 31, 2012, by and among Anderson Strudwick, Inc., Investors Capital Alliance, LLC and Sensus Healthcare, LLC.
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;4.3*&nbsp;
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Form of Warrant Agreement of Sensus Healthcare, LLC, dated as of February 1, 2013, by and between Sensus Healthcare, LLC and certain investors.
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;4.4*&nbsp;
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Form of Warrant Agreement, by and between Sensus Healthcare, Inc. and American Stock Transfer &amp; Trust Company, LLC, as warrant agent, including warrant certificate.
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;4.5*&nbsp;
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Amendment No. 1 to Warrant Agreement of Sensus Healthcare, LLC, dated as of March 31, 2016, by and between Sensus Healthcare, Inc. and Investors Capital Alliance, LLC.
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;4.6&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Amendment No. 2 to Warrant Agreement of Sensus Healthcare, LLC, dated as of April 30, 2016, by and between Sensus Healthcare, Inc. and Investors Capital Alliance, LLC.
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;4.7&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Form of Representatives&#146; Warrant to Purchase Units.
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;5.1&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Opinion of Gunster, Yoakley &amp; Stewart, P.A.
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;&nbsp;10.1+*&nbsp;
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Sensus Healthcare, LLC 2013 Option Plan.
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;10.2*&nbsp;
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Amended and Restated Loan and Security Agreement by and between Sensus Healthcare, LLC and Silicon Valley Bank, dated as of March 12, 2013.
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;10.3*&nbsp;
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Default Waiver and First Amendment to Amended and Restated Loan and Security Agreement by and between Sensus Healthcare, LLC and Silicon Valley Bank, dated May 12, 2015.
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;10.4*&nbsp;
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Asset Purchase Agreement by and between Sensus Healthcare, LLC and Topex, Inc., dated as of April 16, 2010.
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;10.5*&nbsp;
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Form of Indemnification Agreement.
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;10.6*&nbsp;
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Office Lease Agreement, dated as of July 26, 2010, by and between Rexall Sundown, Inc. and Sensus Healthcare, LLC.
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;10.7*&nbsp;
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Amendment to Lease, dated as of January 27, 2014, by and between Rexall Sundown, Inc. and Sensus Healthcare, LLC.
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;10.8+*
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Form of Non-Qualified Option Grant Agreement.
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;10.9+*
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Equity Grant Agreement, dated as of July 30, 2015, by and among Arthur Levine, Sensus Healthcare, LLC and certain contributing members named therein.
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;10.10+*
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Employment Agreement between Sensus Healthcare, Inc. and Joseph C. Sardano.
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;10.11+*
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Employment Agreement between Sensus Healthcare, Inc. and Kalman Fishman.
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;10.12+*
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Employment Agreement between Sensus Healthcare, Inc. and Arthur Levine.
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;10.13&#35;*
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Manufacturing Agreement, dated as of July 20, 2010, by and between RbM Services, LLC and Sensus Healthcare, LLC.
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_37"></A>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	II-6
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS">
	&nbsp;
</DIV>
<A NAME="eolPage147"></A>
<DIV ID="HDR">
	&nbsp;
</DIV>
<DIV STYLE="WIDTH: 708PX; BORDER-TOP: 1PT WHITE SOLID; BORDER-BOTTOM: 1PT WHITE SOLID; BORDER-RIGHT: 1PT WHITE SOLID; BORDER-LEFT: 1PT WHITE SOLID; PADDING-TOP: 9PT; PADDING-BOTTOM: 9PT; PADDING-RIGHT: 3PT; PADDING-LEFT:6PT; MARGIN-TOP:6PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT:0PT; MARGIN-BOTTOM:6PT" ALIGN="CENTER">
<P STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 8PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: BOLD">
<A HREF="#V440371_S1A_HTM_TOC">
	TABLE OF CONTENTS
</A>
</P>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="VERTICAL-ALIGN: TEXT-TOP; TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: -15PT; *MARGIN-TOP: -20PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="72">
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE">
<!-- GUTTER -->
	&nbsp;
</TD>
<TD>
<IMG HEIGHT="1" SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_SPACER.GIF" WIDTH="520">
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	Exhibit No.
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD STYLE="LINE-HEIGHT: NORMAL; VERTICAL-ALIGN: BOTTOM; FONT-WEIGHT: BOLD; FONT-SIZE: 8PT; TEXT-ALIGN: CENTER; BORDER-BOTTOM: 1PT SOLID BLACK" ROWSPAN=1 COLSPAN=1>
	Description
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;10.14+*
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Sensus Heathcare, Inc. 2016 Equity Incentive Plan.
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;10.15*&nbsp;
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Waiver of Silicon Valley Bank, dated as of February 26, 2016.
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;14.1*&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Sensus Healthcare, Inc. Code of Ethics.
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;21.1*&nbsp;
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Subsidiaries.
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;23.1&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Consent of Marcum LLP.
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;23.2&nbsp;&nbsp;
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Consent of Gunster, Yoakley &amp; Stewart, P.A.&nbsp;&#151;&nbsp;included in Exhibit 5.1.
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: CENTER" ROWSPAN=1 COLSPAN=1>
	&nbsp;24.1*&nbsp;
</TD>
<TD STYLE="WIDTH: 12PX; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; BORDER-BOTTOM: NONE" ROWSPAN=1>
<!-- GUTTER -->
	&nbsp;
</TD>
<TD ROWSPAN=1 COLSPAN=1 STYLE="TEXT-ALIGN: LEFT">
	Power of Attorney.
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 1PX">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/05/19/0001144204-16-103669_LINE.GIF" STYLE="WIDTH: 72PX; HEIGHT: 1PT">
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 1PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	*
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Previously filed.
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 1PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	+
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	Indicates a management contract or compensatory plan.
</TD>
</TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="TEXT-INDENT:0PX; TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; TEXT-TRANSFORM: NONE; PADDING-TOP: 3PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="FONT-WEIGHT: NORMAL; FONT-STYLE: NORMAL; LINE-HEIGHT: 12PT; FONT-SIZE: 10PT; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 1PX">
</TD>
<TD STYLE="WIDTH: 20PX; TEXT-ALIGN: LEFT">
	#
</TD>
<TD STYLE="TEXT-ALIGN: LEFT">
	The Registrant has sought confidential treatment with respect to certain portions of this exhibit which has been submitted separately to the Securities and Exchange Commission.
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="WIDTH: 708PX; TEXT-INDENT:0PX; TEXT-ALIGN: CENTER; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; FONT-SIZE: 10PT; LINE-HEIGHT: 12PT; FONT-STYLE: NORMAL; FONT-VARIANT: NORMAL; FONT-WEIGHT: NORMAL; COLOR: BLACK; TEXT-TRANSFORM: NONE; TEXT-DECORATION: NONE; PADDING-TOP: 12PT; PADDING-RIGHT: 0PT; PADDING-LEFT: 0PT; PADDING-BOTTOM: 3PT; MARGIN-TOP: 0PT; MARGIN-RIGHT: 0PT; MARGIN-LEFT: 0PT; MARGIN-BOTTOM: 0PT">
	II-7
</P>
<HR ALIGN="LEFT" STYLE="WIDTH: 708PX; HEIGHT: 2PX; TEXT-ALIGN: CENTER">
</EFX_EXHIBIT_INDEX>
</DIV>
</B>
</B>
</B>
</B>
</B>
</B>
</B>
</B>
</B>
</B>
</B>
</B>
</B>
</B>
</B>
</B>
</B>
</B>
</I>
</I>
</I>
</I>
</I>
</I>
</I>
</I>
</I>
</I>
</I>
</I>
</I>
</I>
</I>
</I>
</I>
</I>
</EFX_FORM>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage148"></A>
<A NAME="V440371_EX1-1_HTM"></A>
<EFX_EXHIBIT_1>
<A NAME="FIS_EXHIBIT_1"></A>
<P STYLE="MARGIN: 0; TEXT-ALIGN: RIGHT">
<B>
	&nbsp;
</B>
</P>
<P STYLE="MARGIN: 0; TEXT-ALIGN: RIGHT">
<B>
	Exhibit 1.1
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN-TOP: 0; MARGIN-BOTTOM: 0; TEXT-ALIGN: CENTER">
<B>
	&nbsp;
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN-TOP: 0; MARGIN-BOTTOM: 0; TEXT-ALIGN: CENTER">
<B>
	FORM OF
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN-TOP: 0; MARGIN-BOTTOM: 0; TEXT-ALIGN: CENTER">
<B>
	&nbsp;
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN-TOP: 0; MARGIN-BOTTOM: 0; TEXT-ALIGN: CENTER">
<B>
	UNDERWRITING AGREEMENT
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN-TOP: 0; MARGIN-BOTTOM: 0; TEXT-ALIGN: CENTER">
<B>
	&nbsp;
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN-TOP: 0; MARGIN-BOTTOM: 0; TEXT-ALIGN: CENTER">
<B>
	between
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN-TOP: 0; MARGIN-BOTTOM: 0; TEXT-ALIGN: CENTER">
<B>
	&nbsp;
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN-TOP: 0; MARGIN-BOTTOM: 0; TEXT-ALIGN: CENTER">
<B>
	SENSUS HEALTHCARE, INC.
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN-TOP: 0; MARGIN-BOTTOM: 0; TEXT-ALIGN: CENTER">
<B>
	&nbsp;
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN-TOP: 0; MARGIN-BOTTOM: 0; TEXT-ALIGN: CENTER">
<B>
	and
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN-TOP: 0; MARGIN-BOTTOM: 0; TEXT-ALIGN: CENTER">
<B>
	&nbsp;
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN-TOP: 0; MARGIN-BOTTOM: 0; TEXT-ALIGN: CENTER">
<B>
	NORTHLAND SECURITIES, INC.
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN-TOP: 0; MARGIN-BOTTOM: 0; TEXT-ALIGN: CENTER">
<B>
	&nbsp;
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN-TOP: 0; MARGIN-BOTTOM: 0; TEXT-ALIGN: CENTER">
<B>
	and
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN-TOP: 0; MARGIN-BOTTOM: 0; TEXT-ALIGN: CENTER">
<B>
	&nbsp;
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN-TOP: 0; MARGIN-BOTTOM: 0; TEXT-ALIGN: CENTER">
<B>
	NEIDIGER, TUCKER, BRUNER, INC.
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN-TOP: 0; MARGIN-BOTTOM: 0; TEXT-ALIGN: CENTER">
<B>
	&nbsp;
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN-TOP: 0; MARGIN-BOTTOM: 0; TEXT-ALIGN: CENTER">
<B>
	as Representatives of the Several Underwriters
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<B>
	&nbsp;
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 1 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<A NAME="eolPage149"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<B>
	&nbsp;
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<B>
	SENSUS HEALTHCARE, INC.
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER; TEXT-INDENT: 0.5IN">
<B>
	&nbsp;
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<B>
<U>
	UNDERWRITING AGREEMENT
</U>
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: RIGHT; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: RIGHT">
	New York, New York
<BR>
	[&bull;], 2016
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	Northland Securities, Inc.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	750 Fifth Avenue, Suite 2401
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	New York, NY 10017
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	and
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	Neidiger, Tucker, Bruner, Inc.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	9540 South Maroon Circle, Suite 250
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	Englewood, CO 90112
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	As Representatives of the several Underwriters named on Schedule
	1 attached hereto
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	Ladies and Gentlemen:
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	The undersigned, Sensus
	Healthcare, Inc., a corporation formed under the laws of the State of Delaware (collectively with its predecessor, Sensus Healthcare,
	LLC, the &ldquo;
<B>
	Company
</B>
	&rdquo;), hereby confirms its agreement (this &ldquo;
<B>
	Agreement
</B>
	&rdquo;) with Northland Securities,
	Inc. and Neidiger, Tucker, Bruner, Inc. (hereinafter referred to as &ldquo;you&rdquo; (including its correlatives) or the &ldquo;
<B>
	Representatives
</B>
	&rdquo;)
	and with the other underwriters named on
<U>
	Schedule 1
</U>
	hereto for which the Representatives are acting as representative (the
	Representatives and such other underwriters being collectively called the &ldquo;
<B>
	Underwriters
</B>
	&rdquo; or, individually, an
	&ldquo;
<B>
	Underwriter
</B>
	&rdquo;) as follows:
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: -0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: -0.5IN">
	1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Purchase
	and Sale of Securities
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	1.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<I>
<U>
	Firm
	Units
</U>
	.
</I>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	1.1.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Nature
	and Purchase of Firm Units
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1.5IN">
	(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
	the basis of the representations and warranties herein contained, but subject to the terms and conditions herein set forth, the
	Company agrees to issue and sell to the several Underwriters, an aggregate of [&bull;] units (each a &ldquo;Unit&rdquo; and collectively,
	the &ldquo;Units&rdquo;), each consisting of one share of the Company&rsquo;s common stock (the &ldquo;Common Stock&rdquo;), par
	value $0.01 per share (the &ldquo;Firm Shares&rdquo;) and one warrant (each a &ldquo;Firm Warrant&rdquo; and collectively, the
	&ldquo;Firm Warrants&rdquo;) to purchase one share of Common Stock (collectively, the &ldquo;Firm Units&rdquo;). The Common Stock
	that is issuable upon the exercise of either the Firm Warrants or the Option Warrants (as defined below) to be issued in this offering
	shall be referred to herein as the &ldquo;Warrant Shares.&rdquo;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1.5IN">
	(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
	Underwriters, severally and not jointly, agree to purchase from the Company the number of Firm Units set forth opposite their respective
	names on
<U>
	Schedule 1
</U>
	attached hereto and made a part hereof at a purchase price of $[&bull;] per unit (93% of the per Firm
	Unit public offering price), $[__] attributable to the share and $[__] attributable to the warrant. The Firm Units are to be offered
	initially to the public at the offering price set forth on the cover page of the Prospectus (as defined in Section 2.1.1 hereof).
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	1.1.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Payment
	and Delivery
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1.5IN">
	(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delivery
	and payment for the Firm Units shall be made at 10:00 a.m., Eastern time, on the third (3rd) Business Day following the effective
	date (the &ldquo;Effective Date&rdquo;) of the Registration Statement (as defined in Section 2.1.1 below) (or the fourth (4th)
	Business Day following the Effective Date if the Registration Statement is declared effective after 4:01 p.m., Eastern time) or
	at such earlier time as shall be agreed upon by the Representatives and the Company, at the offices of Mintz, Levin, Cohn, Ferris,
	Glovsky and Popeo, P.C., Chrysler Center, 666 Third Avenue, New York, NY 10017 (&ldquo;Representatives&rsquo; Counsel&rdquo;),
	or at such other place (or remotely by facsimile or other electronic transmission) as shall be agreed upon by the Representatives
	and the Company. The hour and date of delivery and payment for the Firm Units is called the &ldquo;Closing Date.&rdquo;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 2 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<A NAME="eolPage150"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1.5IN">
	(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment
	for the Firm Units shall be made on the Closing Date by wire transfer in federal (same day) funds, payable to the order of the
	Company upon delivery of the certificates (in form and substance satisfactory to the Underwriters) representing the Firm Units
	(or through the facilities of the Depository Trust Company (&ldquo;DTC&rdquo;)) for the account of the Underwriters. The Firm Units
	shall be registered in such name or names and in such authorized denominations as the Representatives may request in writing at
	least two (2) full Business Days prior to the Closing Date. The Company shall not be obligated to sell or deliver the Firm Units
	except upon tender of payment by the Representatives for all of the Firm Units. The term &ldquo;Business Day&rdquo; means any day
	other than a Saturday, a Sunday or a legal holiday or a day on which banking institutions are authorized or obligated by law to
	close in New York, New York.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	1.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<I>
<U>
	Over-allotment
	Option
</U>
	.
</I>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	1.2.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Option
	Units
</U>
	. For the purposes of covering any over-allotments in connection with the distribution and sale of the Firm Units, the
	Company hereby grants to the Underwriters an option to purchase up to [&bull;] additional Units, each consisting of one share of
	Common Stock (the &ldquo;Option Shares&rdquo;) and one warrant (the &ldquo;Option Warrants&rdquo;) to purchase one share of Common
	Stock, representing fifteen percent (15%) of the Firm Units sold in the offering, from the Company (the &ldquo;Over-allotment Option&rdquo;).
	Such [&bull;] additional Units, the net proceeds of which will be deposited with the Company&rsquo;s account, are hereinafter referred
	to as &ldquo;Option Units.&rdquo; The purchase price to be paid per Option Unit shall be equal to the price per Firm Unit set forth
	in Section 1.1.1 hereof. The Firm Units, the Firm Shares, the Firm Warrants, the Option Units, the Option Shares, the Option Warrants
	and the Warrant Shares are hereinafter referred to together as the &ldquo;Public&nbsp;Securities.&rdquo; The offering and sale
	of the Public Securities is hereinafter referred to as the &ldquo;Offering.&rdquo; For the purpose of this Agreement, the term
	&ldquo;Separation Date&rdquo; shall mean the earlier of (i) the 52
<SUP>
	nd
</SUP>
	day after the Effective Date or (ii) such earlier
	date as may be specified in a notice provided by the Representatives to the Company.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	1.2.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Exercise
	of Option
</U>
	. The Over-allotment Option granted pursuant to Section 1.2.1 hereof may be exercised by the Representatives as to
	all (at any time) or any part (from time to time) of the Option Units within 45 days after the Effective Date, but in no event
	after the Separation Date. The Underwriters shall not be under any obligation to purchase any Option Units prior to the exercise
	of the Over-allotment Option. The Over-allotment Option granted hereby may be exercised by the giving of oral notice to the Company
	from the Representatives, which must be confirmed in writing by overnight mail or facsimile or other electronic transmission setting
	forth the number of Option Units to be purchased and the date and time for delivery of and payment for the Option Units (the &ldquo;Option
	Closing Date&rdquo;), which shall not be later than five (5) full Business Days after the date of the notice or such other time
	as shall be agreed upon by the Company and the Representatives, at the offices of Representatives&rsquo; Counsel or at such other
	place (including remotely by facsimile or other electronic transmission) as shall be agreed upon by the Company and the Representatives.
	If such delivery and payment for the Option Units does not occur on the Closing Date, the Option Closing Date will be as set forth
	in the notice. Upon exercise of the Over-allotment Option with respect to all or any portion of the Option Units, subject to the
	terms and conditions set forth herein, (i) the Company shall become obligated to sell to the Underwriters the number of Option
	Units specified in such notice and (ii) each of the Underwriters, acting severally and not jointly, shall purchase that portion
	of the total number of Option Units then being purchased as set forth in
<U>
	Schedule 1
</U>
	opposite the name of such Underwriter.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	1.2.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Payment
	and Delivery
</U>
	. Payment for the Option Units shall be made on the Option Closing Date by wire transfer in federal (same day)
	funds, payable to the order of the Company upon delivery to you of certificates (in form and substance satisfactory to the Underwriters)
	representing the Option Units (or through the facilities of DTC) for the account of the Underwriters. The Option Units shall be
	registered in such name or names and in such authorized denominations as the Representatives may request in writing at least one
	(1) full Business Day prior to the Option Closing Date. The Company shall not be obligated to sell or deliver the Option Units
	except upon tender of payment by the Representatives for applicable Option Units. The Option Closing Date may be simultaneous with,
	but not earlier than, the Closing Date.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 3; OPTIONS: NEWSECTION; VALUE: 2 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	2
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage151"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	1.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<I>
<U>
	Representatives&rsquo;
	Warrants
</U>
	.
</I>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	1.3.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Purchase
	Warrants
</U>
	. The Company hereby agrees to issue and sell to the Representatives (and/or their designees) on the Closing
	Date a warrant (&ldquo;Representatives&rsquo; Warrant&rdquo;) for the purchase of Units, each consisting of one share of
	Common Stock and one warrant to purchase one share of Common Stock, representing 6% of the Firm Units and Option Units sold
	in this Offering. The Representatives&rsquo; Warrant, in the form attached hereto as
<U>
	Exhibit&nbsp;A
</U>
	(the
	&ldquo;Representatives&rsquo; Warrant Agreement&rdquo;), shall be exercisable, in whole or in part, commencing on a date
	which is one (1) year after the Effective Date and expiring on the five-year anniversary of the Effective Date at an initial
	exercise price per Unit of $[___], which is equal to the exercise price of the Firm Warrants. Other than the expiration date
	and the exercise date, the warrants issuable upon the exercise of the Representative&rsquo;s Warrants will be substantially
	similar to the Firm Warrants to be issued in the Offering. The Representatives&rsquo; Warrant and the Units, the
	shares of Common Stock and the warrants issuable upon exercise thereof, including the shares of Common Stock underlying the
	warrants, are hereinafter referred to together as the &ldquo;Representatives&rsquo; Securities.&rdquo; The Representatives
<B>
</B>
	understand
	and agree that there are significant restrictions pursuant to FINRA Rule 5110 against transferring the Representatives&rsquo;
	Warrant Agreement and the underlying securities during the one hundred eighty (180) days after the Effective Date and by
	their acceptance thereof shall agree that they will not sell, transfer, assign, pledge or hypothecate the
	Representatives&rsquo; Warrant Agreement, or any portion thereof, or be the subject of any hedging, short sale, derivative,
	put or call transaction that would result in the effective economic disposition of such securities for a period of one
	hundred eighty (180) days following the Effective Date to anyone other than (i) an Underwriter or a selected dealer in
	connection with the Offering, or (ii) a bona fide officer or partner of the Underwriters
<B>
</B>
	or of any such Underwriter or
	selected dealer; and only if any such transferee agrees to the foregoing lock-up restrictions.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	1.3.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Delivery
</U>
	.
	Delivery of the Representatives&rsquo; Warrant Agreement shall be made on the Closing Date and shall be issued in the name or names
	and in such authorized denominations as the Representatives may request.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY">
	2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Representations
	and Warranties of the Company
</U>
	. The Company represents and warrants to the Underwriters as of the Applicable Time (as defined
	below), as of the Closing Date and as of the Option Closing Date, if any, as follows:
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<I>
<U>
	Filing
	of Registration Statement
</U>
	.
</I>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	2.1.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Pursuant
	to the Securities Act
</U>
	. The Company has filed with the U.S. Securities and Exchange Commission (the &ldquo;Commission&rdquo;)
	a registration statement, and an amendment or amendments thereto, on Form S-1 (File No. 333-209451), including any related prospectus
	or prospectuses, for the registration of the Public Securities and the Representatives&rsquo; Securities under the Securities Act
	of 1933, as amended (the &ldquo;Securities Act&rdquo;), which registration statement and amendment or amendments have been prepared
	by the Company in all material respects in conformity with the requirements of the Securities Act and the rules and regulations
	of the Commission under the Securities Act (the &ldquo;Securities Act Regulations&rdquo;) and will contain all material statements
	that are required to be stated therein in accordance with the Securities Act and the Securities Act Regulations. Except as the
	context may otherwise require, such registration statement, as amended, on file with the Commission at the time the registration
	statement became effective (including the Preliminary Prospectus included in the registration statement, financial statements,
	schedules, exhibits and all other documents filed as a part thereof or incorporated therein and all information deemed to be a
	part thereof as of the Effective Date pursuant to paragraph (b) of Rule 430A of the Securities Act Regulations (the &ldquo;Rule
	430A Information&rdquo;)), is referred to herein as the &ldquo;Registration Statement.&rdquo; If the Company files any registration
	statement pursuant to Rule 462(b) of the Securities Act Regulations, then after such filing, the term &ldquo;Registration Statement&rdquo;
	shall include such registration statement filed pursuant to Rule 462(b). The Registration Statement has been declared effective
	by the Commission on the date hereof.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	Each prospectus used prior
	to the effectiveness of the Registration Statement, and each prospectus that omitted the Rule 430A Information that was used after
	such effectiveness and prior to the execution and delivery of this Agreement, is herein called a &ldquo;Preliminary Prospectus.&rdquo;
	The Preliminary Prospectus, subject to completion, dated [&bull;], 2016, that was included in the Registration Statement immediately
	prior to the Applicable Time is hereinafter called the &ldquo;Pricing Prospectus.&rdquo; The final prospectus in the form first
	furnished to the Underwriters for use in the Offering is hereinafter called the &ldquo;Prospectus.&rdquo; Any reference to the
	&ldquo;most recent Preliminary Prospectus&rdquo; shall be deemed to refer to the latest Preliminary Prospectus included in the
	Registration Statement.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 4; VALUE: 2 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	3
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage152"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&ldquo;Applicable Time&rdquo;
	means [TIME] [a.m./p.m.], Eastern time, on the date of this Agreement.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&ldquo;Issuer Free Writing
	Prospectus&rdquo; means any &ldquo;issuer free writing prospectus,&rdquo; as defined in Rule 433 of the Securities Act Regulations
	(&ldquo;Rule 433&rdquo;) relating to the Public Securities, including without limitation any &ldquo;free writing prospectus&rdquo;
	(as defined in Rule 405 of the Securities Act Regulations) relating to the Public Securities that is (i)&nbsp;required to be filed
	with the Commission by the Company, (ii)&nbsp;a &ldquo;road show that is a written communication&rdquo; within the meaning of Rule
	433(d)(8)(i), whether or not required to be filed with the Commission, or (iii)&nbsp;exempt from filing with the Commission pursuant
	to Rule 433(d)(5)(i) because it contains a description of the Public Securities or of the Offering that does not reflect the final
	terms, in each case in the form filed or required to be filed with the Commission or, if not required to be filed, in the form
	retained in the Company&rsquo;s records pursuant to Rule 433(g).
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&ldquo;Issuer General Use
	Free Writing Prospectus&rdquo; means any Issuer Free Writing Prospectus that is intended for general distribution to prospective
	investors (other than a &ldquo;
<I>
	bona fide
</I>
	electronic road show,&rdquo; as defined in Rule 433 (the &ldquo;Bona Fide Electronic
	Road Show&rdquo;)), as evidenced by its being specified in
<U>
	Schedule 2-B
</U>
	hereto.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&ldquo;Issuer Limited Use
	Free Writing Prospectus&rdquo; means any Issuer Free Writing Prospectus that is not an Issuer General Use Free Writing Prospectus.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&ldquo;Pricing Disclosure
	Package&rdquo; means any Issuer General Use Free Writing Prospectus issued at or prior to the Applicable Time, the Pricing Prospectus
	and the information included on
<U>
	Schedule 2-A
</U>
	hereto, all considered together.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	2.1.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Pursuant
	to the Exchange Act
</U>
	. The Company has filed with the Commission a Form 8-A (File Number 001-37714), as amended by a Form 8-A/A,
	providing for the registration pursuant to Section 12(b) under the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange
	Act&rdquo;), of the Units, the shares of Common Stock and the Warrants. The registration of the Units, the shares of Common Stock
	and the Warrants under the Exchange Act has been declared effective by the Commission on or prior to the date hereof. The Company
	has taken no action designed to, or likely to have the effect of, terminating the registration of the Units, the shares of Common
	Stock and the Warrants under the Exchange Act, nor has the Company received any notification that the Commission is contemplating
	terminating such registration.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Stock
	Exchange Listing
</U>
	. The Units, the shares of Common Stock and the Warrants have been approved for listing on The NASDAQ Capital
	Market (the &ldquo;Exchange&rdquo;), and the Company has taken no action designed to, or likely to have the effect of, delisting
	the Units, the shares of Common Stock and the Warrants from the Exchange, nor has the Company received any notification that the
	Exchange is contemplating terminating such listing except as described in the Registration Statement, the Pricing Disclosure Package
	and the Prospectus.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	No
	Stop Orders, etc
</U>
	. Neither the Commission nor, to the Company&rsquo;s knowledge, any state regulatory authority has issued any
	order preventing or suspending the use of the Registration Statement, any Preliminary Prospectus or the Prospectus or has instituted
	or, to the Company&rsquo;s knowledge, threatened to institute, any proceedings with respect to such an order. The Company has complied
	with each request (if any) from the Commission for additional information.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Disclosures
	in Registration Statement
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	2.4.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Compliance
	with Securities Act and 10b-5 Representation
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1.5IN">
	(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
	of the Registration Statement and any post-effective amendment thereto, at the time it became effective, complied in all material
	respects with the requirements of the Securities Act and the Securities Act Regulations. Each Preliminary Prospectus, including
	the prospectus filed as part of the Registration Statement as originally filed or as part of any amendment or supplement thereto,
	and the Prospectus, at the time each was filed with the Commission, complied in all material respects with the requirements of
	the Securities Act and the Securities Act Regulations. Each Preliminary Prospectus delivered to the Underwriters for use in connection
	with this Offering
<B>
</B>
	and the Prospectus was or will be identical to the electronically transmitted copies thereof filed with
	the Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 5; VALUE: 2 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	4
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage153"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1.5IN">
	(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
	the Registration Statement nor any amendment thereto, at its effective time, as of the Applicable Time, at the Closing Date or
	at any Option Closing Date (if any), contained, contains or will contain an untrue statement of a material fact or omitted, omits
	or will omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1.5IN">
	(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
	Pricing Disclosure Package, as of the Applicable Time, at the Closing Date or at any Option Closing Date (if any), did not, does
	not and will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the
	statements therein, in the light of the circumstances under which they were made, not misleading; and each Issuer Limited Use Free
	Writing Prospectus hereto does not conflict with the information contained in the Registration Statement, any Preliminary Prospectus,
	the Pricing Prospectus or the Prospectus, and each such Issuer Limited Use Free Writing Prospectus, as supplemented by and taken
	together with the Pricing Prospectus as of the Applicable Time, did not include an untrue statement of a material fact or omit
	to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were
	made, not misleading; provided, however, that this representation and warranty shall not apply to statements made or statements
	omitted in reliance upon and in conformity with written information furnished to the Company with respect to the Underwriters by
	the Representatives expressly for use in the Registration Statement, the Pricing Prospectus or the Prospectus or any amendment
	thereof or supplement thereto. The parties acknowledge and agree that such information provided by or on behalf of any Underwriter
	consists solely of the following disclosure contained in the &ldquo;Underwriting&rdquo; section of the Prospectus: the statements
	set forth in the &ldquo;Underwriting&rdquo; section of the Prospectus only insofar as such statements relate to the names and corresponding
	securities amounts set forth in the table of Underwriters and the amount of selling concession or to over-allotment and related
	activities that may be undertaken by the Underwriters and the sections relating to stabilization by the Underwriters and offer
	restrictions outside of the United States (the &ldquo;Underwriters&rsquo; Information&rdquo;); and
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1.5IN">
	(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
	the Prospectus nor any amendment or supplement thereto (including any prospectus wrapper), as of its issue date, at the time of
	any filing with the Commission pursuant to Rule 424(b), at the Closing Date or at any Option Closing Date, included, includes or
	will include an untrue statement of a material fact or omitted, omits or will omit to state a material fact necessary in order
	to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however,
	that this representation and warranty shall not apply to the&nbsp;Underwriters&rsquo; Information.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	2.4.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Disclosure
	of Agreements
</U>
	. The agreements and documents described in the Registration Statement, the Pricing Disclosure Package and the
	Prospectus conform in all material respects to the descriptions thereof contained therein and there are no agreements or other
	documents required by the Securities Act and the Securities Act Regulations to be described in the Registration Statement, the
	Pricing Disclosure Package and the Prospectus or to be filed with the Commission as exhibits to the Registration Statement, that
	have not been so described or filed. Each agreement or other instrument (however characterized or described) to which the Company
	is a party or by which it is or may be bound or affected and (i)&nbsp;that is referred to in the Registration Statement, the Pricing
	Disclosure Package and the Prospectus, or (ii)&nbsp;is material to the Company&rsquo;s business, has been duly authorized and validly
	executed by the Company, to the extent the agreement or other instrument is purported to be in effect, is in full force and effect
	in all material respects and is enforceable against the Company and, to the Company&rsquo;s knowledge, the other parties thereto,
	in accordance with its terms, except (x)&nbsp;as such enforceability may be limited by bankruptcy, insolvency, reorganization or
	similar laws affecting creditors&rsquo; rights generally, (y)&nbsp;as enforceability of any indemnification or contribution provision
	may be limited under the federal and state securities laws, and (z)&nbsp;that the remedy of specific performance and injunctive
	and other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any
	proceeding therefor may be brought. None of such agreements or instruments has been assigned by the Company, and neither the Company
	nor, to the Company&rsquo;s knowledge, any other party is in default thereunder and, to the Company&rsquo;s knowledge, no event
	has occurred that, with the lapse of time or the giving of notice, or both, would constitute a default thereunder. To the best
	of the Company&rsquo;s knowledge, performance by the Company of the material provisions of such agreements or instruments will
	not result in a violation of any existing applicable law, rule, regulation, judgment, order or decree of any governmental agency
	or court, domestic or foreign, having jurisdiction over the Company or any of its assets or businesses (each, a &ldquo;Governmental
	Entity&rdquo;), including, without limitation, those relating to environmental laws and regulations.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 6; VALUE: 2 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	5
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage154"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	2.4.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Prior
	Securities Transactions
</U>
	. No securities of the Company have been sold by the Company or by or on behalf of, or for the benefit
	of, any person or persons controlling, controlled by or under common control with the Company, except as disclosed in the Registration
	Statement, the Pricing Disclosure Package and the Preliminary Prospectus.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	2.4.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Regulations
</U>
	.
	The disclosures in the Registration Statement, the Pricing Disclosure Package and the Prospectus concerning the effects of federal,
	state, local and all foreign regulation on the Offering and the Company&rsquo;s business as currently contemplated are correct
	in all material respects and no other such regulations are required to be disclosed in the Registration Statement, the Pricing
	Disclosure Package and the Prospectus which are not so disclosed.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Changes
	After Dates in Registration Statement
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	2.5.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	No
	Material Adverse Change
</U>
	. Since the respective dates as of which information is given in the Registration Statement, the Pricing
	Disclosure Package and the Prospectus, except as otherwise specifically stated therein: (i)&nbsp;there has been no material adverse
	change in the financial position or results of operations of the Company, nor any change or development that, singularly or in
	the aggregate, would involve a material adverse change or reasonably be expected to have a material adverse change, in or affecting
	the condition (financial or otherwise), results of operations, business, assets or prospects of the Company (a &ldquo;Material
	Adverse Change&rdquo;); (ii)&nbsp;there have been no material transactions entered into by the Company, other than as contemplated
	pursuant to this Agreement; and (iii)&nbsp;no officer or director of the Company has resigned from any position with the Company.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	2.5.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Recent
	Securities Transactions, etc
</U>
	. Subsequent to the respective dates as of which information is given in the Registration Statement,
	the Pricing Disclosure Package and the Prospectus, and except as may otherwise be indicated or contemplated herein or disclosed
	in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company has not: (i)&nbsp;issued any securities
	or incurred any liability or obligation, direct or contingent, for borrowed money; or (ii)&nbsp;declared or paid any dividend or
	made any other distribution on or in respect to its capital stock.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Independent
	Accountants
</U>
	. To the knowledge of the Company, Marcum LLP (the &ldquo;Auditor&rdquo;), whose report is filed with the Commission
	as part of the Registration Statement, the Pricing Disclosure Package and the Prospectus, is an independent registered public accounting
	firm as required by the Securities Act and the Securities Act Regulations and the Public Company Accounting Oversight Board. The
	Auditor has not, during the periods covered by the financial statements included in the Registration Statement, the Pricing Disclosure
	Package and the Prospectus, provided to the Company any non-audit services, as such term is used in Section 10A(g) of the Exchange
	Act.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Financial
	Statements, etc
</U>
	. The financial statements, including the notes thereto and supporting schedules included in the Registration
	Statement, the Pricing Disclosure Package and the Prospectus, fairly present the financial position and the results of operations
	of the Company at the dates and for the periods to which they apply; and such financial statements have been prepared in conformity
	with U.S. generally accepted accounting principles (&ldquo;GAAP&rdquo;), consistently applied throughout the periods involved (provided
	that unaudited interim financial statements are subject to year-end audit adjustments that are not expected to be material in the
	aggregate and do not contain all footnotes required by GAAP); and the supporting schedules included in the Registration Statement
	present fairly the information required to be stated therein. Except as included therein, no historical or pro forma financial
	statements are required to be included in the Registration Statement, the Pricing Disclosure Package or the Prospectus under the
	Securities Act or the Securities Act Regulations. The pro forma and pro forma as adjusted financial information and the related
	notes, if any, included in the Registration Statement, the Pricing Disclosure Package and the Prospectus have been properly compiled
	and prepared in accordance with the applicable requirements of the Securities Act and the Securities Act Regulations and present
	fairly the information shown therein, and the assumptions used in the preparation thereof are reasonable and the adjustments used
	therein are appropriate to give effect to the transactions and circumstances referred to therein. All disclosures contained in
	the Registration Statement, the Pricing Disclosure Package or the Prospectus regarding &ldquo;non-GAAP financial measures&rdquo;
	(as such term is defined by the rules and regulations of the Commission), if any, comply with Regulation G of the Exchange Act
	and Item 10 of Regulation S-K of the Securities Act, to the extent applicable. Each of the Registration Statement, the Pricing
	Disclosure Package and the Prospectus discloses all material off-balance sheet transactions, arrangements, obligations (including
	contingent obligations), and other relationships of the Company with unconsolidated entities or other persons that may have a material
	current or future effect on the Company&rsquo;s financial condition, changes in financial condition, results of operations, liquidity,
	capital expenditures, capital resources, or significant components of revenues or expenses. Except as disclosed in the Registration
	Statement, the Pricing Disclosure Package and the Prospectus, (a) the Company has not incurred any material liabilities or obligations,
	direct or contingent, or entered into any material transactions other than in the ordinary course of business, (b) the Company
	has not declared or paid any dividends or made any distribution of any kind with respect to its capital stock, (c) there has not
	been any change in the capital stock of the Company, or, other than in the ordinary course of business, any grants under any stock
	compensation plan, and (d) there has not been any Material Adverse Change in the Company&rsquo;s long-term or short-term debt.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 7; VALUE: 2 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	6
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage155"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Authorized
	Capital; Options, etc
</U>
	. The Company had, at the date or dates indicated in the Registration Statement, the Pricing Disclosure
	Package and the Prospectus, the duly authorized, issued and outstanding capitalization as set forth therein. Based on the assumptions
	stated in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company will have on the Closing Date
	the adjusted stock capitalization set forth therein. Except as set forth in, or contemplated by, the Registration Statement, the
	Pricing Disclosure Package and the Prospectus, on the Effective Date, as of the Applicable Time and on the Closing Date and any
	Option Closing Date, there will be no stock options, warrants, or other rights to purchase or otherwise acquire any authorized,
	but unissued shares of Common Stock of the Company or any security convertible or exercisable into shares of Common Stock of the
	Company, or any contracts or commitments to issue or sell shares of Common Stock or any such options, warrants, rights or convertible
	securities.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Valid
	Issuance of Securities, etc.
</U>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	2.9.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Outstanding
	Securities
</U>
	. All issued and outstanding securities of the Company issued prior to the transactions contemplated by this Agreement
	have been duly authorized and validly issued and are fully paid and non-assessable; the holders thereof have no rights of rescission
	with respect thereto, and are not subject to personal liability solely by reason of being such holders; and none of such securities
	were issued in violation of the preemptive rights of any holders of any security of the Company or similar contractual rights granted
	by the Company. The authorized shares of Common Stock conform in all material respects to all statements relating thereto contained
	in the Registration Statement, the Pricing Disclosure Package and the Prospectus. The offers and sales of the Company&rsquo;s outstanding
	securities, including the outstanding shares of Common Stock were at all relevant times either registered under the Securities
	Act and the applicable state securities or &ldquo;blue sky&rdquo; laws or, based in part on the representations and warranties
	of the purchasers of such securites, exempt from such registration requirements.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	2.9.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Securities
	Sold Pursuant to this Agreement
</U>
	. The Public Securities and the Representatives&rsquo; Securities have been duly authorized
	for issuance and sale and, when issued and paid for, will be validly issued, fully paid and non-assessable; the holders thereof
	are not and will not be subject to personal liability solely by reason of being such holders; the Public Securities and the Representatives&rsquo;
	Securities are not and will not be subject to the preemptive rights of any holders of any security of the Company or similar contractual
	rights granted by the Company; and all corporate action required to be taken for the authorization, issuance and sale of the Public
	Securities and the Representatives&rsquo; Securities has been duly and validly taken. The Public Securities and the Representatives&rsquo;
	Securities conform in all material respects to all statements with respect thereto contained in the Registration Statement, the
	Pricing Disclosure Package and the Prospectus. All corporate action required to be taken for the authorization, issuance and sale
	of the Warrants and the Representatives&rsquo; Warrant Agreement has been duly and validly taken; the Representatives&rsquo; Securities
	issuable upon exercise of the Representatives&rsquo; Warrant have been duly authorized and reserved for issuance by all necessary
	corporate action on the part of the Company and when paid for and issued in accordance with the Warrant or the Representatives&rsquo;
	Warrant and the Representatives&rsquo; Warrant Agreement, as the case may be, such Warrant Shares or shares of Common Stock will
	be validly issued, fully paid and non-assessable; the holders thereof are not and will not be subject to personal liability solely
	by reason of being such holders; and such Warrant Shares and shares of Common Stock are not and will not be subject to the preemptive
	rights of any holders of any security of the Company or similar contractual rights granted by the Company.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 8; VALUE: 2 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	7
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage156"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Registration
	Rights of Third Parties
</U>
	. Except as set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus,
	no holders of any securities of the Company or any rights exercisable for or convertible or exchangeable into securities of the
	Company have the right to require the Company to register any such securities of the Company under the Securities Act or to include
	any such securities in a registration statement to be filed by the Company.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Validity
	and Binding Effect of Agreements
</U>
	. This Agreement, the Warrant Agreement dated as of the Closing Date between the Company and
	American Stock Transfer &amp; Trust Company, LLC, as Warrant Agent (the &ldquo;Warrant Agent&rdquo;) with respect to the Warrants,
	in the form attached hereto as
<U>
	Exhibit B
</U>
	(the &ldquo;Warrant Agreement&rdquo;), the Warrants and the Representatives&rsquo;
	Warrant Agreement have been duly and validly authorized by the Company, and, when executed and delivered, will constitute, the
	valid and binding agreements of the Company, enforceable against the Company in accordance with their respective terms, except:
	(i)&nbsp;as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors&rsquo;
	rights generally; (ii)&nbsp;as enforceability of any indemnification or contribution provision may be limited under the federal
	and state securities laws; and (iii)&nbsp;that the remedy of specific performance and injunctive and other forms of equitable relief
	may be subject to the equitable defenses and to the discretion of the court before which any proceeding therefor may be brought.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	No
	Conflicts, etc
</U>
	. The execution, delivery and performance by the Company of this Agreement, the Warrant Agreement, the Representatives&rsquo;
	Warrant Agreement, the Warrants and all ancillary documents, the consummation by the Company of the transactions herein and therein
	contemplated and the compliance by the Company with the terms hereof and thereof do not and will not, with or without the giving
	of notice or the lapse of time or both: (i)&nbsp;result in a material breach of, or conflict with any of the terms and provisions
	of, or constitute a material default under, or result in the creation, modification, termination or imposition of any lien, charge
	or encumbrance upon any property or assets of the Company pursuant to the terms of any agreement or instrument to which the Company
	is a party; (ii)&nbsp;result in any violation of the provisions of the Company&rsquo;s Amended and Restated Certificate of Incorporation
	(as the same may be amended or restated from time to time, the &ldquo;Charter&rdquo;) or the by-laws of the Company; or (iii)&nbsp;violate
	any existing applicable law, rule, regulation, judgment, order or decree of any Governmental Entity as of the date hereof.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	No
	Defaults; Violations
</U>
	. No material default exists in the due performance and observance of any term, covenant or condition of
	any material license, contract, indenture, mortgage, deed of trust, note, loan or credit agreement, or any other agreement or instrument
	evidencing an obligation for borrowed money, or any other material agreement or instrument to which the Company is a party or by
	which the Company may be bound or to which any of the properties or assets of the Company is subject. The Company is not in violation
	of any term or provision of its Charter or by-laws, or in violation of any material franchise, license, permit, applicable law,
	rule, regulation, judgment or decree of any Governmental Entity.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Corporate
	Power; Licenses; Consents
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	2.14.1.&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Conduct
	of Business
</U>
	. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company
	has all requisite corporate power and authority, and has all necessary authorizations, approvals, orders, licenses, certificates
	and permits of and from all governmental regulatory officials and bodies that it needs as of the date hereof to conduct its business
	purpose as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	2.14.2.&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Transactions
	Contemplated Herein
</U>
	. The Company has all corporate power and authority to enter into each of this Agreement, the Warrant Agreement,
	the Representatives&rsquo; Warrant Agreement and the Warrants and to carry out the provisions and conditions hereof and thereof,
	and all consents, authorizations, approvals and orders required in connection therewith have been obtained. No consent, authorization
	or order of, and no filing with, any court, government agency or other body is required for the valid issuance, sale and delivery
	of the Public Securities and the consummation of the transactions and agreements contemplated by this Agreement, the Warrant Agreement,
	the Representatives&rsquo; Warrant Agreement and the Warrants and as contemplated by the Registration Statement, the Pricing Disclosure
	Package and the Prospectus, except with respect to applicable federal and state securities laws and the rules and regulations of
	the Financial Industry Regulatory Authority, Inc. (&ldquo;FINRA&rdquo;).
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 9; VALUE: 2 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	8
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage157"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	D&amp;O
	Questionnaires
</U>
	. To the Company&rsquo;s knowledge, all information contained in the questionnaires (the &ldquo;Questionnaires&rdquo;)
	completed by each of the Company&rsquo;s directors and officers immediately prior to the Offering (the &ldquo;Insiders&rdquo;)
	as supplemented by all information concerning the Company&rsquo;s directors, officers and principal stockholders as described in
	the Registration Statement, the Pricing Disclosure Package and the Prospectus, as well as in the Lock-Up Agreement (as defined
	in Section 2.24 below), provided to the Underwriters, is true and correct in all material respects and the Company has not become
	aware of any information which would cause the information disclosed in the Questionnaires to become materially inaccurate and
	incorrect.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Litigation;
	Governmental Proceedings
</U>
	. There is no action, suit, proceeding, inquiry, arbitration, investigation, litigation or governmental
	proceeding pending or, to the Company&rsquo;s knowledge, threatened against, or involving the Company or, to the Company&rsquo;s
	knowledge, any executive officer or director that, if determined adversely to the Company, would reasonably be expected to result
	in a Material Adverse Change, which has not been disclosed in the Registration Statement, the Pricing Disclosure Package and the
	Prospectus or in connection with the Company&rsquo;s listing application for the listing of the Public Securities on the Exchange.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Good
	Standing
</U>
	. The Company has been duly organized and is validly existing as a corporation and is in good standing under the laws
	of the State of Delaware as of the date hereof, and is duly qualified to do business and is in good standing in each other jurisdiction
	in which its ownership or lease of property or the conduct of business requires such qualification, except where the failure to
	qualify, singularly or in the aggregate, would not have or reasonably be expected to result in a Material Adverse Change.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Insurance
</U>
	.
	The Company carries or is entitled to the benefits of insurance, with reputable insurers, in such amounts and covering such risks
	which the Company believes are adequate, including, but not limited to, directors and officers insurance coverage at least equal
	to $5,000,000 and all such insurance is in full force and effect. The Company has no reason to believe that it will not be able
	(i) to renew its existing insurance coverage as and when such policies expire or (ii) to obtain comparable coverage from similar
	institutions as may be necessary or appropriate to conduct its business as now conducted and at a cost that would not result in
	a Material Adverse Change.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Transactions
	Affecting Disclosure to FINRA
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	2.19.1.&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Finder&rsquo;s
	Fees
</U>
	. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, there are no claims,
	payments, arrangements, agreements or understandings relating to the payment of a finder&rsquo;s, consulting or origination fee
	by the Company or any Insider with respect to the sale of the Public Securities hereunder or any other arrangements, agreements
	or understandings of the Company or, to the Company&rsquo;s knowledge, any of its stockholders that may affect the Underwriters&rsquo;
	compensation, as determined by FINRA.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	2.19.2.&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Payments
	Within Twelve (12) Months
</U>
	. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus,
	the Company has not made any direct or indirect payments (in cash, securities or otherwise) to: (i)&nbsp;any person, as a finder&rsquo;s
	fee, consulting fee or otherwise, in consideration of such person raising capital for the Company or introducing to the Company
	persons who raised or provided capital to the Company; (ii) any FINRA member; or (iii)&nbsp;any person or entity that has any direct
	or indirect affiliation or association with any FINRA member, within the twelve (12) months prior to the Effective Date, other
	than the payment to the Underwriters as provided hereunder in connection with the Offering.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	2.19.3.&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Use
	of Proceeds
</U>
	. None of the net proceeds of the Offering will be paid by the Company to any participating FINRA member or its
	affiliates, except as specifically authorized herein.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	2.19.4.&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	FINRA
	Affiliation
</U>
	. There is no (i) officer or director of the Company, (ii) beneficial owner of 5% or more of any class of the Company's
	securities or (iii) beneficial owner of the Company's unregistered equity securities which were acquired during the 180-day period
	immediately preceding the filing of the Registration Statement that is an affiliate or associated person of a FINRA member participating
	in the Offering (as determined in accordance with the rules and regulations of FINRA).
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 10; VALUE: 2 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	9
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage158"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	2.19.5.&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Information
</U>
	.
	All information provided by the Company in its FINRA questionnaire to Representatives&rsquo; Counsel specifically for use by Representatives&rsquo;
	Counsel in connection with its Public Offering System filings (and related disclosure) with FINRA is true, correct and complete
	in all material respects.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Foreign
	Corrupt Practices Act
</U>
	. The Company or, to the Company&rsquo;s knowledge, any director, officer, agent, employee or affiliate
	of the Company or any other person acting on behalf of the Company, has not, directly or indirectly, given or agreed to give any
	money, gift or similar benefit (other than legal price concessions to customers in the ordinary course of business) to any customer,
	supplier, employee or agent of a customer or supplier, or official or employee of any governmental agency or instrumentality of
	any government (domestic or foreign) or any political party or candidate for office (domestic or foreign) or other person who was,
	is, or may be in a position to help or hinder the business of the Company (or assist it in connection with any actual or proposed
	transaction) that (i)&nbsp;would subject the Company to any damage or penalty in any civil, criminal or governmental litigation
	or proceeding, (ii)&nbsp;if not given in the past, would reasonably be expected to have a Material Adverse Change or (iii)&nbsp;if
	not continued in the future, would reasonably be expected to adversely affect the assets, business, operations or prospects of
	the Company. The Company has taken reasonable steps to ensure that its accounting controls and procedures are sufficient to cause
	the Company to comply in all material respects with the Foreign Corrupt Practices Act of 1977, as amended.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.21&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Compliance
	with OFAC
</U>
	. The Company or, to the Company&rsquo;s knowledge, any director, officer, agent, employee or affiliate of the Company
	or any other person acting on behalf of the Company, is currently subject to any U.S. sanctions administered by the Office of Foreign
	Assets Control of the U.S. Department of the Treasury (&ldquo;OFAC&rdquo;), and the Company will not, directly or indirectly, use
	the proceeds of the Offering hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint
	venture partner or other person or entity, for the purpose of financing the activities of any person currently subject to any U.S.
	sanctions administered by OFAC.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.22&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Money
	Laundering Laws
</U>
	. The operations of the Company are and have been conducted at all times in compliance with applicable financial
	recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money
	laundering statutes of all jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or
	guidelines, issued, administered or enforced by any Governmental Entity (collectively, the &ldquo;Money Laundering Laws&rdquo;);
	and no action, suit or proceeding by or before any Governmental Entity involving the Company with respect to the Money Laundering
	Laws is pending or, to the best knowledge of the Company, threatened.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.23&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Officers&rsquo;
	Certificate
</U>
	. Any certificate signed by any duly authorized officer of the Company and delivered to you or to Representatives&rsquo;
	Counsel shall be deemed a representation and warranty by the Company to the Underwriters as to the matters covered thereby.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.24&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Lock-Up
	Agreements.
</U>
<U>
	Schedule 3
</U>
	hereto contains a complete and accurate list of the Company&rsquo;s officers, directors and each
	owner of the Company&rsquo;s outstanding shares of Common Stock (or securities convertible or exercisable into shares of Common
	Stock) who has executed a Lock-Up Agreement
<B>
<I>
</I>
</B>
	(collectively, the &ldquo;Lock-Up Parties&rdquo;). The Company has caused
	each of the Lock-Up Parties to deliver to the Representatives an executed Lock-Up Agreement, in the form attached hereto as
<U>
	Exhibit
	C
</U>
	(the &ldquo;Lock-Up Agreement&rdquo;), prior to the execution of this Agreement.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.25&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Subsidiaries
</U>
	.
	The Company does not control directly or indirectly, or have any direct or indirect equity or similar interest in, any corporation,
	partnership, limited liability company, joint venture or other business association or entity.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.26&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Related
	Party Transactions
</U>
	. There are no business relationships or related party transactions involving the Company or any other person
	required to be described in the Registration Statement, the Pricing Disclosure Package and the Prospectus that have not been described
	as required.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 11; VALUE: 2 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	10
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage159"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.27&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Board
	of Directors
</U>
	. The Board of Directors of the Company is comprised of the persons set forth under the heading of the Pricing
	Prospectus and the Prospectus captioned &ldquo;Management.&rdquo; The qualifications of the persons serving as board members and
	the overall composition of the board comply with the Exchange Act, the Exchange Act Regulations, the Sarbanes-Oxley Act of 2002
	and the rules promulgated thereunder (the &ldquo;Sarbanes-Oxley Act&rdquo;) applicable to the Company and the listing rules of
	the Exchange. At least one member of the Audit Committee of the Board of Directors of the Company qualifies as an &ldquo;audit
	committee financial expert,&rdquo; as such term is defined under Regulation S-K and the listing rules of the Exchange. In addition,
	at least a majority of the persons serving on the Board of Directors qualify as &ldquo;independent,&rdquo; as defined under the
	listing rules of the Exchange.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.28&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Sarbanes-Oxley
	Compliance
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	2.28.1.&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Disclosure
	Controls
</U>
	. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15
	or 15d-15 under the Exchange Act Regulations, and such controls and procedures are effective to ensure that all material information
	concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company&rsquo;s
	Exchange Act filings and other public disclosure documents.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	2.28.2.&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Compliance
</U>
	.
	The Company is, or at the Applicable Time and on the Closing Date will be, in material compliance with the provisions of the Sarbanes-Oxley
	Act applicable to it, and has implemented or will implement such programs and taken reasonable steps to ensure the Company&rsquo;s
	future compliance (not later than the relevant statutory and regulatory deadlines therefor) with all of the material provisions
	of the Sarbanes-Oxley Act.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.29&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Accounting
	Controls
</U>
	. The Company maintains systems of &ldquo;internal control over financial reporting&rdquo; (as defined under Rules
	13a-15 and 15d-15 under the Exchange Act Regulations) that comply with the requirements of the Exchange Act and have been designed
	by, or under the supervision of, its principal executive and principal financial officers, or persons performing similar functions,
	to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for
	external purposes in accordance with GAAP, including, but not limited to, internal accounting controls sufficient to provide reasonable
	assurance that (i) transactions are executed in accordance with management&rsquo;s general or specific authorizations; (ii) transactions
	are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability;
	(iii) access to assets is permitted only in accordance with management&rsquo;s general or specific authorization; and (iv) the
	recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken
	with respect to any differences. Except as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus,
	the Company is not aware of any material weaknesses in its internal controls. The Company&rsquo;s auditors and the Audit Committee
	of the Board of Directors of the Company have been advised of: (i) all significant deficiencies and material weaknesses in the
	design or operation of internal controls over financial reporting which are known to the Company&rsquo;s management and that have
	adversely affected or are reasonably likely to adversely affect the Company&rsquo; ability to record, process, summarize and report
	financial information; and (ii) any fraud known to the Company&rsquo;s management, whether or not material, that involves management
	or other employees who have a significant role in the Company&rsquo;s internal controls over financial reporting.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.30&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	No
	Investment Company Status
</U>
	. The Company is not and, after giving effect to the Offering and the application of the proceeds
	thereof as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, will not be, required to
	register as an &ldquo;investment company,&rdquo; as defined in the Investment Company Act of 1940, as amended.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.31&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	No
	Labor Disputes
</U>
	. No labor dispute with the employees of the Company exists or, to the knowledge of the Company, is imminent.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 12; VALUE: 2 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	11
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage160"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.32&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Intellectual
	Property Rights
</U>
	. The Company owns or possesses or has valid rights to use all patents, patent applications, trademarks, service
	marks, trade names, trademark registrations, service mark registrations, copyrights, licenses, inventions, trade secrets and similar
	rights (&ldquo;Intellectual Property Rights&rdquo;) necessary for the conduct of the business of the Company as currently carried
	on and as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus. To the knowledge of the Company,
	no action or use by the Company necessary for the conduct of its business as currently carried on and as described in the Registration
	Statement and the Prospectus will involve or give rise to any infringement of, or license or similar fees for, any Intellectual
	Property Rights of others. The Company has not received any notice alleging any such infringement, fee or conflict with asserted
	Intellectual Property Rights of others. Except as would not reasonably be expected to result, individually or in the aggregate,
	in a Material Adverse Change (A) to the knowledge of the Company, there is no infringement, misappropriation or violation by third
	parties of any of the Intellectual Property Rights owned by the Company; (B) there is no pending or, to the knowledge of the Company,
	threatened action, suit, proceeding or claim by others challenging the rights of the Company in or to any such Intellectual Property
	Rights, and the Company is unaware of any facts which would form a reasonable basis for any such claim, that would, individually
	or in the aggregate, together with any other claims in this Section 2.32, reasonably be expected to result in a Material Adverse
	Change; (C) the Intellectual Property Rights owned by the Company and, to the knowledge of the Company, the Intellectual Property
	Rights licensed to the Company have not been adjudged by a court of competent jurisdiction invalid or unenforceable, in whole or
	in part, and there is no pending or, to the Company&rsquo;s knowledge, threatened action, suit, proceeding or claim by others challenging
	the validity or scope of any such Intellectual Property Rights, and the Company is unaware of any facts which would form a reasonable
	basis for any such claim that would, individually or in the aggregate, together with any other claims in this Section 2.32, reasonably
	be expected to result in a Material Adverse Change; (D) there is no pending or, to the Company&rsquo;s knowledge, threatened action,
	suit, proceeding or claim by others that the Company infringes, misappropriates or otherwise violates any Intellectual Property
	Rights or other proprietary rights of others, the Company has not received any written notice of such claim and the Company is
	unaware of any other facts which would form a reasonable basis for any such claim that would, individually or in the aggregate,
	together with any other claims in this Section 2.32, reasonably be expected to result in a Material Adverse Change; and (E) to
	the Company&rsquo;s knowledge, no employee of the Company is in or has ever been in violation in any material respect of any term
	of any employment contract, patent disclosure agreement, invention assignment agreement, non-competition agreement, non-solicitation
	agreement, nondisclosure agreement or any restrictive covenant to or with a former employer where the basis of such violation relates
	to such employee&rsquo;s employment with the Company, or actions undertaken by the employee while employed with the Company and
	could reasonably be expected to result, individually or in the aggregate, in a Material Adverse Change. To the Company&rsquo;s
	knowledge, all technical information developed by and belonging to the Company which is material to the Company&rsquo;s business
	and has not been patented has been kept confidential. The Company is not a party to or bound by any options, licenses or agreements
	with respect to the Intellectual Property Rights of any other person or entity that are required to be set forth in the Registration
	Statement, the Pricing Disclosure Package and the Prospectus and are not described therein. The Registration Statement, the Pricing
	Disclosure Package and the Prospectus contain in all material respects the same description of the matters set forth in the preceding
	sentence. None of the technology employed by the Company that is material to the Company&rsquo;s business has been obtained or
	is being used by the Company in violation of any contractual obligation binding on the Company or, to the Company&rsquo;s knowledge,
	any of its officers, directors or employees, or otherwise in violation of the rights of any persons.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.33&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Taxes
</U>
	.
	The Company has filed all returns (as hereinafter defined) required to be filed with taxing authorities prior to the date hereof
	or has duly obtained extensions of time for the filing thereof unless the failure to file such returns will not cause a Material
	Adverse Change. The Company has paid all taxes (as hereinafter defined) shown as due on such returns that were filed and has paid
	all taxes imposed on or assessed against the Company. The provisions for taxes payable, if any, shown on the financial statements
	filed with or as part of the Registration Statement are sufficient for all accrued and unpaid taxes, whether or not disputed, and
	for all periods to and including the dates of such consolidated financial statements. Except as disclosed in writing to the Underwriters,
	(i) no issues have been raised (and are currently pending) by any taxing authority in connection with any of the returns or taxes
	asserted as due from the Company, and (ii) no waivers of statutes of limitation with respect to the returns or collection of taxes
	have been given by or requested from the Company. The term &ldquo;taxes&rdquo; means all federal, state, local, foreign and other
	net income, gross income, gross receipts, sales, use, ad valorem, transfer, franchise, profits, license, lease, service, service
	use, withholding, payroll, employment, excise, severance, stamp, occupation, premium, property, windfall profits, customs, duties
	or other taxes, fees, assessments or charges of any kind whatever, together with any interest and any penalties, additions to tax
	or additional amounts with respect thereto. The term &ldquo;returns&rdquo; means all returns, declarations, reports, statements
	and other documents required to be filed in respect to taxes.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 13; VALUE: 2 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	12
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage161"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.34&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	ERISA
	Compliance
</U>
	. The Company and any &ldquo;employee benefit plan&rdquo; (as defined under the Employee Retirement Income Security
	Act of 1974, as amended, and the regulations and published interpretations thereunder (collectively, &ldquo;ERISA&rdquo;)) established
	or maintained by the Company or its &ldquo;ERISA Affiliates&rdquo; (as defined below) are in compliance in all material respects
	with ERISA. &ldquo;ERISA Affiliate&rdquo; means, with respect to the Company, any member of any group of organizations described
	in Sections 414(b),(c),(m) or (o) of the Internal Revenue Code of 1986, as amended, and the regulations and published interpretations
	thereunder (the &ldquo;Code&rdquo;) of which the Company is a member. No &ldquo;reportable event&rdquo; (as defined under ERISA)
	has occurred or is reasonably expected to occur with respect to any &ldquo;employee benefit plan&rdquo; established or maintained
	by the Company or any of its ERISA Affiliates. No &ldquo;employee benefit plan&rdquo; established or maintained by the Company
	or any of its ERISA Affiliates, if such &ldquo;employee benefit plan&rdquo; were terminated, would have any &ldquo;amount of unfunded
	benefit liabilities&rdquo; (as defined under ERISA). Neither the Company nor any of its ERISA Affiliates has incurred or reasonably
	expects to incur any material liability under (i) Title IV of ERISA with respect to termination of, or withdrawal from, any &ldquo;employee
	benefit plan&rdquo; or (ii) Sections 412, 4971, 4975 or 4980B of the Code. Each &ldquo;employee benefit plan&rdquo; established
	or maintained by the Company or any of its ERISA Affiliates that is intended to be qualified under Section 401(a) of the Code is
	so qualified and, to the knowledge of the Company, nothing has occurred, whether by action or failure to act, which would cause
	the loss of such qualification.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.35&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Compliance
	with Laws
</U>
	. The Company: (A) is and at all times has been in compliance with all statutes, rules, or regulations, including
	but not limited to those of the United States Food and Drug Administration (&ldquo;FDA&rdquo;), applicable to the ownership, testing,
	development, manufacture, packaging, processing, use, distribution, marketing, labeling, promotion, sale, offer for sale, storage,
	import, export or disposal of any product manufactured or distributed by the Company (&ldquo;Applicable Laws&rdquo;), except as
	could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Change; (B) has not received any
	warning letter, untitled letter or other correspondence or notice from the FDA or any other governmental authority alleging or
	asserting noncompliance with any Applicable Laws or any licenses, certificates, approvals, clearances, authorizations, permits
	and supplements or amendments thereto required by any such Applicable Laws (&ldquo;Authorizations&rdquo;); (C) possesses all material
	Authorizations and such Authorizations are valid and in full force and effect and the Company is not in material violation of any
	term of any such Authorizations; (D) has not received notice of any claim, action, suit, proceeding, hearing, enforcement, investigation,
	arbitration or other action from any governmental authority or third party alleging that any product operation or activity is in
	violation of any Applicable Laws or Authorizations and has no knowledge that any such governmental authority or third party is
	considering any such claim, litigation, arbitration, action, suit, investigation or proceeding; (E) has not received notice that
	any governmental authority has taken, is taking or intends to take action to limit, suspend, modify or revoke any Authorizations
	and has no knowledge that any such governmental authority is considering such action; (F) has filed, obtained, maintained or submitted
	all material reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments as required
	by any Applicable Laws or Authorizations and that all such reports, documents, forms, notices, applications, records, claims, submissions
	and supplements or amendments were complete and correct on the date submitted (or were corrected or supplemented by a subsequent
	submission); and (G) has not, either voluntarily or involuntarily, initiated, conducted, or issued or caused to be initiated, conducted
	or issued, any recall, market withdrawal or replacement, safety alert, post-sale warning, &ldquo;dear doctor&rdquo; letter, or
	other notice or action relating to the alleged lack of safety or efficacy of any product or any alleged product defect or violation
	and, to the Company&rsquo;s knowledge, no third party has initiated, conducted or intends to initiate any such notice or action.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.36&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Ineligible
	Issuer
</U>
	.&nbsp;At the time of filing the Registration Statement and any post-effective amendment thereto, at the time of effectiveness
	of the Registration Statement and any amendment thereto, at the earliest time thereafter that the Company or another offering participant
	made a bona fide offer (within the meaning of Rule 164(h)(2) of the Securities Act Regulations) of the Public Securities and at
	the date hereof, the Company was not and is not an &ldquo;ineligible issuer,&rdquo; as defined in Rule 405, without taking account
	of any determination by the Commission pursuant to Rule 405 that it is not necessary that the Company be considered an ineligible
	issuer.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 14; VALUE: 2 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	13
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage162"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.37&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Real
	Property
</U>
	. Except as set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company
	has good and marketable title in fee simple to, or have valid rights to lease or otherwise use, all items of real or personal property
	which are material to the business of the Company taken as a whole, in each case free and clear of all liens, encumbrances, security
	interests, claims and defects that do not, singly or in the aggregate, materially affect the value of such property and do not
	interfere with the use made and proposed to be made of such property by the Company; and all of the leases and subleases material
	to the business of the Company, considered as one enterprise, and under which the Company holds properties described in the Registration
	Statement, the Pricing Disclosure Package and the Prospectus, are in full force and effect, and the Company has not received any
	notice of any material claim of any sort that has been asserted by anyone adverse to the rights of the Company under any of the
	leases or subleases mentioned above, or affecting or questioning the rights of the Company to the continued possession of the leased
	or subleased premises under any such lease or sublease.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.38&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Environmental
	Laws
</U>
	. The Company is in compliance with all foreign, federal, state and local rules, laws and regulations relating to the use,
	treatment, storage and disposal of hazardous or toxic substances or waste and protection of health and safety or the environment
	which are applicable to their businesses (&ldquo;Environmental Laws&rdquo;), except where the failure to comply would not, singularly
	or in the aggregate, result in a Material Adverse Change. There has been no storage, generation, transportation, handling, treatment,
	disposal, discharge, emission, or other release of any kind of toxic or other wastes or other hazardous substances by, due to,
	or caused by the Company (or, to the Company&rsquo;s knowledge, any other entity for whose acts or omissions the Company is or
	may otherwise be liable) upon any of the property now or previously owned or leased by the Company, or upon any other property,
	in violation of any law, statute, ordinance, rule, regulation, order, judgment, decree or permit or which would, under any law,
	statute, ordinance, rule (including rule of common law), regulation, order, judgment, decree or permit, give rise to any liability,
	except for any violation or liability which would not have, singularly or in the aggregate with all such violations and liabilities,
	a Material Adverse Change; and there has been no disposal, discharge, emission or other release of any kind onto such property
	or into the environment surrounding such property of any toxic or other wastes or other hazardous substances with respect to which
	the Company has knowledge, except for any such disposal, discharge, emission, or other release of any kind which would not have,
	singularly or in the aggregate with all such discharges and other releases, a Material Adverse Change.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.39&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Contracts
	Affecting Capital
</U>
	. There are no transactions, arrangements or other relationships between and/or among the Company, any of
	its affiliates (as such term is defined in Rule 405 of the Securities Act Regulations) and any unconsolidated entity, including,
	but not limited to, any structured finance, special purpose or limited purpose entity that could reasonably be expected to materially
	affect the Company&rsquo;s liquidity or the availability of or requirements for their capital resources required to be described
	or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus which have not been
	described or incorporated by reference as required.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.40&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Loans
	to Directors or Officers
</U>
	. There are no outstanding loans, advances (except normal advances for business expenses in the ordinary
	course of business) or guarantees or indebtedness by the Company to or for the benefit of any of the officers or directors of the
	Company or any of their respective family members, except as disclosed in the Registration Statement, the Pricing Disclosure Package
	and the Prospectus.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.41&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Smaller
	Reporting Company
</U>
	.&nbsp;As of the time of filing of the Registration Statement, the Company was a &ldquo;smaller reporting
	company,&rdquo; as defined in Rule&nbsp;12b-2 of the Exchange Act Regulations.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.42&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Industry
	Data
</U>
	.&nbsp;The statistical and market-related data included in each of the Registration Statement, the Pricing Disclosure Package
	and the Prospectus are based on or derived from sources that the Company reasonably and in good faith believes are reliable and
	accurate or represent the Company&rsquo;s good faith estimates that are made on the basis of data derived from such sources.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.43&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Forward
	Stock Split
</U>
	. The Company has taken all necessary corporate action to effectuate a forward stock split of its shares of Common
	Stock on the basis of 241.95
<B>
<I>
</I>
</B>
	share for each one (1) issued and outstanding shares thereof (the &ldquo;Forward Stock
	Split&rdquo;), such Forward Stock Split to be effective no later than the first trading day of the Firm Units following the date
	hereof.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.44&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Emerging
	Growth Company
</U>
	. From the time of the initial confidential submission of the Registration Statement to the Commission (or, if
	earlier, the first date on which the Company engaged directly in or through any person authorized to act on its behalf in any Testing-the
	Waters Communication) through the date hereof, the Company has been and is an &ldquo;emerging growth company,&rdquo; as defined
	in Section 2(a) of the Securities Act (an &ldquo;Emerging Growth Company&rdquo;). &ldquo;Testing-the-Waters Communication&rdquo;
	means any oral or written communication with potential investors undertaken in reliance on Section 5(d) of the Securities Act.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 15; VALUE: 2 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	14
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage163"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.45&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Testing-the-Waters
	Communications
</U>
	. The Company has not (i) alone engaged in any Testing-the-Waters Communications, other than Testing-the-Waters
	Communications with the written consent of the Representatives and with entities that are qualified institutional buyers within
	the meaning of Rule 144A under the Securities Act or institutions that are accredited investors within the meaning of Rule 501
	under the Securities Act and (ii) authorized anyone other than the Representatives to engage in Testing-the-Waters Communications.
	The Company confirms that the Representatives have been authorized to act on its behalf in undertaking Testing-the-Waters Communications.
	The Company has not distributed any Written Testing-the-Waters Communications other than those listed on
<U>
	Schedule 2-C
</U>
	hereto.
	&ldquo;Written Testing-the-Waters Communication&rdquo; means any Testing-the-Waters Communication that is a written communication
	within the meaning of Rule 405 under the Securities Act.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.46&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Electronic
	Road Show
</U>
	. The Company has made available a Bona Fide Electronic Road Show in compliance with Rule&nbsp;433(d)(8)(ii) of the
	Securities Act Regulations such that no filing of any &ldquo;road show&rdquo; (as defined in Rule&nbsp;433(h) of the Securities
	Act Regulations) is required in connection with the Offering.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.47&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Margin
	Securities
</U>
	. The Company owns no &ldquo;margin securities&rdquo; as that term is defined in Regulation U of the Board of Governors
	of the Federal Reserve System (the &ldquo;Federal Reserve Board&rdquo;), and none of the proceeds of Offering will be used, directly
	or indirectly, for the purpose of purchasing or carrying any margin security, for the purpose of reducing or retiring any indebtedness
	which was originally incurred to purchase or carry any margin security or for any other purpose which might cause any of the Units,
	the shares of Common Stock, or the Warrants to be considered a &ldquo;purpose credit&rdquo; within the meanings of Regulation T,
	U or X of the Federal Reserve Board.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.48&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Minute
	Books
</U>
	. The minute books of the Company have been made available to the Representatives and Representatives&rsquo; Counsel,
	and such books (i) contain a complete summary of all meetings and actions of the board of directors (including each board committee)
	and stockholders of the Company (or analogous governing bodies and interest holders, as applicable), since the time of its respective
	incorporation or organization through the date of the latest meeting and action, and (ii) accurately in all material respects reflect
	all transactions referred to in such minutes. There are no material transactions, agreements, dispositions or other actions of
	the Company that are not properly approved and/or accurately and fairly recorded in the minute books of the Company, as applicable.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: -0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: -0.5IN">
	3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Covenants
	of the Company
</U>
	. The Company covenants and agrees as follows:
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	3.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Amendments
	to Registration Statement
</U>
	. The Company shall deliver to the Representatives, prior to filing, any amendment or supplement to
	the Registration Statement or Prospectus proposed to be filed after the Effective Date and not file any such amendment or supplement
	to which the Representatives shall reasonably object in writing.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	3.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Federal
	Securities Laws
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	3.2.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Compliance
</U>
	.
	The Company, subject to Section 3.2.2, shall comply with the requirements of Rule 430A of the Securities Act Regulations, and will
	notify the Representatives promptly, and confirm the notice in writing, (i)&nbsp;when any post-effective amendment to the Registration
	Statement shall become effective or any amendment or supplement to the Prospectus shall have been filed; (ii)&nbsp;of the receipt
	of any comments from the Commission; (iii)&nbsp;of any request by the Commission for any amendment to the Registration Statement
	or any amendment or supplement to the Prospectus or for additional information; (iv)&nbsp;of the issuance by the Commission of
	any stop order suspending the effectiveness of the Registration Statement or any post-effective amendment or of any order preventing
	or suspending the use of any Preliminary Prospectus or the Prospectus, or of the suspension of the qualification of the Public
	Securities, the Warrant Shares or the Representatives&rsquo; Securities for offering or sale in any jurisdiction, or of the initiation
	or threatening of any proceedings for any of such purposes or of any examination pursuant to Section&nbsp;8(d) or 8(e) of the Securities
	Act concerning the Registration Statement and (v)&nbsp;if the Company becomes the subject of a proceeding under Section&nbsp;8A
	of the Securities Act in connection with the Offering of the Public Securities, the Warrant Shares and the Representatives&rsquo;
	Securities. The Company shall effect all filings required under Rule 424(b) of the Securities Act Regulations, in the manner and
	within the time period required by Rule 424(b) (without reliance on Rule 424(b)(8)), and shall take such steps as it deems necessary
	to ascertain promptly whether the form of prospectus transmitted for filing under Rule 424(b) was received for filing by the Commission
	and, in the event that it was not, it will promptly file such prospectus. The Company shall use its best efforts to prevent the
	issuance of any stop order, prevention or suspension and, if any such order is issued, to obtain the lifting thereof at the earliest
	possible moment.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 16; VALUE: 2 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	15
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage164"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	3.2.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Continued
	Compliance
</U>
	. The Company shall comply with the Securities Act, the Securities Act Regulations, the Exchange Act and the Exchange
	Act Regulations so as to permit the completion of the distribution of the Public Securities as contemplated in this Agreement and
	in the Registration Statement, the Pricing Disclosure Package and the Prospectus. If at any time when a prospectus relating to
	the Public Securities is (or, but for the exception afforded by Rule 172 of the Securities Act Regulations (&ldquo;Rule 172&rdquo;),
	would be) required by the Securities Act to be delivered in connection with sales of the Public Securities, any event shall occur
	or condition shall exist as a result of which it is necessary, in the opinion of Representatives&rsquo; Counsel or for the Company,
	to (i)&nbsp;amend the Registration Statement in order that the Registration Statement will not include an untrue statement of a
	material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading;
	(ii)&nbsp;amend or supplement the Pricing Disclosure Package or the Prospectus in order that the Pricing Disclosure Package or
	the Prospectus, as the case may be, will not include any untrue statement of a material fact or omit to state a material fact necessary
	in order to make the statements therein not misleading in the light of the circumstances existing at the time it is delivered to
	a purchaser or (iii)&nbsp;amend the Registration Statement or amend or supplement the Pricing Disclosure Package or the Prospectus,
	as the case may be, in order to comply with the requirements of the Securities Act or the Securities Act Regulations, the Company
	will promptly (A)&nbsp;give the Representatives notice of such event; (B)&nbsp;prepare any amendment or supplement as may be necessary
	to correct such statement or omission or to make the Registration Statement, the Pricing Disclosure Package or the Prospectus comply
	with such requirements and, a reasonable amount of time prior to any proposed filing or use, furnish the Representatives with copies
	of any such amendment or supplement and (C)&nbsp;file with the Commission any such amendment or supplement; provided that the Company
	shall not file or use any such amendment or supplement to which the Representatives or Representatives&rsquo; Counsel shall reasonably
	object. The Company will furnish to the Underwriters such number of copies of such amendment or supplement as the Underwriters
	may reasonably request. The Company has given the Representatives notice of any filings made pursuant to the Exchange Act or the
	Exchange Act Regulations within 48 hours prior to the Applicable Time. The Company shall give the Representatives notice of its
	intention to make any such filing from the Applicable Time until the later of the Closing Date and the exercise in full or expiration
	of the Over-allotment Option specified in Section 1.2 hereof and will furnish the Representatives with copies of the related document(s)
	a reasonable amount of time prior to such proposed filing, as the case may be, and will not file or use any such document to which
	the Representatives or Representatives&rsquo; Counsel shall reasonably object.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	3.2.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Exchange
	Act Registration
</U>
	. For a period of three (3) years after the date of this Agreement, the Company shall use its best efforts
	to maintain the registration of the shares of Common Stock and the Warrants under the Exchange Act. The Company shall not deregister
	the Units, the shares of Common Stock or the Warrants under the Exchange Act without the prior written consent of the Representatives
	other than in connection with a merger or sale of the Company or similar business combination.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	3.2.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Free
	Writing Prospectuses
</U>
	. The Company agrees that, unless it obtains the prior written consent of the Representatives, it shall
	not make any offer relating to the Public Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise
	constitute a &ldquo;free writing prospectus,&rdquo; or a portion thereof, required to be filed by the Company with the Commission
	or retained by the Company under Rule 433; provided that the Representatives shall be deemed to have consented to each Issuer General
	Use Free Writing Prospectus hereto and any &ldquo;road show that is a written communication&rdquo; within the meaning of Rule 433(d)(8)(i)
	that has been reviewed by the Representatives. The Company represents that it has treated or agrees that it will treat each such
	free writing prospectus consented to, or deemed consented to, by the Underwriters as an &ldquo;issuer free writing prospectus,&rdquo;
	as defined in Rule 433, and that it has complied and will comply with the applicable requirements of Rule 433 with respect thereto,
	including timely filing with the Commission where required, legending and record keeping. If at any time following issuance of
	an Issuer Free Writing Prospectus there occurred or occurs an event or development as a result of which such Issuer Free Writing
	Prospectus conflicted or would conflict with the information contained in the Registration Statement or included or would include
	an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements
	therein, in the light of the circumstances existing at that subsequent time, not misleading, the Company will promptly notify the
	Underwriters and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct
	such conflict, untrue statement or omission.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 17; VALUE: 2 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	16
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage165"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	3.2.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Testing-the-Waters
	Communications
</U>
	. If at any time following the distribution of any Written Testing-the-Waters Communication there occurred or
	occurs an event or development as a result of which such Written Testing-the-Waters Communication included or would include an
	untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements
	therein, in the light of the circumstances existing at that subsequent time, not misleading, the Company shall promptly notify
	the Representatives and shall promptly amend or supplement, at its own expense, such Written Testing-the-Waters Communication to
	eliminate or correct such untrue statement or omission.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	3.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Delivery
	to the Underwriters of Registration Statements
</U>
	. The Company has delivered or made available or shall deliver or make available
	to the Representatives and Representatives&rsquo; Counsel without charge, signed copies of the Registration Statement as originally
	filed and each amendment thereto (including exhibits filed therewith) and signed copies of all consents and certificates of experts,
	and will also deliver to the Underwriters, without charge, a conformed copy of the Registration Statement as originally filed and
	each amendment thereto (without exhibits) for each of the Underwriters. The copies of the Registration Statement and each amendment
	thereto furnished to the Underwriters will be identical to the electronically transmitted copies thereof filed with the Commission
	pursuant to EDGAR, except to the extent permitted by Regulation S-T.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	3.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Delivery
	to the Underwriters of Prospectuses
</U>
	. The Company has delivered or made available or will deliver or make available to each
	Underwriter, without charge, as many copies of each Preliminary Prospectus as such Underwriter reasonably requested, and the Company
	hereby consents to the use of such copies for purposes permitted by the Securities Act. The Company will furnish to each Underwriter,
	without charge, during the period when a prospectus relating to the Public Securities is (or, but for the exception afforded by
	Rule 172, would be) required to be delivered under the Securities Act, such number of copies of the Prospectus (as amended or supplemented)
	as such Underwriter may reasonably request. The Prospectus and any amendments or supplements thereto furnished to the Underwriters
	will be identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent
	permitted by Regulation S-T.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	3.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Effectiveness
	and Events Requiring Notice to the Representatives
</U>
	. The Company shall use its best efforts to cause the Registration Statement
	to remain effective with a current prospectus for at least nine (9) months after the Applicable Time, and shall notify the Representatives
	immediately and confirm the notice in writing: (i)&nbsp;of the effectiveness of the Registration Statement and any amendment thereto;
	(ii)&nbsp;of the issuance by the Commission of any stop order or of the initiation, or the threatening, of any proceeding for that
	purpose; (iii)&nbsp;of the issuance by any state securities commission of any proceedings for the suspension of the qualification
	of the Public Securities for offering or sale in any jurisdiction or of the initiation, or the threatening, of any proceeding for
	that purpose; (iv)&nbsp;of the mailing and delivery to the Commission for filing of any amendment or supplement to the Registration
	Statement or Prospectus; (v)&nbsp;of the receipt of any comments or request for any additional information from the Commission;
	and (vi)&nbsp;of the happening of any event during the period described in this Section 3.5 that, in the judgment of the Company,
	makes any statement of a material fact made in the Registration Statement, the Pricing Disclosure Package or the Prospectus untrue
	or that requires the making of any changes in (a) the Registration Statement in order to make the statements therein not misleading,
	or (b) in the Pricing Disclosure Package or the Prospectus in order to make the statements therein, in light of the circumstances
	under which they were made, not misleading. If the Commission or any state securities commission shall enter a stop order or suspend
	such qualification at any time, the Company shall make every reasonable effort to obtain promptly the lifting of such order.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	3.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Review
	of Financial Statements
</U>
	. For a period of five (5) years after the date of this Agreement, the Company, at its expense, shall
	cause its regularly engaged independent registered public accounting firm to review (but not audit) the Company&rsquo;s financial
	statements for each of the three fiscal quarters immediately preceding the announcement of any quarterly financial information.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 18; VALUE: 2 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	17
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage166"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	3.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Listing
</U>
	.
	The Company shall use its best efforts to maintain the listing of the Units form the date of this Agreement until the Separation
	Date and the shares of Common Stock and the Warrants (including the Public Securities) on the Exchange from the date of this Agreement until three years after
	the Separation Date.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	3.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Financial
	Public Relations Firm
</U>
	. As of the Effective Date, the Company shall have retained a financial public relations firm reasonably
	acceptable to the Representatives and the Company, which shall initially be KCSA Strategic Communications, which firm shall be
	experienced in assisting issuers in initial public offerings of securities and in their relations with their security holders,
	and shall retain such firm or another firm reasonably acceptable to the Representatives for a period of not less than two (2) years
	after the Effective Date.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	3.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Reports
	to the Representatives
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	3.9.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Periodic
	Reports, etc
</U>
	. For a period of three (3) years after the date of this Agreement, the Company shall furnish or make available
	to the Representatives copies of such financial statements and other periodic and special reports as the Company from time to time
	furnishes generally to holders of any class of its securities and also promptly furnish to the Representatives: (i) a copy of each
	periodic report the Company shall be required to file with the Commission under the Exchange Act and the Exchange Act Regulations;
	(ii) a copy of every press release and every news item and article with respect to the Company or its affairs that is material
	and which was released by the Company; (iii) a copy of each Form 8-K prepared and filed by the Company; (iv) five copies of each
	registration statement filed by the Company under the Securities Act; and (v) such additional documents and information with respect
	to the Company and the affairs of any future subsidiaries of the Company as the Representatives may from time to time reasonably
	request; provided the Representatives shall sign, if requested by the Company, a Regulation FD compliant confidentiality agreement
	which is reasonably acceptable to the Representatives and Representatives&rsquo; Counsel in connection with the Representatives&rsquo;
	receipt of such information. Documents filed with the Commission pursuant to its EDGAR system shall be deemed to have been delivered
	to the Representatives pursuant to this Section 3.9.1.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	3.9.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Transfer
	Agent; Transfer Sheets
</U>
	. For a period of three (3) years after the date of this Agreement, the Company shall retain a transfer
	agent and registrar acceptable to the Representatives (the&nbsp;&ldquo;Transfer Agent&rdquo;) and shall furnish to the Representatives
	at the Company&rsquo;s sole cost and expense such transfer sheets of the Company&rsquo;s securities as the Representatives may
	reasonably request, including the daily and monthly consolidated transfer sheets of the Transfer Agent and DTC. American Stock
	Transfer &amp; Trust Company, LLC is acceptable to the Representatives to act as Transfer Agent for the Company&rsquo;s securities.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	3.9.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Trading
	Reports
</U>
	. During such time as the Public Securities are listed on the Exchange, the Company shall provide to the Representatives,
	at the Company&rsquo;s expense, such reports published by Exchange relating to price trading of the Public Securities, as the Representatives
	shall reasonably request.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 19; VALUE: 2 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	18
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage167"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	3.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Payment
	of Expenses
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	3.10.1.&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	General
	Expenses Related to the Offering
</U>
	. The Company hereby agrees to pay on each of the Closing Date and the Option Closing Date,
	if any, to the extent not paid at the Closing Date, all reasonable and necessary expenses incident to the performance of the obligations
	of the Company under this Agreement, including, but not limited to: (a) all filing fees and communication expenses relating to
	the registration of the Public Securities to be sold in the Offering (including the Option Units) with the Commission; (b) all
	Public Filing System filing fees associated with the review of the Offering by FINRA; (c) all fees and expenses relating to the
	listing of such Public Securities on the Exchange and such other stock exchanges as the Company and the Representatives together
	determine; (d) all fees, expenses and disbursements relating to background checks of the Company&rsquo;s officers and directors
	in an amount not to exceed $10,000 in the aggregate; (e) all fees, expenses and disbursements relating to the registration or qualification
	of the Public Securities under the &ldquo;blue sky&rdquo; securities laws of such states and other jurisdictions as the Representatives
	may reasonably designate (including, without limitation, all filing and registration fees, it being agreed that if the Offering
	is commenced on the Exchange, the Company shall make a payment of $5,000 to such counsel at Closing, or if the Offering is commenced
	on the Over-the-Counter Bulletin Board, the Company shall make a payment of $15,000 to such counsel upon the commencement of &ldquo;blue
	sky&rdquo; work by such counsel and an additional $5,000 at Closing); (f) all fees, expenses and disbursements relating to the
	registration, qualification or exemption of the Public Securities under the securities laws of such foreign jurisdictions as the
	Representatives may reasonably designate; (g) the costs of all mailing and printing of the underwriting documents (including, without
	limitation, the Underwriting Agreement, any Blue Sky Surveys and, if appropriate, any Agreement Among Underwriters, Selected Dealers&rsquo;
	Agreement, Underwriters&rsquo; Questionnaire and Power of Attorney), Registration Statements, Prospectuses and all amendments,
	supplements and exhibits thereto and as many preliminary and final Prospectuses as the Representatives may reasonably deem necessary;
	(h) the costs and expenses of a public relations firm; (i) the costs of preparing, printing and delivering certificates representing
	the Public Securities; (j) fees and expenses of the transfer agent for the Public Securities; (k) stock transfer and/or stamp taxes,
	if any, payable upon the transfer of securities from the Company to the Underwriters; (l) the costs associated with post-Closing
	advertising the Offering in the national editions of the Wall Street Journal and New York Times up to $10,000; (m) up to $2,500
	of the costs associated with one set of bound volumes of the public offering materials as well as commemorative mementos and lucite
	tombstones, each of which the Company or its designee shall provide within a reasonable time after the Closing Date in such quantities
	as the Representatives may reasonably request; (n) the fees and expenses of the Company&rsquo;s accountants; (o) the fees and expenses
	of the Company&rsquo;s legal counsel and other agents and representatives; (p) fees and expenses of the Representatives&rsquo;
	legal counsel not to exceed $50,000; (q) the $29,500 cost associated with the Underwriter&rsquo;s use of Ipreo&rsquo;s book-building,
	prospectus tracking and compliance software for the Offering; and (r) up to $20,000 of the Underwriters&rsquo; actual accountable
	&ldquo;road show&rdquo; expenses for the Offering, less the Advance (as such term is defined in Section 8.3 hereof). The Representatives
	may deduct from the net proceeds of the Offering payable to the Company on the Closing Date, or the Option Closing Date, if any,
	the expenses set forth herein to be paid by the Company to the Underwriters.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	3.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Application
	of Net Proceeds
</U>
	. The Company shall apply the net proceeds from the Offering received by it in a manner consistent with the
	application thereof described under the caption &ldquo;Use of Proceeds&rdquo; in the Registration Statement, the Pricing Disclosure
	Package and the Prospectus.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	3.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Delivery
	of Earnings Statements to Security Holders
</U>
	. The Company shall make generally available to its security holders as soon as practicable,
	but not later than the first day of the fifteenth (15
<SUP>
	th
</SUP>
	) full calendar month following the date of this Agreement, an
	earnings statement (which need not be certified by independent registered public accounting firm unless required by the Securities
	Act or the Securities Act Regulations, but which shall satisfy the provisions of Rule 158(a) under Section 11(a) of the Securities
	Act) covering a period of at least twelve (12) consecutive months beginning after the date of this Agreement.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	3.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Stabilization
</U>
	.
	Neither the Company nor, to its knowledge, any of its employees, directors or stockholders (without the consent of the Representatives)
	has taken or shall take, directly or indirectly, any action designed to or that has constituted or that might reasonably be expected
	to cause or result in, under Regulation M of the Exchange Act, or otherwise, stabilization or manipulation of the price of any
	security of the Company to facilitate the sale or resale of the Public Securities.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	3.14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Internal
	Controls
</U>
	. The Company shall maintain a system of internal accounting controls sufficient to provide reasonable assurances that:
	(i)&nbsp;transactions are executed in accordance with management&rsquo;s general or specific authorization; (ii)&nbsp;transactions
	are recorded as necessary in order to permit preparation of financial statements in accordance with GAAP and to maintain accountability
	for assets; (iii)&nbsp;access to assets is permitted only in accordance with management&rsquo;s general or specific authorization;
	and (iv)&nbsp;the recorded accountability for assets is compared with existing assets at reasonable intervals and appropriate action
	is taken with respect to any differences.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	3.15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Accountants
</U>
	.
	As of the date of this Agreement, the Company shall retain an independent registered public accounting firm reasonably acceptable
	to the Representatives, and the Company shall continue to retain a nationally recognized independent registered public accounting
	firm for a period of at least three (3) years after the date of this Agreement. The Representatives acknowledge that the Auditor
	is acceptable to the Representatives.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	3.16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	FINRA
</U>
	.
	The Company shall advise the Representatives (who shall make an appropriate filing with FINRA) if it is or becomes aware that (i)
	any officer or director of the Company, (ii) any beneficial owner of 5% or more of any class of the Company's securities or (iii)
	any beneficial owner of the Company's unregistered equity securities which were acquired during the 180 days immediately preceding
	the filing of the Registration Statement is or becomes an affiliate or associated person of a FINRA member participating in the
	Offering (as determined in accordance with the rules and regulations of FINRA).
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 20; VALUE: 2 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	19
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage168"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	3.17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	No
	Fiduciary Duties
</U>
	. The Company acknowledges and agrees that the Underwriters&rsquo; responsibility to the Company is solely
	contractual in nature and that none of the Underwriters or their affiliates or any selling agent shall be deemed to be acting in
	a fiduciary capacity, or otherwise owes any fiduciary duty to the Company or any of its affiliates in connection with the Offering
	and the other transactions contemplated by this Agreement.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	3.18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Company
	Lock-Up Agreements
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	3.18.1.&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Restriction
	on Sales of Capital Stock
</U>
	. The Company, on behalf of itself and any successor entity, agrees that, without the prior written
	consent of the Representatives, it will not, for a period of 180 days after the date of this Agreement (the &ldquo;Lock-Up Period&rdquo;),
	(i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant
	any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of capital
	stock of the Company or any securities convertible into or exercisable or exchangeable for shares of capital stock of the Company;
	(ii) file or cause to be filed any registration statement with the Commission relating to the offering of any shares of capital
	stock of the Company or any securities convertible into or exercisable or exchangeable for shares of capital stock of the Company
	(excluding filing a Form S-4 in connection with an acquisition or Form S-8 to register securities to be issued under existing employee
	benefit plans); (iii) complete any offering of debt securities of the Company, other than entering into a line of credit with a
	traditional bank or (iv) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic
	consequences of ownership of capital stock of the Company, whether any such transaction described in clause (i), (ii), (iii) or
	(iv) above is to be settled by delivery of shares of capital stock of the Company or such other securities, in cash or otherwise.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	The restrictions contained
	in this Section 3.18.1 shall not apply to (i) the Units, shares of Common Stock or the Warrants to be sold hereunder, (ii) the
	issuance by the Company of shares of Common Stock upon the exercise of a stock option or warrant or the conversion of a security
	outstanding on the date hereof, of which the Representatives have been advised in writing or (iii) the issuance by the Company
	of stock options or shares of capital stock of the Company under any equity compensation plan of the Company, provided that in
	each of (ii) and (iii) above, the underlying shares shall be restricted from sale during the entire Lock-Up Period.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	Notwithstanding the foregoing,
	if (i) during the last 17 days of the Lock-Up Period, the Company issues an earnings release or material news or a material event
	relating to the Company occurs, or (ii) prior to the expiration of the Lock-Up Period, the Company announces that it will release
	earnings results or becomes aware that material news or a material event will occur during the 16-day period beginning on the last
	day of the Lock-Up Period, the restrictions imposed by this Section 3.18.1 shall continue to apply until the expiration of the
	18-day period beginning on the issuance of the earnings release or the occurrence of such material news or material event, as applicable,
	unless the Representatives waive, in writing, such extension; provided, however, that this extension of the Lock-Up Period shall
	not apply to the extent that FINRA has amended or repealed NASD Rule 2711(f)(4), or has otherwise provided written interpretive
	guidance regarding such rule, in each case, so as to eliminate the prohibition of any broker, dealer, or member of a national securities
	association from publishing or distributing any research report, with respect to the securities of an Emerging Growth Company prior
	to or after the expiration of any agreement between the broker, dealer, or member of a national securities association and the
	Emerging Growth Company or its stockholders that restricts or prohibits the sale of securities held by the Emerging Growth Company
	or its stockholders after the initial public offering date.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	3.18.2.&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Restriction
	on Continuous Offerings
</U>
	. Notwithstanding the restrictions contained in Section 3.18.1, the Company, on behalf of itself and
	any successor entity, agrees that, without the prior written consent of the Representatives, it will not, for a period of 12 months
	after the date of this Agreement, directly or indirectly in any &ldquo;at-the-market&rdquo; or continuous equity transaction, offer
	to sell, sell, contract to sell, grant any option to sell or otherwise dispose of shares of capital stock of the Company or any
	securities convertible into or exercisable or exchangeable for shares of capital stock of the Company.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 21; VALUE: 2 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	20
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage169"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	3.19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Release
	of D&amp;O Lock-up Period
</U>
	. If the Representatives, in their sole discretion, agree to release or waive the restrictions set
	forth in the Lock-Up Agreements described in Section 2.24 hereof for an officer or director of the Company and provide the Company
	with notice of the impending release or waiver at least three (3) Business Days before the effective date of the release or waiver,
	the Company agrees to announce the impending release or waiver by a press release substantially in the form of
<U>
	Exhibit D
</U>
	hereto through a major news service at least two (2) Business Days before the effective date of the release or waiver.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	3.20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Blue
	Sky Qualifications
</U>
	. The Company shall use its best efforts, in cooperation with the Underwriters, if necessary, to qualify
	the Public Securities for offering and sale under the applicable securities laws of such states and other jurisdictions (domestic
	or foreign) as the Representatives may designate and to maintain such qualifications in effect so long as required to complete
	the distribution of the Public Securities; provided, however, that the Company shall not be obligated to file any general consent
	to service of process or to qualify as a foreign corporation or as a dealer in securities in any jurisdiction in which it is not
	so qualified or to subject itself to taxation in respect of doing business in any jurisdiction in which it is not otherwise so
	subject.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	3.21&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Reporting
	Requirements
</U>
	. The Company, during the period when a prospectus relating to the Public Securities is (or, but for the exception
	afforded by Rule 172, would be) required to be delivered under the Securities Act, will file all documents required to be filed
	with the Commission pursuant to the Exchange Act within the time periods required by the Exchange Act and Exchange Act Regulations.
	Additionally, the Company shall report the use of proceeds from the issuance of the Public Securities as may be required under
	Rule 463 under the Securities Act Regulations.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	3.22&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Emerging
	Growth Company Status
</U>
	. The Company shall promptly notify the Representatives if the Company ceases to be an Emerging Growth
	Company at any time prior to the later of (i) completion of the distribution of the Public Securities within the meaning of the
	Securities Act and (ii) fifteen (15) days following the completion of the Lock-Up Period.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY">
	4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Conditions
	of Underwriters&rsquo; Obligations
</U>
	. The obligations of the Underwriters to purchase and pay for the Public Securities, as provided
	herein, shall be subject to (i) the continuing accuracy of the representations and warranties of the Company as of the date hereof
	and as of each of the Closing Date and the Option Closing Date, if any; (ii) the accuracy of the statements of officers of the
	Company made pursuant to the provisions hereof; (iii) the performance by the Company of its obligations hereunder; and (iv) the
	following conditions:
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	4.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Regulatory
	Matters
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	4.1.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Effectiveness
	of Registration Statement; Rule 430A Information
</U>
	. The Registration Statement has become effective not later than 5:00 p.m.,
	Eastern time, on the date of this Agreement or such later date and time as shall be consented to in writing by you, and, at each
	of the Closing Date and any Option Closing Date, no stop order suspending the effectiveness of the Registration Statement or any
	post-effective amendment thereto has been issued under the Securities Act, no order preventing or suspending the use of any Preliminary
	Prospectus or the Prospectus has been issued and no proceedings for any of those purposes have been instituted or are pending or,
	to the Company&rsquo;s knowledge, contemplated by the Commission. The Company has complied with each request (if any) from the
	Commission for additional information. The Prospectus containing the Rule 430A Information shall have been filed with the Commission
	in the manner and within the time frame required by Rule 424(b) (without reliance on Rule 424(b)(8)) or a post-effective amendment
	providing such information shall have been filed with, and declared effective by, the Commission in accordance with the requirements
	of Rule 430A.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	4.1.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	FINRA
	Clearance
</U>
	. On or before the date of this Agreement, the Representatives shall have received clearance from FINRA as to the
	amount of compensation allowable or payable to the Underwriters as described in the Registration Statement.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	4.1.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Exchange
	Stock Market Clearance
</U>
	. On the Closing Date, the Company&rsquo;s Units, the shares of Common Stock, and the Warrants, including
	the Firm Units, shall have been approved for listing on the Exchange, subject only to official notice of issuance. On the first
	Option Closing Date (if any), the Company&rsquo;s shares of Common Stock, the Units and the Warrants, including the Option Shares,
	shall have been approved for listing on the Exchange, subject only to official notice of issuance.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 22; VALUE: 2 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	21
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage170"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	4.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Company
	Counsel Matters
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	4.2.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Closing
	Date Opinion of Counsel
</U>
	. On the Closing Date, the Representatives shall have received the favorable opinion of Gunster, Yoakley
	&amp; Stewart, P.A., counsel to the Company, dated the Closing Date and addressed to the Representatives, in the form satisfactory
	to the Representatives and Representatives&rsquo; Counsel.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	4.2.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Opinion
	of Special Intellectual Property Counsel for the Company
</U>
	. On the Closing Date, the Representatives shall have received the
	opinion of Fox Rothchild, LLP, special intellectual property counsel for the Company, dated the Closing Date, addressed to the
	Representatives in the form satisfactory to the Representatives and Representatives&rsquo; Counsel.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	4.2.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Option
	Closing Date Opinions of Counsel
</U>
	. On the Option Closing Date, if any, the Representatives shall have received the favorable
	opinions of each counsel listed in Sections 4.2.1 and 4.2.2, dated the Option Closing Date, addressed to the Representatives and
	in form and substance reasonably satisfactory to the Representatives, confirming as of the Option Closing Date, the statements
	made by such counsels in their respective opinions delivered on the Closing Date.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	4.2.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Reliance
</U>
	.
	In rendering such opinions, such counsel may rely: (i)&nbsp;as to matters involving the application of laws other than the laws
	of the United States and jurisdictions in which they are admitted, to the extent such counsel deems proper and to the extent specified
	in such opinion, if at all, upon an opinion or opinions (in form and substance reasonably satisfactory to the Representatives)
	of other counsel reasonably acceptable to the Representatives, familiar with the applicable laws; and (ii)&nbsp;as to matters of
	fact, to the extent they deem proper, on certificates or other written statements of officers of the Company and officers of departments
	of various jurisdictions having custody of documents respecting the corporate existence or good standing of the Company, provided
	that copies of any such statements or certificates shall be delivered to Representatives&rsquo; Counsel if requested. The opinion
	of Gunster, Yoakley &amp; Stewart, P.A. and any opinion relied upon by Gunster, Yoakley &amp; Stewart, P.A. shall include a statement
	to the effect that it may be relied upon by Representatives&rsquo; Counsel in its opinion delivered to the Underwriters.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	4.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Comfort
	Letters
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	4.3.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Cold
	Comfort Letter
</U>
	. At the time this Agreement is executed you shall have received a cold comfort letter containing statements
	and information of the type customarily included in accountants&rsquo; comfort letters with respect to the financial statements
	and certain financial information contained in the Registration Statement, the Pricing Disclosure Package and the Prospectus, addressed
	to the Representatives and in form and substance satisfactory in all respects to you and to the Auditor, dated as of the date of
	this Agreement.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	4.3.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Bring-down
	Comfort Letter
</U>
	. At each of the Closing Date and the Option Closing Date, if any, the Representatives shall have received from
	the Auditor a letter, dated as of the Closing Date or the Option Closing Date, as applicable, to the effect that the Auditor reaffirms
	the statements made in the letter furnished pursuant to Section 4.3.1, except that the specified date referred to shall be a date
	not more than three (3) business days prior to the Closing Date or the Option Closing Date, as applicable.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 23; VALUE: 2 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	22
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage171"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	4.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Officers&rsquo;
	Certificates
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	4.4.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Officers&rsquo;
	Certificate
</U>
	. The Company shall have furnished to the Representatives a certificate, dated the Closing Date and any Option Closing
	Date (if such date is other than the Closing Date), of its Chief Executive Officer, its President and its Chief Financial Officer
	stating that (i) such officers have carefully examined the Registration Statement, the Pricing Disclosure Package, any Issuer Free
	Writing Prospectus and the Prospectus and, in their opinion, the Registration Statement and each amendment thereto, as of the Applicable
	Time and as of the Closing Date (or any Option Closing Date if such date is other than the Closing Date) did not include any untrue
	statement of a material fact and did not omit to state a material fact required to be stated therein or necessary to make the statements
	therein not misleading, and the Pricing Disclosure Package, as of the Applicable Time and as of the Closing Date (or any Option
	Closing Date if such date is other than the Closing Date), any Issuer Free Writing Prospectus as of its date and as of the Closing
	Date (or any Option Closing Date if such date is other than the Closing Date), the Prospectus and each amendment or supplement
	thereto, as of the respective date thereof and as of the Closing Date, did not include any untrue statement of a material fact
	and did not omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances
	in which they were made, not misleading, (ii) since the effective date of the Registration Statement, no event has occurred which
	should have been set forth in a supplement or amendment to the Registration Statement, the Pricing Disclosure Package or the Prospectus,
	(iii) to the best of their knowledge after reasonable investigation, as of the Closing Date (or any Option Closing Date if such
	date is other than the Closing Date), the representations and warranties of the Company in this Agreement are true and correct
	and the Company has complied with all agreements and satisfied all conditions on its part to be performed or satisfied hereunder
	at or prior to the Closing Date (or any Option Closing Date if such date is other than the Closing Date), and (iv) there has not
	been, subsequent to the date of the most recent audited financial statements included or incorporated by reference in the Pricing
	Disclosure Package, any Material Adverse Change in the financial position or results of operations of the Company, or any change
	or development that, singularly or in the aggregate, would involve a Material Adverse Change or a prospective Material Adverse
	Change, in or affecting the condition (financial or otherwise), results of operations, business, assets or prospects of the Company,
	except as set forth in the Prospectus.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	4.4.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Secretary&rsquo;s
	Certificate
</U>
	. At each of the Closing Date and the Option Closing Date, if any, the Representatives shall have received a certificate
	of the Company signed by the Secretary of the Company, dated the Closing Date or the Option Date, as the case may be, respectively,
	certifying: (i)&nbsp;that each of the Charter and Bylaws is true and complete, has not been modified and is in full force and effect;
	(ii)&nbsp;that the resolutions of the Company&rsquo;s Board of Directors relating to the Offering are in full force and effect
	and have not been modified; (iii) as to the accuracy and completeness of all correspondence between the Company or its counsel
	and the Commission; and (iv)&nbsp;as to the incumbency of the officers of the Company. The documents referred to in such certificate
	shall be attached to such certificate.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	4.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	No
	Material Changes
</U>
	. Prior to and on each of the Closing Date and each Option Closing Date, if any: (i)&nbsp;there shall have
	been no Material Adverse Change or development involving a prospective Material Adverse Change in the condition or prospects or
	the business activities, financial or otherwise, of the Company from the latest dates as of which such condition is set forth in
	the Registration Statement, the Pricing Disclosure Package and the Prospectus; (ii)&nbsp;no action, suit or proceeding, at law
	or in equity, shall have been pending or threatened against the Company or any Insider before or by any court or federal or state
	commission, board or other administrative agency wherein an unfavorable decision, ruling or finding may materially adversely affect
	the business, operations, prospects or financial condition or income of the Company, except as set forth in the Registration Statement,
	the Pricing Disclosure Package and the Prospectus; (iii)&nbsp;no stop order shall have been issued under the Securities Act and
	no proceedings therefor shall have been initiated or threatened by the Commission; and (iv)&nbsp;the Registration Statement, the
	Pricing Disclosure Package and the Prospectus and any amendments or supplements thereto shall contain all material statements which
	are required to be stated therein in accordance with the Securities Act and the Securities Act Regulations and shall conform in
	all material respects to the requirements of the Securities Act and the Securities Act Regulations, and neither the Registration
	Statement, the Pricing Disclosure Package nor the Prospectus nor any amendment or supplement thereto shall contain any untrue statement
	of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein,
	in light of the circumstances under which they were made, not misleading.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	4.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Delivery
	of Agreements
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	4.6.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Lock-Up
	Agreements
</U>
	. On or before the date of this Agreement, the Company shall have delivered to the Representatives executed copies
	of the Lock-Up Agreements from each of the persons listed in
<U>
	Schedule 3
</U>
	hereto.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	4.6.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Warrant
	Agreement
</U>
	. On the Closing Date, the Company shall have delivered to the Representatives executed copies of the Warrant Agreement.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	4.6.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Representatives&rsquo;
	Warrant Agreement
</U>
	. On the Closing Date and the Option Closing Date, the Company shall have delivered to the Representatives
	executed copies of the Representatives&rsquo; Warrant Agreement.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 24; VALUE: 2 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	23
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage172"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	4.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Additional
	Documents
</U>
	. At the Closing Date and at each Option Closing Date (if any) Representatives&rsquo; Counsel shall have been furnished
	with such documents and opinions as they may require for the purpose of enabling Representatives&rsquo; Counsel to deliver an opinion
	to the Underwriters, or in order to evidence the accuracy of any of the representations or warranties, or the fulfillment of any
	of the conditions, herein contained; and all proceedings taken by the Company in connection with the issuance and sale of the Public
	Securities and the Representatives&rsquo; Securities as herein contemplated shall be satisfactory in form and substance to the
	Representatives and Representatives&rsquo; Counsel.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	4.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Forward
	Stock Split
</U>
	. Not later than the first trading day of the Firm Units following the date hereof, the Forward Stock Split shall
	be effective.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: -0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: -0.5IN">
	5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Indemnification
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	5.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Indemnification
	of the Underwriters
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	5.1.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	General
</U>
	.
	Subject to the conditions set forth below, the Company agrees to indemnify and hold harmless each Underwriter, its affiliates and
	each of its and their respective directors, officers, members, employees, representatives, partners, shareholders, affiliates,
	counsel, and agents and each person, if any, who controls any such Underwriter within the meaning of Section 15 of the Securities
	Act or Section 20 of the Exchange Act (collectively the &ldquo;Underwriter Indemnified Parties,&rdquo; and each an &ldquo;Underwriter
	Indemnified Party&rdquo;), against any and all loss, liability, claim, damage and expense whatsoever (including but not limited
	to any and all legal or other expenses reasonably incurred in investigating, preparing or defending against any litigation, commenced
	or threatened, or any claim whatsoever, whether arising out of any action between any of the Underwriter Indemnified Parties and
	the Company or between any of the Underwriter Indemnified Parties and any third party, or otherwise) to which they or any of them
	may become subject under the Securities Act, the Exchange Act or any other statute or at common law or otherwise or under the laws
	of foreign countries (a &ldquo;Claim&rdquo;), arising out of or based upon any untrue statement or alleged untrue statement of
	a material fact contained in (A) the Registration Statement, the Pricing Disclosure Package, any Preliminary Prospectus, the Prospectus,
	or in any Issuer Free Writing Prospectus or in any Written Testing-the-Waters Communication (as from time to time each may be amended
	and supplemented); (B) any materials or information provided to investors by, or with the approval of, the Company in connection
	with the marketing of the Offering, including any &ldquo;road show&rdquo; or investor presentations made to investors by the Company
	(whether in person or electronically); or (C) any application or other document or written communication (in this Section 5, collectively
	called &ldquo;application&rdquo;) executed by the Company or based upon written information furnished by the Company in any jurisdiction
	in order to qualify the Public Securities and Representatives&rsquo; Securities under the securities laws thereof or filed with
	the Commission, any state securities commission or agency, the Exchange or any other national securities exchange; or the omission
	or alleged omission therefrom of a material fact required to be stated therein or necessary to make the statements therein, in
	the light of the circumstances under which they were made, not misleading, unless such statement or omission was made in reliance
	upon, and in conformity with, the Underwriters&rsquo; Information. With respect to any untrue statement or omission or alleged
	untrue statement or omission made in the Registration Statement, Pricing Disclosure Package, or Prospectus, the indemnity agreement
	contained in this Section 5.1.1 shall not inure to the benefit of any Underwriter Indemnified Party to the extent that any loss,
	liability, claim, damage, or expenses of such Underwriter Indemnified Party results from the fact that a copy of the Prospectus
	was not given or sent to the person asserting any such loss, liability, claim, or damage at or prior to the written confirmation
	of sale of the Shares to such person as required by the Securities Act and the Securities Act Regulations, and if the untrue statement
	or omission has been corrected in the Prospectus, unless such failure to deliver the Prospectus was a result of noncompliance by
	the Company with its obligations under Section 3.3 hereof. The Company also agrees that it will reimburse each Underwriter Indemnified
	Party for all fees and expenses (including but not limited to any and all legal or other expenses reasonably incurred in investigating,
	preparing or defending against any litigation, commenced or threatened, or any claim whatsoever, whether arising out of any action
	between any of the Underwriter Indemnified Parties and the Company or between any of the Underwriter Indemnified Parties and any
	third party, or otherwise).
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 25; VALUE: 2 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	24
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage173"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	5.1.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Procedure
</U>
	.
	If any action is brought against an Underwriter Indemnified Party in respect of which indemnity may be sought against the Company
	pursuant to Section 5.1.1, such Underwriter Indemnified Party shall promptly notify the Company in writing of the institution of
	such action and the Company shall assume the defense of such action, including the employment and fees of counsel (subject to the
	approval of such Underwriter Indemnified Party) and payment of actual expenses. Such Underwriter Indemnified Party shall have the
	right to employ its or their own counsel in any such case, but the fees and expenses of such counsel shall be at the expense of
	the Company, and shall be advanced by the Company. The Company shall not be liable for any settlement of any action effected without
	its consent (which shall not be unreasonably withheld). In addition, the Company shall not, without the prior written consent of
	the Underwriters, settle, compromise or consent to the entry of any judgment in or otherwise seek to terminate any pending or threatened
	action in respect of which advancement, reimbursement, indemnification or contribution may be sought hereunder (whether or not
	such Underwriter Indemnified Party is a party thereto) unless such settlement, compromise, consent or termination (i) includes
	an unconditional release of each Underwriter Indemnified Party, acceptable to such Underwriter Indemnified Party, from all liabilities,
	expenses and claims arising out of such action for which indemnification or contribution may be sought and (ii) does not include
	a statement as to or an admission of fault, culpability or a failure to act, by or on behalf of any Underwriter Indemnified Party.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	5.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Indemnification
	of the Company
</U>
	. Each Underwriter, severally and not jointly, agrees to indemnify and hold harmless the Company, its directors,
	its officers who signed the Registration Statement and persons who control the Company within the meaning of Section 15 of the
	Securities Act or Section 20 of the Exchange Act against any and all loss, liability, claim, damage and expense described in the
	foregoing indemnity from the Company to the several Underwriters, as incurred, but only with respect to untrue statements or omissions,
	or alleged untrue statements or omissions made in the Registration Statement, any Preliminary Prospectus, the Pricing Disclosure
	Package or Prospectus or any amendment or supplement thereto or in any application, in reliance upon, and in strict conformity
	with, the Underwriters&rsquo; Information. In case any action shall be brought against the Company or any other person so indemnified
	based on any Preliminary Prospectus, the Registration Statement, the Pricing Disclosure Package or Prospectus or any amendment
	or supplement thereto or any application, and in respect of which indemnity may be sought against any Underwriter, such Underwriter
	shall have the rights and duties given to the Company, and the Company and each other person so indemnified shall have the rights
	and duties given to the several Underwriters by the provisions of Section 5.1.2. The Company agrees promptly to notify the Representatives
	of the commencement of any litigation or proceedings against the Company or any of its officers, directors or any person, if any,
	who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, in connection
	with the issuance and sale of the Public Securities or in connection with the Registration Statement, the Pricing Disclosure Package,
	the Prospectus, or any Issuer Free Writing Prospectus or any Written Testing-the-Waters Communication.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	5.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Contribution
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	5.3.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Contribution
	Rights
</U>
	. If the indemnification provided for in this Section 5 shall for any reason be unavailable to or insufficient to hold
	harmless an indemnified party under Section 5.1 or 5.2 in respect of any loss, claim, damage or liability, or any action in respect
	thereof, referred to therein, then each indemnifying party shall, in lieu of indemnifying such indemnified party, contribute to
	the amount paid or payable by such indemnified party as a result of such loss, claim, damage or liability, or action in respect
	thereof, (i) in such proportion as shall be appropriate to reflect the relative benefits received by the Company, on the one hand,
	and the Underwriters, on the other, from the Offering of the Public Securities, or (ii) if the allocation provided by clause (i)
	above is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred
	to in clause (i) above but also the relative fault of the Company, on the one hand, and the Underwriters, on the other, with respect
	to the statements or omissions that resulted in such loss, claim, damage or liability, or action in respect thereof, as well as
	any other relevant equitable considerations. The relative benefits received by the Company, on the one hand, and the Underwriters,
	on the other, with respect to such Offering shall be deemed to be in the same proportion as the total net proceeds from the Offering
	of the Public Securities purchased under this Agreement (before deducting expenses) received by the Company, as set forth in the
	table on the cover page of the Prospectus, on the one hand, and the total underwriting discounts and commissions received by the
	Underwriters with respect to the Units purchased under this Agreement, as set forth in the table on the cover page of the Prospectus,
	on the other hand. The relative fault shall be determined by reference to whether the untrue or alleged untrue statement of a material
	fact or omission or alleged omission to state a material fact relates to information supplied by the Company or the Underwriters,
	the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such statement
	or omission. The Company and the Underwriters agree that it would not be just and equitable if contributions pursuant to this Section
	5.3.1 were to be determined by pro rata allocation (even if the Underwriters were treated as one entity for such purpose) or by
	any other method of allocation that does not take into account the equitable considerations referred to herein. The amount paid
	or payable by an indemnified party as a result of the loss, claim, damage or liability, or action in respect thereof, referred
	to above in this Section 5.3.1 shall be deemed to include, for purposes of this Section 5.3.1, any legal or other expenses reasonably
	incurred by such indemnified party in connection with investigating or defending any such action or claim. Notwithstanding the
	provisions of this Section 5.3.1 in no event shall an Underwriter be required to contribute any amount in excess of the amount
	by which the total underwriting discounts and commissions received by such Underwriter with respect to the Offering of the Public
	Securities exceeds the amount of any damages that such Underwriter has otherwise been required to pay by reason of such untrue
	or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning
	of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent
	misrepresentation.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 26; VALUE: 2 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	25
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage174"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	5.3.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Contribution
	Procedure
</U>
	. Within fifteen (15) days after receipt by any party to this Agreement (or its representative) of notice of the commencement
	of any action, suit or proceeding, such party will, if a claim for contribution in respect thereof is to be made against another
	party (&ldquo;contributing party&rdquo;), notify the contributing party of the commencement thereof, but the failure to so notify
	the contributing party will not relieve it from any liability which it may have to any other party other than for contribution
	hereunder. In case any such action, suit or proceeding is brought against any party, and such party notifies a contributing party
	or its representative of the commencement thereof within the aforesaid 15 days, the contributing party will be entitled to participate
	therein with the notifying party and any other contributing party similarly notified. Any such contributing party shall not be
	liable to any party seeking contribution on account of any settlement of any claim, action or proceeding affected by such party
	seeking contribution on account of any settlement of any claim, action or proceeding affected by such party seeking contribution
	without the written consent of such contributing party. The contribution provisions contained in this Section 5.3.2 are intended
	to supersede, to the extent permitted by law, any right to contribution under the Securities Act, the Exchange Act or otherwise
	available. Each Underwriter&rsquo;s obligations to contribute pursuant to this Section 5.3 are several and not joint.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: -0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: -0.5IN">
	6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Default
	by an Underwriter
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	6.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Default
	Not Exceeding 10% of Firm Units or Option Units
</U>
	. If any Underwriter or Underwriters shall default in its or their obligations
	to purchase the Firm Units or the Option Units, if the Over-allotment Option is exercised hereunder, and if the number of the Firm
	Units or the Option Units, with respect to which such default relates does not exceed in the aggregate 10% of the number of Firm
	Units or the Option Units that all Underwriters have agreed to purchase hereunder, then such Firm Units or the Option Units to
	which the default relates shall be purchased by the non-defaulting Underwriters in proportion to their respective commitments hereunder.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	6.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Default
	Exceeding 10% of Firm Units or the Option Units
</U>
	. In the event that the default addressed in Section 6.1 relates to more than
	10% of the Firm Units or the Option Units, you may in your discretion arrange for yourself or for another party or parties to purchase
	such Firm Units or the Option Units to which such default relates on the terms contained herein. If, within one (1) Business Day
	after such default relating to more than 10% of the Firm Units or the Option Units, you do not arrange for the purchase of such
	Firm Units or the Option Units, then the Company shall be entitled to a further period of one (1) Business Day within which to
	procure another party or parties satisfactory to you to purchase said Firm Units or the Option Units on such terms. In the event
	that neither you nor the Company arrange for the purchase of the Firm Units or the Option Units to which a default relates as provided
	in this Section 6, this Agreement will automatically be terminated by you or the Company without liability on the part of the Company
	(except as provided in Sections 3.9 and 5 hereof) or the several Underwriters (except as provided in Section 5 hereof); provided,
	however, that if such default occurs with respect to the Option Units, this Agreement will not terminate as to the Firm Units;
	and provided, further, that nothing herein shall relieve a defaulting Underwriter of its liability, if any, to the other Underwriters
	and to the Company for damages occasioned by its default hereunder.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 27; VALUE: 2 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	26
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage175"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	6.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Postponement
	of Closing Date
</U>
	. In the event that the Firm Units or Option Units to which the default relates are to be purchased by the non-defaulting
	Underwriters, or are to be purchased by another party or parties as aforesaid, you or the Company shall have the right to postpone
	the Closing Date or Option Closing Date for a reasonable period, but not in any event exceeding five (5) Business Days, in order
	to effect whatever changes may thereby be made necessary in the Registration Statement, the Pricing Disclosure Package or the Prospectus
	or in any other documents and arrangements, and the Company agrees to file promptly any amendment to the Registration Statement,
	the Pricing Disclosure Package or the Prospectus that in the opinion of Representatives&rsquo; Counsel may thereby be made necessary.
	The term &ldquo;Underwriter&rdquo; as used in this Agreement shall include any party substituted under this Section 6 with like
	effect as if it had originally been a party to this Agreement with respect to such Units, shares of Common Stock or Warrants.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: -0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: -0.5IN">
	7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Additional
	Covenants
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	7.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Board
	Composition and Board Designations
</U>
	. The Company shall ensure that: (i)&nbsp;the qualifications of the persons serving as members
	of the Board of Directors and the overall composition of the Board comply with the Sarbanes-Oxley Act, with the Exchange Act and
	with the listing rules of the Exchange or any other national securities exchange, as the case may be, in the event the Company
	seeks to have its Public Securities listed on another exchange or quoted on an automated quotation system, and (ii)&nbsp;if applicable,
	at least one member of the Audit Committee of the Board of Directors qualifies as an &ldquo;audit committee financial expert,&rdquo;
	as such term is defined under Regulation S-K and the listing rules of the Exchange.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	7.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Prohibition
	on Press Releases and Public Announcements
</U>
	. The Company shall not issue press releases or engage in any other publicity, without
	the Representatives&rsquo; prior written consent, for a period ending at 5:00 p.m., Eastern time, on the first (1
<SUP>
	st
</SUP>
	)
	Business Day following the forty-fifth (45
<SUP>
	th
</SUP>
	) day after the Closing Date, other than normal and customary releases issued
	in the ordinary course of the Company&rsquo;s business.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	7.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Right
	of First Refusal
</U>
	. Provided that the Firm Units are sold in accordance with the terms of this Agreement, the Representatives
	shall have an irrevocable right of first refusal (the &ldquo;Right of First Refusal&rdquo;), for a period of twenty-four (24) months
	after the date the Offering is completed, to act as sole and exclusive co-investment bankers, sole and exclusive co-book-runners,
	sole and exclusive co-financial advisors, sole and exclusive co-underwriters and/or sole and exclusive co-placement agents, at
	the Representatives&rsquo; sole and exclusive discretion, for each and every future public and private equity and debt offering,
	including all equity linked financings (each, a &ldquo;Subject Transaction&rdquo;), during such twenty-four (24) month period,
	of the Company, or any successor to or subsidiary of the Company, on terms and conditions customary to the Representatives for
	such Subject Transactions. For the avoidance of any doubt, the Company shall not retain, engage or solicit any additional investment
	banker, book-runner, financial advisor, underwriter and/or placement agent in a Subject Transaction without the express written
	consent of the Representatives.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	The Company shall notify
	the Representatives of its intention to pursue a Subject Transaction, including the material terms thereof, by providing written
	notice thereof by registered mail or overnight courier service addressed to the Representatives.&nbsp;If either Representative
	fails to exercise its Right of First Refusal with respect to any Subject Transaction within ten (10) Business Days after the mailing
	of such written notice, then the other Representative shall have no further claim or right with respect to the Subject Transaction.
	The Representatives may elect, in their sole and absolute discretion, not to exercise their Right of First Refusal with respect
	to any Subject Transaction; provided that any such election by the Representatives shall not adversely affect the Representatives&rsquo;
	Right of First Refusal with respect to any other Subject Transaction during the twenty-four (24) month period agreed to above.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: -0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: -0.5IN">
	8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Effective
	Date of this Agreement and Termination Thereof
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	8.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Effective
	Date
</U>
	. This Agreement shall become effective when both the Company and the Representatives have executed the same and delivered
	counterparts of such signatures to the other party.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 28; VALUE: 2 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	27
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage176"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	8.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Termination
</U>
	.
	The Representatives shall have the right to terminate this Agreement at any time prior to any Closing Date, (i)&nbsp;if any domestic
	or international event or act or occurrence has materially disrupted, or in your opinion will in the immediate future materially
	disrupt, general securities markets in the United States; or (ii)&nbsp;if trading on the New York Stock Exchange or the Nasdaq
	Stock Market LLC shall have been suspended or materially limited, or minimum or maximum prices for trading shall have been fixed,
	or maximum ranges for prices for securities shall have been required by FINRA or by order of the Commission or any other government
	authority having jurisdiction; or (iii)&nbsp;if the United States shall have become involved in a new war or an increase in major
	hostilities; or (iv)&nbsp;if a banking moratorium has been declared by a New York State or federal authority; or (v)&nbsp;if a
	moratorium on foreign exchange trading has been declared which materially adversely impacts the United States securities markets;
	or (vi)&nbsp;if the Company shall have sustained a material loss by fire, flood, accident, hurricane, earthquake, theft, sabotage
	or other calamity or malicious act which, whether or not such loss shall have been insured, will, in your opinion, make it inadvisable
	to proceed with the delivery of the Firm Units or Option Units; or (vii)&nbsp;if the Company is in material breach of any of its
	representations, warranties or covenants hereunder; or (viii)&nbsp;if the Representatives shall have become aware after the date
	hereof of such a Material Adverse Change in the conditions or prospects of the Company, or such adverse material change in general
	market conditions as in the Representatives&rsquo; judgment would make it impracticable to proceed with the offering, sale and/or
	delivery of the Public Securities or to enforce contracts made by the Underwriters for the sale of the Public Securities.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	8.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Expenses
</U>
	.
	Notwithstanding anything to the contrary in this Agreement, except in the case of a default by the Underwriters, pursuant to Section
	6.2 above, in addition to the discounts, fees and expenses payable to the Representatives hereunder, and regardless whether the
	Offering is consummated, the Company shall be obligated to pay to the Representatives their actual and accountable out-of-pocket
	expenses related to the transactions contemplated herein then due and payable (including the fees and disbursements of Representatives&rsquo;
	Counsel and actual &ldquo;road show&rdquo; expenses) up to $200,000, inclusive of the $50,000 advance for actual out-of-pocket
	accountable expenses previously paid by the Company to the Representatives (the &ldquo;Advance&rdquo;) and upon demand the Company
	shall pay the full amount thereof to the Representatives on behalf of the Underwriters; provided, however, that such expense cap
	in no way limits or impairs the indemnification and contribution provisions of this Agreement. Notwithstanding the foregoing, any
	advance received by the Representatives will be reimbursed to the Company to the extent not actually incurred in compliance with
	FINRA Rule 5110(f)(2)(C).
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	8.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Indemnification
</U>
	.
	Notwithstanding any contrary provision contained in this Agreement, any election hereunder or any termination of this Agreement,
	and whether or not this Agreement is otherwise carried out, the provisions of Section 5 shall remain in full force and effect and
	shall not be in any way affected by, such election or termination or failure to carry out the terms of this Agreement or any part
	hereof.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	8.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Representations,
	Warranties, Agreements to Survive
</U>
	. All representations, warranties and agreements contained in this Agreement or in certificates
	of officers of the Company submitted pursuant hereto, shall remain operative and in full force and effect regardless of (i)&nbsp;any
	investigation made by or on behalf of any Underwriter or its Affiliates or selling agents, any person controlling any Underwriter,
	its officers or directors or any person controlling the Company or (ii)&nbsp;delivery of and payment for the Public Securities.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: -0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: -0.5IN">
	9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Miscellaneous
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	9.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Notices
</U>
	.
	All communications hereunder, except as herein otherwise specifically provided, shall be in writing and shall be mailed (registered
	or certified mail, return receipt requested), personally delivered or sent by facsimile transmission and confirmed and shall be
	deemed given when so delivered or faxed and confirmed or if mailed, two (2) days after such mailing.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN">
	If to the Representatives:
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN">
	Northland Securities, Inc.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN">
	750 Fifth Avenue, Suite 2401
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN">
	New York, NY 10017
<BR>
	Attention: [&#9679;]
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN">
	Fax No.: [&#9679;]
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN">
	and
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN">
	Neidiger, Tucker, Bruner, Inc.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN">
	9540 South Maroon Circle, Suite 250
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN">
	Englewood, CO 80112
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN">
	Attention: [&#9679;]
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN">
	Fax No.: [&#9679;]
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 29; VALUE: 2 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	28
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage177"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN; TEXT-INDENT: 0.5IN">
	&nbsp;&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN">
	with a copy (which shall not constitute notice) to:
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 35.1PT">
<BR>
<FONT STYLE="FONT-SIZE: 10PT">
	Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
</FONT>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 35.1PT">
	Attention: Ivan K. Blumenthal, Esq.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 35.1PT">
	Fax No.:&nbsp;(212) 983-3115&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN">
	If to the Company:
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN">
	Sensus Healthcare, LLC
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN">
	851 Broken Sound Pkwy. NW #215
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 35.1PT">
	Boca Raton, Florida 33487
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 35.1PT">
	Attention: Joseph C. Sardano, Chief Executive Officer
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN">
	Fax No.: (561) 948-2739
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN">
	with a copy (which shall not constitute notice) to:
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN">
	Gunster, Yoakley &amp; Stewart, P.A.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN">
	450 E. Las Olas Blvd., Suite 1400
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN">
	Fort Lauderdale, Florida 33301
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN">
	Attention: David C. Scileppi, Esq.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.5IN">
	Fax No.: 954-888-2033
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	9.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Headings
</U>
	.
	The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way limit or affect the
	meaning or interpretation of any of the terms or provisions of this Agreement.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	9.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Amendment
</U>
	.
	This Agreement may only be amended by a written instrument executed by each of the parties hereto.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	9.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Entire
	Agreement
</U>
	. This Agreement (together with the other agreements and documents being delivered pursuant to or in connection with
	this Agreement) constitutes the entire agreement of the parties hereto with respect to the subject matter hereof and thereof, and
	supersedes all prior agreements and understandings of the parties, oral and written, with respect to the subject matter hereof.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	9.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Binding
	Effect
</U>
	. This Agreement shall inure solely to the benefit of and shall be binding upon the Representatives, the Underwriters,
	the Company and the controlling persons, directors and officers referred to in Section 5 hereof, and their respective successors,
	legal representatives, heirs and assigns, and no other person shall have or be construed to have any legal or equitable right,
	remedy or claim under or in respect of or by virtue of this Agreement or any provisions herein contained. The term &ldquo;successors
	and assigns&rdquo; shall not include a purchaser, in its capacity as such, of securities from any of the Underwriters.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	9.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Governing
	Law; Consent to Jurisdiction; Trial by Jury
</U>
	. This Agreement shall be governed by and construed and enforced in accordance with
	the laws of the State of New York, without giving effect to conflict of laws principles thereof. Each of the Company and the Underwriters
	hereby agree that any action, proceeding or claim against it arising out of, or relating in any way to this Agreement shall be
	brought and enforced in the New York Supreme Court, County of New York, or in the United States District Court for the Southern
	District of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive. Each of the Company
	and the Underwriters hereby waive any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum.
	Any such process or summons to be served upon the Company may be served by transmitting a copy thereof by registered or certified
	mail, return receipt requested, postage prepaid, addressed to it at the address set forth in Section 9.1 hereof. Such mailing shall
	be deemed personal service and shall be legal and binding upon the Company in any action, proceeding or claim. The parties agree
	that the prevailing party(ies) in any such action shall be entitled to recover from the other party(ies) all of its reasonable
	attorneys&rsquo; fees and expenses relating to such action or proceeding and/or incurred in connection with the preparation therefor.
	The Company (on its behalf and, to the extent permitted by applicable law, on behalf of its stockholders and affiliates) and each
	of the Underwriters hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by
	jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 30; VALUE: 2 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	29
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage178"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	9.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Execution
	in Counterparts
</U>
	. This Agreement may be executed in one or more counterparts, and by the different parties hereto in separate
	counterparts, each of which shall be deemed to be an original, but all of which taken together shall constitute one and the same
	agreement, and shall become effective when one or more counterparts has been signed by each of the parties hereto and delivered
	to each of the other parties hereto. Delivery of a signed counterpart of this Agreement by facsimile or email/pdf transmission
	shall constitute valid and sufficient delivery thereof.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	9.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Waiver,
	etc
</U>
	. The failure of any of the parties hereto to at any time enforce any of the provisions of this Agreement shall not be deemed
	or construed to be a waiver of any such provision, nor to in any way effect the validity of this Agreement or any provision hereof
	or the right of any of the parties hereto to thereafter enforce each and every provision of this Agreement. No waiver of any breach,
	non-compliance or non-fulfillment of any of the provisions of this Agreement shall be effective unless set forth in a written instrument
	executed by the party or parties against whom or which enforcement of such waiver is sought; and no waiver of any such breach,
	non-compliance or non-fulfillment shall be construed or deemed to be a waiver of any other or subsequent breach, non-compliance
	or non-fulfillment.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
	[Signature Page Follows]
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 31; VALUE: 2 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	30
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage179"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	If the foregoing correctly
	sets forth the understanding between the Underwriters and the Company, please so indicate in the space provided below for that
	purpose, whereupon this letter shall constitute a binding agreement between us.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD>
	&nbsp;
</TD>
<TD COLSPAN="2">
<FONT STYLE="FONT-SIZE: 10PT">
	Very truly yours,
</FONT>
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD>
	&nbsp;
</TD>
<TD COLSPAN="2">
	&nbsp;
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD>
	&nbsp;
</TD>
<TD COLSPAN="2">
<FONT STYLE="FONT-SIZE: 10PT">
	SENSUS HEALTHCARE, INC.
</FONT>
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 50%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 4%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 46%">
	&nbsp;
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD>
	&nbsp;
</TD>
<TD>
<FONT STYLE="FONT-SIZE: 10PT">
	By:
</FONT>
</TD>
<TD STYLE="BORDER-BOTTOM: BLACK 1PT SOLID; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD>
	&nbsp;
</TD>
<TD>
	&nbsp;
</TD>
<TD>
<FONT STYLE="FONT-SIZE: 10PT">
	Name:
</FONT>
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD>
	&nbsp;
</TD>
<TD>
	&nbsp;
</TD>
<TD>
<FONT STYLE="FONT-SIZE: 10PT">
	Title:
</FONT>
</TD>
</TR>
</TABLE>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 222.3PT; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	Confirmed as of the date first written above mentioned, on behalf
	of itself and as Representatives of the several Underwriters named on
<U>
	Schedule 1
</U>
	hereto:
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	NORTHLAND SECURITIES, INC.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 4%">
<FONT STYLE="FONT-SIZE: 10PT">
	By:
</FONT>
</TD>
<TD STYLE="WIDTH: 46%; BORDER-BOTTOM: BLACK 1PT SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 50%">
	&nbsp;
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD>
	&nbsp;
</TD>
<TD>
<FONT STYLE="FONT-SIZE: 10PT">
	Name:
</FONT>
</TD>
<TD>
	&nbsp;
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD>
	&nbsp;
</TD>
<TD>
<FONT STYLE="FONT-SIZE: 10PT">
	Title:
</FONT>
</TD>
<TD>
	&nbsp;
</TD>
</TR>
</TABLE>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.25IN; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	NEIDIGER, TUCKER, BRUNER, INC.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 4%">
<FONT STYLE="FONT-SIZE: 10PT">
	By:
</FONT>
</TD>
<TD STYLE="WIDTH: 46%; BORDER-BOTTOM: BLACK 1PT SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 50%">
	&nbsp;
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD>
	&nbsp;
</TD>
<TD>
<FONT STYLE="FONT-SIZE: 10PT">
	Name:
</FONT>
</TD>
<TD>
	&nbsp;
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD>
	&nbsp;
</TD>
<TD>
<FONT STYLE="FONT-SIZE: 10PT">
	Title:
</FONT>
</TD>
<TD>
	&nbsp;
</TD>
</TR>
</TABLE>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0 0 0 0.25IN; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	[Signature
	Page]
</FONT>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Sensus
	Healthcare, Inc. &ndash; Underwriting Agreement
</FONT>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER; TEXT-INDENT: 0.5IN">
<B>
	&nbsp;
</B>
</P>
<!-- FIELD: PAGE; SEQUENCE: 32 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<A NAME="eolPage180"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<B>
	&nbsp;
</B>
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_38"></A>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<B>
<U>
	SCHEDULE 1
</U>
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER; TEXT-INDENT: 0.5IN">
	&nbsp;&nbsp;&nbsp;&nbsp;
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 60%; BORDER-COLLAPSE: COLLAPSE">
<TR STYLE="VERTICAL-ALIGN: BOTTOM">
<TD NOWRAP STYLE="WIDTH: 46%; TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-SIZE: 10PT">
<B>
	Underwriter
</B>
</FONT>
</TD>
<TD NOWRAP STYLE="WIDTH: 27%; TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-SIZE: 10PT">
<B>
	Total&nbsp;Number&nbsp;of
</B>
</FONT>
<BR>
<FONT STYLE="FONT-SIZE: 10PT">
<B>
	Firm Units&nbsp;to&nbsp;be
</B>
</FONT>
<BR>
<FONT STYLE="FONT-SIZE: 10PT">
<B>
	Purchased
</B>
</FONT>
</TD>
<TD NOWRAP STYLE="WIDTH: 27%; TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-SIZE: 10PT">
<B>
	Number&nbsp;of&nbsp;Option
<BR>
	Units
<BR>
	to&nbsp;be&nbsp;Purchased&nbsp;if
</B>
</FONT>
<BR>
<FONT STYLE="FONT-SIZE: 10PT">
<B>
	the&nbsp;Over-
<BR>
	Allotment&nbsp;Option
</B>
</FONT>
<BR>
<FONT STYLE="FONT-SIZE: 10PT">
<B>
	is&nbsp;Fully&nbsp;Exercised
</B>
</FONT>
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: BOTTOM">
<TD STYLE="TEXT-ALIGN: CENTER">
	&nbsp;
</TD>
<TD STYLE="TEXT-ALIGN: CENTER">
	&nbsp;
</TD>
<TD STYLE="TEXT-ALIGN: CENTER">
	&nbsp;
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
<TD>
<FONT STYLE="FONT-SIZE: 10PT">
	Northland Securities, Inc.
</FONT>
</TD>
<TD STYLE="TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
<TD STYLE="TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: WHITE">
<TD>
	&nbsp;
</TD>
<TD STYLE="TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
<TD STYLE="TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-BOTTOM: 1PT">
<FONT STYLE="FONT-SIZE: 10PT">
	Neidiger, Tucker, Bruner, Inc.
</FONT>
</TD>
<TD STYLE="BORDER-BOTTOM: BLACK 1PT SOLID; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
<TD STYLE="BORDER-BOTTOM: BLACK 1PT SOLID; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</EFX_UNIDENTIFIED_TABLE>
<TR STYLE="VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: WHITE">
<TD>
	&nbsp;
</TD>
<TD STYLE="TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
<TD STYLE="TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="PADDING-BOTTOM: 2.5PT">
<FONT STYLE="FONT-SIZE: 10PT">
<B>
	TOTAL
</B>
</FONT>
</TD>
<TD STYLE="BORDER-BOTTOM: BLACK 2.25PT DOUBLE">
	&nbsp;
</TD>
<TD STYLE="BORDER-BOTTOM: BLACK 2.25PT DOUBLE; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 33; OPTIONS: NEWSECTION; VALUE: 1 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER; WIDTH: 34%">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Sch
</FONT>
	.
	1-
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	1
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage181"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<B>
	&nbsp;
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<B>
<U>
	SCHEDULE 2-A
</U>
</B>
<BR>
<BR>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<B>
	Pricing Information
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	Number of Firm Units: [&bull;]
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	Number of Firm Shares: [&bull;]
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	Number of Firm Warrants: [&bull;]
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	Number of Option Units: [&bull;]
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	Public Offering Price per Unit: $[&bull;]
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	Underwriting Discount per Unit: $[&bull;]
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-INDENT: 0.5IN">
	&nbsp;&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	Proceeds to Company per Unit (before expenses): $[&bull;]
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 34; OPTIONS: NEWSECTION; VALUE: 1 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Sch
</FONT>
	. 2-
<!-- FIELD: SEQUENCE; TYPE: UPPERLETTER; NAME: PAGENO -->
	A
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage182"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<B>
	&nbsp;
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<B>
<U>
	SCHEDULE 2-B
</U>
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<EFX_BUSINESS>
<A NAME="FIS_BUSINESS_2"></A>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<B>
	Issuer General Use Free Writing Prospectuses
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	[ADD]
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 35; VALUE: 1 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Sch
</FONT>
	. 2-
<!-- FIELD: SEQUENCE; TYPE: UPPERLETTER; NAME: PAGENO -->
	B
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage183"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<B>
	&nbsp;
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<B>
<U>
	SCHEDULE 2-C
</U>
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<B>
	Written Testing-the-Waters Communications
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	[None.]&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 36; VALUE: 1 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Sch
</FONT>
	. 2-
<!-- FIELD: SEQUENCE; TYPE: UPPERLETTER; NAME: PAGENO -->
	C
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage184"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<B>
	&nbsp;
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<B>
<U>
	SCHEDULE 3
</U>
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<B>
	List of Lock-Up Parties
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER; TEXT-INDENT: 0.5IN">
<B>
	&nbsp;
</B>
</P>
<!-- FIELD: PAGE; SEQUENCE: 37; OPTIONS: NEWSECTION; VALUE: 1 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	Sch
</FONT>
	. 3-
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	1
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage185"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<B>
	&nbsp;
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<B>
<U>
	EXHIBIT&nbsp;A
</U>
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER; TEXT-INDENT: 0.5IN">
<B>
	&nbsp;
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<B>
	Representatives&rsquo; Warrant Agreement
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<B>
	&nbsp;
</B>
</P>
<!-- FIELD: PAGE; SEQUENCE: 38; OPTIONS: NEWSECTION; VALUE: 1 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	E
<FONT STYLE="FONT-SIZE: 8PT">
	X
</FONT>
</FONT>
	.
<!-- FIELD: SEQUENCE; TYPE: UPPERLETTER; NAME: PAGENO -->
	A
<!-- FIELD: /SEQUENCE -->
	-1
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage186"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<B>
	&nbsp;
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<B>
<U>
	EXHIBIT&nbsp;B
</U>
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER; TEXT-INDENT: 0.5IN">
<B>
	&nbsp;
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<B>
	Warrant Agreement
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
<B>
	&nbsp;
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<B>
<U>
	EXHIBIT C
</U>
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<B>
	&nbsp;
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<B>
	Lock-Up Agreement
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<B>
	&nbsp;
</B>
</P>
<!-- FIELD: PAGE; SEQUENCE: 39; VALUE: 1 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
<FONT STYLE="FONT-SIZE: 8PT">
</FONT>
</FONT>
<!-- FIELD: SEQUENCE; TYPE: UPPERLETTER; NAME: PAGENO -->
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage187"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<B>
	&nbsp;
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<B>
<U>
	EXHIBIT D
</U>
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER; TEXT-INDENT: 0.5IN">
<B>
	&nbsp;
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<B>
	Form of Press Release
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">
<B>
	&nbsp;
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
<B>
	Sensus Healthcare, Inc.
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-INDENT: 0.5IN">
<B>
	&nbsp;
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
<B>
	[Date]
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	Sensus Healthcare, Inc. (the &ldquo;Company&rdquo;) announced today
	that Northland Securities, Inc. and Neidiger, Tucker, Bruner, Inc. acting as underwriters in the Company&rsquo;s recent public
	offering of&nbsp; _______ of the Company&rsquo;s units (containing [___] shares of the Company&rsquo;s common stock and [___] warrants
	to purchase shares of the Company&rsquo;s common stock), are [waiving] [releasing] a lock-up restriction with respect to
<U>
	_________
</U>
	&nbsp;
	units, (containing [_____] shares of the Company&rsquo;s common and warrants to purchase [____] shares of the Company&rsquo;s common
	stock) held by [certain officers or directors] [an officer or director] of the Company.&nbsp; The [waiver] [release] will take
	effect on&nbsp; _________, 20___, and the shares may be sold on or after such date.&nbsp;&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-INDENT: 0.5IN">
	&nbsp;
<B>
	&nbsp;
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
<B>
	This press release is not an offer or sale of the securities
	in the United States or in any other jurisdiction where such offer or sale is prohibited, and such securities may not be offered
	or sold in the United States absent registration or an exemption from registration under the Securities Act of 1933, as amended.
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 40; OPTIONS: LAST -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	E
<FONT STYLE="FONT-SIZE: 8PT">
	X
</FONT>
</FONT>
	.
<!-- FIELD: SEQUENCE; TYPE: UPPERLETTER; NAME: PAGENO -->
	C
<!-- FIELD: /SEQUENCE -->
	-1
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_BUSINESS>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0">
</P>
</EFX_EXHIBIT_1>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage188"></A>
<A NAME="V440371_EX4-6_HTM"></A>
<EFX_EXHIBIT_4>
<A NAME="FIS_EXHIBIT_4"></A>
<P STYLE="MARGIN: 0">
<B>
	&nbsp;
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: RIGHT">
<B>
	Exhibit 4.6
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER">
<B>
	&nbsp;
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER">
<B>
<U>
	AMENDMENT NO. 2 TO WARRANT
</U>
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
<B>
	THIS
</B>
<B>
	AMENDMENT
	NO. 2 TO WARRANT
</B>
	(this &ldquo;
<U>
	Amendment
</U>
	&rdquo;) is hereby entered into between Sensus Healthcare, Inc., a Delaware corporation
	(the &ldquo;
<U>
	Company
</U>
	&rdquo;), and the undersigned warrant holder (&ldquo;
<U>
	Holder
</U>
	&rdquo;) as of April 27, 2016 (the
	&ldquo;
<U>
	Effective Date
</U>
	&rdquo;).
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER">
<B>
	WITNESSETH:
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
<B>
	WHEREAS
</B>
	, the
	Company previously issued a warrant, dated as of March 31, 2011 (the &ldquo;
<U>
	Warrant
</U>
	&rdquo;),
	to acquire equity interests of the Company in connection with an engagement letter, dated March 15, 2010, to conduct a private
	securities offering; and
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
<B>
	WHEREAS
</B>
	, the
	Warrant is set to expire on April 30, 2016 if not exercised prior to such date; and
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
<B>
	WHEREAS
</B>
	, the
	Company and Holder desire to extend the exercise period of the Warrant until May 30, 2016.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
<B>
	NOW, THEREFORE
</B>
	,
	in consideration of the mutual covenants contained herein, and for other good and valuable consideration, the receipt and adequacy
	of which is hereby acknowledged, the Company and Holder hereby agree that the terms of the Warrant are hereby modified and, to
	the extent inconsistent with the terms of the Warrant superseded as follows:
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Amendment
	to Term of Warrant
</U>
	. In accordance with
<U>
	Section 7
</U>
	of the Warrant, the Expiration Date is hereby extended to May 30, 2016.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Capitalized
	Terms
</U>
	. Capitalized terms herein shall have the meanings ascribed to them in the Warrant, except as otherwise expressly provided
	in this Amendment.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Effect
	of Amendment
</U>
	. Except and to the extent modified by this Amendment, the provisions of the Warrant shall remain in full force
	and effect and are hereby incorporated into and made a part of this Amendment as if fully stated herein.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
<B>
	&nbsp;
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
<B>
	IN WITNESS WHEREOF
</B>
	,
	the Company and Holder have caused this Amendment to be executed as of the Effective Date.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD>
	&nbsp;
</TD>
<TD COLSPAN="2">
<FONT STYLE="FONT-SIZE: 10PT">
<B>
	SENSUS HEALTHCARE, INC.
</B>
</FONT>
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 50%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 6%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%">
	&nbsp;
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD>
	&nbsp;
</TD>
<TD>
<FONT STYLE="FONT-SIZE: 10PT">
	By:
</FONT>
</TD>
<TD STYLE="BORDER-BOTTOM: BLACK 1PT SOLID">
<FONT STYLE="FONT-SIZE: 10PT">
	/s/Joseph Sardano
</FONT>
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD>
	&nbsp;
</TD>
<TD>
<FONT STYLE="FONT-SIZE: 10PT">
	Name:
</FONT>
</TD>
<TD>
	Joseph Sardano
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD>
	&nbsp;
</TD>
<TD>
<FONT STYLE="FONT-SIZE: 10PT">
	Title:
</FONT>
</TD>
<TD>
<FONT STYLE="FONT-SIZE: 10PT">
	Chief Executive Officer
</FONT>
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD>
	&nbsp;
</TD>
<TD>
	&nbsp;
</TD>
<TD>
	&nbsp;
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD>
	&nbsp;
</TD>
<TD COLSPAN="2">
<FONT STYLE="FONT-SIZE: 10PT">
<B>
	INVESTORS CAPITAL ALLIANCE, LLC
</B>
</FONT>
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD>
	&nbsp;
</TD>
<TD>
	&nbsp;
</TD>
<TD>
	&nbsp;
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD>
	&nbsp;
</TD>
<TD>
<FONT STYLE="FONT-SIZE: 10PT">
	By:
</FONT>
</TD>
<TD STYLE="BORDER-BOTTOM: BLACK 1PT SOLID">
<FONT STYLE="FONT-SIZE: 10PT">
	/s/ William McCall
</FONT>
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD>
	&nbsp;
</TD>
<TD>
<FONT STYLE="FONT-SIZE: 10PT">
	Name:
</FONT>
</TD>
<TD>
<FONT STYLE="FONT-SIZE: 10PT">
	William McCall
</FONT>
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD>
	&nbsp;
</TD>
<TD>
<FONT STYLE="FONT-SIZE: 10PT">
	Title:
</FONT>
</TD>
<TD>
<FONT STYLE="FONT-SIZE: 10PT">
	Managing Partner
</FONT>
</TD>
</TR>
</TABLE>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 1; OPTIONS: LAST -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	&nbsp;
</P>
</EFX_EXHIBIT_4>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage189"></A>
<A NAME="V440371_EX4-7_HTM"></A>
<EFX_EXHIBIT_4>
<A NAME="FIS_EXHIBIT_4_2"></A>
<P STYLE="MARGIN: 0">
	&nbsp;
</P>
<P STYLE="MARGIN: 0; TEXT-ALIGN: RIGHT">
<B>
	Exhibit 4.7
</B>
</P>
<P STYLE="MARGIN: 0">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER">
<B>
	Form of Representatives&rsquo; Warrant
	Agreement
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.2PT">
	THE REGISTERED HOLDER
	OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT EXCEPT
	AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR
	HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FOLLOWING THE EFFECTIVE DATE (DEFINED BELOW) TO ANYONE
	OTHER THAN (I) NORTHLAND SECURITIES, INC.,&nbsp;
<FONT STYLE="TEXT-TRANSFORM: UPPERCASE">
	NEIDIGER, TUCKER, BRUNER, INC.
</FONT>
	&nbsp;OR
	AN UNDERWRITER OR A SELECTED DEALER IN CONNECTION WITH THE OFFERING, OR (II) A BONA FIDE OFFICER OR PARTNER OF NORTHLAND SECURITIES,
	INC., NEIDIGER, TUCKER, BRUNER, INC. OR OF ANY SUCH UNDERWRITER OR SELECTED DEALER.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.2PT">
	THIS PURCHASE WARRANT
	IS NOT EXERCISABLE PRIOR TO [________________] [
<B>
	DATE THAT IS ONE YEAR FROM THE EFFECTIVE DATE OF THE OFFERING
</B>
	]. VOID AFTER
	5:00 P.M., EASTERN TIME, [___________________] [
<B>
	DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING
</B>
	].
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.2PT">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER">
<B>
	UNIT PURCHASE WARRANT
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER; TEXT-INDENT: 0.5IN">
<B>
	&nbsp;
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER">
	For the Purchase of [_____] Units
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER">
	of
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER">
	SENSUS HELTHCARE, INC.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER; TEXT-INDENT: 0.5IN">
<FONT STYLE="TEXT-TRANSFORM: UPPERCASE">
	&nbsp;
</FONT>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
	1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Unit
	Purchase Warrant
</U>
	. THIS CERTIFIES THAT, in consideration of funds duly paid and for other good and valuable consideration, including
	provision of services, by or on behalf of [Northland Securities, Inc./Neidiger, Tucker, Bruner, Inc., or its or their assigns,]
	(&ldquo;
<B>
	Holder
</B>
	&rdquo;), as registered owner of this Unit Purchase Warrant (the &ldquo;
<B>
<U>
	Purchase Warrant
</U>
</B>
	&rdquo;),
	to Sensus Healthcare, Inc., a Delaware corporation (the &ldquo;
<B>
	Company
</B>
	&rdquo;), Holder is entitled, at any time or from
	time to time from [________________] [
<B>
	DATE THAT IS ONE YEAR FROM THE EFFECTIVE DATE OF THE OFFERING
</B>
	] (the &ldquo;
<B>
	Commencement
	Date
</B>
	&rdquo;), and until at or before 5:00 p.m., Eastern time, [____________] [
<B>
	DATE THAT IS FIVE YEARS FROM THE EFFECTIVE
	DATE OF THE OFFERING
</B>
	] (the&nbsp;&rdquo;
<B>
	Expiration&nbsp;Date
</B>
	&rdquo;), but not thereafter, to subscribe for, purchase
	and receive, in whole or in part, up to [____] units (&ldquo;
<B>
<U>
	Units
</U>
</B>
	&rdquo;) of the Company, each Unit consisting of
	one share of common stock of the Company, par value $0.01 per share (&ldquo;
<B>
<U>
	Common Stock
</U>
</B>
	&rdquo;) and one warrant
	to purchase one share of Common Stock (&ldquo;
<B>
<U>
	Warrant(s)
</U>
</B>
	&rdquo;), subject to adjustment as provided in Section 6
	hereof. Each Warrant shall be in substantially the same form as the warrant included in the Units being registered for sale to
	the public (&ldquo;
<B>
<U>
	Public Warrants
</U>
</B>
	&rdquo;) by way of the Company&rsquo;s Registration Statement on Form S-1 (No.
	333-209145) (&ldquo;
<B>
<U>
	Registration Statement
</U>
</B>
	&rdquo;). No actual Units shall be issued upon exercise of this Purchase
	Warrant, and upon exercise thereof and payment of the applicable Exercise Price as provided for herein, the Holder shall be entitled
	to receive shares of Common Stock and Warrants, as the case may be. All references in this Purchase Warrant to &ldquo;Units&rdquo;
	shall refer to the purchase of the Common Stock and Warrants, as the case may be, that each Unit is divisible into. If the Expiration
	Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the
	next succeeding day which is not such a day in accordance with the terms herein. During the period commencing on the Effective
	Date and ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This
	Purchase Warrant is initially exercisable at $7.80 per Unit;&nbsp;
<U>
	provided
</U>
	,&nbsp;
<U>
	however
</U>
	, that upon the occurrence
	of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per
	Unit and the number of shares of Common Stock and Warrants to be received upon such exercise, shall be adjusted as therein specified.
	The term &ldquo;
<B>
	Exercise Price
</B>
	&rdquo; shall mean the initial exercise price or the adjusted exercise price, depending on
	the context. The term &ldquo;
<B>
	Effective Date
</B>
	&rdquo; shall mean [____], 2016, the date of that certain Underwriting Agreement,
	by and between the Company and Northland Securities, Inc. and Neidiger, Tucker, Bruner, Inc., as representatives of the underwriters
	named therein (the &ldquo;
<B>
	Underwriting Agreement
</B>
	&rdquo;).
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 1 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	1
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage190"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Exercise
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Exercise
	Form
</U>
	. In order to exercise this Purchase Warrant, the exercise form attached hereto must be duly executed and completed and
	delivered to the Company, together with this Purchase Warrant and payment of the Exercise Price for the Units being purchased payable
	in cash by wire transfer of immediately available funds to an account designated by the Company or by certified check or official
	bank check. In the event of a partial exercise or assignment hereof, the Company shall issue and deliver to or upon the order of
	the Holder a new Purchase Warrant of like tenor, in the name of the Holder or as the Holder (upon payment by the Holder of applicable
	transfer taxes) may request, evidencing the right to purchase the aggregate number of Units for which such Purchase Warrant may
	still be exercised. If the subscription rights represented hereby shall not be exercised at or before 5:00 p.m., Eastern time,
	on the Expiration Date, this Purchase Warrant shall become and be void without further force or effect, and all rights represented
	hereby shall cease and expire.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Cashless
	Exercise
</U>
	.&nbsp; If at any time after the Commencement Date there is no effective registration statement registering, or no
	current prospectus available for, the resale of the shares of Common Stock, Warrants underlying the Purchase Warrants and shares
	of Common Stock underlying the Warrants issuable hereunder by the Holder, then in lieu of exercising this Purchase Warrant by payment
	of cash or check payable to the order of the Company pursuant to Section 2.1 above, Holder may elect to receive the number shares
	of Common Stock and Warrants equal to the value of this Purchase Warrant (or the portion thereof being exercised), by surrender
	of this Purchase Warrant to the Company, together with the exercise form attached hereto, in which event the Company shall issue
	to Holder shares of Common Stock in accordance with the following formula:
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD NOWRAP STYLE="WIDTH: 1%; FONT-SIZE: 10PT; TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-SIZE: 10PT">
	X
</FONT>
</TD>
<TD NOWRAP STYLE="WIDTH: 1%; FONT-SIZE: 10PT; TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-SIZE: 10PT">
	=
</FONT>
</TD>
<TD NOWRAP STYLE="WIDTH: 8%; TEXT-ALIGN: CENTER">
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN-TOP: 0PT; MARGIN-BOTTOM: 0PT; TEXT-ALIGN: CENTER">
<U>
	&nbsp;&nbsp;Y(A-B)&nbsp;&nbsp;
</U>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN-TOP: 0PT; MARGIN-BOTTOM: 0PT; TEXT-ALIGN: CENTER">
	A
</P>
</TD>
<TD NOWRAP STYLE="WIDTH: 90%; FONT-SIZE: 10PT">
	&nbsp;
</TD>
</TR>
</TABLE>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	Where,
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN">
	X=The number of shares of Common Stock to be
	issued to Holder;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN">
	Y=The number of Units for which the Purchase Warrant
	is being exercised;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN">
	A=The fair market value of one share of Common
	Stock; and
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN">
	B=The Exercise Price.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	The number Warrants
	to purchase Common Stock issuable upon cashless exercise will be equal to the number of shares of Common Stock issuable in accordance
	with the above formula.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	For purposes of this
	Section 2.2, the fair market value of a share of Common Stock is defined as follows:
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 74.1PT; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: -23.4PT">
	&nbsp;
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 7%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 7%; FONT-SIZE: 10PT">
<FONT STYLE="FONT-SIZE: 10PT">
	(i)
</FONT>
</TD>
<TD STYLE="WIDTH: 86%; FONT-SIZE: 10PT">
<FONT STYLE="FONT-SIZE: 10PT">
	if the Company&rsquo;s Common Stock is traded on a
	securities exchange, the value shall be deemed to be the closing price on such exchange as of the trading day immediately
	prior to the day
	of which the exercise form being submitted in connection with the exercise of the Purchase Warrant;
	or
</FONT>
</TD>
</TR>
</TABLE>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 74.15PT; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: -23.75PT">
	&nbsp;
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 7%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 7%; FONT-SIZE: 10PT">
<FONT STYLE="FONT-SIZE: 10PT">
	(ii)
</FONT>
</TD>
<TD STYLE="WIDTH: 86%; FONT-SIZE: 10PT">
<FONT STYLE="FONT-SIZE: 10PT">
	if the Company&rsquo;s Common Stock is actively traded
	over-the-counter, the value shall be deemed to be the closing bid price as of the trading day immediately prior to the day
	of which the exercise form being submitted in connection with the exercise of the Purchase Warrant; if there is no active
	public market, the value shall be the fair market value thereof, as determined in good faith by the Company&rsquo;s
	Board of Directors.
</FONT>
</TD>
</TR>
</TABLE>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Delivery
	of Shares and Warrants
</U>
	. Upon exercise, the applicable number of shares of Common Stock and Warrants shall be delivered to the
	Holder within three (3) business days of the Company&rsquo;s receipt of the exercise form completed and payment of the applicable
	Exercise Price, if paid in cash.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Legend
</U>
	.
	Each certificate representing the shares of Common Stock and Warrants issued hereunder shall bear a legend as follows unless
	such securities have been registered under the Securities Act of 1933, as amended (the &ldquo;
<B>
	Act
</B>
	&rdquo;):
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&ldquo;The securities
	represented by this certificate have not been registered under the Securities Act of 1933, as amended (the &ldquo;
<B>
	Securities
	Act
</B>
	&rdquo;), or applicable state law. Neither the securities nor any interest therein may be offered for sale, sold or otherwise
	transferred except pursuant to an effective registration statement under the Securities Act, or pursuant to an exemption from registration
	under the Securities Act and applicable state law which, in the opinion of counsel to the Company, is available.&rdquo;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 2 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	2
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage191"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
	3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Transfer
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	3.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	General
	Restrictions
</U>
	. The registered Holder of this Purchase Warrant agrees by his, her or its acceptance hereof, that such Holder
	will not: (a) sell, transfer, assign, pledge or hypothecate this Purchase Warrant for a period of one hundred eighty (180) days
	following the Effective Date to anyone other than: (i) Northland Securities, Inc. (&ldquo;
<B>
	Northland
</B>
	&rdquo;), Neidiger, Tucker,
	Bruner, Inc. (&ldquo;
<B>
	Neidiger
</B>
	&rdquo;) or an underwriter or a selected dealer participating in the offering contemplated
	by the Underwriting Agreement (the &ldquo;
<B>
	Offering
</B>
	&rdquo;), or (ii) a bona fide officer or partner of Northland, Neidiger
	or of any such underwriter or selected dealer, in each case in accordance with FINRA Rules 5110(g)(1) and 5110(g)(2)(A)(ii), or
	(b) cause this Purchase Warrant or the securities issuable hereunder to be the subject of any hedging, short sale, derivative,
	put or call transaction that would result in the effective economic disposition of this Purchase Warrant or the securities hereunder,
	except as provided for in FINRA Rule 5110(g)(2). On and after 180 days after the Effective Date, transfers to others may be made
	subject to compliance with or exemptions from applicable securities laws. In order to make any permitted assignment, the Holder
	must deliver to the Company the assignment form attached hereto duly executed and completed, together with the Purchase Warrant
	and payment of all transfer taxes, if any, payable in connection therewith. The Company shall within three (3) business days transfer
	this Purchase Warrant on the books of the Company and shall execute and deliver a new Purchase Warrant or Purchase Warrants of
	like tenor to the appropriate assignee(s) expressly evidencing the right to purchase the aggregate number of shares of Common Stock
	and Warrants purchasable hereunder or such portion of such number as shall be contemplated by any such assignment.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	3.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Restrictions
	Imposed by the Securities Act
</U>
	. The securities evidenced by this Purchase Warrant shall not be transferred unless and until:
	(i) the Company has received the opinion of counsel for the Holder that the securities may be transferred pursuant to an exemption
	from registration under the Securities Act and applicable state securities laws, the availability of which is established to the
	reasonable satisfaction of the Company (the Company hereby agreeing that the opinion of Mintz, Levin, Cohn, Ferris, Glovsky and
	Popeo, P.C. shall be deemed satisfactory evidence of the availability of an exemption), or (ii) a registration statement or a post-effective
	amendment to the Registration Statement relating to the offer and sale of such securities has been filed by the Company and declared
	effective by the U.S. Securities and Exchange Commission (the&nbsp;&ldquo;
<B>
	Commission
</B>
	&rdquo;) and compliance with applicable
	state securities law has been established.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
	4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Registration
	Rights
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	4.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Demand
	Registration
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	4.1.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Grant
	of Right
</U>
	. The Company, upon written demand (a &ldquo;
<B>
	Demand Notice
</B>
	&rdquo;) of the Holder(s) of at least 51% of the Purchase
	Warrants (&ldquo;
<B>
	Majority Holders
</B>
	&rdquo;), agrees to register, on one occasion, all or any portion of the shares of Common
	Stock, Warrants underlying the Purchase Warrants and shares of Common Stock underlying the Warrants (collectively, the &ldquo;
<B>
	Registrable
	Securities
</B>
	&rdquo;). On such occasion, the Company will file a registration statement with the Commission covering the Registrable
	Securities within sixty (60) days after receipt of a Demand Notice and use its reasonable best efforts to have the registration
	statement declared effective promptly thereafter, subject to compliance with review by the Commission;&nbsp;
<U>
	provided
</U>
	,&nbsp;
<U>
	however
</U>
	,
	that the Company shall not be required to comply with a Demand Notice if the Company has filed a registration statement with respect
	to which the Holder is entitled to piggyback registration rights pursuant to Section 4.2 hereof and either: (i) the Holder has
	elected to participate in the offering covered by such registration statement or (ii) if such registration statement relates to
	an underwritten primary offering of securities of the Company, until the offering covered by such registration statement has been
	withdrawn or until thirty (30) days after such offering is consummated. The demand for registration may be made at any time during
	a period of four (4) years beginning on the Commencement Date. The Company covenants and agrees to give written notice of its receipt
	of any Demand Notice by any Holder(s) to all other registered Holders of the Purchase Warrants and/or the Registrable Securities
	within ten (10) days after the date of the receipt of any such Demand Notice.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 3 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	3
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage192"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	4.1.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Terms
</U>
	.
	The Company shall bear all fees and expenses attendant to the registration of the Registrable Securities pursuant to Section 4.1.1,
	but the Holders shall pay any and all underwriting commissions and the expenses of any legal counsel selected by the Holders to
	represent them in connection with the sale of the Registrable Securities. The Company agrees to use its reasonable best efforts
	to cause the filing required herein to become effective promptly and to qualify or register the Registrable Securities in such
	states as are reasonably requested by the Holder(s);&nbsp;
<U>
	provided
</U>
	,&nbsp;
<U>
	however
</U>
	, that in no event shall the Company
	be required to register the Registrable Securities in a state in which such registration would cause: (i) the Company to be obligated
	to register or license to do business in such state or submit to general service of process in such State, or (ii) the principal
	shareholders of the Company to be obligated to escrow their shares of capital stock of the Company. The Company shall cause any
	registration statement filed pursuant to the demand right granted under Section 4.1.1 to remain effective for a period of at least
	twelve (12) consecutive months after the date that the Holders of the Registrable Securities covered by such registration statement
	are first given the opportunity to sell all of such securities. The Holders shall only use the prospectuses provided by the Company
	to sell the shares covered by such registration statement, and will immediately cease to use any prospectus furnished by the Company
	if the Company advises the Holder that such prospectus may no longer be used due to a material misstatement or omission. Notwithstanding
	the provisions of this Section 4.1.2, the Holder shall be entitled to a demand registration under this Section 4.1.2 on only one
	(1) occasion and such demand registration right shall terminate on the fifth anniversary of the effectiveness of the registration
	statement in accordance with FINRA Rule 5110(f)(2)(G)(iv).
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	4.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	&ldquo;Piggy-Back&rdquo;
	Registration
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	4.2.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Grant
	of Right
</U>
	. In addition to the demand right of registration described in Section 4.1 hereof, the Holder shall have the right,
	for a period of no more than seven (7) years from the date of effectiveness of the registration statement in accordance with FINRA
	Rule 5110(f)(2)(G)(v), to include the Registrable Securities as part of any other registration of securities filed by the Company
	(other than in connection with a transaction contemplated by Rule 145(a) promulgated under the Securities Act or pursuant to Form
	S-8 or any equivalent form);&nbsp;
<U>
	provided
</U>
	,&nbsp;
<U>
	however
</U>
	, that if, solely in connection with any primary underwritten
	public offering for the account of the Company, the managing underwriter(s) thereof shall, in its reasonable discretion, impose
	a limitation on the number of shares of common stock which may be included in the Registration Statement because, in such underwriter(s)&rsquo;
	judgment, marketing or other factors dictate such limitation is necessary to facilitate public distribution, then the Company shall
	be obligated to include in such Registration Statement only such limited portion of the Registrable Securities with respect to
	which the Holder requested inclusion hereunder as the underwriter shall reasonably permit. Any exclusion of Registrable Securities
	shall be made pro rata among the Holders seeking to include Registrable Securities in proportion to the number of Registrable Securities
	sought to be included by such Holders;&nbsp;
<U>
	provided
</U>
	,&nbsp;
<U>
	however
</U>
	, that the Company shall not exclude any Registrable
	Securities unless the Company has first excluded all outstanding securities, the holders of which are not entitled to inclusion
	of such securities in such Registration Statement or are not entitled to pro rata inclusion with the Registrable Securities.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	4.2.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Terms
</U>
	. The Company shall bear all fees and expenses attendant to registering the Registrable Securities pursuant to Section
	4.2.1 hereof, but the Holders shall pay any and all underwriting commissions and the expenses of any legal counsel selected by
	the Holders to represent them in connection with the sale of the Registrable Securities. In the event of such a proposed registration,
	the Company shall furnish the then Holders of outstanding Registrable Securities with not less than thirty (30) days written notice
	prior to the proposed date of filing of such registration statement. Such notice to the Holders shall continue to be given for
	each registration statement filed by the Company until such time as all of the Registrable Securities have been sold by the Holder.
	The holders of the Registrable Securities shall exercise the &ldquo;piggy-back&rdquo; rights provided for herein by giving written
	notice within ten (10) days of the receipt of the Company&rsquo;s notice of its intention to file a registration statement. Except
	as otherwise provided in this Purchase Warrant, there shall be no limit on the number of times the Holder may request registration
	under this Section 4.2.2;&nbsp;
<U>
	provided
</U>
	,&nbsp;
<U>
	however
</U>
	, that such registration rights shall terminate on the sixth
	anniversary of the Commencement Date.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	4.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	General
	Terms
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	4.3.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Indemnification
</U>
	.
	The Company shall indemnify the Holder(s) of the Registrable Securities to be sold pursuant to any registration statement hereunder
	and each person, if any, who controls such Holders within the meaning of Section 15 of the Securities Act or Section 20 (a) of
	the Securities Exchange Act of 1934, as amended (&ldquo;
<B>
	Exchange Act
</B>
	&rdquo;), against all loss, claim, damage, expense or
	liability (including all reasonable attorneys&rsquo; fees and other expenses reasonably incurred in investigating, preparing or
	defending against any claim whatsoever) to which any of them may become subject under the Securities Act, the Exchange Act or otherwise,
	arising from such registration statement but only to the same extent and with the same effect as the provisions pursuant to which
	the Company has agreed to indemnify the Underwriters contained in Section 5.1 of the Underwriting Agreement. The Holder(s) of the
	Registrable Securities to be sold pursuant to such registration statement, and their successors and assigns, shall severally, and
	not jointly, indemnify the Company, against all loss, claim, damage, expense or liability (including all reasonable attorneys&rsquo;
	fees and other expenses reasonably incurred in investigating, preparing or defending against any claim whatsoever) to which they
	may become subject under the Securities Act, the Exchange Act or otherwise, arising from information furnished by or on behalf
	of such Holders, or their successors or assigns, in writing, for specific inclusion in such registration statement to the same
	extent and with the same effect as the provisions contained in Section 5.2 of the Underwriting Agreement pursuant to which the
	Underwriters have agreed to indemnify the Company.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 4 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	4
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage193"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	4.3.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Exercise of Purchase Warrants
</U>
	. Nothing contained in this Purchase Warrant shall be construed as requiring the Holder(s)
	to exercise their Purchase Warrants prior to or after the initial filing of any registration statement or the effectiveness thereof.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	4.3.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Documents
	Delivered to Holders
</U>
	. The Company shall furnish to each Holder participating in any of the foregoing offerings and to each
	underwriter of any such offering, if any, a signed counterpart, addressed to such Holder or underwriter, of: (i) an opinion of
	counsel to the Company, dated the effective date of such registration statement (and, if such registration statement includes an
	underwritten public offering, an opinion dated the date of the closing under any underwriting agreement related thereto), and (ii)
	a &ldquo;cold comfort&rdquo; letter dated the effective date of such registration statement (and, if such registration includes
	an underwritten public offering, a letter dated the date of the closing under the underwriting agreement) signed by the independent
	registered public accounting firm which has issued a report on the Company&rsquo;s financial statements included in such registration
	statement, in each case covering substantially the same matters with respect to such registration statement (and the prospectus
	included therein) and, in the case of such accountants&rsquo; letter, with respect to events subsequent to the date of such financial
	statements, as are customarily covered in opinions of issuer&rsquo;s counsel and in accountants&rsquo; letters delivered to underwriters
	in underwritten public offerings of securities. The Company shall also deliver promptly to each Holder participating in the offering
	requesting the correspondence and memoranda described below and to the managing underwriter, if any, copies of all correspondence
	between the Commission and the Company, its counsel or auditors and all memoranda relating to discussions with the Commission or
	its staff with respect to the registration statement and permit each Holder and underwriter to do such investigation, upon reasonable
	advance notice, with respect to information contained in or omitted from the registration statement as it deems reasonably necessary
	to comply with applicable securities laws or rules of FINRA. Such investigation shall include access to books, records and properties
	and opportunities to discuss the business of the Company with its officers and independent auditors, all to such reasonable extent
	and at such reasonable times as any such Holder shall reasonably request.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	4.3.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Underwriting
	Agreement
</U>
	. The Company shall enter into an underwriting agreement with the managing underwriter(s), if any, selected by any
	Holders whose Registrable Securities are being registered pursuant to this Section 4, which managing underwriter shall be reasonably
	satisfactory to the Company. Such agreement shall be reasonably satisfactory in form and substance to the Company, each Holder
	and such managing underwriters, and shall contain such representations, warranties and covenants by the Company and such other
	terms as are customarily contained in agreements of that type used by the managing underwriter. The Holders shall be parties to
	any underwriting agreement relating to an underwritten sale of their Registrable Securities and may, at their option, require
	that any or all the representations, warranties and covenants of the Company to or for the benefit of such underwriters shall
	also be made to and for the benefit of such Holders. Such Holders shall not be required to make any representations or warranties
	to or agreements with the Company or the underwriters except as they may relate to such Holders, their securities and their intended
	methods of distribution.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	4.3.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Documents to be Delivered by Holder(s)
</U>
	. Each of the Holder(s) participating in any of the foregoing offerings shall furnish
	to the Company a completed and executed questionnaire provided by the Company requesting information customarily sought of selling
	security holders.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	4.3.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Damages
</U>
	. Should the registration statement or the effectiveness thereof required by Sections 4.1 and 4.2 hereof be delayed
	by the Company or the Company otherwise fails to comply with such provisions, the Holder(s) shall, in addition to any other legal
	or other relief available to the Holder(s), be entitled to obtain specific performance or other equitable (including injunctive)
	relief against the threatened breach of such provisions or the continuation of any such breach, without the necessity of proving
	actual damages and without the necessity of posting bond or other security.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 5 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	5
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage194"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
	5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	New
	Purchase Warrants to be Issued
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	5.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Partial
	Exercise or Transfer
</U>
	. Subject to the restrictions in Section 3 hereof, this Purchase Warrant may be exercised or assigned in
	whole or in part. In the event of the exercise or assignment hereof in part only, upon surrender of this Purchase Warrant for cancellation,
	together with the duly executed exercise or assignment form and funds sufficient to pay any Exercise Price and/or transfer tax
	if exercised pursuant to Section 2.1 hereto, the Company shall cause to be delivered to the Holder without charge a new Purchase
	Warrant of like tenor to this Purchase Warrant in the name of the Holder evidencing the right of the Holder to purchase the number
	of Units (or underlying shares of Common Stock and Warrants) purchasable hereunder as to which this Purchase Warrant has not been
	exercised or assigned.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	5.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Lost
	Certificate
</U>
	. Upon receipt by the Company of evidence satisfactory to it of the loss, theft, destruction or mutilation of this
	Purchase Warrant and of reasonably satisfactory indemnification or the posting of a bond, the Company shall execute and deliver
	a new Purchase Warrant of like tenor and date. Any such new Purchase Warrant executed and delivered as a result of such loss, theft,
	mutilation or destruction shall constitute a substitute contractual obligation on the part of the Company.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
	6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Adjustments
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	6.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Adjustments
	to Exercise Price and Number of Securities
</U>
	. The Exercise Price and the number of shares of Common Stock, Warrants underlying
	the Purchase Warrants and shares of Common Stock underlying the Warrants, shall be subject to adjustment from time to time as hereinafter
	set forth:
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	6.1.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Share
	Dividends
</U>
	; Split Ups. If, after the date hereof, and subject to the provisions of Section 6.3 below, the number of outstanding
	shares of Common Stock is increased by a stock dividend payable in shares of Common Stock or by a split up of shares of Common
	Stock or other similar event, then, on the effective day thereof, the number of shares of Common Stock, Warrants underlying the
	Purchase Warrants and shares of Common Stock underlying the Warrants, purchasable hereunder shall be increased in proportion to
	such increase in outstanding shares, and the Exercise Price shall be proportionately decreased.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	6.1.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Aggregation
	of Shares
</U>
	. If, after the date hereof, and subject to the provisions of Section 6.3 below, the number of outstanding shares
	of Common Stock is decreased by a consolidation, combination or reclassification of shares of Common Stock or other similar event,
	then, on the effective date thereof, the number of shares of Common Stock, Warrants underlying the Purchase Warrants and shares
	of Common Stock underlying the Warrants, purchasable hereunder shall be decreased in proportion to such decrease in outstanding
	shares of Common Stock, and the Exercise Price shall be proportionately increased.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	6.1.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Replacement
	of Securities upon Reorganization, etc
</U>
	. In case of any reclassification or reorganization of the outstanding shares of Common
	Stock other than a change covered by Section 6.1.1 or 6.1.2 hereof or that solely affects the par value of such shares of Common
	Stock, or in the case of any share reconstruction or amalgamation or consolidation of the Company with or into another corporation
	(other than a consolidation or share reconstruction or amalgamation in which the Company is the continuing corporation and that
	does not result in any reclassification or reorganization of the outstanding shares of Common Stock), or in the case of any sale
	or conveyance to another corporation or entity of the property of the Company as an entirety or substantially as an entirety in
	connection with which the Company is dissolved, the Holder of this Purchase Warrant shall have the right thereafter (until the
	expiration of the right of exercise of this Purchase Warrant) to receive upon the exercise hereof, for the same aggregate Exercise
	Price payable hereunder immediately prior to such event, the kind and amount of shares of stock or other securities or property
	(including cash) receivable upon such reclassification, reorganization, share reconstruction or amalgamation, or consolidation,
	or upon a dissolution following any such sale or transfer, by a Holder of the number of shares of Common Stock of the Company
	obtainable upon exercise of this Purchase Warrant and the underlying Warrants immediately prior to such event; and if any reclassification
	also results in a change in shares of Common Stock covered by Section 6.1.1 or 6.1.2, then such adjustment shall be made pursuant
	to Sections 6.1.1, 6.1.2 and this Section 6.1.3. The provisions of this Section 6.1.3 shall similarly apply to successive reclassifications,
	reorganizations, share reconstructions or amalgamations, or consolidations, sales or other transfers.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 6 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	6
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage195"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 1IN">
	6.1.4 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Changes
	in Form of Purchase Warrant
</U>
	. This form of Purchase Warrant need not be changed because of any change pursuant to this Section
	6.1, and Purchase Warrants issued after such change may state the same Exercise Price and the same number of Units (and underlying
	shares of Common Stock and Warrants) as are stated in the Purchase Warrants initially issued pursuant to the Underwriting Agreement.
	The acceptance by any Holder of the issuance of new Purchase Warrants reflecting a required or permissive change shall not be
	deemed to waive any rights to an adjustment occurring after the Commencement Date or the computation thereof.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	6.2 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Substitute
	Purchase Warrant
</U>
	. In case of any consolidation of the Company with, or share reconstruction or amalgamation of the Company
	with or into, another corporation (other than a consolidation or share reconstruction or amalgamation which does not result in
	any reclassification or change of the outstanding shares of Common Stock), the corporation formed by such consolidation or share
	reconstruction or amalgamation shall execute and deliver to the Holder a supplemental Purchase Warrant providing that the holder
	of each Purchase Warrant then outstanding or to be outstanding shall have the right thereafter (until the stated expiration of
	such Purchase Warrant) to receive, upon exercise of such Purchase Warrant, the kind and amount of shares of stock and other securities
	and property receivable upon such consolidation or share reconstruction or amalgamation, by a holder of the number of shares of
	Common Stock of the Company for which such Purchase Warrant might have been exercised immediately prior to such consolidation,
	share reconstruction or amalgamation, sale or transfer. Such supplemental Purchase Warrant shall provide for adjustments which
	shall be identical to the adjustments provided for in this Section 6. The above provision of this Section shall similarly apply
	to successive consolidations or share reconstructions or amalgamations.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	6.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Elimination
	of Fractional Interests
</U>
	. The Company shall not be required to issue certificates representing fractions of a share of Common
	Stock or a Warrant upon the exercise of the Purchase Warrant, nor shall it be required to issue scrip or pay cash in lieu of any
	fractional interests, it being the intent of the parties that all fractional interests shall be eliminated by rounding any fraction
	up or down, as the case may be, to the nearest whole number of shares of Common Stock or other securities, properties or rights.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
	7. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Reservation and Listing
</U>
	. The Company shall at all times reserve and keep available out of its authorized Common Stock, solely
	for the purpose of issuance upon exercise of the Purchase Warrants and the shares of Common Stock, Warrants underlying the Purchase
	Warrants and shares of Common Stock underlying the Warrants issuable hereunder, such number of shares of Common Stock or other
	securities, properties or rights as shall be issuable upon the exercise thereof. The Company covenants and agrees that, upon exercise
	of the Purchase Warrants and payment of the Exercise Price therefor, in accordance with the terms hereby, all securities issuable
	upon such exercise shall be duly and validly issued, fully paid and non-assessable and not subject to preemptive rights of any
	shareholder. The Company further covenants and agrees that upon exercise of the Warrants underlying the Purchase Warrants and payment
	of the respective Warrant exercise price therefor, all Common Stock and other securities issuable upon such exercise shall be duly
	and validly issued, fully paid and non-assessable and not subject to preemptive rights of any stockholder. As long as the Purchase
	Warrants shall be outstanding, the Company shall use its commercially reasonable efforts to cause all the shares of Common Stock
	and Warrants underlying the Purchase Warrants issuable hereunder and shares of Common Stock underlying the Warrants issuable upon
	exercise of the Warrants to be listed (subject to official notice of issuance) on all securities exchanges (or, if applicable on
	the OTC Bulletin Board or OTC Markets Group, Inc. or any successor trading market) on which the Common Stock issued to the public
	in connection with the Offering may then be listed and/or quoted.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
	8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Certain
	Notice Requirements
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	8.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Holder&rsquo;s
	Right to Receive Notice
</U>
	. Nothing herein shall be construed as conferring upon the Holders the right to vote or consent or to
	receive notice as a shareholder for the election of directors or any other matter, or as having any rights whatsoever as a shareholder
	of the Company. If, however, at any time prior to the expiration of the Purchase Warrants and their exercise, any of the events
	described in Section 8.2 shall occur, then, in one or more of said events, the Company shall give written notice of such event
	at least fifteen days prior to the date fixed as a record date or the date of closing the transfer books for the determination
	of the shareholders entitled to such dividend, distribution, conversion or exchange of securities or subscription rights, or entitled
	to vote on such proposed dissolution, liquidation, winding up or sale. Such notice shall specify such record date or the date of
	the closing of the transfer books, as the case may be. Notwithstanding the foregoing, the Company shall deliver to each Holder
	a copy of each notice given to the other shareholders of the Company at the same time and in the same manner that such notice is
	given to the shareholders.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 7 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	7
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage196"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	8.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Events Requiring Notice
</U>
	. The Company shall be required to give the notice described in this Section 8 upon one or more of
	the following events: (i) if the Company shall take a record of the holders of its shares of Common Stock for the purpose of entitling
	them to receive a dividend or distribution payable otherwise than in cash, or a cash dividend or distribution payable otherwise
	than out of retained earnings, as indicated by the accounting treatment of such dividend or distribution on the books of the Company,
	(ii) the Company shall offer to all the holders of its shares of Common Stock any additional shares of capital stock of the Company
	or securities convertible into or exchangeable for shares of capital stock of the Company, or any option, right or warrant to subscribe
	therefor, or (iii) a dissolution, liquidation or winding up of the Company (other than in connection with a consolidation or share
	reconstruction or amalgamation) or a sale of all or substantially all of its property, assets and business shall be proposed.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	8.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Notice
	of Change in Exercise Price
</U>
	. The Company shall, promptly after an event requiring a change in the Exercise Price pursuant to
	Section 6 hereof, send notice to the Holders of such event and change (&ldquo;
<B>
	Price Notice
</B>
	&rdquo;). The Price Notice shall
	describe the event causing the change and the method of calculating same and shall be certified as being true and accurate by the
	Company&rsquo;s Chief Financial Officer.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	8.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Transmittal
	of Notices
</U>
	. All notices, requests, consents and other communications under this Purchase Warrant shall be in writing and shall
	be deemed to have been duly made when hand delivered, or mailed by express mail or private courier service: (i) if to the registered
	Holder of the Purchase Warrant, to the address of such Holder as shown on the books of the Company, or (ii) if to the Company,
	to the following address or to such other address as the Company may designate by notice to the Holders:
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN; TEXT-ALIGN: JUSTIFY">
	If to the Holder:
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN">
	Northland Securities, Inc.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN">
	750 Fifth Avenue, Suite 2401
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN">
	New York, NY 10017
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN">
	Attention: [_____]
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN">
	Fax No.: [_____]
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN">
	and
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN">
	Neidiger, Tucker, Bruner, Inc.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN">
	9540 South Maroon Circle, Suite 250
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN">
	Englewood, CO 80112
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN">
	Attention: [_____]
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN">
	Fax No.: [_____]
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN">
	with a copy (which shall not constitute notice) to:
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 35.1PT">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 35.1PT">
	Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 35.1PT">
	Attention: Ivan K. Blumenthal, Esq.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 35.1PT">
	Fax No.:&nbsp;(212) 983-3115
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN">
	If to the Company:
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN">
	Sensus Healthcare, Inc.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN">
	851 Broken Sound Pkwy. NW #215
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 35.1PT">
	Boca Raton, Florida 33487
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 35.1PT">
	Attention: Joseph C. Sardano, Chief Executive Officer
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN">
	Fax No.: (561) 948-2739
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 8 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	8
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage197"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN">
	with a copy (which shall not constitute notice) to:
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN">
	Gunster, Yoakley &amp; Stewart, P.A.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN">
	450 E. Las Olas Blvd., Suite 1400
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN">
	Fort Lauderdale, Florida 33301
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN">
	Attention: David C. Scileppi, Esq.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN">
	Fax No.: 954-888-2033
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
	9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Miscellaneous
</U>
	.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	9.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Amendments
</U>
	.
	The Company, Northland and Neidiger may from time to time supplement or amend this Purchase Warrant without the approval of any
	of the Holders in order to cure any ambiguity, to correct or supplement any provision contained herein that may be defective or
	inconsistent with any other provisions herein, or to make any other provisions in regard to matters or questions arising hereunder
	that the Company and Northland and Neidiger may deem necessary or desirable and that the Company, Northland and Neidiger deem shall
	not adversely affect the interest of the Holders. All other modifications or amendments shall require the written consent of and
	be signed by the party against whom enforcement of the modification or amendment is sought.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	9.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Headings
</U>
	.
	The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way limit or affect the
	meaning or interpretation of any of the terms or provisions of this Purchase Warrant.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	9.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Entire
	Agreement
</U>
	. This Purchase Warrant (together with the other agreements and documents being delivered pursuant to or in connection
	with this Purchase Warrant) constitutes the entire agreement of the parties hereto with respect to the subject matter hereof, and
	supersedes all prior agreements and understandings of the parties, oral and written, with respect to the subject matter hereof.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	9.4 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Binding Effect
</U>
	. This Purchase Warrant shall inure solely to the benefit of and shall be binding upon, the Holder and the
	Company and their permitted assignees, respective successors, legal representative and assigns, and no other person shall have
	or be construed to have any legal or equitable right, remedy or claim under or in respect of or by virtue of this Purchase Warrant
	or any provisions herein contained.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	9.5 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Governing Law; Submission to Jurisdiction; Trial by Jury
</U>
	. This Purchase Warrant shall be governed by and construed and enforced
	in accordance with the laws of the State of New York, without giving effect to conflict of laws principles thereof. Each of the
	Company and the Holder hereby agree that any action, proceeding or claim against it arising out of, or relating in any way to this
	Purchase Warrant shall be brought and enforced in the New York Supreme Court, County of New York, or in the United States District
	Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive.
	Each of the Company and the Holder hereby waive any objection to such exclusive jurisdiction and that such courts represent an
	inconvenient forum. Any process or summons to be served upon the Company or the Holder may be served by transmitting a copy thereof
	by registered or certified mail, return receipt requested, postage prepaid, addressed to it at the address set forth in Section
	8 hereof. Such mailing shall be deemed personal service and shall be legal and binding in any action, proceeding or claim. The
	Company and the Holder agree that the prevailing party(ies) in any such action shall be entitled to recover from the other party(ies)
	all of its reasonable attorneys&rsquo; fees and expenses relating to such action or proceeding and/or incurred in connection with
	the preparation therefor. The Company (on its behalf and, to the extent permitted by applicable law, on behalf of its stockholders
	and affiliates) and the Holder hereby irrevocably waive, to the fullest extent permitted by applicable law, any and all right to
	trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	9.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Waiver,
	etc
</U>
	. The failure of the Company or the Holder to at any time enforce any of the provisions of this Purchase Warrant shall not
	be deemed or construed to be a waiver of any such provision, nor to in any way affect the validity of this Purchase Warrant or
	any provision hereof or the right of the Company or any Holder to thereafter enforce each and every provision of this Purchase
	Warrant. No waiver of any breach, non-compliance or non-fulfillment of any of the provisions of this Purchase Warrant shall be
	effective unless set forth in a written instrument executed by the party or parties against whom or which enforcement of such waiver
	is sought; and no waiver of any such breach, non-compliance or non-fulfillment shall be construed or deemed to be a waiver of any
	other or subsequent breach, non-compliance or non-fulfillment.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 9 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	9
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage198"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	9.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Execution
	in Counterparts
</U>
	. This Purchase Warrant may be executed in one or more counterparts, and by the different parties hereto in
	separate counterparts, each of which shall be deemed to be an original, but all of which taken together shall constitute one and
	the same agreement, and shall become effective when one or more counterparts has been signed by each of the parties hereto and
	delivered to each of the other parties hereto. Such counterparts may be delivered by facsimile transmission or other electronic
	transmission.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	9.8 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>
	Exchange Agreement
</U>
	. As a condition of the Holder&rsquo;s receipt and acceptance of this Purchase Warrant, Holder agrees
	that, at any time prior to the complete exercise of this Purchase Warrant by Holder, if the Company, Northland and Neidiger enter
	into an agreement (&ldquo;
<B>
	Exchange Agreement
</B>
	&rdquo;) pursuant to which they agree that all outstanding Purchase Warrants
	will be exchanged for securities or cash or a combination of both, then Holder shall agree to such exchange and become a party
	to the Exchange Agreement.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER">
<B>
	[
<I>
	Signature Page Follows
</I>
	]
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 10 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	10
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage199"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-INDENT: 0.5IN">
	IN WITNESS WHEREOF, the Company has caused
	this Purchase Warrant to be signed by its duly authorized officer as of the ____ day of _______, 2016.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD COLSPAN="2" STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT">
	SENSUS HEALTHCARE, INC.
</FONT>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
	&nbsp;
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 3%; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 47%; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 50%; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT">
	By:
</FONT>
</TD>
<TD STYLE="BORDER-BOTTOM: BLACK 1PT SOLID; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
	&nbsp;
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: JUSTIFY">
	&nbsp;
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT">
	Name:
</FONT>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
	&nbsp;
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: JUSTIFY">
	&nbsp;
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT">
	Title:
</FONT>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
	&nbsp;
</TD>
</TR>
</TABLE>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 11 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	11
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage200"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER">
	[
<I>
	Form to be used to exercise Purchase
	Warrant
</I>
	]
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	Date: __________, 20___
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	The undersigned
	hereby elects irrevocably to exercise the Purchase Warrant for _______ shares (the &ldquo;
<B>
	Shares
</B>
	&rdquo;) of Common Stock,
	par value $0.01 per share (&ldquo;
<B>
	Common Stock
</B>
	&rdquo;), and Warrants to purchase [________] shares of Common Stock (&ldquo;
<B>
	Warrants
</B>
	&rdquo;)
	of Sensus Healthcare, Inc., a Delaware corporation (the &ldquo;
<B>
	Company
</B>
	&rdquo;), and hereby makes payment of $____ (at the
	rate of $7.80 per one share of Common Stock and one Warrant to purchase one share of Common Stock) in payment of the Exercise Price
	pursuant thereto. Please issue the shares of Common Stock and Warrants as to which this Purchase Warrant is exercised in accordance
	with the instructions given below and, if applicable, a new Purchase Warrant representing the number of shares of Common Stock
	and Warrants for which this Purchase Warrant has not been exercised.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN; TEXT-INDENT: 0.5IN">
	or
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	The undersigned
	hereby elects irrevocably to convert its right to purchase _________ shares of Common Stock (&ldquo;Shares&rdquo;) and Warrants
	to purchase _________ shares of Common Stock (&ldquo;Warrants&rdquo;) of the Company under the Purchase Warrant, pursuant to Section
	2.2 of the Purchase Warrant.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	The undersigned
	agrees and acknowledges that the calculation set forth above is subject to confirmation by the Company and any disagreement with
	respect to the calculation shall be resolved by the Company in its sole discretion.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	Please
	issue the Shares and Warrant as to which this Purchase Warrant is exercised in accordance with the instructions given below
	and, if applicable, a new Purchase Warrant representing the number of Units for which this Purchase Warrant has not been
	converted.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 6%; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 10%; TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT">
	Signature
</FONT>
</TD>
<TD STYLE="WIDTH: 44%; BORDER-BOTTOM: BLACK 1PT SOLID; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 40%; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</TD>
</TR>
</TABLE>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 6%; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18%; TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT">
	Signature&nbsp;Guaranteed
</FONT>
</TD>
<TD STYLE="WIDTH: 36%; BORDER-BOTTOM: BLACK 1PT SOLID; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 40%; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</TD>
</TR>
</TABLE>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
	INSTRUCTIONS FOR REGISTRATION OF SECURITIES
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 8%; TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT">
	Name:
</FONT>
</TD>
<TD STYLE="WIDTH: 35%; BORDER-BOTTOM: BLACK 1PT SOLID; TEXT-ALIGN: CENTER">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 57%; TEXT-ALIGN: CENTER">
	&nbsp;
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: JUSTIFY">
	&nbsp;
</TD>
<TD STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-SIZE: 10PT">
	(Print in Block Letters)
</FONT>
</TD>
<TD STYLE="TEXT-ALIGN: CENTER">
	&nbsp;
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: JUSTIFY">
	&nbsp;
</TD>
<TD STYLE="TEXT-ALIGN: CENTER">
	&nbsp;
</TD>
<TD STYLE="TEXT-ALIGN: CENTER">
	&nbsp;
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT">
	Address:
</FONT>
</TD>
<TD STYLE="BORDER-BOTTOM: BLACK 1PT SOLID; TEXT-ALIGN: CENTER">
	&nbsp;
</TD>
<TD STYLE="TEXT-ALIGN: CENTER">
	&nbsp;
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: JUSTIFY">
	&nbsp;
</TD>
<TD STYLE="TEXT-ALIGN: CENTER">
	&nbsp;
</TD>
<TD STYLE="TEXT-ALIGN: CENTER">
	&nbsp;
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: JUSTIFY">
	&nbsp;
</TD>
<TD STYLE="BORDER-BOTTOM: BLACK 1PT SOLID; TEXT-ALIGN: CENTER">
	&nbsp;
</TD>
<TD STYLE="TEXT-ALIGN: CENTER">
	&nbsp;
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: JUSTIFY">
	&nbsp;
</TD>
<TD STYLE="TEXT-ALIGN: CENTER">
	&nbsp;
</TD>
<TD STYLE="TEXT-ALIGN: CENTER">
	&nbsp;
</TD>
</TR>
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="TEXT-ALIGN: JUSTIFY">
	&nbsp;
</TD>
<TD STYLE="BORDER-BOTTOM: BLACK 1PT SOLID; TEXT-ALIGN: CENTER">
	&nbsp;
</TD>
<TD STYLE="TEXT-ALIGN: CENTER">
	&nbsp;
</TD>
</TR>
</TABLE>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 45PT; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	NOTICE: The signature
	to this form must correspond with the name as written upon the face of the Purchase Warrant without alteration or enlargement or
	any change whatsoever, and must be guaranteed by a bank, other than a savings bank, or by a trust company or by a firm having membership
	on a registered national securities exchange.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 12 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	12
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<A NAME="eolPage201"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER">
	[
<I>
	Form to be used to assign Purchase Warrant
</I>
	]
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
	ASSIGNMENT
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
	(To be executed by the registered Holder
	to effect a transfer of the within Purchase Warrant):
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
	FOR VALUE RECEIVED, __________________
	does hereby sell, assign and transfer unto the right to purchase securities of Sensus Healthcare, Inc., a Delaware corporation
	(the &ldquo;
<B>
	Company
</B>
	&rdquo;), evidenced by the Purchase Warrant and does hereby authorize the Company to transfer such right
	on the books of the Company.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
	Dated: __________, 20__
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 10%; TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT">
	Signature
</FONT>
</TD>
<TD STYLE="WIDTH: 39%; BORDER-BOTTOM: BLACK 1PT SOLID; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 51%; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</TD>
</TR>
</TABLE>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; BORDER-COLLAPSE: COLLAPSE">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 17%; TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT">
	Signature&nbsp;Guaranteed
</FONT>
</TD>
<TD STYLE="WIDTH: 32%; BORDER-BOTTOM: BLACK 1PT SOLID; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 51%; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</TD>
</TR>
</TABLE>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	NOTICE: The signature to this form must correspond with the
	name as written upon the face of the within Purchase Warrant without alteration or enlargement or any change whatsoever, and must
	be guaranteed by a bank, other than a savings bank, or by a trust company or by a firm having membership on a registered national
	securities exchange.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	&nbsp;
</P>
<!-- FIELD: PAGE; SEQUENCE: 13; OPTIONS: LAST -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="BORDER-COLLAPSE: COLLAPSE; WIDTH: 100%; FONT-SIZE: 10PT">
<TR STYLE="VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT">
<TD STYLE="WIDTH: 33%">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 34%; TEXT-ALIGN: CENTER">
<!-- FIELD: SEQUENCE; TYPE: ARABIC; NAME: PAGENO -->
	13
<!-- FIELD: /SEQUENCE -->
</TD>
<TD STYLE="WIDTH: 33%; TEXT-ALIGN: RIGHT">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
</P>
</EFX_EXHIBIT_4>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage202"></A>
<A NAME="V440371_EX5-1_HTM"></A>
<EFX_EXHIBIT_5>
<A NAME="FIS_EXHIBIT_5"></A>
<P STYLE="MARGIN: 0">
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: RIGHT">
<B>
	Exhibit 5.1
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER">
<B>
	&nbsp;
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER">
	May 19, 2016
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	Sensus Healthcare, Inc.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	851 Broken Sound Pkwy., NW #215
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	Boca Raton, Florida 33487
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 0.5IN; TEXT-ALIGN: JUSTIFY">
<B>
<I>
	Re:&#9;Sensus Healthcare,
	Inc. &ndash; Registration Statement on Form S-1
</I>
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
	Ladies and Gentlemen:
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	We have acted as counsel
	to Sensus Healthcare, Inc., a Delaware corporation (the &ldquo;
<B>
	Registrant
</B>
	&rdquo;), in connection with the preparation and
	filing with the Securities and Exchange Commission (the &ldquo;
<B>
	Commission
</B>
	&rdquo;) under the Securities Act of 1933, as amended
	(the &ldquo;
<B>
	Securities Act
</B>
	&rdquo;), of a registration statement on Form S-1 originally filed with the Commission on February
	10, 2016, as thereafter amended (as so amended, the &ldquo;
<B>
	Registration Statement
</B>
	&rdquo;), registering the proposed issuance
	and sale by the Registrant of (i) up to $10,937,500 worth of units (the &ldquo;
<B>
	Firm Units
</B>
	&rdquo;) of the Registrant, each
	representing one authorized but unissued share of common stock of the Registrant, par value $0.01 per share (&ldquo;
<B>
	Common Stock
</B>
	&rdquo;),
	and a warrant to purchase one share of Common Stock, (ii) up to an additional $1,640,625 worth of units (the &ldquo;
<B>
	Overallotment
	Units
</B>
	&rdquo;, and together with the Firm Units, the &ldquo;
<B>
	Units
</B>
	&rdquo;), each comprised of one share of Common Stock
	and one warrant to purchase one share of Common Stock, proposed to be issued and sold pursuant to an over-allotment option granted
	by the Registrant to the several underwriters (the &ldquo;
<B>
	Underwriters
</B>
	&rdquo;) named in Schedule I to the underwriting agreement
	to be entered into by and among the Registrant and the Underwriters (the &ldquo;
<B>
	Underwriting Agreement
</B>
	&rdquo;), (iii) warrants
	to acquire up to $941,850 worth of units to be issued to certain of the Underwriters pursuant to the Underwriting Agreement (the
	&ldquo;
<B>
	Underwriters&rsquo; Warrants
</B>
	&rdquo;)&nbsp;and (iv) all shares of Common Stock issued as part of the Units, (v) all
	warrants issued as part of the Units and the Underwriters&rsquo; Warrants (collectively, the &ldquo;
<B>
	Warrants
</B>
	&rdquo;), and
	(vi) all shares of Common Stock underlying the Warrants (altogether, the &ldquo;
<B>
	Public
</B>
<B>
	Securities
</B>
	&rdquo;). Following
	the effectiveness of the Registration Statement, it is our understanding that the Registrant intends to sell the Public Securities
	to the Underwriters pursuant to the Underwriting Agreement.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	We do not express any
	opinion herein as to any laws other than the laws of the State of New York and the provisions of the Delaware General Corporation
	Law (the &ldquo;
<B>
	DGCL
</B>
	&rdquo;) that are applicable to our opinion set forth below. Except as described above, we have neither
	examined nor do we express any opinion with respect to Delaware law. Without limiting the foregoing, we express no opinion on Delaware
	contracts law or on general principles of equity, considerations of public policy, judicial discretion or other considerations
	which may affect the application of the DGCL to specific facts.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER">
<B>
	&nbsp;
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER">
</P>
<!-- FIELD: PAGE; SEQUENCE: 1 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<A NAME="eolPage203"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER">
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	Sensus Healthcare, Inc.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	May 19, 2016
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	Page 2 of 4
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER">
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER">
<B>
	&nbsp;
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER">
<B>
<U>
	Documents Reviewed
</U>
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	In rendering the following
	opinion, as to various questions of fact material to our opinion, we have (except to the extent otherwise expressly stated herein)
	relied on the examination of originals or copies, certified or otherwise identified to our satisfaction of the following documents
	(collectively, the &ldquo;
<B>
	Documents
</B>
	&rdquo;), examination of such other documents, instruments and certificates we have deemed
	relevant or necessary to form the basis for the opinions set forth in this opinion letter, and upon the accuracy of the statements,
	representations and warranties made in the following documents, and we have made no independent investigation or inquiry with respect
	to such factual matters:
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN-TOP: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 0.75IN">
</TD>
<TD STYLE="WIDTH: 0.25IN">
	A.
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
	The Registration Statement;
</TD>
</TR>
</TABLE>
<P STYLE="MARGIN-TOP: 0PT; MARGIN-BOTTOM: 0PT; FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN-TOP: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 0.75IN">
</TD>
<TD STYLE="WIDTH: 0.25IN">
	B.
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
	An Officer&rsquo;s Certificate furnished to us by Joseph C. Sardano, President and Chief Executive
	Officer of the Registrant, dated as of the date of this opinion letter;
</TD>
</TR>
</TABLE>
<P STYLE="MARGIN-TOP: 0PT; MARGIN-BOTTOM: 0PT; FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN-TOP: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 0.75IN">
</TD>
<TD STYLE="WIDTH: 0.25IN">
	C.
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
	A copy of the Registrant&rsquo;s Amended and Restated Certificate of Incorporation, as amended
	to date, as filed with the Commission as Exhibit&nbsp;3.1 to the Registration Statement on Form S-1 (filed 2/10/16) (No. 333-209451);
</TD>
</TR>
</TABLE>
<P STYLE="MARGIN-TOP: 0PT; MARGIN-BOTTOM: 0PT; FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN-TOP: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 0.75IN">
</TD>
<TD STYLE="WIDTH: 0.25IN">
	D.
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
	A copy of the Registrant&rsquo;s Bylaws, as amended to date, as filed with the Commission as Exhibit&nbsp;3.2
	to Amendment No. 1 to Registration Statement on Form S-1 (filed 3/10/16) (No. 333-209451);
</TD>
</TR>
</TABLE>
<P STYLE="MARGIN-TOP: 0PT; MARGIN-BOTTOM: 0PT; FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN-TOP: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 0.75IN">
</TD>
<TD STYLE="WIDTH: 0.25IN">
	E.
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
	The form of Underwriting Agreement filed with the Commission as Exhibit 1.1 to Amendment No. 4
	to the Registration statement on Form S-1 (filed 5/19/2016)(No. 333-209451);
</TD>
</TR>
</TABLE>
<P STYLE="MARGIN-TOP: 0PT; MARGIN-BOTTOM: 0PT; FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN-TOP: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 0.75IN">
</TD>
<TD STYLE="WIDTH: 0.25IN">
	F.
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
	A form of Common Stock certificate;
</TD>
</TR>
</TABLE>
<P STYLE="MARGIN-TOP: 0PT; MARGIN-BOTTOM: 0PT; FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN-TOP: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 0.75IN">
</TD>
<TD STYLE="WIDTH: 0.25IN">
	G.
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
	A copy of the Warrant Agreement, by and between the Registrant and American Stock Transfer &amp;
	Trust Company, LLC, as warrant agent, including the form of Warrant (the &ldquo;
<B>
	Warrant Agreement
</B>
	&rdquo;), as filed with
	the Commission as Exhibit 4.4 to Amendment No. 3 to the Registration statement on Form S-1 (filed 5/13/2016)(No. 333-209451);
</TD>
</TR>
</TABLE>
<P STYLE="MARGIN-TOP: 0PT; MARGIN-BOTTOM: 0PT; FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN-TOP: 0PT; MARGIN-BOTTOM: 0PT">
<TR STYLE="VERTICAL-ALIGN: TOP">
<TD STYLE="WIDTH: 0.75IN">
</TD>
<TD STYLE="WIDTH: 0.25IN">
	H.
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
	A form of the Underwriters&rsquo; Warrant Agreement, to be entered into by and between the Registrant
	and Certain of the Underwriters pursuant to the Underwriting Agreement (the &ldquo;
<B>
	Underwriters&rsquo; Warrant Agreement
</B>
	&rdquo;)
	filed with the Commission as Exhibit 1.1 to Amendment No. 4 to the Registration statement on Form S-1 (filed 5/19/2016)(No. 333-209451).
</TD>
</TR>
</TABLE>
<P STYLE="MARGIN-TOP: 0PT; MARGIN-BOTTOM: 0PT; FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	We have made no investigation
	or review of any matters relating to the Registrant or any other person other than as expressly stated herein. Without limiting
	the foregoing and with your consent, (i)&nbsp;we have made no examination or investigation to verify the accuracy or completeness
	of any financial, accounting, statistical or other similar information set forth in the Registration Statement or in any of the
	other Documents, or with respect to any other accounting or financial matter and accounts, and express no opinion with respect
	thereto; and (ii) we have not conducted a search or investigation of the records, files or indices of any court or governmental
	authority for litigation, action, suits, proceedings, orders, judgments, decrees, filings, arbitrations, or otherwise.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
</P>
<!-- FIELD: PAGE; SEQUENCE: 2 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<A NAME="eolPage204"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	Sensus Healthcare, Inc.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	May 19, 2016
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	Page 3 of 4
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER">
<B>
<U>
	Opinions
</U>
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	Based upon and subject
	to the foregoing, and subject to the limitations, qualifications and assumptions set forth in this opinion letter, as of the date
	hereof, when (i)&nbsp;the Registration Statement, as finally amended, has become effective under the Securities Act; (ii)&nbsp;
	when the price at which the Public Securities are to be sold has been approved by or on behalf of the Board of Directors of the
	Registrant; and (iii)&nbsp;the Public Securities have been issued, delivered and paid for in accordance with the terms and conditions
	set forth in the Underwriting Agreement, as described in the Registration Statement, it is our opinion that:
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	1.&#9;The Units have
	been duly authorized by the Registrant and when issued, delivered and paid for in accordance with the terms of the Underwriting
	Agreement, will represent the valid and binding obligations of the Registrant, enforceable against the Registrant in accordance
	with their terms (subject to the effect of bankruptcy, insolvency, fraudulent conveyance, reorganization, receivership, moratorium,
	and other laws affecting the rights and remedies of creditors or secured parties generally and to the exercise of judicial discretion
	in accordance with the general principles of equity, whether applied by a court of law or equity).
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	2.&#9;The shares of
	Common Stock issued as part of, or underlying any of, the Public Securities have been duly authorized by the Registrant and, when
	issued and delivered in accordance with the terms of the Underwriting Agreement and/or the Warrant Agreement, as applicable, will
	be validly issued, fully paid and nonassessable.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	3.&#9;The Warrants
	and the Underwriters&rsquo; Warrants have been duly authorized by the Registrant, and when issued, delivered and paid for in accordance
	with the terms of the Underwriting Agreement, Warrant Agreement and/or the Underwriters&rsquo; Warrant Agreement, will represent
	the valid and binding obligations of the Registrant, enforceable against the Registrant in accordance with their terms (subject
	to the effect of bankruptcy, insolvency, fraudulent conveyance, reorganization, receivership, moratorium, and other laws affecting
	the rights and remedies of creditors or secured parties generally and to the exercise of judicial discretion in accordance with
	the general principles of equity, whether applied by a court of law or equity).
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	Nothing contained in
	this opinion letter shall be deemed to be an opinion other than as set forth in the immediately preceding paragraphs 1, 2 and 3.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER">
<B>
<U>
	Limitations and Qualifications
</U>
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	Our opinion set forth
	in this opinion letter is based upon the facts in existence and the laws, statutes, rules, regulations and judicial decisions (collectively,
	&ldquo;
<B>
	Laws
</B>
	&rdquo;) in effect on the date hereof, and we expressly disclaim any obligation to update our opinion herein,
	regardless of whether changes in such facts or Laws come to our attention after the delivery hereof.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
</P>
<!-- FIELD: PAGE; SEQUENCE: 3 -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<A NAME="eolPage205"></A>
<DIV STYLE="PAGE-BREAK-BEFORE: ALWAYS; MARGIN-TOP: 6PT; MARGIN-BOTTOM: 12PT">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	Sensus Healthcare, Inc.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	May 19, 2016
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	Page 4 of 4
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	The opinion set forth
	in this opinion letter is limited to matters expressly set forth herein and no opinion is to be implied or may be inferred beyond
	the matters expressly stated herein. We have assumed no obligation to advise you beyond the opinion specifically expressed herein.
	Except as provided in the next paragraph, this opinion letter may not be disclosed, quoted, filed with a governmental agency or
	otherwise referred to without our written consent.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	We hereby consent to
	the filing of this opinion letter with the Commission as Exhibit&nbsp;5.1 to the Registration Statement in accordance with the
	requirements of Item&nbsp;601(b)(5) of Regulation&nbsp;S-K promulgated under the Securities Act and to the use of our name therein
	and in the Registration Statement under the caption &ldquo;Legal Matters.&rdquo; In giving this consent, we do not hereby admit
	that we are within the category of persons whose consent is required under Section&nbsp;7 of the Securities Act or the rules and
	regulations of the Commission.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0.5IN">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 3IN; TEXT-ALIGN: JUSTIFY">
	Respectfully submitted,
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 3IN; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 3IN; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 3IN; TEXT-ALIGN: JUSTIFY">
	/s/ GUNSTER, YOAKLEY &amp; STEWART,
	P.A.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 3IN; TEXT-ALIGN: JUSTIFY">
	GUNSTER, YOAKLEY &amp; STEWART,
	P.A.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0 0PT 3IN; TEXT-ALIGN: JUSTIFY">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	RBL/JTJ/GLS
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
</P>
<!-- FIELD: PAGE; SEQUENCE: 4; OPTIONS: LAST -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
<FONT STYLE="VERTICAL-ALIGN: BASELINE">
	&nbsp;
</FONT>
</P>
<P STYLE="MARGIN: 0">
</P>
</EFX_EXHIBIT_5>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage206"></A>
<A NAME="V440371_EX23X1_HTM"></A>
<EFX_EXHIBIT_23>
<A NAME="FIS_EXHIBIT_23"></A>
<P STYLE="MARGIN: 0">
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: RIGHT">
<B>
	Exhibit 23.1
</B>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	&nbsp;
</P>
<EFX_EXPERTS_CONSENT>
<A NAME="FIS_EXPERTS_CONSENT"></A>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: CENTER">
<FONT STYLE="TEXT-TRANSFORM: UPPERCASE">
<B>
<U>
	Independent
	Registered Public Accounting Firm&rsquo;s Consent
</U>
</B>
</FONT>
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0; TEXT-ALIGN: JUSTIFY">
	We consent to the inclusion in this Registration
	Statement of Sensus Healthcare, Inc. on Amendment No. 4 to Form S-1 [FILE NO. 333-209451] of our report dated February 9, 2016,
	with respect to our audits of the financial statements as of December 31, 2015 and 2014 and for each of the years in the three-year
	period ended December 31, 2015, which report appears in the Prospectus, which is part of this Registration Statement. We also consent
	to the reference to our Firm under the heading &ldquo;Experts&rdquo; in such Prospectus.
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	/s/ Marcum LLP
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	West Palm Beach, FL
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	May 19, 2016
</P>
</EFX_EXPERTS_CONSENT>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	&nbsp;
</P>
<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0PT 0">
	&nbsp;
</P>
<P STYLE="MARGIN: 0">
</P>
<!-- FIELD: PAGE; SEQUENCE: 1; OPTIONS: LAST -->
<DIV STYLE="MARGIN-TOP: 12PT; MARGIN-BOTTOM: 6PT; BORDER-BOTTOM: BLACK 1PT SOLID">
<P STYLE="MARGIN: 0PT">
	&nbsp;
</P>
</DIV>
<!-- FIELD: /PAGE -->
</EFX_EXHIBIT_23>

<!-- FOOTER LOGO -->
</BODY>
</HTML>
